UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
| | | | | | | | | | | |
| Filed by the Registrant | ☒ | Filed by a party other than the Registrant | ☐ |
Check the appropriate box:
| | | | | |
| ☒ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material Under Rule 14a-12 |
ADT INC.
(Name of Registrant as Specified In Its Charter)
Payment of Filing Fee (Check all boxes that apply):
| | | | | |
| ☐ | No fee required |
| ☐ | Fee paid previously with preliminary materials. |
| ☒ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
PRELIMINARY PROXY SUBJECT TO COMPLETION, DATED [ ], 2026
ADT Inc.
1501 Yamato Road
Boca Raton, Florida 33431
[ ], 2026
Dear Stockholders:
You are cordially invited to attend a special meeting of stockholders of ADT Inc., a Delaware corporation (the “Company”, “we”, “us” and “our”), to be held on [ ], 2027 at [ ], Eastern Time (unless the special meeting is adjourned or postponed). The special meeting will be held exclusively online via live webcast. You will be able to virtually attend and vote at the special meeting by visiting www.virtualshareholdermeeting.com/ADT2027SM and using the 16-digit control number included in the proxy materials. For purposes of attendance at the special meeting, all references in the enclosed proxy statement to “present” shall mean virtually present or represented by proxy at the special meeting.
As previously announced, on October 29, 2026, the Company entered into an Agreement and Plan of Merger (the “merger agreement”) with Abode Parent, LLC, a Delaware limited liability company (“Parent”), and Abode Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), providing for, subject to the satisfaction or waiver (to the extent permitted by law) of specified conditions, the acquisition of the Company by Parent at a price of $10.00 in cash, without interest, per share of common stock of the Company, par value $0.01 per share (the “common stock”), and each share of Class B common stock of the Company, par value $0.01 per share (the “Class B common stock” and, together with the common stock, the “Company common stock”), issued and outstanding immediately prior to the effective time of the merger (other than certain excluded shares and shares held by stockholders who have properly exercised appraisal rights). Subject to the terms and conditions of the merger agreement, Merger Sub will be merged with and into the Company (the “merger”), with the Company surviving the merger as a wholly owned subsidiary of Parent (the “surviving corporation”). If the merger is consummated, you will be entitled to receive an amount in cash equal to $10.00, without interest and subject to any applicable withholding taxes, in exchange for each share of Company common stock you own at the effective time of the merger (unless you have validly exercised and do not withdraw your appraisal rights under Section 262 of the General Corporation Law of the State of Delaware).
The board of directors of the Company (the “Board”) has reviewed, discussed and considered the terms and conditions of the merger agreement, the merger and the other transactions contemplated by the merger agreement. The Board unanimously (i) determined that it is in the best interests of the Company and the stockholders of the Company, and declared it advisable, that the Company enter into the merger agreement and consummate the merger, (ii) approved the merger agreement and the consummation of the merger, (iii) directed that the merger agreement be submitted to the holders of Company common stock for adoption, (iv) recommended that the Company’s stockholders entitled to vote adopt the merger agreement and (v) directed that a special meeting of the holders of shares of Company common stock be called.
At the special meeting, you will be asked to consider and vote on (i) a proposal to adopt the merger agreement (the “merger agreement proposal”), (ii) a proposal to approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the consummation of the merger (the “advisory compensation proposal”) and (iii) a proposal to adjourn the special meeting to another date, time or place, if necessary to solicit additional proxies in favor of the proposal to adopt the merger agreement (the “adjournment proposal”). The Board recommends you vote “FOR” the merger agreement proposal, “FOR” the advisory compensation proposal and “FOR” the adjournment proposal.
The proxy statement accompanying this letter provides you with more specific information concerning the special meeting, the merger agreement, the merger and the other transactions contemplated by the merger agreement. The proxy statement also describes the actions and determinations of the Board in connection with its evaluation of the merger agreement and the merger. We encourage you to carefully read the accompanying proxy statement and the copy of the merger agreement attached as Annex A thereto, as they contain important information about, among other things, the merger and how it affects you.
Your vote is important regardless of the number of shares of Company common stock that you own. We cannot complete the merger unless the merger agreement proposal is approved by the affirmative vote (in person or by proxy) of the holders of a majority of outstanding shares of Company common stock entitled to vote thereon at the special meeting. Whether or not you plan to attend the special meeting, we want to make sure your shares are represented at the meeting. Please follow the voting instructions provided on the enclosed proxy card to submit your vote.
After reading the accompanying proxy statement, please authorize a proxy to vote your shares of Company common stock by completing, dating, signing and returning your proxy card, grant your proxy electronically over the Internet or telephonically as described in the accompanying proxy statement or vote your shares by attending and voting at the special meeting. Instructions regarding the methods of authorizing your proxy are detailed in the section of the accompanying proxy statement titled “The Special Meeting—Voting Procedures”. If you attend the special meeting and vote thereat, your vote will revoke any proxy that you have previously submitted. If you hold Company common stock through an account with a brokerage firm, bank or other nominee, please follow the instructions you receive from them to vote your Company common stock. Your bank, broker or other nominee cannot vote on any of the proposals, including the merger agreement proposal, without your instructions. If you have any questions or need assistance voting, please contact our proxy solicitor:
Sodali & Co
430 Park Avenue 14th Floor
New York, New York 10022
Stockholders may call toll-free: (800) 662-5200
Banks and brokers may call: (203) 658-9400
Email: ADT@info.sodali.com
| | | | | |
| By Order of the Board of Directors | |
| Sincerely, |
| |
| [ ] |
| |
| JAMES D. DEVRIES |
| Chairman of the Board of Directors, President, and Chief Executive Officer |
[ ], 2026
The merger has not been approved or disapproved by the Securities and Exchange Commission or any state securities commission. Neither the Securities and Exchange Commission nor any state securities commission has passed upon the merits or fairness of the merger or upon the adequacy or accuracy of the information contained in this document or the accompanying proxy statement. Any representation to the contrary is a criminal offense.
The accompanying proxy statement is dated [ ], 2026, and, together with the enclosed form of proxy card, is first being mailed to the Company’s stockholders on or about [ ], 2026.
ADT Inc.
1501 Yamato Road
Boca Raton, Florida 33431
[ ], 2026
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON [ ], 2027
Notice is hereby given that a special meeting of stockholders of ADT Inc., a Delaware corporation (the “Company”, “we”, “us” and “our”), will be held on [ ], 2027 at [ ] Eastern Time (unless the special meeting is adjourned or postponed). The special meeting will be held exclusively online via live webcast. The Company’s stockholders will be able to virtually attend and vote at the special meeting by visiting www.virtualshareholdermeeting.com/ADT2027SM and using the 16-digit control number included in the proxy materials. Whether or not you expect to virtually attend the special meeting, please complete, date, sign, and return the proxy card, grant your proxy electronically over the Internet or telephonically as described in the accompanying proxy statement, or vote over the telephone or the Internet as instructed in these materials, as promptly as possible in order to ensure your representation at the special meeting. Even if you have voted by proxy, you may still vote if you virtually attend the special meeting. Please note, however, that if your shares are held of record by a broker, bank, or other nominee and you wish to vote online during the special meeting, you must obtain a 16-digit control number from such organization (typically found on their voting instruction form). For purposes of attendance at the special meeting, all references in the enclosed proxy statement to “present” shall mean virtually present or represented by proxy at the special meeting. The special meeting will be held for the following purposes:
| | | | | | | | |
Items of Business: | | 1.To consider and vote on a proposal to adopt the Agreement and Plan of Merger, dated as of October 29, 2026 (the “merger agreement”), by and among the Company, Abode Parent, LLC, a Delaware limited liability company (“Parent”), and Abode Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company (the “merger”), with the Company surviving the merger as a wholly owned subsidiary of Parent (the “surviving corporation”). We refer to this proposal as the “merger agreement proposal”. 2.To consider and vote on a proposal to approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to our named executive officers in connection with the consummation of the merger, which proposal we refer to as the “advisory compensation proposal”. 3.To consider and vote on a proposal to adjourn the special meeting to another date, time or place, if necessary to solicit additional proxies in favor of the proposal to adopt the merger agreement, which proposal we refer to as the “adjournment proposal”. |
| | |
Record Date: | | Only the Company’s stockholders of record at the close of business on [ ], 2026—the record date for the special meeting—will be entitled to notice of, and to vote at, the special meeting and any postponement or adjournment thereof. |
| | | | | | | | |
| | |
General: | | The merger agreement proposal must be approved by the affirmative vote (in person or by proxy) of the holders of a majority of outstanding shares of Company common stock entitled to vote on the matter. Assuming a quorum is present, if you fail to authorize a proxy to vote your shares of Company common stock or vote at the special meeting, fail to instruct your bank, broker or other nominee on how to vote, or abstain from the merger agreement proposal, it will have the same effect as a vote against the merger agreement proposal. Accordingly, your vote is very important regardless of the number of shares of Company common stock that you own. Whether or not you plan to attend the special meeting, we request that you vote your shares of Company common stock. If you attend the special meeting and you are a Company stockholder of record at the close of business on the record date, you may continue to have your shares of Company common stock voted as instructed in your proxy, or you may withdraw your proxy and vote your shares of Company common stock at the special meeting. If you fail to authorize a proxy to vote your shares of Company common stock or vote at the special meeting, or fail to instruct your broker, bank or other nominee on how to vote, the effect will be that the shares of Company common stock that you own will not be counted for purposes of determining whether a quorum is present at the special meeting and will have the same effect as a vote “AGAINST” the merger agreement proposal. The approval of each of the advisory compensation proposal and the adjournment proposal requires the affirmative vote (in person or by proxy) of the holders of a majority in voting power of the shares of Company common stock present in person or represented by proxy at the special meeting and entitled to vote on such proposal. Assuming a quorum is present, if you fail to authorize a proxy to vote your shares of Company common stock or vote at the special meeting, or fail to instruct your bank, broker or other nominee on how to vote, it will have no effect on the outcome of these proposals. Abstentions will have the same effect as a vote “AGAINST” the advisory compensation proposal and the adjournment proposal. Whether or not a quorum is present, the chairperson of the special meeting may adjourn the special meeting. For Company stockholders of record, any proxy may be revoked at any time prior to its exercise by delivery of a properly executed, later-dated proxy card, by authorizing your proxy or voting instructions electronically over the Internet or telephonically at a later date than your previously authorized proxy, by submitting a written revocation of your proxy to our Corporate Secretary, or by voting at the special meeting. For Company stockholders that hold their shares in “street name”, you will need to revoke or resubmit your proxy in accordance with the instructions provided by your broker, bank or other nominee. Attendance at the special meeting alone will not be sufficient to revoke a previously authorized proxy. For more information concerning the special meeting, the merger agreement, the merger and the other transactions contemplated by the merger agreement, please review the accompanying proxy statement and the copy of the merger agreement attached as Annex A thereto. |
| | |
| | The board of directors of the Company (the “Board”) has reviewed, discussed and considered the terms and conditions of the merger agreement, the merger and the other transactions contemplated by the merger agreement. The Board unanimously (i) determined that it is in the best interests of the Company and the stockholders of the Company, and declared it advisable, that the Company enter into the merger agreement and consummate the merger, (ii) approved the merger agreement and the consummation of the merger, (iii) directed that the merger agreement be submitted to the holders of Company common stock for adoption, (iv) recommended that the Company’s stockholders entitled to vote adopt the merger agreement and (v) directed that a special meeting of the holders of shares of Company common stock be called. |
| | |
| | Accordingly, the Board recommends a vote “FOR” the merger agreement proposal, “FOR” the advisory compensation proposal and “FOR” the adjournment proposal. |
| | | | | | | | |
| | |
| | Whether or not you plan to attend the special meeting, we want to make sure your shares are represented at the meeting. You may cast your vote by authorizing your proxy in advance of the special meeting by internet, telephone or mail. Please sign, date and return, as promptly as possible, the enclosed proxy card in the reply envelope provided or grant your proxy electronically over the Internet or telephonically (in accordance with the instructions detailed in the section of this proxy statement titled “The Special Meeting—Voting Procedures”). If you attend the special meeting and vote thereat, your vote will revoke any proxy that you have previously submitted. If you hold your shares in “street name”, you should instruct your bank, broker or other nominee how to vote your shares in accordance with the voting instruction form that you will receive from your bank, broker or other nominee. Your bank, broker or other nominee cannot vote on any of the proposals, including the merger agreement proposal, without your instructions. If you sign, date and mail your proxy card without indicating how you wish to vote, your proxy will be counted as a vote “FOR” the merger agreement proposal, “FOR” the advisory compensation proposal and “FOR” the adjournment proposal. |
| | | | | |
| By Order of the Board of Directors | |
| Sincerely, |
| |
| [ ] |
| |
| DAVID W. SMAIL |
| Executive Vice President, Chief Legal Officer and Secretary |
| |
| Dated: [ ], 2026 |
TABLE OF CONTENTS
| | | | | |
PROXY STATEMENT | 1 |
SUMMARY | 2 |
The Parties | 2 |
The Special Meeting | 3 |
Record Date and Stockholders Entitled to Vote; Vote Required | 3 |
Voting by Company Directors, Executive Officers and Principal Securityholders | 3 |
The Merger; Certain Effects of the Merger; Consideration To Be Received in the Merger | 4 |
Background of the Merger | 4 |
Recommendation of the Board | 4 |
Opinions of the Company’s Financial Advisors | 5 |
Effects on the Company if the Merger Is Not Consummated | 6 |
Financing of the Merger | 6 |
Limited Guarantee | 7 |
Interests of the Company’s Directors and Executive Officers in the Merger | 8 |
Material U.S. Federal Income Tax Consequences of the Merger | 8 |
Regulatory Approvals in Connection with the Merger | 8 |
Appraisal Rights | 8 |
Go Shop | 9 |
No Solicitation | 10 |
Conditions of the Merger | 10 |
Termination of the Merger Agreement | 11 |
Termination Fees | 13 |
Current Price of Common Stock | 13 |
Additional Information | 14 |
QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER | 15 |
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS | 23 |
THE PARTIES | 24 |
ADT Inc. | 24 |
Abode Parent, LLC | 24 |
Abode Merger Sub, Inc. | 24 |
THE SPECIAL MEETING | 25 |
Date, Time and Place | 25 |
Purpose of the Special Meeting | 25 |
Recommendation of the Board | 25 |
Record Date and Stockholders Entitled to Vote | 25 |
Quorum | 26 |
Vote Required | 26 |
Voting Procedures | 27 |
How Proxies Are Voted | 28 |
Revocation of Proxies | 28 |
Solicitation of Proxies | 28 |
Adjournments | 29 |
Voting by Company Directors, Executive Officers and Principal Securityholders | 29 |
Appraisal Rights | 29 |
| | | | | |
Other Matters | 30 |
Assistance | 30 |
PROPOSAL 1: MERGER AGREEMENT PROPOSAL | 31 |
PROPOSAL 2: ADVISORY COMPENSATION PROPOSAL | 32 |
PROPOSAL 3: ADJOURNMENT PROPOSAL | 33 |
THE MERGER | 34 |
Overview | 34 |
Background of the Merger | 34 |
Recommendation of the Board | 43 |
Reasons for the Merger | 44 |
Certain Financial Forecasts | 51 |
Financial Forecasts | 54 |
Opinions of the Company’s Financial Advisors | 54 |
Certain Effects of the Merger | 66 |
Effects on the Company if the Merger Is Not Consummated | 67 |
Financing of the Merger | 67 |
Limited Guarantee | 70 |
Appraisal Rights | 71 |
Interests of the Company’s Directors and Executive Officers in the Merger | 75 |
Potential Payments to Named Executive Officers | 79 |
Material U.S. Federal Income Tax Consequences of the Merger | 80 |
Regulatory Approvals in Connection with the Merger | 82 |
Delisting and Deregistration of the Common Stock | 83 |
THE MERGER AGREEMENT | 84 |
Explanatory Note Regarding the Merger Agreement | 84 |
Effects of the Merger | 85 |
Closing and Effective Time of the Merger | 85 |
Directors and Officers of the Surviving Corporation | 85 |
Consideration To Be Received in the Merger | 85 |
Excluded Shares | 86 |
Treatment of Company Long-Term Incentive Awards | 86 |
Payment for Stock | 87 |
Transfer Books; No Further Ownership Rights | 87 |
Lost, Stolen or Destroyed Certificates | 87 |
Termination of Exchange Fund | 88 |
No Liability | 88 |
Appraisal Rights | 88 |
Representations and Warranties | 88 |
Covenants Regarding Conduct of Business by the Company Pending the Effective Time | 91 |
Go Shop; No Solicitation; Change in Board Recommendation | 94 |
Reasonable Best Efforts | 99 |
Financing | 101 |
Indemnification and Insurance | 102 |
Employee Benefits Matters | 104 |
Certain Additional Covenants and Agreements | 105 |
| | | | | |
Conditions of the Merger | 105 |
Termination of the Merger Agreement | 105 |
Termination Fees | 107 |
Limitation of Liability | 108 |
Fees and Expenses | 108 |
Withholding Taxes | 109 |
Amendment or Supplement | 109 |
Extension of Time, Waiver, etc. | 109 |
Governing Law; Jurisdiction | 109 |
Specific Enforcement | 110 |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 111 |
MARKET PRICE AND DIVIDEND INFORMATION | 114 |
HOUSEHOLDING | 115 |
STOCKHOLDER PROPOSALS | 116 |
WHERE YOU CAN FIND ADDITIONAL INFORMATION | 117 |
| | | | | | | | |
Annex A | Agreement and Plan of Merger, dated as of October 29, 2026, by and among Abode Parent, LLC, Abode Merger Sub, Inc. and ADT Inc. | A-1 |
Annex B | Opinion of Citigroup Global Markets Inc., dated October 28, 2026 | B-1 |
Annex C | Opinion of Goldman Sachs & Co. LLC, dated October 29, 2026 | C-1 |
ADT INC.
1501 Yamato Road
Boca Raton, Florida 33431
SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON [ ], 2027
PROXY STATEMENT
This proxy statement contains information relating to a special meeting of stockholders of ADT Inc., a Delaware corporation (the “Company”, “we”, “us” or “our”). All references to “Parent” refer to Abode Parent, LLC, a Delaware limited liability company and an affiliate of FLB Partners T, L.P., a Delaware limited partnership (“Thrive Holdings”); and all references to “Merger Sub” refer to Abode Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent. In addition, throughout this proxy statement we refer to the Agreement and Plan of Merger, dated as of October 29, 2026, by and among Parent, Merger Sub and the Company as the “merger agreement”.
The special meeting will be held on [ ], 2027 at [ ], Eastern Time (unless the special meeting is postponed or adjourned), in a virtual-only meeting format. The Company’s stockholders will be able to virtually attend and vote at the special meeting by visiting www.virtualshareholdermeeting.com/ADT2027SM and using the 16-digit control number included in the proxy materials. We are furnishing this proxy statement to holders (“Company stockholders”) of common stock (the “common stock”) and Class B common stock (the “Class B common stock” and, together with the common stock, the “Company common stock”), in each case par value $0.01 per share as part of the solicitation of proxies by the board of directors of the Company (the “Board”), for exercise at the special meeting and at any postponements or adjournments thereof. This proxy statement is dated [ ], 2026 and is first being mailed to Company stockholders on or about [ ], 2026.
SUMMARY
This summary highlights selected information in this proxy statement and may not contain all of the information about the merger agreement, the merger or the other transactions contemplated by the merger agreement that is important to you. We have included page references in parentheses to direct you to more complete descriptions of the topics presented in this summary. You should carefully read this proxy statement in its entirety, including the annexes hereto and the other documents to which we have referred you, for a more complete understanding of the matters being considered at the special meeting, including, without limitation, the merger agreement attached as Annex A to this proxy statement. You may obtain, without charge, copies of documents incorporated by reference into this proxy statement by following the instructions under the section of this proxy statement titled “Where You Can Find Additional Information” beginning on page 117.
The Parties
(page 24)
ADT Inc.
The Company is a leading provider of security, interactive, and smart home solutions serving residential and small business customers in the United States whose mission is to empower people to protect and connect what matters most through innovative offerings, unrivaled safety and a premium experience because it believes that everyone deserves to feel safe. The Company is strategically evolving toward a platform-centric model focused on integrated home intelligence and its efforts are centered on its proprietary ADT+ application, which is designed to serve as a foundational ecosystem for both professionally installed and self-installed solutions, integrating human expertise with ambient sensing capabilities. The Company primarily conducts business under the ADT brand, which it believes is a key competitive advantage and a contributor to its success due to the importance customers place on reputation and trust when purchasing home security products and services. The strength of the Company’s brand, which first became associated with home security services in 1874, is based upon a long-standing record of delivering high-quality, reliable products and services; expertise in system sales, installation, and monitoring; and superior customer care, all driven by the Company’s industry-leading experience and knowledge. As of September 30, 2026, the Company had approximately six million security monitoring service subscribers. The Company serves its customers through its nationwide sales and service offices, monitoring and support centers, and large network of installation and service professionals.
The Company’s principal executive offices are located at 1501 Yamato Road, Boca Raton, Florida 33431, and its telephone number is (561) 988-3600. Shares of common stock are listed on the New York Stock Exchange (the “NYSE”) under the trading symbol “ADT”. Shares of Class B common stock are not listed for trading on any securities exchange.
Abode Parent, LLC
Parent is a Delaware limited liability company that was formed by Thrive Holdings solely for the purpose of entering into the merger agreement and related agreements and consummating the transactions contemplated thereby. Parent has not conducted any business operations other than in connection with its formation and the transactions and the related agreements. Upon the consummation of the transactions contemplated by the merger agreement and the related agreements, the Company will be a wholly owned subsidiary of Parent.
The principal executive offices of Parent are located at 295 Lafayette Street, 7th Floor, New York, New York 10012, and its telephone number is (646) 680-0240.
Abode Merger Sub, Inc.
Merger Sub is a Delaware corporation and a wholly owned subsidiary of Parent that was formed solely for the purpose of entering into the merger agreement and related agreements and consummating the transactions contemplated thereby. Merger Sub has not conducted any business operations other than in connection with its formation and the transactions contemplated by the merger agreement and related agreements. Upon the
consummation of the transactions contemplated by the merger agreement and related agreements, Merger Sub will cease to exist.
The principal executive offices of Merger Sub are located at 295 Lafayette Street, 7th Floor, New York, New York 10012, and its telephone number is (646) 680-0240.
The Special Meeting
(page 25)
The special meeting of Company stockholders will be held on [ ], 2027 at [ ], Eastern Time. The special meeting will be held exclusively online via live webcast. The Company’s stockholders will be able to virtually attend and vote at the special meeting by visiting www.virtualshareholdermeeting.com/ADT2027SM and using the 16-digit control number included in the proxy materials. Please see the section of this proxy statement titled “The Special Meeting” for additional information on the special meeting, including how to vote your shares of Company common stock.
Record Date and Stockholders Entitled to Vote; Vote Required
(page 25 and page 26)
Only the Company’s stockholders of record at the close of business on [ ], 2026, the record date for the special meeting, will be entitled to notice of, and to vote at, the special meeting and any postponement or adjournment thereof. As of the close of business on the record date, there were [ ] shares of Company common stock outstanding and entitled to vote, consisting of [ ] shares of common stock and [54,744,525] shares of Class B common stock. Each Company stockholder is entitled to one vote per share of Company common stock held by such Company stockholder as of the close of business on the record date on each of the proposals presented in this proxy statement. Holders of common stock and of Class B common stock will vote together as a single class on each of the proposals.
The approval of the proposal for the Company’s stockholders to adopt the merger agreement (the “merger agreement proposal”) requires the affirmative vote (in person or by proxy) of the holders of a majority of outstanding shares of Company common stock, voting together as a single class, entitled to vote on the matter (the “Company stockholder approval”). Under Delaware law and the merger agreement, the receipt of such required vote is a condition to the consummation of the merger. The approval of the proposal to approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to our named executive officers in connection with the consummation of the merger (the “advisory compensation proposal”) requires the affirmative vote of the holders of a majority in voting power of the shares present in person or represented by proxy at the special meeting and entitled to vote on such proposal. The approval of the proposal to adjourn the special meeting to another date, time or place, if necessary to solicit additional proxies in favor of the proposal to adopt the merger agreement (the “adjournment proposal”) requires the affirmative vote of the holders of a majority in voting power of the shares present in person or represented by proxy at the special meeting and entitled to vote on such proposal (whether or not a quorum is present). Approval of the advisory compensation proposal and the adjournment proposal is not a condition to the consummation of the merger. The vote on each of the advisory compensation proposal and the adjournment proposal is a vote separate and apart from the vote to approve the merger agreement proposal. Accordingly, you may vote to approve the merger agreement proposal and vote not to approve the advisory compensation proposal or the adjournment proposal and vice versa.
Voting by Company Directors, Executive Officers and Principal Securityholders
(page 29)
As of November 19, 2026, the Company’s directors and executive officers beneficially owned in the aggregate 30,465,266 shares of Company common stock, or approximately 4.17% of the outstanding shares of Company common stock as of October 27, 2026. Although none of the directors or executive officers is obligated to vote in
favor of the merger agreement proposal, we currently expect that each of these individuals will vote all of his or her shares “FOR” each of the proposals to be presented at the special meeting.
The Merger; Certain Effects of the Merger; Consideration To Be Received in the Merger
(page 34, page 66 and page 85)
On October 29, 2026, the Company entered into the merger agreement with Parent and Merger Sub, providing for, subject to the satisfaction or waiver (to the extent permitted by law) of specified conditions, the acquisition of the Company by Parent at a price of $10.00 in cash, without interest, per share of Company common stock issued and outstanding (the “merger consideration”). Subject to the terms and conditions of the merger agreement, Merger Sub will be merged with and into the Company (the “merger” and, together with the other transactions contemplated by the merger agreement, the “transactions”), with the Company surviving the merger as a wholly owned subsidiary of Parent. A copy of the merger agreement is included as Annex A to this proxy statement.
If the merger is consummated, each share of Company common stock that is issued and outstanding as of immediately prior to the time the merger is consummated (the “effective time”) will be converted automatically into, and will thereafter represent only, the right to receive an amount in cash equal to $10.00 per share, without interest and subject to any applicable withholding taxes, other than shares of Company common stock that are (i) held by the Company as treasury shares immediately prior to the effective time or held by Parent or Merger Sub, which will be canceled and will cease to exist and no consideration will be delivered in exchange therefor (such shares, the “excluded shares”) or (ii) held by Company stockholders who have validly exercised their statutory rights of appraisal under Section 262 (“Section 262”) of the Delaware General Corporation Law (the “DGCL”) (such shares of such Company stockholders, the “appraisal shares”).
If the merger is consummated, Parent will use its reasonable best efforts, with the reasonable cooperation of the Company, to cause the common stock to be delisted from the NYSE and deregistered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as soon as reasonably practicable following the effective time, and, accordingly, the common stock will no longer be publicly traded.
Background of the Merger
(page 34)
A description of the process we undertook that led to the proposed merger, including our discussions with representatives of Thrive Holdings, is included in this proxy statement under “The Merger—Background of the Merger”.
Recommendation of the Board
(page 43)
The Board has reviewed, discussed and considered the terms and conditions of the merger agreement, the merger and the other transactions contemplated by the merger agreement. The Board unanimously (i) determined that it is in the best interests of the Company and the stockholders of the Company, and declared it advisable, that the Company enter into the merger agreement and consummate the merger, (ii) approved the merger agreement and the consummation of the merger, (iii) directed that the merger agreement be submitted to the holders of Company common stock for adoption, (iv) recommended that the Company’s stockholders entitled to vote adopt the merger agreement and (v) directed that a special meeting of the holders of shares of Company common stock be called. Accordingly, the Board recommends a vote “FOR” the merger agreement proposal, “FOR” the advisory compensation proposal and “FOR” the adjournment proposal. For a discussion of the factors that the Board considered in determining to recommend that the Company’s stockholders adopt the merger agreement, please see the section of this proxy statement titled “The Merger—Reasons for the Merger” beginning on page 44.
Prior to the adoption of the merger agreement proposal by the Company stockholders, under certain circumstances, and in compliance with certain obligations contained in the merger agreement, the Board may effect an adverse recommendation change (as defined in the section of this proxy statement titled “The Merger Agreement
—Go Shop; No Solicitation; Change in Board Recommendation”), including by withdrawing or withholding the foregoing recommendation, in response to an intervening event (as defined in the section of this proxy statement titled “The Merger Agreement—Go Shop; No Solicitation; Change in Board Recommendation”) or in response to a takeover proposal (as defined in the section of this proxy statement titled “The Merger Agreement—Go Shop; No Solicitation; Change in Board Recommendation”), if the Board complies with certain procedures in the merger agreement.
Opinions of the Company’s Financial Advisors
Opinion of Citigroup Global Markets Inc.
(page 54)
The Company retained Citigroup Global Markets Inc. (“Citi”) as its financial advisor in connection with the merger. In connection with Citi’s engagement, the Company requested that Citi evaluate the fairness, from a financial point of view, to the holders of shares of Company common stock of the merger consideration pursuant to the merger agreement. On October 28, 2026, at a meeting of the Board held to evaluate the merger and at which the merger agreement was approved, Citi rendered to the Board an oral opinion, confirmed by delivery of a written opinion, dated October 28, 2026, to the effect that, as of that date and based on and subject to various assumptions made, procedures followed, matters considered and limitations and qualifications on the review undertaken by Citi as set forth in its written opinion, the merger consideration to be received by the holders of shares of Company common stock in the merger pursuant to the merger agreement was fair, from a financial point of view, to such holders.
The full text of Citi’s written opinion, dated October 28, 2026, to the Board, which sets forth, among other things, the assumptions made, procedures followed, matters considered and limitations and qualifications on the review undertaken by Citi in rendering its opinion, is attached to this proxy statement as Annex B and is incorporated herein by reference in its entirety. The summary of Citi’s opinion in the section titled “The Merger—Opinions of the Company’s Financial Advisors—Opinion of Citigroup Global Markets Inc.” beginning on page 54 is qualified in its entirety by reference to the full text of Citi’s opinion. Citi’s opinion was rendered to the Board (in its capacity as such) in connection with its evaluation of the merger and was limited to the fairness, from a financial point of view, to the holders of shares of Company common stock of the merger consideration pursuant to the merger agreement. Citi’s opinion did not address any other terms, aspects or implications of the merger. Citi’s opinion is not intended to be and does not constitute a recommendation to any stockholder as to how such stockholder should vote or act on any matters relating to the merger.
For more information, see the section titled “The Merger—Opinions of the Company’s Financial Advisors—Opinion of Citigroup Global Markets Inc.” beginning on page 54.
Opinion of Goldman Sachs & Co. LLC
(page 60)
Goldman Sachs & Co. LLC (“Goldman Sachs”) delivered its opinion to the Board that, as of October 29, 2026 and based upon and subject to the factors and assumptions set forth therein, the $10.00 in cash per share of Company common stock to be paid to the holders (other than Parent and its affiliates) of shares of Company common stock, taken in the aggregate, pursuant to the merger agreement was fair from a financial point of view to such holders of shares of Company common stock, taken in the aggregate.
The full text of the written opinion of Goldman Sachs, dated October 29, 2026, which sets forth assumptions made, procedures followed, matters considered and limitations on the review undertaken in connection with the opinion, is attached as Annex C. Goldman Sachs provided advisory services and its opinion for the information and assistance of the Board in connection with its consideration of the merger. Goldman Sachs’ opinion is not a recommendation as to how any holder of shares of Company common stock should vote with respect to the merger or any other matter. For its services in connection with the merger, the Company agreed to pay Goldman Sachs a
transaction fee that is estimated, based on information available as of the date of this proxy statement, at approximately $69 million, all of which is contingent upon consummation of the merger.
Effects on the Company if the Merger Is Not Consummated
(page 67)
In the event that the Company stockholder approval is not obtained or if the merger is not consummated for any other reason, Company stockholders will not receive any payment for their shares of Company common stock in connection with the merger. Instead, the Company will remain an independent public company, the common stock will continue to be listed and traded on the NYSE, the common stock will continue to be registered under the Exchange Act and Company stockholders will continue to own their shares of Company common stock and will continue to be subject to the same general risks and opportunities as they currently are with respect to ownership of the Company common stock.
Under certain circumstances, if the merger agreement is terminated, the Company may be obligated to pay to Parent a $227,000,000 termination fee (or $114,000,000 if the merger agreement is terminated by the Company to enter into an acquisition agreement with respect to a superior proposal with any person prior to the expiration of the go-shop period or, in certain circumstances, with an excluded party) (the “Company termination fee”). Under certain other specified circumstances, Parent will be required to pay the Company a termination fee of $473,000,000 (the “Parent termination fee”). Please see the section of this proxy statement titled “The Merger Agreement—Termination Fees” beginning on page 107.
Financing of the Merger
(page 67)
The consummation of the merger is not conditioned on Parent’s receipt of any financing. Parent plans to fund the merger consideration with committed equity financing and debt financing, as described below.
FLB Partners T, L.P. (“Thrive Holdings”) has committed to contribute, directly or indirectly, to Parent, as equity capital, an amount of cash in immediately available funds equal to $4,895,000,000 (the “equity commitment”), subject to the terms and conditions set forth in the equity commitment letter provided by Thrive Holdings to Parent, dated as of October 29, 2026 (the “equity commitment letter”), which will be used by Parent, together with the debt financing proceeds and other available funding amounts at the closing of the merger (described below), solely for the purpose of funding, and to the extent necessary to fund, the obligations of Parent pursuant to the merger agreement to pay (i) the aggregate cash payments required thereunder at the closing of the merger, including the aggregate merger consideration (the “closing obligations”) and (ii) all fees and expenses required to be paid at closing by Parent or Merger Sub as set forth in the merger agreement (the “expense obligations” and, together with the closing obligations, the “obligations”).
Additionally, (i) Apollo Capital Management, L.P. on behalf of one or more investment funds, separate accounts and other entities owned (in whole or in part), controlled, managed and/or advised by it or its affiliates (in such capacity, “ACM” and together with Apollo Global Funding, LLC, “Apollo”; Apollo, together with any other person that commits to provide any portion of the backstop credit facilities (as defined below) or the syndicated credit facilities (as defined below), collectively, the “debt financing sources”) has committed to provide Parent, upon the terms and subject to the conditions set forth in the debt commitment letter provided by Apollo and Atlas SP Partners, L.P. (“Atlas”) to Parent, dated October 29, 2026 (the “backstop commitment letter”), debt financing in an aggregate principal amount of $9,727,500,000, consisting of (x) a senior secured term loan facility in an aggregate principal amount of $6,250,000,000 (the “backstop term facility”), (y) a senior secured revolving credit facility in an aggregate principal amount of $700,000,000 (the “backstop revolving credit facility”) and (z) a senior secured delayed draw term loan facility in an aggregate principal amount of $2,777,500,000 (the “delayed draw term facility” and together with the backstop term facility and the backstop revolving credit facility, collectively, the “backstop credit facilities”), (ii) Atlas has committed to provide Parent, upon the terms and conditions set forth in the backstop commitment letter (regardless of whether the backstop commitment letter remains in effect with respect to the backstop credit facilities), a receivables backstop facility in an aggregate principal amount of $550,000,000
(the “receivables backstop facility”), (iii) ACM and the other debt financing sources party thereto from time to time have committed to provide, upon the terms and subject to the conditions set forth in the debt commitment letter provided by Apollo to Parent, dated October 29, 2026 (the “syndicated commitment letter” and, together with the backstop commitment letter, the “debt commitment letters” and the debt commitment letters, together with the preferred equity commitment letter and the equity commitment letter, the “commitment letters”) debt financing in an aggregate principal amount of $9,727,500,000, consisting of (w) a senior secured term loan facility in an aggregate principal amount of $4,350,000,000 (the “syndicated term facility”), (x) a senior secured revolving credit facility in an aggregate principal amount of $700,000,000 (the “syndicated revolving credit facility”), (y) a senior secured bridge facility in an aggregate principal amount of $2,777,500,000 (the “secured bridge facility”) and (z) a senior unsecured bridge facility in an aggregate amount of $1,900,000,000 (the “unsecured bridge facility” and, together with the syndicated term facility, the syndicated revolving credit facility and the secured bridge facility, the “syndicated credit facilities” and the syndicated credit facilities, together with the backstop credit facilities and the receivables backstop facility, the “credit facilities”) and (iv) investment funds or managed accounts affiliated with Apollo (the “preferred equity financing sources”) have committed to purchase from an indirect parent entity of Parent, upon the terms and subject to the conditions set forth in the preferred equity commitment letter, dated October 29, 2026 (the “preferred equity commitment letter”), preferred equity interests (the “preferred equity interests”) with an aggregate initial liquidation preference of up to $1.625 billion. Borrowings under either of the backstop credit facilities or the syndicated credit facilities (but not both), excluding the delayed draw term facility and the secured bridge facility, and the proceeds from the sale of the preferred equity interests may be used to finance the merger, repay all indebtedness for borrowed money outstanding under the Company’s existing term loan credit agreements, be used to redeem, defease or satisfy and discharge all outstanding senior secured notes due 2027, make payments in respect of any restricted stock units and/or performance stock units, stock options and/or other company equity awards or contingent cash awards as contemplated in the merger agreement and for working capital and general corporate purposes. The receivables backstop facility may be used to finance the repayment, refinancing or replacement of the Receivables Facility (as defined in the merger agreement). The proceeds from the delayed draw term facility and the secured bridge facility may be used to finance the consideration in a consent solicitation, tender offer, exchange offer, offer to purchase or change of control offer with respect to one or more series of Company Rollover Notes (as defined in the merger agreement).
Parent has entered into two alternative sets of debt commitments. Under the syndicated commitment letter, ACM has committed to provide a portion of the syndicated credit facilities, and Parent and Apollo expect additional financial institutions to commit to provide the remainder. If, prior to December 31, 2026, the syndicated credit facilities become fully committed, the backstop commitment letter will terminate with respect to the backstop credit facilities, and Parent expects to finance the merger with the syndicated credit facilities. If the syndicated credit facilities do not become fully committed prior to the Backstop Trigger Event (as defined in the merger agreement), the syndicated commitment letter will no longer be in effect and Parent expects to finance the merger with the backstop credit facilities. In either case, the receivables backstop facility will remain available in accordance with the backstop commitment letter.
Limited Guarantee
(page 70)
Subject to the terms and conditions set forth in the limited guarantee provided by Thrive Holdings (in such capacity, the “Guarantor”), the Guarantor has guaranteed certain payment obligations of Parent under the merger agreement, subject to an aggregate maximum cap of $481,000,000 for payment of (i) the Parent termination fee of $473,000,000 (to the extent payable), (ii) certain reimbursement and indemnification obligations of Parent relating to the Company’s cooperation with the financing and treatment of the Company’s outstanding notes, subject to an aggregate cap of $3,000,000, and (iii) reasonable and documented costs and expenses of the Company, together with interest, in connection with the Company’s successful enforcement of Parent’s obligation to pay the Parent termination fee, subject to an aggregate cap of $5,000,000 (collectively, the “guaranteed obligations”).
Interests of the Company’s Directors and Executive Officers in the Merger
(page 75)
The Company’s directors and executive officers have interests in the merger that may be different from, or in addition to, the interests of the Company’s stockholders generally. The Board was aware of and carefully considered these interests, among other matters, in evaluating and negotiating the merger agreement, in approving the merger agreement and in determining to recommend that the Company’s stockholders approve the merger agreement proposal and the advisory compensation proposal. These interests are described in more detail, and certain of them are quantified, in the section of this proxy statement titled “The Merger—Interests of the Company’s Directors and Executive Officers in the Merger” beginning on page 75.
Material U.S. Federal Income Tax Consequences of the Merger
(page 80)
The receipt of cash pursuant to the merger will be a taxable transaction for U.S. federal income tax purposes. Generally, for U.S. federal income tax purposes, if you are a holder of Company common stock who is a U.S. holder (as defined below in the section of this proxy statement titled “The Merger—Material U.S. Federal Income Tax Consequences of the Merger”), you will recognize capital gain or loss equal to the difference between the amount of cash you receive in the merger and your adjusted tax basis in your shares of Company common stock converted into cash in the merger. If you are a holder of Company common stock who is a non-U.S. holder (as defined below in the section of this proxy statement titled “The Merger—Material U.S. Federal Income Tax Consequences of the Merger”) beginning on page 80, the merger will generally not be taxable to you under U.S. federal income tax laws unless you have certain connections to the United States or the Company common stock constitutes a USRPI (as defined below in the section of this proxy statement titled “The Merger—Material U.S. Federal Income Tax Consequences of the Merger”) beginning on page 80 and certain other conditions are met.
You should read the section of this proxy statement titled “The Merger—Material U.S. Federal Income Tax Consequences of the Merger” beginning on page 80 for a more complete discussion of the material U.S. federal income tax consequences of the merger. You should consult your own tax advisor for a full understanding of how the merger will affect your federal, state, local and/or non-U.S. taxes.
Regulatory Approvals in Connection with the Merger
(page 82)
The consummation of the merger is subject to the requirements of and review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the rules and regulations promulgated thereunder (the “HSR Act”) and the rules promulgated by the Federal Trade Commission (“FTC”). As described below in the section titled “—Conditions of the Merger” beginning on page 105, the obligations of the parties to effect the merger are subject to, among other things, the applicable waiting period under the HSR Act having expired or been terminated. Both the Company and Parent filed their respective Notification and Report Forms with the FTC and the Antitrust Division of the Department of Justice (“DOJ”) on November 13, 2026. The waiting period applicable to the consummation of the merger under the HSR Act is scheduled to expire at 11:59 p.m. Eastern Time on December 14, 2026.
The merger agreement includes covenants obligating each of the parties to use reasonable best efforts to cause the closing conditions to be satisfied as promptly as reasonably practicable and to take certain actions to resolve objections under any applicable laws.
Appraisal Rights
(page 71)
If the merger is consummated, holders of record and beneficial owners of Company common stock who do not wish to accept the merger consideration are entitled to seek appraisal of their shares of Company common stock under Section 262 of the DGCL (“Section 262”) and, if all procedures described in Section 262 are strictly complied
with, to receive payment in cash for the fair value of their shares of Company common stock exclusive of any element of value arising from the accomplishment or expectation of the merger, as determined by the Delaware Court of Chancery (the “Delaware Court”), together with interest, if any, to be paid upon the amount determined to be the fair value. The “fair value” of your shares of Company common stock as determined by the Delaware Court may be more or less than, or the same as, the merger consideration that you are otherwise entitled to receive under the merger agreement. These rights are known as “appraisal rights”. This proxy statement serves as a notice of such appraisal rights pursuant to Section 262.
Persons who exercise appraisal rights under Section 262 will not receive the merger consideration they would otherwise be entitled to receive pursuant to the merger agreement. They will instead receive an amount determined to be the “fair value” of their shares of Company common stock following petition to, and an appraisal by, the Delaware Court. Persons considering seeking appraisal should recognize that the fair value of their shares of Company common stock determined under Section 262 could be more than, the same as or less than the merger consideration they would otherwise be entitled to receive pursuant to the merger agreement. Strict compliance with the procedures set forth in Section 262 is required. Failure to comply strictly with all of the procedures set forth in Section 262 may result in the withdrawal, loss or waiver of appraisal rights. Consequently, and in view of the complexity of the provisions of Section 262, persons wishing to exercise appraisal rights are urged to consult their legal and financial advisors before attempting to exercise such rights.
A holder of record or a beneficial owner of shares of Company common stock who (i) continuously holds such shares through the effective time, (ii) has not consented to or otherwise voted in favor of the merger or otherwise withdrawn, lost or waived appraisal rights, (iii) strictly complies with the procedures under Section 262, (iv) does not thereafter withdraw his, her or its demand for appraisal of such shares and (v) in the case of a beneficial owner, a person who (A) reasonably identifies in his, her or its demand the holder of record of the shares for which the demand is made, (B) provides documentary evidence of such beneficial owner’s beneficial ownership and a statement that such documentary evidence is a true and correct copy of what it purports to be and (C) provides an address at which such beneficial owner consents to receive notices given by the Company and to be set forth on the Chancery List (as defined in the section of this proxy statement titled “The Merger—Appraisal Rights”), will be entitled to receive the fair value of his, her or its shares of Company common stock exclusive of any element of value arising from the accomplishment or expectation of the merger, as determined by the Delaware Court, together with interest, if any, to be paid upon the amount determined to be the fair value.
A copy of Section 262 may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. The foregoing summary is not a complete statement of the law relating to appraisal rights and is qualified in its entirety by reference to Section 262 and any amendments thereto after the date of this proxy statement. Any person who desires to exercise his, her or its appraisal rights should review carefully Section 262 and is urged to consult his, her or its legal and financial advisors before electing or attempting to exercise such rights. For more information, please see the section of this proxy statement titled “The Merger—Appraisal Rights”.
Go Shop
(page 94)
The merger agreement provides that, from October 29, 2026 until 11:59 p.m. New York City time, on November 28, 2026 (the “go-shop period”) (which period may be extended, solely with respect to excluded parties (as defined under the section of this proxy statement titled “The Merger Agreement—Go Shop; No Solicitation; Change in Board Recommendation”), by written notice to Parent for up to 10 calendar days), the Company and its subsidiaries and their respective representatives are permitted to, directly or indirectly, initiate, solicit, cause, encourage or facilitate, whether publicly or otherwise, takeover proposals (as defined under the section of this proxy statement titled “The Merger Agreement—Go Shop; No Solicitation; Change in Board Recommendation”) (or inquiries, proposals or offers or other efforts or attempts that may reasonably be expected to lead to a takeover proposal) (including by providing access to non-public information concerning the Company or any of its subsidiaries pursuant to an acceptable confidentiality agreement (as defined under the section of this proxy statement
titled “The Merger Agreement—Go Shop; No Solicitation; Change in Board Recommendation”)), enter into, engage in and maintain discussions or negotiations with any persons or groups of persons with respect to takeover proposals (or inquiries, proposals or offers or other efforts or attempts that may reasonably be expected to lead to a takeover proposal) and otherwise cooperate with or assist or participate in, or facilitate, any such inquiries, proposals, offers, efforts, attempts, discussions or negotiations.
No Solicitation
(page 94)
Following the go-shop period described above under “—Go Shop”, the merger agreement generally restricts the Company’s ability to directly or indirectly (i) initiate, solicit, cause or knowingly encourage or facilitate (including by furnishing non-public information) takeover proposals or inquiries from third parties, (ii) enter into, engage in, continue or otherwise participate in discussions or negotiations with third parties regarding any takeover proposal, (iii) furnish to any other person any non-public information in connection with or for the purpose of encouraging or facilitating a takeover proposal, (iv) enter into any agreement providing for or relating to a takeover proposal, (v) approve, endorse or recommend any takeover proposals or (vi) submit any takeover proposals for approval of the Company stockholders. Under certain circumstances, however, prior to receipt of the Company stockholder approval and in compliance with certain obligations contained in the merger agreement, the Company is permitted to engage in negotiations with, and provide information (pursuant to an acceptable confidentiality agreement) to, third parties that have made a takeover proposal that did not result from a material breach of the Company’s non-solicitation obligations upon the Board’s (or an authorized Board committee’s) determination in good faith, after consultation with financial advisors and outside legal counsel, that such takeover proposal constitutes, or would reasonably be expected to result in, a superior proposal (as defined under the section of this proxy statement titled “The Merger Agreement—Go Shop; No Solicitation; Change in Board Recommendation”) and the failure to take such action would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable law.
Conditions of the Merger
(page 105)
Each party’s obligations to effect the merger are subject to the satisfaction (or waiver, if permissible under applicable law), on or prior to the closing date of the merger (the “closing date”), of certain conditions, including:
•no judgment enacted, promulgated, issued, entered, amended or enforced by any governmental authority of competent jurisdiction or any applicable law in the United States will be in effect enjoining, restraining or otherwise making illegal, preventing or prohibiting the consummation of the merger (the “restraints”);
•the waiting period (and any extension thereof) applicable to the consummation of the merger under the HSR Act will have expired or early termination thereof will have been granted; and
•receipt of the Company stockholder approval.
The obligations of Parent and Merger Sub to effect the merger are subject to the satisfaction (or written waiver by Parent, if permissible under applicable law), on or prior to the closing date, of the following additional conditions (in addition to those described above):
•the accuracy of the representations and warranties of the Company to the extent specified in the merger agreement, subject to certain materiality qualifications;
•the Company having complied with or performed, in all material respects, the obligations required to be complied with or performed by the Company and its subsidiaries at or prior to the effective time under the merger agreement; and
•the absence of any Material Adverse Effect (as defined in the section of this proxy statement titled “The Merger Agreement—Representations and Warranties”) since the date of the merger agreement.
The obligations of the Company to consummate the merger are subject to the satisfaction (or written waiver by the Company, if permissible under applicable law) at or prior to the closing of the following additional conditions:
•the accuracy of the representations and warranties of Parent and Merger Sub to the extent specified in the merger agreement, subject to certain materiality qualifications; and
•Parent and Merger Sub having complied with or performed, in all material respects, the obligations required to be complied with or performed by them at or prior to the effective time under the merger agreement.
The consummation of the merger is not conditioned upon Parent’s receipt of financing. Each party may waive any of the conditions to its obligations to consummate the merger except where waiver is not permitted by law.
Termination of the Merger Agreement
(page 105)
The merger agreement may be terminated and the transactions abandoned at any time prior to the effective time, whether before or after receipt of the Company stockholder approval, by the mutual written consent of the Company and Parent.
Termination by Either the Company or Parent
In addition, the Company, on the one hand, or Parent, on the other hand, may terminate the merger agreement and abandon the transactions at any time prior to the effective time, whether before or after receipt of the Company stockholder approval, if:
•the effective time has not occurred on or prior to July 29, 2027 (the “outside date”); provided that this right to terminate the merger agreement (i) will not be available to any party if the breach by such party of its representations and warranties set forth in the merger agreement or the failure of such party to perform any of its obligations under the merger agreement has been a principal cause of or principally responsible for the failure of the effective time to occur on or prior to such date (it being understood that Parent and Merger Sub are deemed a single party for such purpose) and (ii) is subject to the proviso described in the third bullet in the section titled “—Termination by the Company”;
•any restraint in the U.S. having the effect set forth in the first bullet described above in the section titled “—Conditions of the Merger” is in effect and has become final and nonappealable; provided that the party seeking to terminate the merger agreement pursuant to this right to terminate has used the required efforts to prevent the entry of and to remove such restraint in accordance with its obligations under the merger agreement; or
•the special meeting of Company stockholders (including any adjournments or postponements thereof) has concluded and Company stockholder approval is not obtained.
Termination by Parent
Parent may also terminate the merger agreement and abandon the transactions by written notice to the Company at any time prior to the effective time, whether before or after receipt of the Company stockholder approval, if:
•the Company has breached any of its representations or warranties or failed to perform or comply with any of its covenants or agreements in the merger agreement, which breach or failure to perform or comply (i) would give rise to the failure of any of the conditions set forth under the fourth and fifth bullets described above in the section titled “—Conditions of the Merger” and (ii) which is incapable of being cured or, if capable of being cured by the outside date, has not been cured by the earlier of (x) the outside date and (y) the date that is 45 calendar days following receipt by the Company of written notice from Parent of such breach or failure to perform or comply stating Parent’s intention to terminate the merger agreement pursuant to this right to terminate and the basis for such termination; provided that Parent will not have the
right to terminate the merger agreement pursuant to this right to terminate if Parent or Merger Sub is then in material breach of any of its representations, warranties, covenants or agreements under the merger agreement; or
•(i) the Board or a duly authorized committee thereof will have made an adverse recommendation change or (ii) the Company will have materially breached its non-solicitation obligations under the merger agreement.
Termination by the Company
The Company may also terminate the merger agreement and abandon the transactions by written notice to Parent at any time prior to the effective time, whether before or after receipt of the Company stockholder approval (except as otherwise noted), if:
•either of Parent or Merger Sub has breached any of its representations or warranties or failed to perform or comply with any of its covenants or agreements in the merger agreement, which breach or failure to perform or comply (i) (A) would give rise, individually or in the aggregate, to any effect, change, event or occurrence that would or would reasonably be expected to prevent or materially delay, interfere with, hinder or impair the consummation by Parent or Merger Sub of any of the transactions, or (B) would give rise to the failure of any of the conditions set forth under the seventh and eighth bullet points described above in the section titled “—Conditions of the Merger” and (ii) which is incapable of being cured or, if capable of being cured by the outside date, has not been cured by the earlier of (x) the outside date and (y) the date that is 45 calendar days following receipt by Parent of written notice from the Company identifying such breach or failure to perform or comply and stating the Company’s intention to terminate the merger agreement pursuant to this right to terminate and the basis for such termination; provided that the Company will not have the right to terminate the merger agreement pursuant to this right to terminate if the Company is then in material breach of any of its representations, warranties, covenants or agreements under the merger agreement;
•prior to receipt of Company stockholder approval, if the Company has received a superior proposal and the Board has authorized the Company to enter into a definitive agreement to consummate a superior proposal (after complying with the procedures described in the section of this proxy statement titled “The Merger Agreement—Go Shop; No Solicitation; Change in Board Recommendation”), in order to enter into a Company acquisition agreement with respect to such superior proposal; provided that prior to or concurrently with (and as a condition to) such termination the Company pays or causes to be paid the applicable Company termination fee in the manner provided for in the merger agreement; or
•all of the conditions under the first, second, third, fourth, fifth and sixth bullets described above in the section titled “—Conditions of the Merger” have been satisfied or waived in writing (to the extent such waiver is permitted by applicable law) (other than those conditions that by their nature are to be satisfied at the closing of the merger), the Company has irrevocably confirmed in writing to Parent that all conditions under the seventh and eighth bullets described above in the section titled “—Conditions of the Merger” have been satisfied (other than those conditions that by their nature are to be satisfied at the closing of the merger) or that it has irrevocably waived any such unsatisfied conditions, the merger is required to be consummated, and the Company is ready, willing and able to consummate the merger on the date such notice is delivered and through the end of the next succeeding three business days, and the merger is not consummated by the later of (x) three business days after delivery of such notice to Parent and (y) the date the merger was required to be consummated as described in the section of this proxy statement titled “The Merger Agreement—Closing and Effective Time of the Merger” (provided that no party will be permitted to terminate the merger agreement pursuant to the first bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by Either the Company or Parent” during such three-business-day period).
Termination Fees
(page 107)
The Company will be required to pay to Parent the Company termination fee if:
•the Company or Parent terminates the merger agreement pursuant to the provisions described in the first or third bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by Either the Company or Parent” or pursuant to the provisions described in the section titled “—Termination of the Merger Agreement—Termination by Parent”; provided that (i) at the time of termination neither Parent nor Merger Sub is then in material breach of its representations, warranties, covenants or agreements under the merger agreement such that the Company would be entitled to terminate the merger agreement pursuant to the provision described in the first bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by the Company”, (ii) a bona fide takeover proposal will have been publicly made, publicly proposed or otherwise publicly communicated by a third party after the date of the merger agreement and not publicly withdrawn at least three business days prior to the time the merger agreement is terminated (or, in the case of a termination because the Company stockholder approval was not obtained, the date of the special meeting) and (iii) within 12 months of the date the merger agreement is terminated, the Company enters into a definitive agreement with respect to a takeover proposal and such takeover proposal is subsequently consummated (regardless of whether such consummation occurs within the 12-month period) or consummates a takeover proposal; provided, that for purposes of clauses (ii) and (iii), the references to “20%” in the definition of “takeover proposal” are deemed to be references to “50%”; or
•Parent terminates the merger agreement pursuant to the provision described in the second bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by Parent” or the Company terminates the merger agreement pursuant to the provision described in the second bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by the Company”.
The Company termination fee will be $114,000,000 (rather than $227,000,000) if the merger agreement is terminated by the Company pursuant to the provision described in the second bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by the Company” in connection with entering into a Company acquisition agreement with any person prior to the expiration of the go-shop period (including any extensions thereof in accordance with the terms of the merger agreement) as described below in the section titled “The Merger Agreement—Go Shop; No Solicitation; Change in Board Recommendation”.
Parent will be required to pay to the Company the Parent termination fee of $473,000,000 if (i) the Company terminates the merger agreement pursuant to the provisions described in the first or third bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by the Company” or (ii) if Parent terminates the merger agreement pursuant to the provisions described in the first bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by Either the Company or Parent” and at such time the Company could have terminated the merger agreement pursuant to the provisions described in the first or third bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by the Company”.
Current Price of Common Stock
On [ ], 2026, the latest practicable trading day before the filing of this proxy statement, the reported closing price for shares of common stock on the NYSE was $[ ]. You are encouraged to obtain current market quotations for shares of Company common stock in connection with voting your Company common stock.
Additional Information
(page 117)
You can find more information about the Company in the periodic reports and other information we file with the U.S. Securities and Exchange Commission (the “SEC”). Our SEC filings are available over the Internet at the SEC’s web site at www.sec.gov.
QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER
The following questions and answers are intended to briefly address some commonly asked questions regarding the special meeting, the merger and the merger agreement. These questions and answers may not address all questions that may be important to you. You should read the more detailed information contained elsewhere in this proxy statement, the annexes to this proxy statement and the documents referred to or incorporated by reference in this proxy statement.
Q:Why am I receiving this proxy statement?
A:On October 29, 2026, the Company entered into the merger agreement with Parent and Merger Sub. Pursuant to the terms of the merger agreement, Merger Sub will be merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent.
You are receiving this proxy statement in connection with the solicitation of proxies by the Board in favor of the merger agreement proposal and the other matters to be voted on at the special meeting described below under “—What proposals will be considered at the special meeting?”
Q:As a holder of Company common stock, what will I receive in the merger?
A:If the merger is consummated, you will be entitled to receive $10.00 in cash, without interest and subject to any applicable withholding taxes, for each share of Company common stock that you own immediately prior to the effective time.
The receipt of cash pursuant to the merger will be a taxable transaction for U.S. federal income tax purposes. Please see the section of this proxy statement titled “The Merger—Material U.S. Federal Income Tax Consequences of the Merger” beginning on page 80 for a more detailed description of the United States federal income tax consequences of the merger. You should consult your own tax advisor for a full understanding of how the merger will affect your federal, state, local and/or non-U.S. taxes.
Q:When and where is the special meeting of our stockholders?
A:The special meeting of Company stockholders will be held on [ ], 2027 at [ ], Eastern Time (unless the special meeting is adjourned or postponed). The special meeting will be held exclusively online via live webcast. The Company’s stockholders will be able to virtually attend and vote at the special meeting by visiting www.virtualshareholdermeeting.com/ADT2027SM and using the 16-digit control number included in the proxy materials. We encourage you to access the special meeting before the start time of [ ], Eastern Time. Please allow ample time to log into the special meeting and test your computer systems.
Q:Who is entitled to attend and vote at the special meeting?
A:Only the Company’s stockholders of record at the close of business on [ ], 2026, the record date for the special meeting, will be entitled to notice of, and to vote at, the special meeting and any postponement or adjournment thereof. As of the close of business on the record date, there were [ ] shares of Company common stock outstanding and entitled to vote, consisting of [ ] shares of common stock and [54,744,525] shares of Class B common stock. Each Company stockholder is entitled to one vote per share of Company common stock held by such Company stockholder as of the close of business on the record date on each of the proposals presented in this proxy statement. Holders of common stock and of Class B common stock will vote together as a single class on each of the proposals.
If on [ ], 2026, you were a “record” holder of Company common stock (in other words, if you held Company common stock in your own name in the stock register maintained by our transfer agent, Broadridge Financial Solutions, Inc. (“Broadridge”)), then you are a stockholder of record as of the close of business on the record date, and you may vote online during the special meeting, vote by proxy over the telephone, vote by proxy via the internet, or vote by proxy card by completing, signing, dating and mailing the enclosed proxy card in the envelope provided. Whether or not you plan to virtually attend the special meeting, we recommend that you provide voting instructions promptly by proxy to ensure your vote is
counted. You may still virtually attend the special meeting and vote online during the special meeting even if you have already voted by proxy.
If on [ ], 2026, you were the beneficial owner of Company common stock held in “street name” (in other words, if your Company common stock is held in the name of your bank, broker or other nominee), you should have received a proxy card and voting instructions with these proxy materials from that organization rather than from the Company. In order to vote, complete and mail the proxy card received from your broker, bank or other nominee to ensure that your vote is counted. Alternatively, you may vote by telephone or over the internet as instructed by your broker. Street name holders may vote online at the special meeting only if they obtain a 16-digit control number from their broker (typically found on their voting instruction form). If you hold your shares in street name and want to participate in the special meeting but did not receive a 16-digit control number, you must contact your broker for instructions to access the meeting.
For additional information on how to vote at the special meeting, please see the section of this proxy statement titled “The Special Meeting—Voting Procedures” beginning on page 27.
For a period of 10 days ending on the day before the special meeting, a list of Company stockholders entitled to vote at the special meeting will be available for inspection for any purpose germane to the special meeting, between the hours of 9:00 a.m. and 5:00 p.m. Eastern Time, at the Company’s principal executive offices located at 1501 Yamato Road, Boca Raton, Florida 33431, by contacting the Corporate Secretary of the Company.
Q:How do I virtually attend the special meeting?
A:The special meeting will be a completely virtual meeting of stockholders and will be conducted via live webcast. You are entitled to virtually attend the special meeting only if you were a stockholder of record or were the beneficial owner of Company common stock held in “street name” at the close of business on [ ], 2026. The Company’s stockholders of record will be able to virtually attend and vote at the special meeting by visiting www.virtualshareholdermeeting.com/ADT2027SM and using the 16-digit control number included in the proxy materials. Beneficial owners of Company common stock held in “street name” may attend the special meeting, but may vote online at the special meeting only if they obtain a 16-digit control number from their broker (typically found on their voting instruction form). If you hold your shares in street name and want to participate in the special meeting but did not receive a 16-digit control number, you must contact your broker for instructions to access the meeting.
The meeting webcast will begin promptly at [ ] Eastern Time on [ ], 2027. Online access will begin at [ ] Eastern Time, and we encourage you to access the meeting prior to the start time.
Q:What proposals will be considered at the special meeting?
A:At the special meeting, Company stockholders will be asked to consider and vote on the following proposals:
•the merger agreement proposal;
•the advisory compensation proposal; and
•the adjournment proposal.
Q:What constitutes a quorum for purposes of the special meeting?
A:The holders of a majority in voting power of the outstanding capital stock of the Company entitled to vote at the special meeting, present in person or represented by proxy, constitute a quorum of Company stockholders for the transaction of business at the special meeting. Virtual attendance at the special meeting constitutes presence in person for quorum purposes at the special meeting. Abstentions will be counted as shares present for the purposes of determining the presence of a quorum. Broker non-votes will not be
counted as shares present for purposes of determining the presence of a quorum unless your bank, broker or other nominee has been instructed to vote on at least one of the proposals presented in this proxy statement. Whether or not a quorum is present at the special meeting of the Company stockholders, the chairperson of the special meeting may adjourn the special meeting, without notice, if the time and place of the adjourned meeting, if any, are announced at the special meeting at which the adjournment is taken. If, however, the adjournment is for more than 30 days, or if after the adjournment a new record date is fixed for the adjourned meeting, we will provide a notice of the adjourned meeting to each Company stockholder of record entitled to vote at the adjourned special meeting (provided that the special meeting may not be adjourned without Parent’s written consent (not to be unreasonably withheld, delayed or conditioned), more than 30 days after the date for which the special meeting was originally scheduled). In the event that a quorum is not present at the special meeting, or if there are insufficient votes to adopt the merger agreement at the time of the special meeting, we expect that the special meeting will be postponed or adjourned to solicit additional proxies.
Q:What vote of our stockholders is required to approve each of the proposals?
A:The approval of the merger agreement proposal requires the affirmative vote (in person or by proxy) of the holders of a majority of outstanding shares of Company common stock entitled to vote on the matter. Under Delaware law and the merger agreement, the receipt of such required vote is a condition to the consummation of the merger. Note that you may vote to approve the merger agreement proposal and vote not to approve the advisory compensation proposal or adjournment proposal and vice versa. Abstentions, failures to vote (including a failure to authorize a proxy to vote on a Company stockholder’s behalf) and broker non-votes will have the same effect as a vote “AGAINST” the merger agreement proposal.
The approval of the advisory compensation proposal requires the affirmative vote (in person or by proxy) of holders of a majority in voting power of the shares present in person or by proxy and entitled to vote on such proposal at the special meeting. Assuming a quorum is present, if you fail to authorize a proxy to vote your shares of Company common stock or vote at the special meeting, or fail to instruct your bank, broker or other nominee on how to vote, it will have no effect on the outcome of the advisory compensation proposal. Abstentions will have the same effect as a vote “AGAINST” the advisory compensation proposal.
The approval of the adjournment proposal requires the affirmative vote (in person or by proxy) of holders of a majority in voting power of the shares present in person or by proxy and entitled to vote on such proposal at the special meeting. Assuming a quorum is present, if you fail to authorize a proxy to vote your shares of Company common stock or vote at the special meeting, or fail to instruct your bank, broker or other nominee on how to vote, it will have no effect on the outcome of the adjournment proposal. Abstentions will have the same effect as a vote “AGAINST” the adjournment proposal. The Company does not intend to call a vote on this proposal if the merger agreement proposal is approved at the special meeting.
A broker “non-vote” occurs when a bank, broker or other nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with respect to that item and has not received voting instructions from the beneficial owner, but does have discretionary voting power over other “routine” items and submits votes for those matters. The Company does not expect any broker non-votes at the special meeting because the rules applicable to banks, brokers and other nominees only provide such bank, broker or other nominee with discretionary authority to vote on proposals that are considered “routine”, whereas each of the proposals to be presented at the special meeting is considered “non-routine”. As a result, no bank, broker or other nominee will be permitted to vote your shares of Company common stock at the special meeting without receiving instructions.
Q:How does the Board recommend that I vote?
A:The Board recommends a vote “FOR” the merger agreement proposal, “FOR” the advisory compensation proposal and “FOR” the adjournment proposal.
For a discussion of the factors that the Board considered in determining to recommend the approval of the merger agreement proposal, please see the section of this proxy statement titled “The Merger—Reasons for the Merger” beginning on page 44.
In addition, in considering the recommendation of the Board with respect to the merger agreement proposal, the advisory compensation proposal and the adjournment proposal, you should be aware that some of the Company’s directors and executive officers have interests that may be different from, or in addition to, the interests of the Company’s stockholders generally. Please see the section of this proxy statement titled “The Merger—Interests of the Company’s Directors and Executive Officers in the Merger” beginning on page 75.
Q:How do the Company’s directors and executive officers intend to vote?
A:As of the close of business on November 19, 2026, the Company’s directors and executive officers beneficially owned in the aggregate 30,465,266 shares of Company common stock, or approximately 4.17% of the outstanding shares of Company common stock as of the close of business on October 27, 2026. Although none of the directors or executive officers is obligated to vote to approve the merger agreement proposal, we currently expect that each of these individuals will vote all of his or her shares “FOR” each of the proposals to be presented at the special meeting.
Q:Do any of the Company’s directors or executive officers have any interests in the merger that are different from, or in addition to, my interests as a Company stockholder?
A:Yes. In considering the recommendation of the Board with respect to the merger agreement proposal, the advisory compensation proposal and the adjournment proposal, you should be aware and take into account the fact that certain of the Company’s directors and executive officers have interests in the merger that may be different from, or in addition to, the interests of the Company’s stockholders generally. The Board was aware of and carefully considered these interests, among other matters, in evaluating and negotiating the merger agreement, in approving the merger agreement and in determining to recommend that the Company’s stockholders approve the merger agreement proposal and the advisory compensation proposal. These interests are described in more detail, and certain of them are quantified, in the section of this proxy statement titled “The Merger—Interests of the Company’s Directors and Executive Officers in the Merger” beginning on page 75.
Q:
What happens if I transfer my Company common stock before the special meeting?
A:The record date for the special meeting is earlier than the date of the special meeting. If you own Company common stock as of the close of business on the record date and transfer your shares after the record date but prior to the special meeting, you will retain your right to vote such shares of Company common stock at the special meeting. However, the right to receive the merger consideration will pass to the person to whom you transferred your shares of Company common stock.
Q:How do I vote if I am a Company stockholder of record or hold my shares in “street name”?
A:If you are a Company stockholder of record, you may vote online during the special meeting, vote by proxy over the telephone, vote by proxy via the internet, or vote by proxy card by completing, signing, dating and mailing the enclosed proxy card in the envelope provided. You may still virtually attend the special meeting and vote online during the special meeting even if you have already voted by proxy.
If your shares of Company common stock are held in a stock brokerage account by a bank, broker or other nominee, you are considered the beneficial owner of shares held in “street name”, and you should have received a proxy card and voting instructions with these proxy materials from that organization rather than from the Company. In order to vote, complete and mail the proxy card received from your broker, bank or other nominee to ensure that your vote is counted. Alternatively, you may vote by telephone or over the internet as instructed by your broker. Street name holders may vote online at the special meeting only if they obtain a 16-digit control number from their broker (typically found on their voting instruction form). If you hold your shares in street name and want to participate in the special meeting but did not receive a 16-
digit control number, you must contact your broker for instructions to access the meeting. Without following the voting instructions provided by your broker, your common stock held in “street name” will not be voted, which will have the same effect as a vote “AGAINST” the merger agreement proposal, assuming a quorum is present, and will not have any effect on the advisory compensation proposal and adjournment proposal.
For more detailed instructions on how to vote using one of these methods, please see the section of this proxy statement titled “The Special Meeting—Voting Procedures” beginning on page 27.
Whether or not you plan to attend the special meeting, we urge you to vote now to ensure your vote is counted. You may still attend the special meeting and vote during the live webcast if you have already voted by proxy.
Q:What will happen if I abstain from voting or fail to vote on any of the proposals?
A:The approval of the merger agreement proposal requires the affirmative vote (in person or by proxy) of the holders of a majority of outstanding shares of Company common stock entitled to vote on the matter. If you fail to authorize a proxy to vote your shares or to vote at the special meeting, or fail to instruct your broker, bank or other nominee on how to vote, the effect will be that the shares of Company common stock that you own will not be counted for purposes of determining whether a quorum is present at the special meeting and will have the same effect as a vote “AGAINST” the merger agreement proposal.
The approval of each of the advisory compensation proposal and the adjournment proposal requires the affirmative vote (in person or by proxy) of the holders of a majority in voting power of the shares of Company common stock present in person or by proxy at the special meeting and entitled to vote on such proposal. Assuming a quorum is present, if you fail to authorize a proxy to vote your shares or vote at the special meeting, or fail to instruct your bank, broker or other nominee on how to vote, it will have no effect on the outcome of these proposals. Abstentions will have the same effect as a vote “AGAINST” the advisory compensation proposal and the adjournment proposal.
Q:What is a proxy?
A:A proxy is your legal designation of another person to vote your shares of Company common stock. The written document describing the matters to be considered and voted on at the special meeting is called a “proxy statement”. The document used to designate a proxy to vote your shares of Company common stock is called a “proxy card”. Jeffrey A. Likosar and David W. Smail, each with full power of substitution, have been designated as proxy holders for the special meeting by the Board.
Q:What if I return a proxy card or otherwise vote but do not make specific choices?
A:If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares of Company common stock will be voted in accordance with the recommendation of the Board: “FOR” the merger agreement proposal, “FOR” the advisory compensation proposal and “FOR” the adjournment proposal.
Q:Can I change my vote after I have delivered my proxy?
A:Yes. For the Company stockholders of record, any time after you have submitted a proxy card and before the proxy card is exercised, you may revoke or change your vote in one of three ways:
•you may submit a new proxy card bearing a later date (which automatically revokes the earlier proxy or voting instructions) in accordance with the instructions detailed in the section of this proxy statement titled “The Special Meeting—Voting Procedures”; or
•you may submit a written notice of revocation to the Company’s Corporate Secretary at ADT Inc., 1501 Yamato Road, Boca Raton, Florida 33431; or
•you may attend the special meeting and vote during the live webcast. Attendance at the special meeting will not, in and of itself, constitute revocation of a previously granted proxy.
Please note that if you want to revoke your proxy by sending a new proxy card or a written notice of revocation to the Company, you should ensure that you send your new proxy card or written notice of revocation in sufficient time for it to be received by the Company prior to the special meeting.
If you hold your shares in “street name”, you will need to revoke or resubmit your proxy in accordance with the instructions provided by your broker, bank or other nominee. For more information, please see the section of this proxy statement titled “The Special Meeting—Voting Procedures” beginning on page 27.
Q:What should I do if I receive more than one set of voting materials?
A:You may receive more than one set of voting materials, including multiple copies of this proxy statement or multiple proxy or voting instruction cards. For example, if you hold your Company common stock in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold Company common stock. Please submit each proxy and voting instruction card that you receive to ensure that all of your shares of Company common stock are voted.
Q:If I hold my Company common stock in certificated form, should I send in my stock certificates now?
A:No. If you hold stock certificates representing shares of Company common stock, you should not send in such certificates at this time. If and when the merger is consummated, each holder of Company common stock, who holds share certificates or book-entry shares not held through the Depository Trust Company (“DTC”) and who is entitled to the merger consideration will receive a letter of transmittal and instructions advising such Company stockholder how to surrender its Company common stock in exchange for the merger consideration. You should not return your stock certificates with the enclosed proxy card, and you should not forward your stock certificates to the paying agent without a letter of transmittal. For more information, please see the section of this proxy statement titled “The Merger Agreement—Payment for Stock” beginning on page 87.
Q:Am I entitled to exercise appraisal rights instead of receiving the merger consideration for my Company common stock?
A:Yes. Holders of Company common stock are entitled to appraisal rights under Section 262 of the DGCL so long as they take certain actions and meet certain conditions, including that they do not vote (in person or by proxy) in favor of the merger agreement proposal. For more information regarding appraisal rights, please see the section of this proxy statement titled “The Merger—Appraisal Rights” beginning on page 71. Failure to strictly comply with Section 262 of the DGCL may result in your waiver of, or inability to exercise, appraisal rights.
Q:When is the merger expected to be consummated?
A:We currently expect to consummate the merger during the first quarter of 2027, subject to receipt of the Company stockholder approval, the expiration or termination of the waiting period applicable to the merger under the HSR Act and the satisfaction or waiver of the other conditions to the merger described in the merger agreement.
Q:What effect will the merger have on the Company?
A:If the merger is consummated, Merger Sub will be merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent. If the merger is consummated, Parent will use its reasonable best efforts, with the reasonable cooperation of the Company, to cause common stock to be delisted from the NYSE and deregistered under the Exchange Act as soon as reasonably practicable following the effective time, and, accordingly, the common stock will no longer be publicly traded.
Q:Is the closing of the merger subject to any conditions?
A:Yes. The obligations of each of the Company, Parent and Merger Sub to effect the merger are subject to the satisfaction or waiver, on or prior to the closing date, of certain conditions, including each of the following:
•no judgment enacted, promulgated, issued, entered, amended or enforced by any governmental authority of competent jurisdiction or any applicable law in the United States shall be in effect enjoining, restraining or otherwise making illegal, preventing or prohibiting the consummation of the merger;
•the waiting period (and any extension thereof) applicable to the consummation of the merger under the HSR Act shall have expired or early termination thereof shall have been granted; and
•approval by the Company’s stockholders of the merger agreement proposal.
In addition, each party’s obligation to effect the merger is subject to, among other things, the accuracy of certain representations and warranties of the other party, subject to certain materiality qualifications, and the compliance or performance by such other party in all material respects with its obligations required to be complied with or performed at or prior to the effective time.
For more information, please see the section of this proxy statement titled “The Merger Agreement—Conditions of the Merger” beginning on page 105.
Q:What happens if the merger is not consummated?
A:In the event that the Company stockholder approval is not obtained or if the merger is not consummated for any other reason, Company stockholders will not receive any payment for their shares of Company common stock in connection with the merger. Instead, the Company will remain an independent public company, the common stock will continue to be listed and traded on the NYSE, the common stock will continue to be registered under the Exchange Act and the Company stockholders will continue to own their shares of Company common stock and will continue to be subject to the same general risks and opportunities as they currently are with respect to ownership of the Company common stock.
Under certain circumstances, the Company will be required to pay Parent a termination fee equal to $227,000,000 (or $114,000,000 if the merger agreement is terminated by the Company to enter into an acquisition agreement with respect to a superior proposal with any person prior to the expiration of the go-shop period (including any extension thereof)) and, under certain other circumstances, Parent will be required to pay the Company a termination fee equal to $473,000,000. For more information, please see the section of this proxy statement titled “The Merger Agreement—Termination Fees” beginning on page 107.
Q:Does the Company participate in householding?
A:The SEC has approved rules that permit companies to deliver a single copy of proxy materials (or annual report, as applicable) to multiple stockholders sharing an address unless a company has received contrary instructions from one or more of the stockholders at that address. This means that only one copy of this proxy statement may have been sent to multiple stockholders in your household. This process, which is commonly referred to as “householding”, potentially means extra convenience for Company stockholders and cost savings for companies.
If you would prefer to opt out of or into householding in the future, or would like to receive a separate copy of the proxy materials, please contact our transfer agent, Broadridge (either by calling toll-free at (866) 540-7095, or by writing to Broadridge, Householding Department, 51 Mercedes Way, Edgewood, New York 11717). Upon written or oral request, Broadridge will promptly provide a separate copy of this proxy statement. Our householding process does not include accounts that are maintained at a brokerage firm or bank. Stockholders who hold their shares in street name can request information about householding from their banks, brokers or other nominees.
Q:Where can I find the voting results of the special meeting?
A:The preliminary voting results for the special meeting are expected to be announced at the special meeting. In addition, within four business days following the special meeting, the Company will file the final voting results of the special meeting (or, if the final voting results have not yet been certified, the preliminary results) with the SEC on a Current Report on Form 8-K.
Q:What should I do now?
A:You should read this proxy statement carefully and in its entirety, including the annexes, and return your completed, signed and dated proxy card(s) by mail in the enclosed postage-paid envelope or submit your voting instructions by telephone or over the internet as soon as possible so that your shares will be voted in accordance with your instructions.
Q:Who can help answer my questions?
A:If you need assistance in completing your proxy card or have questions regarding the special meeting, please contact our proxy solicitor:
Sodali & Co
430 Park Avenue 14th Floor
New York, New York 10022
Stockholders may call toll-free: (800) 662-5200
Banks and brokers may call: (203) 658-9400
Email: ADT@info.sodali.com
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This proxy statement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the Company’s expectations, plans, intentions, strategies or prospects, including expected benefits of the merger. Generally, the words “may,” “will,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “projects,” “assumes,” “guides,” “targets,” “forecasts,” “sees,” “seeks,” “should,” “could,” “would,” “predicts,” “potential,” “strategy,” “future,” “opportunity,” “work toward,” “intends,” “guidance,” “confidence,” “positioned,” “design,” “strive,” “continue,” “track,” “look forward to” and similar expressions used in this proxy statement are intended to identify forward-looking statements. All statements other than statements of historical or current fact are, or may be deemed to be, forward-looking statements.
Such statements are based upon the current beliefs, expectations and assumptions of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements.
These risks, uncertainties and changes in circumstances include, but are not limited to: (i) the risk that the merger may not be completed in a timely manner or at all; (ii) the failure to receive, on a timely basis or otherwise, the required approvals of the merger by the Company’s stockholders; (iii) the possibility that any or all of the various conditions to the consummation of the merger may not be satisfied or waived, including the failure to receive any required regulatory approvals from any applicable governmental entities (or any conditions, limitations or restrictions placed on such approvals); (iv) the possibility that competing offers or acquisition proposals for the Company will be made; (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the definitive transaction agreement relating to the merger, including in circumstances which would require the Company to pay a termination fee; (vi) the effect of the announcement or pendency of the merger on the Company’s ability to attract, motivate or retain key executives and employees, its ability to maintain relationships with its customers, suppliers and other business counterparties, or its operating results and business generally; (vii) risks related to the merger diverting management’s attention from the Company’s ongoing business operations; (viii) the risk of stockholder litigation in connection with the merger, including resulting expense or delay; and (ix) (A) any other risks or uncertainties discussed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) and the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026, June 30, 2026, and September 30, 2026 (the “Quarterly Reports”) filed by the Company with the SEC, and, in particular, the risk factors set forth under the headings “Risk Factors” and the risks and uncertainties discussed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Annual Report and the Quarterly Reports and (B) other risk factors identified from time to time in other filings with the SEC. Filings with the SEC are available on the SEC’s website at http://www.sec.gov.
Forward-looking statements speak only as of the date they are made, and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise unless required by law. Readers of this proxy statement are cautioned not to unduly rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this proxy statement.
THE PARTIES
ADT Inc.
The Company is a leading provider of security, interactive, and smart home solutions serving residential and small business customers in the United States whose mission is to empower people to protect and connect what matters most through innovative offerings, unrivaled safety and a premium experience because it believes that everyone deserves to feel safe. The Company is strategically evolving toward a platform-centric model focused on integrated home intelligence and its efforts are centered on its proprietary ADT+ application, which is designed to serve as a foundational ecosystem for both professionally installed and self-installed solutions, integrating human expertise with ambient sensing capabilities. The Company primarily conducts business under the ADT brand, which it believes is a key competitive advantage and a contributor to its success due to the importance customers place on reputation and trust when purchasing home security products and services. The strength of the Company’s brand, which first became associated with home security services in 1874, is based upon a long-standing record of delivering high-quality, reliable products and services; expertise in system sales, installation, and monitoring; and superior customer care, all driven by the Company’s industry-leading experience and knowledge. As of September 30, 2026, the Company had approximately six million security monitoring service subscribers. The Company serves its customers through its nationwide sales and service offices, monitoring and support centers, and large network of installation and service professionals.
The Company’s principal executive offices are located at 1501 Yamato Road, Boca Raton, Florida 33431, and its telephone number is (561) 988-3600. Shares of common stock are listed on the NYSE under the trading symbol “ADT”. Shares of Class B common stock are not listed for trading on any securities exchange.
Abode Parent, LLC
Parent is a Delaware limited liability company that was formed by Thrive Holdings solely for the purpose of entering into the merger agreement and the related agreements and consummating the transactions contemplated thereby. Parent has not conducted any business operations other than in connection with its formation and the transactions and the related agreements. Upon the consummation of the transactions contemplated by the merger agreement and the related agreements, the Company will be a wholly owned subsidiary of Parent.
The principal executive offices of Parent are located at 295 Lafayette Street, 7th Floor, New York, New York 10012, and its telephone number is (646) 680-0240.
Abode Merger Sub, Inc.
Merger Sub is a Delaware corporation and a wholly owned subsidiary of Parent that was formed solely for the purpose of entering into the merger agreement and the related agreements and consummating the transactions contemplated thereby. Merger Sub has not conducted any business operations other than in connection with its formation and the transactions contemplated by the merger agreement and related agreements. Upon the consummation of the transactions contemplated by the merger agreement and related agreements, Merger Sub will cease to exist.
The principal executive offices of Merger Sub are located at 295 Lafayette Street, 7th Floor, New York, New York 10012, and its telephone number is (646) 680-0240.
THE SPECIAL MEETING
We are furnishing this proxy statement to the holders of Company common stock as part of the solicitation of proxies by the Board for exercise at the special meeting and at any postponements or adjournments thereof.
Date, Time and Place
The special meeting of Company stockholders will be held on [ ], 2027 at [ ], Eastern Time (unless the special meeting is adjourned or postponed). The special meeting will be held exclusively online via live webcast. The Company’s stockholders will be able to virtually attend and vote at the special meeting by visiting www.virtualshareholdermeeting.com/ADT2027SM and using the 16-digit control number included in the proxy materials. All stockholders are entitled to attend the special meeting; however, you will only be entitled to vote at the special meeting if you were a stockholder of record at the close of business on [ ], 2026, the record date for the special meeting, or if you were a beneficial owner of Company common stock as of the close of business on the record date.
Purpose of the Special Meeting
The special meeting is being held for the following purposes:
•to consider and vote on the merger agreement proposal;
•to consider and vote on the advisory compensation proposal; and
•to consider and vote on the adjournment proposal.
A copy of the merger agreement is attached as Annex A to this proxy statement, which we incorporate by reference into this proxy statement.
Recommendation of the Board
The Board has carefully reviewed, discussed and considered the terms and conditions of the merger agreement, the merger and the other transactions contemplated by the merger agreement. The Board unanimously (i) determined that it is in the best interests of the Company and the stockholders of the Company, and declared it advisable, that the Company enter into the merger agreement and consummate the merger, (ii) approved the merger agreement and the consummation of the merger, (iii) directed that the merger agreement be submitted to the holders of Company common stock for adoption, (iv) recommended that the Company’s stockholders entitled to vote adopt the merger agreement and (v) directed that a special meeting of the holders of shares of Company common stock be called. Accordingly, the Board recommends a vote “FOR” the merger agreement proposal, “FOR” the advisory compensation proposal and “FOR” the adjournment proposal.
For a discussion of the factors that the Board considered in determining to recommend the approval of the merger agreement proposal, please see the section of this proxy statement titled “The Merger—Reasons for the Merger” beginning on page 44.
Record Date and Stockholders Entitled to Vote
Only the Company’s stockholders of record at the close of business on [ ], 2026, the record date for the special meeting, will be entitled to notice of, and to vote at, the special meeting and any postponement or adjournment thereof. As of the close of business on the record date, there were [ ] shares of Company common stock outstanding and entitled to vote, consisting of [ ] shares of common stock and [54,744,525] shares of Class B common stock. Each Company stockholder is entitled to one vote per share of Company common stock held by such Company stockholder as of the close of business on the record date on each of the proposals presented in this proxy statement, and the holders of the common stock and the Class B common stock will vote together as a single class on each of the proposals.
For a period of 10 days ending on the day before the special meeting, a list of Company stockholders entitled to vote at the special meeting will be available for inspection for any purpose germane to the meeting, between the hours of 9:00 a.m. and 5:00 p.m. Eastern Time, at the Company’s principal executive offices located at 1501 Yamato Road, Boca Raton, Florida 33431, by contacting the Corporate Secretary of the Company.
Quorum
The holders of a majority in voting power of the outstanding capital stock of the Company entitled to vote at the special meeting, present in person or represented by proxy, constitute a quorum for the transaction of business at the special meeting. Virtual attendance at the special meeting constitutes presence in person for quorum purposes at the special meeting. Abstentions will be counted as shares present for the purposes of determining the presence of a quorum. Because each of the proposals to be presented at the special meeting is considered “non-routine,” shares held in “street name” for which the beneficial owner has not provided voting instructions to its bank, broker or other nominee will not be counted as present for purposes of determining the presence of a quorum.
If a quorum is not present at the special meeting, the special meeting may be adjourned as described below under “—Adjournments”.
Vote Required
Approval of the Merger Agreement Proposal
The approval of the merger agreement proposal requires the affirmative vote (in person or by proxy) of the holders of a majority of outstanding shares of Company common stock entitled to vote on the matter. Under Delaware law and the merger agreement, the receipt of such required vote is a condition to the consummation of the merger. Note that you may vote to approve the merger agreement proposal and vote not to approve the advisory compensation proposal or adjournment proposal and vice versa.
Abstentions, failures to vote (including a failure to authorize a proxy to vote on a Company stockholder’s behalf) and broker non-votes will have the same effect as a vote “AGAINST” the merger agreement proposal.
Approval of the Advisory Compensation Proposal
The approval of the advisory compensation proposal requires the affirmative vote of the holders of a majority in voting power of the shares present in person or represented by proxy at the special meeting and entitled to vote on such proposal. Assuming a quorum is present, if you fail to authorize a proxy to vote your shares of Company common stock or vote at the special meeting, or fail to instruct your bank, broker or other nominee on how to vote, it will have no effect on the outcome of the advisory compensation proposal. Abstentions will have the same effect as a vote “AGAINST” the advisory compensation proposal.
The vote on the advisory compensation proposal is a vote separate and apart from the vote to approve the merger agreement proposal. Accordingly, you may vote to approve the merger agreement proposal and vote not to approve the advisory compensation proposal and vice versa. In addition, because the vote on the advisory compensation proposal is advisory only, it will not be binding on the Company, the Board, Parent or the surviving corporation. Therefore, because the Company is contractually obligated to pay the compensation that may be paid or become payable to our named executive officers in connection with the consummation of the merger, if the merger is approved by our stockholders, such compensation will be payable, subject only to the conditions applicable thereto, regardless of the outcome of the vote on the advisory compensation proposal.
Approval of the Adjournment Proposal
The approval of the adjournment proposal requires the affirmative vote of the holders of a majority in voting power of the shares present in person or represented by proxy at the special meeting and entitled to vote on such proposal (whether or not a quorum is present). Assuming a quorum is present, if you fail to authorize a proxy to vote your shares of Company common stock or vote at the special meeting, or fail to instruct your bank, broker or other nominee on how to vote, it will have no effect on the outcome of the adjournment proposal. Abstentions will have
the same effect as a vote “AGAINST” the adjournment proposal. The Company does not intend to call a vote on this proposal if the merger agreement proposal is approved at the special meeting.
The vote on the adjournment proposal is a vote separate and apart from the vote to approve the merger agreement proposal. Accordingly, you may vote to approve the merger agreement proposal and vote not to approve the adjournment proposal and vice versa.
Approval of the advisory compensation proposal and the adjournment proposal is not a condition to the consummation of the merger.
A broker “non-vote” occurs when a bank, broker or other nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with respect to that item and has not received voting instructions from the beneficial owner, but does have discretionary voting power over other “routine” items and submits votes for those matters. The Company does not expect any broker non-votes at the special meeting because the rules applicable to banks, brokers and other nominees only provide such organizations with discretionary authority to vote on proposals that are considered “routine”, whereas each of the proposals to be presented at the special meeting is considered “non-routine”. As a result, no bank, broker or other nominee will be permitted to vote your shares of Company common stock at the special meeting without receiving instructions.
Voting Procedures
Whether or not you plan to attend the special meeting and regardless of the number of shares of Company common stock you own, your careful consideration of, and vote on, the merger agreement is important and we encourage you to vote promptly.
If on [ ], 2026, you were a record holder of Company common stock (in other words, you held Company common stock in your own name in the stock register maintained by our transfer agent, Broadridge) and to ensure that your shares of Company common stock are voted at the special meeting, we recommend that you provide voting instructions promptly by proxy, even if you plan to attend the special meeting, using one of the following three methods.
•Voting by Mail: To vote by mail using a proxy card, please complete, sign, date and mail the enclosed proxy card in the envelope provided. If you return your signed proxy card to us before the special meeting, we will vote your shares as you direct. For your mailed proxy card to be counted, we must receive it before 11:59 p.m. Eastern Time on [ ], 2027, one day before the special meeting.
•Voting by Telephone: To vote by telephone, dial toll-free (800) 690-6903 using a touch-tone phone and follow the recorded instructions. Have your proxy card available when you call. You will be asked to provide the company number and 16-digit control number from the enclosed proxy card. Your telephone vote must be received by 11:59 p.m. Eastern Time on [ ], 2027, one day before the special meeting, to be counted.
•Voting via the Internet: To vote via the internet, go to www.proxyvote.com and follow the on-screen instructions. Your internet vote must be received by 11:59 p.m. Eastern Time on [ ], 2027, one day before the special meeting, to be counted.
You may also vote by attending the special meeting and voting during the live webcast.
If on [ ], 2026, you were the beneficial owner of Company common stock held in “street name” (in other words, if your Company common stock is held in the name of your bank, broker or other nominee), you should have received a proxy card and voting instructions with these proxy materials from that organization rather than from the Company. In order to vote, complete and mail the proxy card received from your broker, bank or other nominee to ensure that your vote is counted. Alternatively, you may vote by telephone or over the internet as instructed by your broker. Street name holders may vote online at the special meeting only if they obtain a 16-digit control number from their broker (typically found on their voting instruction form). If you hold your shares in street name and want
to participate in the special meeting but did not receive a 16-digit control number, you must contact your broker for instructions to access the meeting. Without following the voting instructions provided by your broker, your common stock held in “street name” will not be voted, which will have the same effect as a vote “AGAINST” the merger agreement proposal and will not have any effect on the advisory compensation proposal and adjournment proposal.
For additional questions about the merger, assistance in submitting proxies or voting, or to request additional copies of this proxy statement or the enclosed proxy card, please contact Sodali & Co, which is acting as the Company’s proxy solicitation agent in connection with the merger, toll-free at (800) 662-5200.
How Proxies Are Voted
If you complete and submit your proxy card or voting instructions, the persons named as proxies will follow your instructions. If you are a holder of record and you submit a proxy card or voting instructions but do not direct how to vote on each item, the persons named as proxies therein will vote in favor of the merger agreement proposal, the advisory compensation proposal and the adjournment proposal.
Revocation of Proxies
For Company stockholders of record, any time after you have submitted a proxy card and before the proxy card is exercised, you may revoke or change your vote in one of three ways:
•you may submit a new proxy card bearing a later date (which automatically revokes the earlier proxy or voting instructions) in accordance with the instructions detailed in the section above titled “—Voting Procedures”;
•you may submit a written notice of revocation to the Company’s Corporate Secretary at ADT Inc., 1501 Yamato Road, Boca Raton, Florida 33431; or
•you may attend the special meeting and vote during the live webcast. Attendance at the special meeting will not, in itself, constitute revocation of a previously granted proxy.
Please note that if you want to revoke your proxy by sending a new proxy card or a written notice of revocation to the Company, you should ensure that you send your new proxy card or written notice of revocation in sufficient time for it to be received by the Company prior to the special meeting.
If you hold your shares in “street name”, you will need to revoke or resubmit your proxy in accordance with the instructions provided by your broker, bank or other nominee. If your broker, bank or other nominee allows you to submit a proxy via the internet or by telephone, you may be able to change your vote by submitting a new proxy via the internet or by telephone (or by mail). In order to attend the special meeting and vote during the webcast, which will have the same effect as revoking any previously submitted voting instructions, follow the instructions provided by your broker, bank or other nominee for purposes of attending and participating in the special meeting.
Solicitation of Proxies
The Company will bear the cost of soliciting proxies, including the expense of preparing, printing and distributing this proxy statement. In addition to soliciting proxies by mail, telephone or electronic means, we may request brokers to solicit their customers and will, upon request, reimburse them for the reasonable, out-of-pocket costs of forwarding proxy materials in accordance with customary practice and SEC and the NYSE regulations. We may also use the services of our directors, officers and other employees to solicit proxies, personally or by telephone, without additional compensation. In addition, the Company has retained Sodali & Co, 430 Park Avenue 14th Floor, New York, New York 10022, to solicit proxies at a total cost to the Company of approximately $40,000, plus reimbursement of customary out-of-pocket expenses.
Adjournments
Under the Company’s bylaws, whether or not a quorum is present, the chairperson of the special meeting may adjourn the special meeting from time to time. No notice of the adjourned meeting need be given if the time and place, if any, of the adjourned meeting and the means of remote communication, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at the adjourned meeting are announced at the special meeting at which the adjournment is taken or are otherwise provided in a manner permitted by the DGCL. If, however, the adjournment is for more than 30 days, or if after the adjournment a new record date is fixed for the adjourned meeting, we will provide a notice of the adjourned meeting to each Company stockholder of record entitled to vote at the adjourned meeting. The special meeting may also be adjourned if the adjournment proposal is approved. In the event that a quorum is not present at the special meeting, or if there are insufficient votes to adopt the merger agreement at the time of the special meeting, we expect that the special meeting will be postponed or adjourned to solicit additional proxies (provided that the special meeting may not be adjourned, without Parent’s written consent (not to be unreasonably withheld, delayed or conditioned), more than 30 days after the date for which the special meeting was originally scheduled). At any subsequent reconvening of the special meeting at which a quorum is present, any business may be transacted that might have been transacted at the special meeting.
Voting by Company Directors, Executive Officers and Principal Securityholders
As of November 19, 2026, the Company’s directors and executive officers beneficially owned in the aggregate 30,465,266 shares of Company common stock, or approximately 4.17% of the outstanding shares of Company common stock as of October 27, 2026. Although none of the directors or executive officers is obligated to vote to approve the merger agreement proposal, we currently expect that each of these individuals will vote all of his or her shares “FOR” each of the proposals to be presented at the special meeting.
The Company’s directors and executive officers have interests in the merger that may be different from, or in addition to, the interests of the Company’s stockholders generally. For more information, please see the section of this proxy statement titled “The Merger—Interests of the Company’s Directors and Executive Officers in the Merger” beginning on page 75.
Appraisal Rights
If the merger is consummated, holders of record and beneficial owners of shares of Company common stock who do not vote in favor of the merger agreement proposal, who properly demand appraisal of their shares and who otherwise comply with the procedures of Section 262 are entitled to seek appraisal of their shares of Company common stock under Section 262 and, if all procedures described in Section 262 are strictly complied with, to receive payment in cash for the fair value of their shares of Company common stock exclusive of any element of value arising from the accomplishment or expectation of the merger, as determined by the Delaware Court, together with interest, if any, to be paid upon the amount determined to be the fair value. The “fair value” of your shares of Company common stock as determined by the Delaware Court may be more or less than, or the same as, the merger consideration that you are otherwise entitled to receive under the merger agreement. These rights are known as “appraisal rights”. This proxy statement serves as a notice of such appraisal rights pursuant to Section 262. If immediately before the merger, the shares of the class or series of stock of the Company were listed on a national securities exchange, the Delaware Court will dismiss the appraisal proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (i) the total number of shares entitled to appraisal exceeds 1% of the outstanding shares of the class or series eligible for appraisal or (ii) the value of the consideration provided in the merger for such total number of shares exceeds $1,000,000. Because the Class B common stock is not listed on a securities exchange, these thresholds do not apply to holders of Class B common stock.
Persons who exercise appraisal rights under Section 262 will not receive the merger consideration they would otherwise be entitled to receive pursuant to the merger agreement. They will instead receive an amount determined to be the “fair value” of their shares of Company common stock following petition to, and an appraisal by, the Delaware Court. Persons considering seeking appraisal should recognize that the fair value of their shares of Company common stock determined under Section 262 could be more than, the same as or less than the merger consideration they would otherwise be entitled to receive pursuant to the merger agreement. Strict compliance with the procedures set forth in Section 262 is required. Failure to comply
strictly with all of the procedures set forth in Section 262 may result in the withdrawal, loss or waiver of appraisal rights. Consequently, and in view of the complexity of the provisions of Section 262, persons wishing to exercise appraisal rights are urged to consult their legal and financial advisors before attempting to exercise such rights.
A holder of record or a beneficial owner of shares of Company common stock who (i) continuously holds such shares through the effective time, (ii) has not consented to or otherwise voted in favor of the merger or otherwise withdrawn, lost or waived appraisal rights, (iii) strictly complies with the procedures under Section 262, (iv) does not thereafter withdraw his, her or its demand for appraisal of such shares and (v) in the case of a beneficial owner, a person who (A) reasonably identifies in his, her or its demand the holder of record of the shares for which the demand is made, (B) provides documentary evidence of such beneficial owner’s beneficial ownership and a statement that such documentary evidence is a true and correct copy of what it purports to be and (C) provides an address at which such beneficial owner consents to receive notices given by the Company and to be set forth on the Chancery List (as defined in the section of this proxy statement titled “The Merger—Appraisal Rights” beginning on page 71), will be entitled to receive the fair value of his, her or its shares of Company common stock exclusive of any element of value arising from the accomplishment or expectation of the merger, as determined by the Delaware Court, together with interest, if any, to be paid upon the amount determined to be the fair value. The summary included herein does not constitute legal or other advice, nor does it constitute a recommendation that persons seek to exercise their appraisal rights under Section 262.
A copy of Section 262 may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. The foregoing summary is not a complete statement of the law relating to appraisal rights and is qualified in its entirety by reference to Section 262 and any amendments thereto after the date of this proxy statement. Any person who desires to exercise his, her or its appraisal rights should review carefully Section 262 and is urged to consult his, her or its legal and financial advisors before electing or attempting to exercise such rights. For more information, please see the section of this proxy statement titled “The Merger—Appraisal Rights” beginning on page 71.
Other Matters
Pursuant to the DGCL and the Company’s bylaws, only the matters set forth in the notice of special meeting may be brought before the special meeting.
Assistance
If you have any questions or need assistance in completing your proxy card or have questions regarding the special meeting, please contact Sodali & Co, which is acting as the Company’s proxy solicitation agent in connection with the merger, toll-free at (800) 662-5200. Brokers may call at (203) 658-9400.
PROPOSAL 1: MERGER AGREEMENT PROPOSAL
We are asking holders of shares of Company common stock to vote on a proposal to adopt the merger agreement. You are urged to carefully read this proxy statement in its entirety for more detailed information concerning the merger and the merger agreement, including the information set forth under the sections of this proxy statement titled “The Merger” and “The Merger Agreement”. A copy of the merger agreement is attached as Annex A to this proxy statement. Approval of this proposal is a condition to the consummation of the merger. In the event this proposal is not approved, the merger cannot be consummated.
Under applicable law, we cannot complete the merger without the affirmative vote of the holders of a majority of outstanding shares of Company common stock entitled to vote thereon. If you abstain from voting or fail to cast your vote, in person or by proxy, it will have the same effect as a vote against the proposal to adopt the merger agreement.
The Board unanimously recommends a vote “FOR” the approval of the merger agreement proposal.
PROPOSAL 2: ADVISORY COMPENSATION PROPOSAL
Pursuant to Section 14A of the Exchange Act, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and Rule 14a-21(c) under the Exchange Act, we are asking holders of Company common stock to approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to our named executive officers in connection with the consummation of the merger. As required by those rules, we ask the holders of Company common stock to vote on the approval of the following resolution:
“RESOLVED, that the compensation that may be paid or become payable to the Company’s named executive officers in connection with the consummation of the merger, as disclosed in the table titled “Potential Payments to Named Executive Officers”, including the associated narrative discussion, and the agreements, arrangements or understandings pursuant to which such compensation may be paid or become payable, are hereby APPROVED.”
The vote on executive compensation payable in connection with the consummation of the merger is a vote separate and apart from the vote to approve the merger agreement proposal, and approval of the advisory compensation proposal is not a condition to the consummation of the merger. Accordingly, you may vote to approve the merger agreement proposal and vote not to approve such compensation and vice versa. Because the vote is advisory in nature only, it will not be binding on the Company, the Board, Parent or the surviving corporation; as the Company is contractually obligated to pay such compensation, such compensation will be paid or become payable, subject only to the conditions applicable thereto, if the merger is consummated and regardless of the outcome of the advisory vote.
The approval of the advisory compensation proposal requires the affirmative vote of the holders of a majority in voting power of the shares of Company common stock present in person or represented by proxy at the special meeting and entitled to vote on such proposal. Assuming a quorum is present, abstentions will have the same effect as a vote “AGAINST” the advisory compensation proposal, and failures to vote (including a failure to authorize a proxy to vote on a Company stockholder’s behalf) and broker non-votes will have no effect on the outcome of the advisory compensation proposal.
The Board unanimously recommends a vote “FOR” the approval of the advisory compensation proposal.
PROPOSAL 3: ADJOURNMENT PROPOSAL
The Company is asking holders of Company common stock to approve a proposal to adjourn the special meeting to another date, time or place, if necessary, to solicit additional proxies in favor of the proposal to adopt the merger agreement. The Company currently does not intend to propose adjournment of the special meeting if there are sufficient votes in favor of the merger agreement proposal. The vote on the adjournment proposal is a vote separate and apart from the vote to approve the merger agreement proposal, and approval of the adjournment proposal is not a condition to the consummation of the merger. Accordingly, you may vote to approve the merger agreement proposal and vote not to approve the adjournment proposal and vice versa.
The approval of the adjournment proposal requires the affirmative vote of the holders of a majority in voting power of the shares of Company common stock present in person or represented by proxy at the special meeting and entitled to vote on such proposal. Abstentions will have the same effect as a vote “AGAINST” the adjournment proposal. Failures to vote (including a failure to authorize a proxy to vote on a Company stockholder's behalf) and broker non-votes will have no effect on the outcome of the adjournment proposal.
The Board unanimously recommends a vote “FOR” the approval of the adjournment proposal.
THE MERGER
Overview
The Company is seeking the adoption by the holders of Company common stock of the merger agreement the Company entered into on October 29, 2026 with Parent and Merger Sub. Under the terms of the merger agreement, subject to the satisfaction or (if permissible under applicable law) waiver of specified conditions, Merger Sub will be merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent. The Board has unanimously determined that it is in the best interests of the Company and the stockholders of the Company, and declared it advisable, that the Company enter into the merger agreement and consummate the merger, approved the merger agreement and the consummation of the merger and recommended that the Company’s stockholders entitled to vote adopt the merger agreement.
Background of the Merger
The following chronology summarizes key meetings and events that led to the signing of the merger agreement, as well as certain subsequent developments. This chronology does not purport to catalogue every conversation of, by, with or among members of the Board, the Company’s management, the Company’s financial advisors, legal advisors or other representatives, Thrive Holdings or its financial advisors, legal advisors, financing sources, affiliates or other representatives or any other person.
As part of their ongoing review of the Company’s business, together with the Company’s financial and legal advisors, the Board and the Company’s management team periodically review and evaluate the Company’s business and operations, long-term strategy, capital structure, competitive position, historical performance, future prospects, equity valuation and related trends, analyst and investor perspectives and input, and opportunities to increase stockholder value. These reviews have, from time to time, including following the sale by affiliates of Apollo of its remaining equity interests in the Company in May 2026, included discussions as to whether the Company should continue to execute on its strategy as a standalone company, pursue various acquisitions, divestitures, commercial relationships or strategic partnerships or pursue a sale of the Company or other potential strategic alternatives, in each case considering whether any such alternative would enhance stockholder value or accelerate its realization and the potential benefits and risks thereof. As a result, members of Company management have, from time to time, engaged in discussions with representatives of various third parties regarding such opportunities.
On July 23, 2026, while in New York City in connection with a regularly scheduled meeting of the Board, James D. DeVries, Chairman, President and Chief Executive Officer of the Company, and Jeffrey A. Likosar, President, Corporate Development and Transformation, and Chief Financial Officer of the Company, were introduced to representatives of Thrive Holdings by a representative of Apollo. Following this introduction, Mr. DeVries and Mr. Likosar met with representatives of Thrive Holdings, who had expressed interest in learning more about the Company, and representatives of Apollo. Following the meeting, representatives of Thrive Holdings expressed interest in engaging in additional preliminary discussions with the Company regarding the exploration of a potential transaction between the Company and Thrive Holdings. Subsequently, Mr. DeVries and representatives of Thrive Holdings discussed the potential entry into a non-disclosure agreement to facilitate further discussions, including the sharing of non-public information to conduct due diligence, and arranging a management meeting between representatives of the Company and of Thrive Holdings to further assess a potential transaction.
On July 30, 2026, Mr. DeVries informed the Board via email of Thrive Holdings’ interest in engaging in preliminary discussions regarding a potential transaction and of Company management’s intention to enter into a non-disclosure agreement with Thrive Holdings in advance of an initial meeting at the Company’s headquarters the following week, which representatives of Apollo, in its capacity as a potential debt financing source, also planned to attend.
On August 2, 2026, the Company and an affiliate of Thrive Holdings entered into a non-disclosure agreement (the “Thrive NDA”). On August 3, 2026, in light of Apollo’s role as a potential source of debt financing, the Company also entered into a non-disclosure agreement with Apollo (the “Apollo NDA”). Both the Thrive NDA and the Apollo NDA contained a customary standstill provision that would automatically terminate upon the entry by the
Company into a qualifying definitive transaction agreement with a third party, in addition to other customary provisions. Neither the Thrive NDA nor the Apollo NDA contained a “don’t ask, don’t waive” provision.
On August 3, 2026, Mr. DeVries and several other members of the Company’s executive leadership team met with representatives of Thrive Holdings and Apollo at the Company’s headquarters in Florida to discuss the Company’s strategy, objectives, performance, key initiatives, structure, and certain considerations between public and private ownership structures, including in the context of a potential transaction between the Company and Thrive Holdings. During this meeting, Thrive Holdings provided members of Company management with certain preliminary materials prepared by Thrive Holdings regarding its view on the Company’s market and growth opportunities, as well as Thrive Holdings’ investment thesis for the Company. Later that day, Mr. DeVries indicated to representatives of Thrive Holdings that, if Thrive Holdings wished to proceed with further discussions, it would need to submit an indication of interest that included a proposed price and clarity regarding expected debt and equity financing sources.
On August 4, 2026, Mr. DeVries updated the Board via email on the August 3 meeting, including the positive feedback received from representatives of Thrive Holdings and reported that he had told the representatives of Thrive Holdings that if it wished to proceed with further discussions with the Company, it should submit an indication of interest, including a price and details regarding its debt and equity financing sources. Mr. DeVries also noted the independent research Thrive Holdings had conducted, that they had several due diligence follow-up requests and stated that he would continue to update the Board if and when discussions with Thrive Holdings progressed.
Between August 4 and August 13, 2026, members of Company management responded to various information and data requests from Thrive Holdings, which were focused on certain historical performance detail beyond information contained in the Company’s filings and investor presentations, but did not include information regarding the Company’s expected future performance.
On August 13, 2026, Thrive Holdings submitted to the Company a non-binding indication of interest to acquire all of the outstanding shares of Company common stock at a price of $8.60 in cash per share (the “First Thrive Proposal”), subject to the completion of confirmatory due diligence. The First Thrive Proposal was accompanied by a non-binding “highly confident” letter from Apollo, dated August 12, 2026, stating that Apollo was highly confident of its ability to provide up to $10 billion of financing to fund the transaction. The First Thrive Proposal represented a premium of approximately 19.7% to the 30-day volume-weighted average price of Company common stock of $7.18, a premium of approximately 24.1% to the 60-day volume-weighted average price of Company common stock of $6.93 and a premium of approximately 17.6% to the closing price of Company common stock of $7.31, in each case as of August 12, 2026, the last trading day prior to the Company’s receipt of the First Thrive Proposal.
On August 16, 2026, the Board met to discuss the First Thrive Proposal with members of Company management and representatives of Cravath, Swaine & Moore LLP (“Cravath”), legal advisor to the Company, in attendance. At the Board’s request, representatives of Cravath reviewed with the Board the fiduciary duties owed by members of the Board to the Company and its stockholders and other legal matters relevant to the Board’s consideration of a potential sale transaction. Mr. DeVries reviewed, among other things, Company management’s interactions with Thrive Holdings to date, the proposed transaction structure, including Apollo’s potential role as a financing source, the proposed purchase price and potential next steps. Mr. Likosar then reviewed the Company’s existing multi-year financial framework (as described in the section of this proxy statement titled “—Certain Financial Forecasts”), initially developed in late 2025 to reflect various and ongoing Board conversations regarding the Company’s strategy and objectives and to inform the Company’s guidance to investors and analysts. Mr. Likosar also updated the Board on the Company’s 2026 performance, progress on key initiatives and related considerations, including an assessment of risks and opportunities and future expectations relative to this framework, along with the historical trading price of the common stock and recent investor input and expectations. Following deliberation, including regarding the Company’s long-term strategic and financial outlook, associated risks and opportunities, available alternatives and related process considerations, the Board concluded that the First Thrive Proposal undervalued the Company and was not sufficient to warrant further engagement. Following the meeting, at the
direction of the Board, Mr. DeVries called representatives of Thrive Holdings to convey the Board’s view that the value provided in the First Thrive Proposal did not warrant further engagement.
On August 20, 2026, Thrive Holdings submitted to the Company a revised non-binding indication of interest to acquire all of the outstanding shares of Company common stock at a price of $9.00 in cash per share (the “Second Thrive Proposal”), conditioned on the cessation of the Company’s regular quarterly dividend between the signing of a potential transaction agreement and the closing of such potential transaction, and subject to the completion of confirmatory due diligence. The Second Thrive Proposal represented a premium of approximately 23.5% to the 30-day volume-weighted average price of Company common stock of $7.29, a premium of approximately 29.5% to the 60-day volume-weighted average price of Company common stock of $6.95 and a premium of approximately 21.8% to the closing price of Company common stock of $7.39, in each case as of August 19, 2026, the last trading day prior to the Company’s receipt of the Second Thrive Proposal.
Also on August 20, 2026, the Board, together with members of Company management and representatives of Cravath, met to discuss the Second Thrive Proposal. Mr. DeVries reviewed recent communications with Thrive Holdings and members of the Board discussed, among other things, their fiduciary duties, the merits of engaging one or more investment banks to serve as financial advisors to the Company in connection with the exploration of a potential transaction with Thrive Holdings or an alternative transaction, the proposed response to the Second Thrive Proposal, the Company’s long-term financial outlook, the implications of being a publicly traded company versus being privately held, and certain process considerations. Following discussion, the Board directed Company management to interview at least two investment banks and to inform Thrive Holdings that the Board would engage one or more financial advisors to assist the Board in evaluating the proposal and would not engage on value until it had discussed such proposal with such advisors.
Over the following several days, members of Company management selected Citi and Goldman Sachs to act as the Company’s financial advisors in connection with the exploration of a potential transaction with Thrive Holdings or an alternative transaction. In selecting Citi and Goldman Sachs as financial advisors, Company management, in consultation with the Board, considered Citi’s and Goldman Sachs’ reputations as internationally recognized investment banking firms with substantial experience in similar transactions, including in the Company’s industry, and, in the case of Citi, its familiarity with the Company.
On August 31, 2026, the Board, together with members of Company management and representatives of each of Cravath, Citi and Goldman Sachs, met to discuss the Second Thrive Proposal. At the Board’s request, representatives of each of Citi and Goldman Sachs presented their respective preliminary financial analyses of the Company based on publicly available information and the multi-year financial framework. Mr. Likosar then reviewed the Company’s existing multi-year financial framework and, following Mr. Likosar’s presentation, the Board discussed the presentation, including, among other things, 2026 performance, progress on growth initiatives, the associated risks implicit in the framework, assumptions regarding growth initiatives, potential impacts of increased investment spending on future operating performance and financial metrics, and investor perceptions regarding the Company’s long-term outlook and their desire to see more specific near-term evidence of progress. Following discussion regarding the valuation of the Company, the Board concluded that the Second Thrive Proposal did not adequately reflect the value of the Company and that the Board was not prepared to engage substantively at the price reflected in the Second Thrive Proposal. The Board directed Company management and the Company’s advisors to communicate to Thrive Holdings that the Board did not believe the Second Thrive Proposal merited additional engagement and that, although the Board was not actively considering a sale of the Company, the Board would be willing to evaluate an offer from Thrive Holdings if the revised offer was materially higher.
On September 1, 2026, at the direction of the Board, Mr. DeVries informed representatives of Thrive Holdings that the Second Thrive Proposal undervalued the Company and that although the Board was not actively considering a sale of the Company, the Board would be willing to evaluate a revised offer reflecting a materially higher per share price and a price in the “double digits”.
Also on September 1, 2026, representatives of Citi and Goldman Sachs spoke with representatives of Evercore Group L.L.C. (“Evercore”), financial advisor to Thrive Holdings, to reiterate the Board’s views regarding the
purchase price reflected in the Second Thrive Proposal, including that the Board would expect a price per share in the “double digits”.
On September 3, 2026, representatives of Thrive Holdings informed Mr. DeVries that Thrive Holdings was confident there was a path to a transaction with a “double-digit” price per share of Company common stock and delivered to Company management a list of additional due diligence requests that Thrive Holdings would need addressed to continue its valuation work.
Also on September 3, 2026, the Board, together with members of Company management and representatives of each of Cravath, Citi and Goldman Sachs, met to discuss Thrive Holdings’ communication and its request for additional due diligence. After discussion, the Board supported providing Thrive Holdings with limited information reasonably necessary to support its valuation, including the Company’s multi-year financial framework, while limiting broader confirmatory due diligence activities pending further developments, and authorized Company management and the Company’s advisors to respond to Thrive Holdings’ due diligence requests on that basis.
Between September 3 and September 28, 2026, members of Company management and representatives and advisors of the Company provided due diligence materials requested by Thrive Holdings and its representatives that were reasonably necessary to support Thrive Holdings’ valuation.
On September 8, 2026, Company management shared with the Board the customary relationship disclosure letters that were received from Citi on August 31, 2026 and from Goldman Sachs on September 7, 2026.
On September 21, 2026, representatives of Thrive Holdings requested a meeting between senior members of management of Thrive Holdings and Mr. DeVries to discuss the potential transaction and on September 22, 2026, Mr. DeVries and a senior representative of Thrive Holdings met by videoconference to discuss the Company’s business strategy, market opportunities, Thrive Holdings’ investment thesis and other topics related to a potential transaction.
On September 23, 2026, Thrive Holdings submitted to the Company a revised non-binding indication of interest to acquire all of the outstanding shares of Company common stock at a price of $9.85 in cash per share (the “Third Thrive Proposal”), conditioned on the cessation of the Company’s regular quarterly dividend, together with a revised “highly confident” letter from Apollo, dated September 22, 2026, stating that Apollo was highly confident of its ability to provide up to $11 billion of financing to fund the transaction. The Third Thrive Proposal represented a premium of approximately 37.4% to the 30-day volume-weighted average price of Company common stock of $7.17, a premium of approximately 37.6% to the 60-day volume-weighted average price of Company common stock of $7.16 and a premium of approximately 55.4% to the closing price of Company common stock of $6.34, in each case as of September 23, 2026, the last trading day prior to the Company’s receipt of the Third Thrive Proposal.
On September 24, 2026, the Company entered into engagement letters with each of Citi and Goldman Sachs memorializing their respective engagements as the Company’s financial advisors, which, in each case, had commenced in late August 2026.
Later on September 24, 2026, the Board, together with members of Company management and representatives of each of Cravath, Citi and Goldman Sachs, met to discuss the Third Thrive Proposal. At the Board’s request, Mr. DeVries and representatives of Citi and Goldman Sachs reviewed, among other things, (i) the terms of the Third Thrive Proposal, including the proposed cessation of the Company’s regular quarterly dividend, (ii) prior communications regarding Thrive Holdings’ ability and willingness to reach a “double-digit” price per share of Company common stock, (iii) increased financing support for the proposed transaction from Apollo, (iv) the updated preliminary financial analyses of Citi and Goldman Sachs and (v) changes in market conditions since prior Board discussions and the relationship between the Company’s intrinsic value and public-market valuation. Representatives of Citi and Goldman Sachs also previewed potential responses to the Third Thrive Proposal and reviewed the likelihood of interest from other potential acquirors and the potential pre-signing and post-signing market check mechanisms, including the costs and benefits of each mechanism. After discussing the risks of each approach, including the greater potential business disruption from a longer process, the greater likelihood of a leak and the possibility that further outreach may not yield additional interest in the Company on comparable or better terms, the Board determined that the risks of contacting other potential acquirors with which the Company did not
have an existing business relationship and/or confidentiality agreement prior to signing outweighed the benefits. Instead, the Board determined that the Company should focus on discussions with Thrive Holdings, including negotiating favorable merger agreement terms regarding the Board’s ability to consider superior proposals (including by soliciting such proposals in a “go shop” period following signing of a definitive merger agreement) and an acceptable termination fee, and that Company management should confidentially contact one potential strategic partner with which the Company was in ongoing and regular discussions about potential strategic partnerships and one existing stockholder to gauge its interest in a potential control transaction involving the Company. The Board and its advisors also discussed the Company’s existing multi-year financial framework, including the significant execution risks of, investor sentiment toward, and investment required for the Company’s strategic initiatives and stockholder perception of this type of investment. Following discussion, the Board directed Mr. DeVries, working with representatives of Citi and Goldman Sachs, to communicate to Thrive Holdings the views expressed by the Board during the meeting, including a counterproposal of $10.35 in cash per share. The Board also directed Mr. DeVries and representatives of Citi and Goldman Sachs to communicate to Thrive Holdings the Board’s expectations regarding a higher, “double-digit” price per share of Company common stock, the continued payment of the Company’s regular quarterly dividend through the closing and the completion of confirmatory due diligence on an expedited basis.
On September 25, 2026, Mr. DeVries communicated to representatives of Thrive Holdings the Board’s rejection of the Third Thrive Proposal and a counterproposal of $10.35 in cash per share, with the Company continuing to pay its regular quarterly dividend prior to closing. Representatives of Thrive Holdings indicated that Thrive Holdings would need to evaluate whether it could increase the proposal and expressed its intention to continue to seek the cessation of the Company’s regular quarterly dividend.
On September 27, 2026, following a call between Mr. DeVries and representatives of Thrive Holdings, Thrive Holdings submitted to the Company a revised non-binding indication of interest to acquire all of the outstanding shares of Company common stock at a price of $10.00 in cash per share (the “Fourth Thrive Proposal”), conditioned on the cessation of the Company’s regular quarterly dividend, and proposing a four-week exclusivity period. The Fourth Thrive Proposal represented a premium of approximately 40.9% to the 30-day volume-weighted average price of Company common stock of $7.10, a premium of approximately 39.9% to the 60-day volume-weighted average price of Company common stock of $7.15 and a premium of approximately 56.3% to the closing price of Company common stock of $6.40, in each case as of September 25, 2026, the last trading day prior to the Company’s receipt of the Fourth Thrive Proposal. In its letter, Thrive Holdings stated that it had reached the maximum value it was prepared to ascribe to the Company.
On September 28, 2026, the Board, together with members of Company management and representatives of each of Cravath, Citi and Goldman Sachs, met to discuss the Fourth Thrive Proposal. Mr. DeVries reviewed the terms of the Fourth Thrive Proposal, including the increased price, the request for exclusivity, the cessation of the Company’s regular quarterly dividend and the characterization of the proposal as the maximum value Thrive Holdings was prepared to ascribe to the Company, as well as potential responses and alternatives to the Fourth Thrive Proposal. Mr. DeVries and representatives of Cravath also reviewed certain legal and process considerations related to the Fourth Thrive Proposal, including a summary of the proposed key provisions of a draft merger agreement. Following discussion, the Board authorized Company management, in consultation with the Company’s advisors, to communicate to Thrive Holdings that the Company would pursue a potential transaction with Thrive Holdings at the proposed purchase price of $10.00 in cash per share. The Board further authorized Company management, in consultation with the Company’s advisors, to negotiate for the ability to continue to pay the Company’s regular quarterly dividend and to resist any exclusivity arrangement, but directed Company management to continue to pursue a potential transaction even if unable to secure the ability to continue to pay the Company’s regular quarterly dividend.
Also on September 28, 2026, following the Board meeting, Mr. DeVries held a videoconference with representatives of Thrive Holdings, at the conclusion of which the parties agreed to continue the exploration of the potential transaction on the basis of (i) a price of $10.00 in cash per share, (ii) the cessation of the Company’s regular quarterly dividend following the execution of a definitive merger agreement, (iii) no exclusivity period and (iv) the completion of confirmatory due diligence and signing by the end of October 2026. Following the videoconference with representatives of Thrive Holdings, Mr. DeVries updated the Board on the meeting via email.
Between September 28 and October 28, 2026, members of Company management and representatives and advisors of the Company provided additional due diligence materials to Thrive Holdings and its representatives and advisors, including through a virtual data room, to which Thrive Holdings and its advisors were given access in early October 2026. Members of Company management, with representatives of Cravath, Citi and Goldman Sachs in attendance, as applicable, also held numerous calls and exchanged correspondence with representatives of Thrive Holdings and its advisors, including Evercore and Kirkland & Ellis LLP (“Kirkland”), legal advisor to Thrive Holdings, regarding due diligence and other transaction-related matters. Additionally, between October 13 and October 20, 2026, members of Company management, with representatives of Cravath, Citi and Goldman Sachs in attendance, as applicable, held due diligence sessions with representatives of Thrive Holdings and its advisors covering legal, tax, human resources, cybersecurity, information technology, business, financial and accounting, free cash flow and data and product matters, including an in-person business due diligence session in Florida on October 15, 2026.
On September 29, 2026, Mr. DeVries confirmed in writing to representatives of Thrive Holdings the Company’s willingness to proceed on the basis of the terms discussed on September 28, 2026, as well as the parties’ plan to complete confirmatory due diligence and the signing process by the end of October 2026.
On September 30, 2026, Cravath sent an initial draft of the merger agreement on behalf of the Company to Kirkland. This draft provided for, among other things: (i) a “go-shop” period of 30 days (with an extension period of up to 15 days), (ii) a termination fee payable by the Company of (A) 1.0% of the fully diluted equity value of the Company in the event the merger agreement was terminated for the Company to enter into a superior proposal received during the go-shop period (or any extension thereof) and (B) 2.0% of the fully diluted equity value of the Company otherwise, (iii) a reverse termination fee payable by Parent in the event of a financing failure of 10.0% of the fully diluted equity value of the Company, (iv) the acceleration and cash payment of all outstanding long-term incentive awards and (v) financing provisions providing for Apollo as the sole debt financing source.
On October 5, 2026, Mr. DeVries met with a representative of an existing stockholder of the Company to ask whether it would be interested in signing a non-disclosure agreement and subsequently receiving material non-public information about a potential transaction involving the Company. Representatives of the stockholder contacted Mr. DeVries on October 14, 2026 and declined, stating the stockholder did not wish to be subject to trading restrictions.
On October 8, 2026, at a previously scheduled meeting at the Company’s headquarters with a potential strategic partner of and potential investor in the Company, Mr. DeVries asked whether the potential strategic partner would consider a control transaction involving the Company. The potential strategic partner had previously received the multi-year financial framework and requested additional time to consider the opportunity. Mr. DeVries again met with the potential strategic partner on October 27, 2026 and it communicated its decision to decline to pursue such a transaction.
Also on October 8, 2026, Kirkland sent a revised draft of the merger agreement on behalf of Thrive Holdings to Cravath, which included certain changes to the Company’s September 30 draft. This draft provided for, among other things: (i) entry into voting and support agreements by certain of the Company’s stockholders, (ii) a reduced “go-shop” extension period of up to 10 days, (iii) an increased termination fee payable by the Company of (A) 1.5% of the fully diluted equity value of the Company in the event the merger agreement was terminated for the Company to enter into a superior proposal received during the go-shop period (or any extension thereof) and (B) 3.5% of the fully diluted equity value of the Company otherwise, (iv) a reduced reverse termination fee payable by Parent in the event of a financing failure of 4.5% of the fully diluted equity value of the Company and (v) a revised treatment of Company long-term incentive awards, under which only vested Company long-term incentive awards would be converted into the right to receive a cash payment, and all unvested long-term incentive awards would remain subject to their existing vesting terms.
On October 12, 2026, Mr. DeVries spoke with representatives of Thrive Holdings, who requested, among other things, (i) permission under the Thrive NDA to speak with certain of Thrive Holdings’ existing limited partners regarding potential equity financing for the transaction, (ii) permission to engage with certain Company stockholders regarding potential support for the transaction and (iii) confirmation that the Company would not declare a dividend prior to entry into a definitive agreement.
Later on October 12, 2026, representatives of each of Evercore and Kirkland requested, on Thrive Holdings’ behalf, the Company’s consent under the Thrive NDA for Thrive Holdings to discuss equity financing with certain of its limited partners, and indicated that Thrive Holdings expected to request consent for certain additional limited partners following those discussions.
On October 13, 2026, following discussion with Company management, representatives of Citi and Goldman Sachs informed representatives of Evercore that the Company would permit Thrive Holdings to engage in discussions with up to ten of its existing limited partners, subject to Thrive Holdings’ written confirmation that it had completed all substantive due diligence and was prepared to execute a definitive agreement by the end of October 2026. Representatives of Cravath conveyed the same position to representatives of Kirkland.
Later that evening, representatives of Evercore reported to representatives of Citi and Goldman Sachs that Thrive Holdings remained committed to working toward signing by the end of October 2026.
Also on October 13, 2026, Cravath sent to Kirkland a revised draft of the merger agreement on behalf of the Company, which included certain changes to Thrive Holdings’ October 8 draft. This draft provided for, among other things: (i) no voting and/or support agreements with any Company stockholder, (ii) the long-term incentive award treatment originally proposed by the Company of the acceleration and cash payment of all outstanding long-term incentive awards, (iii) a reduced termination fee payable by the Company of (A) 1.25% of the fully diluted equity value of the Company in the event the merger agreement was terminated for the Company to enter into a superior proposal received during the go-shop period (or any extension thereof) and (B) 2.5% of the fully diluted equity value of the Company otherwise and (iv) an increased reverse termination fee payable by Parent in the event of a financing failure of 8.5% of the fully diluted equity value of the Company.
On October 14, 2026, a representative of Thrive Holdings informed representatives of Evercore, who informed representatives of Citi and Goldman Sachs via email, that Thrive Holdings had identified no substantive issues in its due diligence review and remained on track to execute a definitive agreement by the end of October 2026 on the terms discussed between the parties on September 28, 2026.
Later on October 14, 2026, following a discussion between Mr. DeVries and representatives of Thrive Holdings and consultation with representatives of Citi and Goldman Sachs, the Company consented to Thrive Holdings engaging in discussions with certain of its existing limited partners as potential equity financing sources. On October 17 and October 22, 2026, at the request of Thrive Holdings, the Company consented to Thrive Holdings engaging with certain other additional existing limited partners.
During the period from October 14, 2026 through October 28, 2026, representatives of Kirkland and Cravath exchanged drafts and discussed the terms of the equity commitment letter, the preferred equity commitment letter, the limited guarantee and the various debt commitment letters relating to the transaction.
On October 15, 2026, a representative of Thrive Holdings contacted Mr. DeVries to reiterate Thrive Holdings’ interest in approaching certain Company stockholders prior to the execution of the merger agreement to determine whether such stockholders would be willing to execute support agreements and/or, if such parties were interested in doing so, to roll over their equity interests in the Company in connection with the transaction.
Also on October 15, 2026, representatives of Cravath and Kirkland discussed the financing for the transaction, including the debt and equity financing structure and the desire of Thrive Holdings to have discussions with existing Company stockholders regarding support arrangements and with the ratings agencies regarding the existing Company financings in connection with the rating evaluation and rating assessment services provided by such rating agencies. During the same discussion, representatives of Cravath indicated to representatives of Kirkland that the Company would not agree to Thrive Holdings’ approaching certain Company stockholders prior to signing. Kirkland reiterated to Cravath Thrive Holdings’ request for consent to approach the rating agencies on October 16, 2026.
On October 16, 2026, representatives of Evercore reviewed with representatives of Citi and Goldman Sachs Thrive Holdings’ proposed financing plan and rating agency process, including that (i) at signing, Apollo would provide a direct debt commitment as the sole debt financing source in an amount sufficient to fund the transaction
proceeds and all of the Company’s existing indebtedness, (ii) following signing, the direct debt commitment would be replaced by commitments in respect of a customary syndicated bridge facility and (iii) Thrive Holdings expected to require a marketing period in January 2027 for the debt financing. Following that discussion, the Company agreed to proceed with the rating evaluation and rating assessment services with the rating agencies.
Between October 18 and October 20, 2026, members of Company management, representatives of Citi, representatives of Goldman Sachs, representatives of Thrive Holdings and representatives of Evercore held preparatory sessions in advance of the rating agency presentations, and on October 20, 2026, members of Company management and representatives of Thrive Holdings met in person with representatives of rating agencies in New York City.
Also on October 20, 2026, Kirkland sent a revised draft of the merger agreement on behalf of Thrive Holdings to Cravath, which included certain changes to the Company’s October 13 draft. This draft provided for, among other things: (i) entry into voting and support agreements by certain of the Company’s stockholders, as contemplated in Thrive Holdings’ October 8 draft, (ii) an increased termination fee payable by the Company of (A) 1.5% of the fully diluted equity value of the Company in the event the merger agreement was terminated for the Company to enter into a superior proposal received during the go-shop period (or any extension thereof) and (B) 3.2% of the fully diluted equity value of the Company otherwise, (iii) a reduced reverse termination fee payable by Parent in the event of a financing failure of 5.0% of the fully diluted equity value of the Company, (iv) the long-term incentive award treatment originally proposed in Thrive Holdings’ October 8 draft of the merger agreement under which only vested Company long-term incentive awards would be converted into the right to receive a cash payment, and all unvested long-term incentive awards would remain subject to their existing vesting terms and (v) the two-part financing structure.
On October 22, 2026, the Board and members of Company management met for a regularly scheduled Board meeting. As part of the meeting, members of Company management and representatives of each of Cravath, Citi and Goldman Sachs provided an update on the potential transaction with Thrive Holdings, including with respect to the status and terms of the primary transaction documents and open issues, due diligence and Thrive Holdings’ financing and communication plan should the potential transaction proceed.
Also on October 22, 2026, Mr. DeVries held a videoconference with representatives of Thrive Holdings and discussed the rating agency meetings, feedback from which was received on October 26, 2026, overall due diligence workstreams and Board feedback gathered earlier that day.
Also on October 22, 2026, representatives of Cravath and Kirkland held calls regarding Thrive Holdings’ October 20 draft of the merger agreement and the financing for the proposed transaction.
On October 23, 2026, Cravath sent a revised draft of the merger agreement to Kirkland, which included certain changes to Thrive Holdings’ October 20 draft, including: (i) no voting and/or support agreements with any existing Company stockholders, (ii) the long-term incentive award treatment originally proposed by the Company of the acceleration and cash payment of all outstanding long-term incentive awards, (iii) a reduced termination fee payable by the Company of 3.0% of the fully diluted equity value of the Company in the event the merger agreement was terminated other than for the Company to enter into a superior proposal received during the go-shop period (or any extension thereof), (iv) an increased reverse termination fee payable by Parent in the event of a financing failure of 8.5% of the fully diluted equity value of the Company and (v) reinsertion of the financing structure reflected in the Company’s September 30 draft, under which Apollo would provide a direct debt commitment as the sole debt financing source.
On October 27, 2026, a subscription-based credit market-oriented publication published an article reporting that the Company and Thrive Holdings were in discussions for Thrive Holdings to acquire the Company. Neither the Company nor Thrive Holdings commented on the article. On October 28, 2026, the Company’s closing share price was $7.41, a 7.9% increase from the prior day. Following the publication of the article, neither the Company nor its financial advisors received any inbound calls regarding interest in a potential transaction with the Company.
Later on October 27, 2026, Kirkland sent a revised draft of the merger agreement on behalf of Thrive Holdings to Cravath, which included certain changes to the Company’s October 23 draft. This draft provided for (i) only
vested Company long-term incentive awards converting into the right to receive a cash payment, and all unvested long-term incentive awards remaining subject to their existing vesting terms, (ii) a reduced reverse termination fee payable by Parent in the event of a financing failure of 5.5% of the fully diluted equity value of the Company and (iii) the two-part financing structure.
On October 27 and 28, 2026, the Board received updated customary relationship disclosure letters from each of Citi and Goldman Sachs.
On October 28, 2026, prior to the Board meetings, Cravath sent a revised draft of the merger agreement to Kirkland, which included certain changes to Thrive Holdings’ October 27 draft, including: (i) the long-term incentive award treatment originally proposed by the Company of the acceleration and cash payment of all outstanding long-term incentive awards and (ii) an increased reverse termination fee payable by Parent in the event of a financing failure of 7.5% of the fully diluted equity value of the Company.
On the afternoon of October 28, 2026, the Board, together with members of Company management and representatives of each of Cravath, Citi and Goldman Sachs, met to discuss the status of the proposed transaction. Representatives of Cravath delivered a legal presentation regarding the Board’s fiduciary duties and other relevant legal considerations in the context of a review of a potential sale transaction and outlined the terms of the merger agreement with Thrive Holdings. Representatives of Cravath, Citi and Goldman Sachs reviewed the remaining material issues with respect to the merger agreement, including the treatment of long-term incentive awards and the parent termination fee. Following discussion, the Board directed Company management, in consultation with the Company’s advisors, to finalize negotiations of the limited remaining open items in the merger agreement and the other transaction documents on terms substantially consistent with those presented to and discussed with the Board. The Board also agreed to reconvene later that day to review the resolution of the final open items.
Throughout the day and evening of October 28 until the announcement on October 29, 2026, the Company and its advisors and Thrive Holdings and its advisors finalized the remaining open items, including agreeing (i) that only vested Company long-term incentive awards would be converted into the right to receive a cash payment, and all unvested long-term incentive awards would remain subject to their existing vesting terms and (ii) to a reverse termination fee payable by Parent in the event of a financing failure of 6.25% of the fully diluted equity value of the Company.
On the evening of October 28, 2026, the Board, together with members of Company management and representatives of each of Cravath, Citi and Goldman Sachs, again met to discuss the final terms of the proposed transaction. Representatives of Cravath delivered a legal presentation regarding the Board’s fiduciary duties and other relevant legal considerations in the context of a review of a potential sale transaction and outlined the terms of the merger agreement with Thrive Holdings. Representatives of Cravath, Citi and Goldman Sachs reviewed the resolution of the final merger agreement terms. Representatives of Citi also reviewed with the Board its financial analysis and rendered to the Board its oral opinion, which was subsequently confirmed by delivery of a written opinion, dated October 28, 2026, and that is attached to this proxy statement as Annex B, to the effect that, as of that date and based on and subject to various assumptions made, procedures followed, matters considered and limitations and qualifications on the review undertaken by Citi as set forth in its written opinion, the merger consideration to be received by the holders of shares of Company common stock in the merger pursuant to the merger agreement was fair, from a financial point of view, to such holders, as more fully described below in the section titled “The Merger—Opinions of the Company’s Financial Advisors—Opinion of Citigroup Global Markets Inc.” beginning on page 54. Representatives of Goldman Sachs also reviewed with the Board its financial analysis and rendered to the Board its oral opinion, which was subsequently confirmed by delivery of a written opinion, dated October 29, 2026, and that is attached to this proxy statement as Annex C, that, as of the date of such opinion and based upon and subject to the factors and assumptions set forth therein, the $10.00 in cash per share of Company common stock to be paid to the holders (other than Parent and its affiliates) of shares of Company common stock, taken in the aggregate, pursuant to the merger agreement was fair from a financial point of view to such holders of shares of Company common stock, taken in the aggregate. For a detailed discussion of Goldman Sachs’ opinion, please see below in “The Merger—Opinions of the Company’s Financial Advisors—Opinion of Goldman Sachs & Co. LLC” beginning on page 60 and Annex C of this proxy statement.
After discussion and consideration of a variety of factors, including those described in the section of this proxy statement titled “—Reasons for the Merger” beginning on page 44, the Board, on October 28, 2026, unanimously (i) determined that it is in the best interests of the Company and the stockholders of the Company, and declared it advisable, that the Company enter into the merger agreement and consummate the merger, (ii) approved the merger agreement and the consummation of the merger, (iii) directed that the merger agreement be submitted to the holders of Company common stock for adoption at the special meeting, (iv) recommended that the holders of Company common stock vote in favor of (x) the adoption of the merger agreement, (y) the approval, by a non-binding, advisory vote, of the specified compensation arrangements disclosed in this proxy statement that may be paid or become payable to the Company’s named executive officers in connection with the merger and (z) the proposal to adjourn the special meeting to another date, time or place, if necessary to solicit additional proxies in favor of the proposal to adopt the merger agreement, (v) approved and adopted in all respects the form, terms and conditions of the limited guarantee and authorized the execution and delivery of the other transaction documents to which the Company is a party and (vi) called for a special meeting of the holders of Company common stock for the purposes set forth above.
On October 29, 2026, the Company, Parent and Merger Sub executed the merger agreement, and the parties executed the other transaction documents, including the limited guarantee and the equity commitment letter.
Later on October 29, 2026, prior to the opening of trading, the Company and Thrive Holdings issued a joint press release announcing entry into the merger agreement, and the Company made related filings with the SEC, including a Current Report on Form 8-K.
Recommendation of the Board
At the special meeting of the Board held on October 28, 2026, after due consideration, including of the material factors described in the section below titled “—Reasons for the Merger”, and detailed discussions with the Company’s management and its legal and financial advisors at such meeting and prior meetings of the Board, the Board unanimously:
•determined that it is in the best interests of the Company and the stockholders of the Company, and declared it advisable, that the Company enter into the merger agreement and consummate the merger;
•approved the merger agreement and the consummation of the merger;
•directed that the merger agreement be submitted to the holders of Company common stock for adoption at the special meeting;
•recommended that the holders of Company common stock vote in favor of (i) the adoption of the merger agreement, (ii) the approval, by a non-binding, advisory vote, of the specified compensation arrangements disclosed in this proxy statement that may be paid or become payable to the Company’s named executive officers in connection with the merger and (iii) the proposal to adjourn the special meeting to another date, time or place, if necessary to solicit additional proxies in favor of the proposal to adopt the merger agreement;
•approved and adopted in all respects the form, terms and conditions of the limited guarantee and authorized the execution and delivery of the other transaction documents to which the Company is a party; and
•called for a special meeting of the holders of Company common stock for the purpose of (i) submitting the merger agreement to such stockholders for adoption, (ii) submitting to such stockholders a non-binding, advisory proposal to approve the compensation that may be paid or become payable to the Company’s named executive officers in connection with the merger and (iii) submitting to such stockholders a proposal to adjourn the special meeting to another date, time or place, if necessary to solicit additional proxies in favor of the proposal to adopt the merger agreement.
Reasons for the Merger
As described above in the section titled “—Background of the Merger” beginning on page 34, prior to and in reaching its unanimous decision to (i) determine that it is in the best interests of the Company and the stockholders of the Company, and declare it advisable, that the Company enter into the merger agreement and consummate the merger, (ii) approve the merger agreement and the consummation of the merger, (iii) direct that the merger agreement be submitted to the holders of Company common stock for adoption at the special meeting, (iv) recommend that the holders of Company common stock vote in favor of (x) the adoption of the merger agreement, (y) the approval, by a non-binding, advisory vote, of the specified compensation arrangements disclosed in this proxy statement that may be paid or become payable to the Company’s named executive officers in connection with the merger and (z) the proposal to adjourn the special meeting to another date, time or place, if necessary to solicit additional proxies in favor of the proposal to adopt the merger agreement, (v) approve and adopt in all respects the form, terms and conditions of the limited guarantee and authorize the execution and delivery of the other transaction documents to which the Company is a party and (vi) call a special meeting of the holders of Company common stock for the purposes set forth above, the Board consulted with and received the advice of its financial advisors and outside legal counsel, discussed certain topics with the Company’s management and considered a variety of factors weighing in favor of the merger, the merger agreement and the transactions contemplated thereby, including the following non-exhaustive list of material factors (not necessarily in order of relative importance):
•the fact that the merger consideration of $10.00 per share of Company common stock, payable in cash, represents a premium of approximately:
◦56% over the closing price per share of common stock on September 25, 2026, the last full trading day prior to Thrive Holdings’ submission to the Company of a non-binding indication of interest to acquire all of the outstanding shares of Company common stock at a price of $10.00 in cash per share;
◦46% over the unaffected closing price per share of common stock on October 27, 2026, the last full trading day prior to the publication of a media report on the evening of October 27, 2026 regarding a potential transaction involving the Company;
◦52% over the 30-day volume-weighted average trading price per share of common stock as of October 27, 2026, the last full trading day prior to the publication of a media report on the evening of October 27, 2026 regarding a potential transaction involving the Company;
◦43.5% over the 60-day volume-weighted average trading price per share of common stock as of October 27, 2026, the last full trading day prior to the publication of a media report on the evening of October 27, 2026 regarding a potential transaction involving the Company; and
◦44% over the 90-day volume-weighted average trading price per share of common stock as of October 27, 2026, the last full trading day prior to the publication of a media report on the evening of October 27, 2026 regarding a potential transaction involving the Company.
•the fact that the merger consideration is all cash, which provides certainty, immediate value and liquidity to holders of Company common stock immediately upon the closing of the merger, especially when viewed against internal or external risks and uncertainties associated with the Company’s standalone strategy, and the time to ultimately realize the value associated with such strategy;
•the Board’s evaluation of the Company’s outlook as an independent public company, including the Company’s business, operations, financial condition (historical, current and projected), earnings, prospects, competitive position and industry dynamics, technological threats, macro-economic factors, and the multi-year financial framework prepared by Company management (as described in the section of this proxy statement titled “—Certain Financial Forecasts” beginning on page 51), including the Board’s assessment of the various management assumptions therein, the associated execution risk, and the timing of the associated value realization;
•the Board also considered the Company’s historical stock price performance and public market valuation relative to such framework and the potential impact (which cannot be quantified) of the foregoing factors on the trading price of common stock, and determined the certainty of value provided by the merger consideration was more favorable to Company stockholders than the risk-adjusted present value of remaining an independent public company. In making this determination, the Board carefully reviewed and considered:
◦the likelihood of achieving the Company’s multi-year financial framework, including the costs of achieving the full potential of the framework, as well as the significant execution risks associated with concurrently achieving each of the growth initiatives included in the framework, including the potential for additional capital requirements to execute the Company’s strategic plans and stockholder perception of this type of investment given stockholder expectations that the Company will continue to generate substantial recurring free cash flow and return capital to stockholders;
◦the fact that the multi-year financial framework required the Company to achieve improvement in certain metrics that were well in excess of the Company’s historical performance and that the Company experienced a slower start to several strategic initiatives in 2026 than anticipated, putting additional pressure on subsequent years in the multi-year framework;
◦the fact that a substantial portion of the Company’s value on a standalone basis, as reflected in the Financial Forecasts and the discounted cash flow analyses reviewed with the Board, depends on cash flows expected to be generated in the later years of the forecast period and beyond, and that the achievement of such results is subject to greater uncertainty given the inherent difficulty of forecasting results for periods further in the future, as compared to the certainty of value of the merger consideration;
◦the fact that the multi-year financial framework was subject to certain market, competitive, technology, counterparty, macro-economic and sector-specific risks not within the control of the Company, which the Board considered based upon its knowledge of the Company’s business and competitive dynamics that might adversely affect the Company’s ability to achieve the objectives in the multi-year financial framework;
◦the fact that the Company’s actual financial results in future periods could differ materially from the multi-year financial framework, or that the targeted results could take longer to achieve;
◦the possibility that the price of Company common stock could be negatively impacted if the Company failed to meet investor expectations, including if the Company failed to achieve the objectives in the multi-year financial framework or to convince investors of its progress in the near term; and
◦the possibility that even if the Company fully achieved its multi-year financial framework, that may not result in the Company’s financial performance being fully reflected in its public market valuation, including as a result of the lack of comparable publicly traded companies to inform valuation.
•the Board’s assessment, after a review of strategic alternatives and discussions with the Company’s management and its legal and financial advisors, of the potential risks, rewards and uncertainties associated with a range of alternatives to a sale of the Company, including remaining an independent public company, and the Board’s resulting determination that the potential value that might result from such alternatives did not represent a more favorable alternative for the Company’s stockholders than the merger;
•the Board’s understanding of the risks and uncertainties in the industry in which the Company competes, and the risks that the Company would face if it continued to operate on a standalone public company basis, including:
◦risks relating to the home security and automation market, including rapid technological and industry changes and the need to develop or acquire new products and capabilities, the highly competitive and fragmented nature of the do-it-for-me and do-it-yourself markets, the increased interoperability of
smart home devices making it easier and less costly for consumers to switch providers, and the possibility that the insurance industry stops offering homeowners incentives for the use of alarm monitoring services;
◦risks relating to the retirement of older technologies and the development of new technologies incompatible with the Company’s existing offerings, the reliance of a majority of the Company’s existing subscriber base on legacy systems that are nearing or have reached the end of their supported lifecycles and are incompatible with the ADT+ platform and the significant capital expenditures that may be required to migrate these subscribers;
◦risks relating to the Company’s strategic partnerships and technology initiatives, which may require the Company to undertake significant commitments and make substantial expenditures with no assurance that the expected benefits from these partnerships will be realized;
◦risks relating to the operation of the Company, including the Company’s dependence on long customer tenure and the possibility that customer attrition rates rise significantly, cyberattacks or other unauthorized access to the Company’s systems or those of interconnected third parties, uncertainty in the development, deployment and use of AI, including generative AI, and the Company’s reliance on third-party suppliers, software licensors, telecommunications providers and signal processing centers, including supply disruptions;
◦risks relating to litigation and intellectual property, including class actions and other lawsuits involving alleged violations of privacy, consumer protection, employment and other laws and infringement claims by third parties;
◦risks relating to financial, liquidity and tax matters, including the Company’s ability to generate sufficient cash flows to meet its significant debt obligations, the use of a significant portion of the Company’s cash flow to service its debt, which may impede the Company’s ability to grow the business or require non-strategic divestitures, exposure to higher interest rates on variable rate debt and costlier refinancing of fixed rate debt, and the Company’s ability to realize the full value of its goodwill and other identifiable intangible assets or of its significant deferred tax assets;
◦risks relating to the Company’s customer generation strategies, including its reliance on independent, third-party authorized dealers and affinity marketing programs and the reputational and legal risks of dealers’ sales practices that may violate telemarketing, consumer protection or other applicable laws;
◦risks relating to the Company being less diversified and entirely dependent on consumer and small business markets following the Company’s 2023 sale of its commercial business, the 2024 exit from the residential solar business and the 2025 sale of its multifamily business;
◦risks relating to changes in U.S. trade policy, including the imposition of tariffs and the resulting consequences;
◦risks relating to compliance with existing and future applicable laws and regulations; and
◦other risks and uncertainties, including the risk factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and in the Company’s Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2026, June 30, 2026 and September 30, 2026;
•the financial analyses presented to the Board by Citi and the oral opinion rendered by Citi to the Board, which was confirmed by delivery of a written opinion, dated October 28, 2026, to the effect that, as of that date and based on and subject to various assumptions made, procedures followed, matters considered and limitations and qualifications on the review undertaken by Citi as set forth in its written opinion, the merger consideration to be received by the holders of shares of Company common stock in the merger pursuant to the merger agreement was fair, from a financial point of view, to such holders, as more fully described
below in the section titled “The Merger—Opinions of the Company’s Financial Advisors—Opinion of Citigroup Global Markets Inc.” beginning on page 54;
•the oral opinion of Goldman Sachs which was subsequently confirmed by delivery of a written opinion, dated October 29, 2026 and that is attached to this proxy statement as Annex C, that as of the date of such opinion and based upon and subject to the factors and assumptions set forth therein, the $10.00 in cash per share of Company common stock to be paid to the holders (other than Parent and its affiliates) of shares of Company common stock, taken in the aggregate, pursuant to the merger agreement was fair from a financial point of view to such holders of shares of Company common stock, taken in the aggregate, as more fully described below in the section titled “The Merger—Opinions of the Company’s Financial Advisors—Opinion of Goldman Sachs & Co. LLC” beginning on page 60 and Annex C of this proxy statement;
•the Board’s belief that the merger consideration represents fair value for the shares of Company common stock, taking into account the Board’s familiarity with the Company’s current and historical financial condition, results of operations, business, competitive position and prospects, the Company’s future business plan and potential long-term value, as well as the market the Company operates in and precedent transactions that have occurred within such market;
•the Board’s assessment, taking into account the other factors described herein, of the Company’s value on a standalone basis relative to the $10.00 per share of Company common stock to be paid in cash in connection with the merger, and the possibility that the trading price of shares of Company common stock would not reach and sustain such price, even if the Company is able to execute on its plans and objectives, or that doing so could take a considerable period of time;
•the Board’s consideration of the current state of the economy, the housing market, consumer discretionary spending and the debt financing markets and uncertainty surrounding forecasted economic conditions in the near term and the long term, which could negatively affect the Company’s financial performance;
•the provisions of the merger agreement that permit (or permitted, in the case of clause (i)(x)), (i) the Company (x) during the go-shop period, to solicit alternative acquisition proposals from, and participate in discussions and negotiations with, third parties and (y) to consider and respond to unsolicited acquisition proposals, including to furnish information to and conduct negotiations with third parties, under certain circumstances specified in the merger agreement and (ii) the Board, under certain circumstances and subject to certain conditions, prior to receipt of the Company stockholder approval, to (x) effect an adverse recommendation change or (y) terminate the merger agreement in order to enter into a definitive agreement providing for the consummation of a superior proposal, provided that the Company complies with its obligations relating to superior proposals under the merger agreement and concurrently pays to Parent the Company termination fee of $227,000,000 or $114,000,000, as applicable, as described in the sections of this proxy statement titled “The Merger Agreement—Termination of the Merger Agreement” and “The Merger Agreement—Termination Fees” and above in the section titled “—Background of the Merger” beginning on pages 105, 107 and 34, respectively;
•the Board’s consideration of the significant risks to the Company and its business that could result from contacting other potential counterparties prior to signing a definitive agreement with Thrive Holdings, including the greater potential business disruption resulting from a longer process (including with respect to the Company’s business relationships, potential employee turnover, turnover in the Company’s stockholder base and potential stock price volatility), the greater likelihood of a leak given the increased number of parties, along with their advisors and potential financing sources and the possibility that further outreach to potential counterparties may not yield additional interest in the Company on comparable or better terms (as described above in the section titled “—Background of the Merger” beginning on page 34), and the fact that the “go-shop” provision Thrive Holdings agreed to provide would allow the Company to solicit alternative acquisition proposals following announcement of the merger;
•the fact that the merger agreement provides the Company sufficient operating flexibility to conduct its business in the ordinary course until the earlier of the consummation of the merger or the termination of the merger agreement, as more fully described in the section of this proxy statement titled “The Merger Agreement—Covenants Regarding Conduct of Business by the Company Pending the Effective Time” beginning on page 91;
•the fact that outreach by the Company’s management to an existing stockholder and a potential strategic partner prior to the signing of the merger agreement to gauge such entities’ interest in a potential control transaction involving the Company did not yield interest in a potential transaction;
•the process expected to be undertaken by the Company’s management and the Company’s advisors during the go-shop period to solicit and evaluate potential strategic alternatives;
•the course and history of arm’s-length negotiations with Thrive Holdings, which negotiations the Board believed resulted in the Company obtaining the highest price that Thrive Holdings was willing to pay for the Company, as evidenced by the Company’s ability to increase Thrive Holdings’ proposed price per share of Company common stock from $8.60 in its August 13, 2026 initial proposal to $10.00 per share in its September 27, 2026 final offer, an increase of approximately 16%, as further described above in the section titled “—Background of the Merger” beginning on page 34;
•the fact that the merger is not subject to a financing condition, that Parent obtained committed debt financing for the merger from reputable financing sources, that Thrive Holdings committed to make available and provide to Parent, pursuant to the equity commitment letter, the full amount in cash necessary, along with the committed debt financing and the preferred equity financing, to fund the aggregate merger consideration, and that, if any portion of the debt financing for the merger becomes unavailable, Parent is required to use commercially reasonable efforts to obtain alternative financing in an amount sufficient to consummate the merger, subject to the terms and conditions set forth in the merger agreement, in each case, as further described in the section titled “—Financing of the Merger” beginning on page 67;
•the fact that the Guarantor provided a limited guarantee in favor of the Company, which supports Parent’s obligation to pay (i) the Parent termination fee (if and when due and payable), (ii) reasonable and documented out-of-pocket costs and expenses of the Company or any of its subsidiaries and their respective representatives in connection with the financing of the merger and (iii) reasonable and documented costs and expenses of the Company in connection with the successful enforcement of Parent’s obligations to pay the Parent termination fee (in the case of clauses (ii) and (iii), subject to the caps set forth in the merger agreement), as described in the section titled “—Limited Guarantee” beginning on page 70;
•the provisions of the merger agreement that permit the Company (i) to seek specific performance of Parent’s obligations under the merger agreement, including to use its commercially reasonable efforts to obtain the debt financing in accordance with the terms of the merger agreement, and (ii) subject to the satisfaction of certain additional conditions set forth in the merger agreement, if the debt financing (x) has been funded in accordance with its terms or (y) will be funded in accordance with its terms at the closing of the merger if the equity financing is funded at the closing of the merger, to cause the equity financing to be funded in accordance with the equity commitment letter and to cause the merger to occur;
•the Board’s belief, after discussion with the Company’s legal and financial advisors, that the amount of the Company termination fee is comparable to termination fees in transactions of a similar size, is reasonable, would not preclude a superior proposal from being made and would not likely be required to be paid unless the Company entered into a more favorable transaction;
•the other terms and conditions of the merger agreement and the debt and equity financing documents, which were reviewed by the Board with the Company’s outside legal counsel and financial advisors, and the fact that such terms were the product of arm’s-length negotiations between the parties;
•the high probability that the merger would be consummated based on, among other things, the absence of a financing contingency, the limited scope of required regulatory approvals in connection with the merger and the $473,000,000 Parent termination fee, payable to the Company if the merger agreement is terminated in certain circumstances, which payment is guaranteed by the Guarantor in accordance with the aggregate maximum cap as described below in the section titled “—Limited Guarantee”, pursuant to the limited guarantee delivered by it, Thrive Holdings’ ability to complete acquisition transactions and its experience with transactions in the Company’s industry;
•the high probability that the merger would be completed in a reasonable timeframe and in an orderly manner, which could reduce the period during which the Company’s business would be subject to the potential uncertainty of closing and related disruption;
•the fact that the resolutions approving the merger agreement and the transactions contemplated thereby, including the merger, were unanimously adopted by the Board, which consists of a majority of directors who are independent of the Company and not affiliated with Thrive Holdings and are not employees of the Company or any of its subsidiaries;
•the fact that the merger agreement would be subject to adoption by the Company’s stockholders, and that stockholders would be free to reject the merger by voting against the adoption of the merger agreement; and
•the availability of appraisal rights under the DGCL to Company stockholders who comply with all of the required procedures for perfecting appraisal rights under the DGCL in connection with the merger, including the fact that such stockholders will have the right to demand appraisal and payment of the fair value of their shares as determined by the Delaware Court, as further described below in the section titled “—Appraisal Rights” beginning on page 88.
In the course of its deliberations, the Board also considered a variety of risks and other countervailing factors related to the merger agreement and the merger, including the following material factors (not necessarily in order of relative importance):
•the loss of the potential upside in the Company’s multi-year financial framework in the event the transactions contemplated by the merger agreement are consummated;
•the risks and costs to the Company if the merger is not completed on the terms or timeline currently contemplated or at all due to a failure of certain conditions, such as the occurrence of a material adverse effect or a failure to obtain required approvals of the transaction by the required regulatory authorities, even if the merger agreement is adopted by the Company’s stockholders, including:
◦the possibility that the trading price of Company common stock may decline to the extent that the market price of the Company common stock currently reflects positive market assumptions that the merger will be consummated;
◦the potential negative impact on the Company’s ability to attract, hire and retain key employees, as current and prospective employees may experience uncertainty about their future roles with the Company following the merger or if the merger is not successfully completed;
◦the potential disruption to the Company’s business and distraction of its workforce and management team from day-to-day operations and from pursuing other opportunities that could be beneficial to the Company, in each case without realizing any of the benefits of having the merger completed and the potential adverse effects on the financial and other results of the Company as a result of such disruption; and
◦harm to the Company’s reputation and its relationships with investors, customers, suppliers, business partners and other third parties due to the interim operating restrictions imposed upon the business in the merger agreement or any adverse perception of any failure to successfully complete the merger;
•the fact that holders of shares of Company common stock will have no ongoing equity interest in the surviving corporation following the merger, meaning that the holders of shares of Company common stock will not (by virtue of their holding shares of Company common stock) participate in the Company’s potential future earnings or growth;
•the Company’s agreement to restrict the payment of any regular quarterly dividend that would otherwise be distributed prior to the consummation of the merger in order to achieve the maximum value Thrive Holdings was willing to ascribe to the Company;
•the restrictions on the conduct of the Company’s business prior to the consummation of the merger, which may delay or prevent the Company from undertaking certain significant financing transactions and business opportunities that may arise or any other action that it might otherwise take with respect to the operations and strategy of the Company, even if such actions would prove beneficial to the Company;
•the risk that the parties may incur significant costs and material delays resulting from seeking regulatory approvals and other clearances, consents and approvals necessary for consummation of the merger;
•the provisions of the merger agreement that restrict the Company’s ability, following the go-shop period (or any extension thereof), to solicit or participate in discussions or negotiations regarding alternative acquisition proposals with third parties, subject to specified exceptions, and that require the Company to negotiate with Parent (if Parent desires to propose revisions to the merger agreement and negotiate) prior to the Company being able to terminate the merger agreement to accept a superior proposal;
•the possibility that the Company’s obligation to pay the Company termination fee of $114,000,000 or $227,000,000, as applicable, to Parent upon the termination of the merger agreement under certain circumstances could discourage other potential acquirors from making an alternative proposal to acquire the Company, as further described in the section of this proxy statement titled “The Merger Agreement—Termination Fees” beginning on page 107;
•the significant costs involved in connection with negotiating the merger agreement and consummating the merger, such as legal, accounting and financial advisory fees, and the fact that if the merger is not consummated, the Company may be required to bear such costs;
•the possibility that, although the merger provides Company stockholders the opportunity to realize a premium to the price at which Company common stock traded prior to the public announcement of the merger, the price of Company common stock might otherwise increase (or have increased) in the future to a price greater than the merger consideration;
•the risk of litigation in connection with the execution of the merger agreement and the consummation of the merger and the other transactions contemplated thereby;
•the possibility that the financing contemplated by the backstop commitment letter, the syndicated commitment letter, the preferred equity commitment letter and the equity commitment letter will not be obtained, resulting in Parent not having sufficient funds to complete the merger;
•the fact that Parent and Merger Sub are newly formed entities with no material assets other than their rights under the commitment letters and that the Company has agreed that, notwithstanding the Company’s specific performance remedy under the merger agreement, the Company’s monetary remedy in the event of a breach of the merger agreement by Parent or Merger Sub may be limited to receipt of the Parent termination fee of $473,000,000, and that under certain circumstances the Company may not be entitled to such Parent termination fee or monetary damages at all;
•the fact that an all-cash transaction would be taxable to the holders of common stock that are U.S. holders for U.S. federal income tax purposes; and
•various other risks associated with the merger and the business of the Company, as more fully described in the section of this proxy statement titled “Cautionary Statement Regarding Forward-Looking Statements” beginning on page 23.
The Board unanimously determined that, overall, these potential risks, uncertainties and other potentially negative factors were outweighed by the benefits that the Board expects to achieve for the Company’s stockholders as a result of the transactions contemplated by the merger agreement. The Board was aware that there can be no assurance about future results, including results considered or expected as disclosed in the foregoing reasons.
In addition, the Board was aware of and considered the fact that the Company’s directors and executive officers have financial interests in the merger that may be different from, or in addition to, those of Company stockholders generally, as described more fully below in the section titled “—Interests of the Company’s Directors and Executive Officers in the Merger” beginning on page 75.
The foregoing discussion of the factors considered by the Board is not intended to be exhaustive, but rather includes the material factors considered by the Board. In light of the factors described above and other factors that the Board believed were appropriate, the Board unanimously (i) determined that it is in the best interests of the Company and the stockholders of the Company, and declared it advisable, that the Company enter into the merger agreement and consummate the merger, (ii) approved the merger agreement and the consummation of the merger, (iii) directed that the merger agreement be submitted to the holders of Company common stock for adoption at the special meeting, (iv) recommended that the holders of Company common stock vote in favor of (x) the adoption of the merger agreement, (y) the approval, by a non-binding, advisory vote, of the specified compensation arrangements disclosed in this proxy statement that may be paid or become payable to the Company’s named executive officers in connection with the merger and (z) the proposal to adjourn the special meeting to another date, time or place, if necessary to solicit additional proxies in favor of the proposal to adopt the merger agreement, (v) approved and adopted in all respects the form, terms and conditions of the limited guarantee and authorized the execution and delivery of the other transaction documents to which the Company is a party and (vi) called for a special meeting of the holders of Company common stock for the purposes set forth above. In view of the wide variety of factors considered by the Board in connection with its evaluation of the merger and the complexity of these matters, the Board did not consider it practical, and did not attempt, to quantify, rank or otherwise assign relative weights to the specific factors it considered in reaching its decision and did not undertake to make any specific determination as to whether any particular factor, or any aspect of any particular factor, was favorable or unfavorable to the ultimate determination of the Board. Rather, the Board made its recommendation based on the totality of the information available to the Board, including discussions with, and questioning of, the Company’s management and its financial and legal advisors. In considering the factors discussed above, individual members of the Board may have given different weights to different factors.
This explanation of the Board’s reasons for its recommendations and other information presented in this section is forward-looking in nature and, therefore, should be read in light of the factors described in the section of this proxy statement titled “Cautionary Statement Regarding Forward-Looking Statements” beginning on page 23.
Certain Financial Forecasts
Other than annual guidance, periodic quarterly updates and other investor updates provided from time-to-time, the Company does not, as a matter of ordinary course, publicly disclose forecasts as to future performance, earnings or other results due to, among other things, the unpredictability of the underlying assumptions and estimates. The Company is especially reluctant to disclose projections for extended periods due to the increasing uncertainty, unpredictability and subjectivity of such assumptions and estimates when applied to time periods further in the future. In early 2026, however, the Company provided targets for certain operating metrics based on the multi-year financial framework to investors. The Company has included in this proxy statement certain financial forecasts from the Company’s multi-year financial framework, initially developed in late 2025 that, to the extent described herein, were furnished to the Board, Citi and Goldman Sachs as described below.
These Financial Forecasts (as defined below) were not prepared with a view toward compliance with published guidelines of the SEC, the guidelines established by the American Institute of Certified Public Accountants for
preparation or presentation of prospective financial information or generally accepted accounting principles in the United States (“GAAP”). This information is not fact and should not be relied upon as being necessarily predictive of actual future results, and readers of this proxy statement are cautioned not to place undue reliance on the forecasted multi-year financial framework. A summary of this information is presented below.
The Financial Forecasts were, in the view of the Company’s management, prepared on a reasonable basis and in good faith, reflecting the best available estimates and judgments, and planned initiative execution and benefits, as of late 2025. As described below, the Financial Forecasts were prepared for the Company’s internal use and in connection with management’s ordinary course long-range planning and were not subsequently updated or revised to reflect the Company’s recent performance or business trends or in connection with the merger. However, no assurances can be made regarding future events and the estimates and assumptions underlying these Financial Forecasts involve judgments with respect to, among other things, more recent or future economic, competitive, regulatory and financial market conditions and future business decisions that may not occur, may not produce the anticipated results or may otherwise be subject to significant business, economic, competitive and regulatory uncertainties and contingencies, including, among other things, the inherent uncertainty of the business and economic conditions affecting the industries in which the Company operates, and the risks and uncertainties described in the section of this proxy statement titled “Cautionary Statement Regarding Forward-Looking Statements” beginning on page 23, all of which are difficult to predict and many of which are outside the control of the Company and, upon consummation of the transactions contemplated by the merger agreement, including the merger, will be beyond the control of Thrive Holdings and the surviving corporation. Company stockholders are urged to review the Company’s SEC filings for a description of risk factors with respect to the Company’s business. There can be no assurance that the underlying assumptions will prove to be accurate or that the projected results will be realized. Actual results likely will differ, and may differ materially, from those reflected in the Financial Forecasts, whether or not the merger is consummated. The inclusion in this proxy statement of the Financial Forecasts below should not be regarded as an indication that the Company, Thrive Holdings or Parent, their respective boards of directors (or equivalent governing bodies) or their respective financial advisors considered, or now consider, these forecasts to be a reliable predictor of future results. The Financial Forecasts are not fact, and neither they nor any underlying assumptions should be relied upon as being indicative of future results. Readers of this proxy statement are cautioned not to place reliance on this information. The Financial Forecasts assume that the Company would continue to operate as a standalone company and do not reflect any impact of the proposed merger, including any impact of the negotiation or execution of the proposed merger, the expenses that may be incurred in connection with the proposed merger or the consummation thereof or the effect of any business or strategic decision or action that has been or will be taken as a result of the merger agreement having been executed or in anticipation of the proposed merger.
The Financial Forecasts include certain non-GAAP financial measures, including Adjusted EBITDA and Unlevered Free Cash Flow (each as defined below). The Company’s management included forecasts of non-GAAP financial measures in the Financial Forecasts because the Company’s management believes that non-GAAP financial measures can be helpful in comparing the Company’s past financial performance and future results and can be useful to investors because they provide (i) a basis to compare the Company’s operating performance with that of other companies and (ii) additional information about how the Company’s management evaluates the business. Company stockholders should also note that these non-GAAP financial measures presented in this proxy statement are not prepared under any comprehensive set of accounting rules or principles and do not reflect all of the amounts associated with the Company’s results of operations as determined in accordance with GAAP. Company stockholders should also note that these non-GAAP financial measures presented in this proxy statement have no standardized meaning prescribed by GAAP and, therefore, have limits in their usefulness to Company stockholders. Because of the non-standardized definitions, the non-GAAP financial measures in this proxy statement and the accompanying footnotes may be calculated differently from, and may not be directly comparable to, similarly titled measures used by the Company’s competitors and other companies, or any similarly titled measures used by Thrive Holdings or its affiliates.
Due to the inherent limitations of non-GAAP financial measures, Company stockholders should consider non-GAAP measures only as a supplement to, not as a substitute for or as a superior measure to, measures of financial
performance prepared in accordance with GAAP. The footnotes to the tables below provide certain supplemental information with respect to the calculation of these non-GAAP financial measures.
The Financial Forecasts included in this proxy statement have been prepared by, and are the responsibility of, the Company’s management. PricewaterhouseCoopers LLP has not audited, reviewed, examined, compiled nor applied agreed upon procedures with respect to the accompanying Financial Forecasts and, accordingly, PricewaterhouseCoopers LLP does not express an opinion or any other form of assurance with respect thereto. The PricewaterhouseCoopers LLP report incorporated by reference in this proxy statement relates to the Company’s previously issued financial statements. It does not extend to the Financial Forecasts and should not be read to do so.
The non-GAAP financial measures included in the Financial Forecasts that were approved by the Company for use by Citi and Goldman Sachs were used by each of Citi and Goldman Sachs in connection with their respective financial analyses and opinions and by the Board for its consideration of the merger and were provided to Thrive Holdings and its affiliates. Financial measures provided to a financial advisor or counterparty in connection with a business combination transaction are not subject to SEC rules regarding disclosures of non-GAAP financial measures, and reconciliations of non-GAAP financial measures were not relied upon by the Board, Citi or Goldman Sachs in connection with their respective evaluations of the merger. In addition, Thrive Holdings was not provided with any such reconciliation. Accordingly, the Company has not provided a reconciliation of the non-GAAP financial measures included in the Financial Forecasts to the relevant GAAP financial measures in this proxy statement.
By including in this proxy statement the Financial Forecasts below, none of the Company, Thrive Holdings or any of their respective representatives has made or makes any representation to any person regarding the ultimate performance of the Company compared to the information contained in the Financial Forecasts. Accordingly, the Financial Forecasts should not be construed as financial guidance, nor relied upon as such, and the Financial Forecasts may differ in important respects from the 2026 earnings guidance, which the Company’s management prepared based on a different set of assumptions. The inclusion of the Financial Forecasts in this proxy statement does not constitute an admission or representation by the Company that the information contained therein is material. The Financial Forecasts summarized in this section reflected the opinions, estimates and judgments of the Company’s management at the time they were prepared and have not been updated to reflect any changes since such Financial Forecasts were prepared. NONE OF THE COMPANY, THRIVE HOLDINGS OR, AFTER CONSUMMATION OF THE MERGER, THE SURVIVING CORPORATION, UNDERTAKES ANY OBLIGATION, EXCEPT AS REQUIRED BY LAW, TO UPDATE OR OTHERWISE REVISE THE FINANCIAL FORECASTS TO REFLECT CIRCUMSTANCES EXISTING SINCE THEIR PREPARATION, CHANGES IN GENERAL ECONOMIC OR INDUSTRY CONDITIONS OR THE OCCURRENCE OF UNANTICIPATED EVENTS, EVEN IN THE EVENT THAT ANY OR ALL OF THE UNDERLYING ASSUMPTIONS ARE SHOWN TO BE IN ERROR. IN LIGHT OF THE FOREGOING FACTORS AND UNCERTAINTIES INHERENT IN THE FINANCIAL FORECASTS, READERS OF THIS PROXY STATEMENT ARE CAUTIONED NOT TO PLACE RELIANCE ON THIS INFORMATION.
The Company’s management prepared the nonpublic, unaudited prospective multi-year financial framework containing information for fiscal years 2026 through 2030 (the “Financial Forecasts”). The Financial Forecasts were prepared for the Company’s internal use and in connection with management’s ordinary course long-range plan for the Company and were first discussed and previewed with the Board in the second quarter of 2026, with the final framework reviewed by the Board at its meeting held on August 31, 2026. The Financial Forecasts reviewed by the Board included Revenue, Adjusted EBITDA and Unlevered Free Cash Flow for a stub period consisting of the second half of fiscal year 2026. Following the completion of the third quarter of fiscal year 2026, the fourth quarter amounts were derived by subtracting the Company’s actual results for the first three quarters of fiscal year 2026 from the fiscal year 2026 estimates in the Financial Forecasts or, in the case of certain components of Unlevered Free Cash Flow, by prorating the applicable fiscal year 2026 estimates. There were no changes to the underlying assumptions or other updates to reflect actual performance. The Financial Forecasts were not otherwise updated or revised to reflect the Company’s recent performance or business trends or in connection with the merger. The Financial Forecasts were made available to Thrive Holdings in the course of its due diligence in connection with its review of a potential transaction with the Company.
The Financial Forecasts were provided to, and considered and reviewed by the Board in connection with the Board’s evaluation of the potential merger and its determination on October 28, 2026 that it is in the best interests of the Company and the stockholders of the Company, and its declaration that it is advisable, that the Company enter into the merger agreement and consummate the merger, its approval of the merger agreement and the consummation of the merger and its recommendation that the Company’s stockholders entitled to vote adopt the merger agreement. The Financial Forecasts were the only forecasts prepared by Company management that were approved by the Company for use by Citi and Goldman Sachs in connection with their opinions and their respective financial analyses in connection therewith, as summarized below in the sections titled “The Merger—Opinions of the Company’s Financial Advisors—Opinion of Citigroup Global Markets Inc.” beginning on page 54 and “The Merger—Opinions of the Company’s Financial Advisors—Opinion of Goldman Sachs & Co. LLC” beginning on page 60.
The following table sets forth a summary of the Financial Forecasts, which summary is not included in this proxy statement to induce any Company stockholder to vote in favor of adopting the merger agreement proposal or approving any other proposals to be voted on at the special meeting or to influence any Company stockholder to make any investment decision with respect to the merger, including whether to seek appraisal rights with respect to their shares:
Financial Forecasts
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Year Ended December 31 |
| ($ in millions) | | Q4 ‘26E | | ‘27E | | ‘28E | | ‘29E | | ‘30E |
| Total Revenue | | 1,240 | | | 5,544 | | | 5,921 | | | 6,318 | | | 6,734 | |
Adjusted EBITDA(1) | | 691 | | | 2,723 | | | 2,950 | | | 3,224 | | | 3,530 | |
Unlevered Free Cash Flow(2) | | 247 | | | 913 | | | 1,077 | | | 1,281 | | | 1,506 | |
______________
(1)“Adjusted EBITDA” is defined as income (loss) from continuing operations adjusted for (i) interest; (ii) taxes; (iii) depreciation and amortization, including depreciation of subscriber system assets and other fixed assets and amortization of dealer and other intangible assets; (iv) amortization of deferred costs and deferred revenue associated with subscriber acquisitions; (v) share-based compensation expense; (vi) merger, restructuring, integration, and other items; (vii) impairment charges; and (viii) other non-cash or non-routine adjustments not necessary to operate the Company’s business. Adjusted EBITDA is a non-GAAP financial measure and should not be considered as an alternative to net income or operating income as a measure of operating performance or cash flows or as a measure of liquidity.
(2)Unlevered Free Cash Flow was arithmetically calculated by Citi and Goldman Sachs solely using information provided in Financial Forecasts and was approved by the Company for use by Citi and Goldman Sachs and deemed part of the Financial Forecasts approved for use by Citi and Goldman Sachs, for the purposes of their respective opinions and financial analyses. “Unlevered Free Cash Flow” is defined as Adjusted EBITDA less depreciation and amortization and stock based compensation expense (“Adjusted EBIT”), (i) less taxes on Adjusted EBIT, (ii) plus depreciation and amortization, (iii) plus or less changes in working capital, (iv) less capital expenditures, (v) less net cash subscriber acquisition costs, (vi) less finance lease payments and other items, (vii) plus accounting adjustments (including expensed subscriber acquisition costs, other special items and ASC 606 adjustments that align the timing of GAAP revenue with the timing of cash revenue). Unlevered Free Cash Flow is a non-GAAP financial measure and should not be considered as an alternative to net income, operating income or cash flows from operating activities as a measure of operating performance or of cash flows or as a measure of liquidity.
Opinions of the Company’s Financial Advisors
Opinion of Citigroup Global Markets Inc.
The Company retained Citi as its financial advisor in connection with the merger. In connection with Citi’s engagement, the Company requested that Citi evaluate the fairness, from a financial point of view, to the holders of shares of Company common stock of the merger consideration pursuant to the merger agreement. On October 28, 2026, at a meeting of the Board held to evaluate the merger and at which the merger agreement was approved, Citi rendered to the Board an oral opinion, confirmed by delivery of a written opinion, dated October 28, 2026, to the effect that, as of that date and based on and subject to various assumptions made, procedures followed, matters considered and limitations and qualifications on the review undertaken by Citi as set forth in its written opinion, the merger consideration to be received by the holders of shares of Company common stock in the merger pursuant to the merger agreement was fair, from a financial point of view, to such holders.
The full text of Citi’s written opinion, dated October 28, 2026, to the Board, which sets forth, among other things, the assumptions made, procedures followed, matters considered and limitations and qualifications on the review undertaken by Citi in rendering its opinion, is attached to this proxy statement as Annex B and is incorporated herein by reference in its entirety. The summary of Citi’s opinion set forth below is qualified in its entirety by reference to the full text of Citi’s opinion. Citi’s opinion was rendered to the Board (in its capacity as such) in connection with its evaluation of the merger and was limited to the fairness, from a financial point of view, to the holders of shares of Company common stock of the merger consideration pursuant to the merger agreement. Citi’s opinion did not address any other terms, aspects or implications of the merger. Citi’s opinion is not intended to be and does not constitute a recommendation to any stockholder as to how such stockholder should vote or act on any matters relating to the merger.
In arriving at its opinion, Citi:
•reviewed a draft, dated October 28, 2026, of the merger agreement and held discussions with certain senior officers, directors and other representatives and advisors of the Company concerning the business, operations and prospects of the Company;
•reviewed certain publicly available business and financial information relating to the Company as well as certain financial forecasts and other information and data relating to the Company which were prepared and provided to or discussed with Citi by the management of the Company; and
•reviewed the financial terms of the merger as set forth in the merger agreement in relation to, among other things: current and historical market prices and trading volumes of the common stock; certain historical and projected earnings and other operating data of the Company; and the capitalization and financial condition of the Company.
In addition to the foregoing, Citi conducted such other analyses and examinations and considered such other information and financial, economic and market criteria as Citi deemed appropriate in arriving at its opinion. The issuance of Citi’s opinion was authorized by Citi’s fairness opinion committee.
In rendering its opinion, Citi assumed and relied, without independent verification, upon the accuracy and completeness of all financial and other information and data publicly available or provided to or otherwise reviewed by or discussed with Citi and upon the assurances of the management of the Company that they were not aware of any relevant information that had been omitted or that remained undisclosed to Citi. With respect to financial forecasts and other information and data relating to the Company provided to or otherwise reviewed by or discussed with Citi, Citi was advised by the management of the Company, and Citi assumed, with the Board’s consent, that such forecasts and other information and data were reasonably prepared in good faith on bases reflecting the best currently available estimates and judgments of the management of the Company as to, and were a reasonable basis upon which to evaluate, the future financial performance of the Company. Citi expressed no view or opinion as to any financial and other information or data (or any underlying assumptions on which any such financial and other information or data are based) provided to or otherwise reviewed by or discussed with Citi.
Citi assumed, with the Board’s consent, that the merger would be consummated in accordance with the terms, conditions and agreements set forth in the merger agreement, and in compliance with all applicable laws, documents and other requirements, without waiver, modification or amendment of any material term, condition or agreement and that, in the course of obtaining the necessary governmental, regulatory or third party approvals, consents and releases for the merger, no delay, limitation, restriction or condition would be imposed or occur that would have an adverse effect on the Company or the merger (including the contemplated benefits thereof) or that otherwise would be meaningful in any respect to Citi’s analyses or opinion. Representatives of the Company advised Citi, and Citi further assumed, that the final terms of the merger agreement would not vary, in any material respect, from those set forth in the draft reviewed by Citi. Citi did not make, and was not provided with, an independent evaluation or appraisal of the assets or liabilities (contingent, derivative, off-balance sheet, accrued or otherwise) of the Company or any other business or person, nor did Citi make any physical inspection of the properties or assets of the Company or any other business or person. Citi’s opinion did not address any terms (other than the merger consideration to the extent expressly specified in Citi’s opinion), aspects or implications of the merger, including, without limitation, the form or structure of
the merger, the allocation of the merger consideration between the different classes of Company stock, or any other agreement, arrangement or understanding to be entered into in connection with, related to or contemplated by the merger or otherwise. Citi did not express any opinion as to the prices at which the common stock would trade at any time, or any other securities would trade or otherwise be transferable at any time, including following the announcement of the merger. Citi did not evaluate the solvency or fair value of the Company, or any other entity under any state, federal or other laws relating to bankruptcy, insolvency or similar matters. Citi was not requested to, and it did not, solicit third party indications of interest in the possible acquisition of all or a part of the Company, nor was Citi requested to consider, and its opinion did not address, the underlying business decision of the Company to effect or enter into the merger, the relative merits of the merger as compared to any alternative business strategies that might exist for the Company or the effect of any other transaction in which the Company might engage or that the Company might consider. Citi also expressed no view as to, and its opinion did not address, the fairness (financial or otherwise) of the amount or nature or any other aspect of any compensation or other consideration to any officers, directors or employees of any parties to the merger (in their capacity as such), or any class of such persons, relative to the merger consideration or otherwise. Citi did not express any opinion or view with respect to accounting, tax, regulatory, legal or similar matters and Citi relied, with the Board’s consent, upon the assessments of representatives of the Company as to such matters. Citi’s opinion was necessarily based upon information available to Citi, and financial, stock market and other conditions and circumstances existing, as of the date of its opinion. Although subsequent developments might affect Citi’s opinion, Citi has no obligation to update, revise or reaffirm its opinion.
In preparing its opinion, Citi performed a variety of financial and comparative analyses, including those described below. The preparation of a financial opinion is a complex analytical process involving various determinations as to the most appropriate and relevant methods of financial analysis and the application of those methods to the particular circumstances and, therefore, a financial opinion is not readily susceptible to partial analysis or summary description. Citi arrived at its opinion based on the results of all analyses undertaken by it and factors assessed as a whole, and it did not draw, in isolation, conclusions from or with regard to any one factor or method of analysis for purposes of its opinion.
The estimates used by Citi for purposes of its analyses and the valuation ranges resulting from any particular analysis are not necessarily indicative of actual values or predictive of future results or values, which may be significantly more or less favorable than those suggested by such analyses. In addition, analyses relating to the value of businesses or securities do not purport to be appraisals or to reflect the prices at which businesses or securities actually may be sold or acquired. Accordingly, the estimates used in, and the results derived from, Citi’s analyses are inherently subject to substantial uncertainty.
Citi was not requested to, and it did not, recommend or determine the specific consideration payable in the merger. The type and amount of consideration payable in the merger were determined through negotiations between the Company and Parent and the Company’s decision to enter into the merger agreement was solely that of the Board. Citi’s opinion was only one of many factors considered by the Board in its evaluation of the merger and should not be viewed as determinative of the views of the Board or the management of the Company with respect to the merger, the merger consideration or any other aspect of the transactions contemplated by the merger agreement.
Summary of Financial Analyses of Citi
The following is a summary of the material financial analyses prepared for and reviewed with the Board in connection with the rendering of Citi’s opinion, dated October 28, 2026, to the Board. The summary set forth below does not purport to be a complete description of the financial analyses performed by, and underlying the opinion of, Citi, nor does the order of the financial analyses described represent the relative importance or weight given to those financial analyses by Citi. Certain financial analyses summarized below include information presented in tabular format. In order to fully understand the financial analyses, the tables must be read together with the text of each summary as the tables alone do not constitute a complete description of the financial analyses. Considering the data in the tables below without considering the full narrative description of the financial analyses, including the methodologies and assumptions underlying the financial analyses, could create a misleading or incomplete view of such financial analyses. Future results may be different from those described and such differences may be material. Approximate implied equity value per share reference ranges derived from the financial analyses described below and other per share ranges presented for
reference purposes only were rounded to the nearest $0.05, except with respect to the current share price and the 52-week trading range analysis. Financial data utilized for the Company in the financial analyses described below, to the extent based on financial forecasts and estimates of management, were based on certain financial forecasts and other information and data relating to the Company provided to or discussed with Citi by the management of the Company, and approved for Citi’s use by the Company (see the “Financial Forecasts” as further summarized in the section titled “—Certain Financial Forecasts”).
Discounted Cash Flow Analysis
Citi conducted a discounted cash flow analysis of the Company using the Financial Forecasts for the purpose of determining an implied fully diluted equity value per share of Company common stock. Citi calculated the estimated present value of unlevered free cash flows that the Company was forecasted to generate during the period from the fourth quarter of fiscal year ending December 31, 2026 through fiscal year ending December 31, 2030 based on the Financial Forecasts. Citi calculated a range of illustrative terminal values for the Company as of December 31, 2030 by applying a selected range of enterprise value to adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) less capitalized subscriber acquisition costs multiples of 8.0x to 10.0x to the Company’s estimated terminal year adjusted EBITDA less capitalized subscriber acquisition costs, burdened by stock-based compensation expense. The unlevered free cash flows and the range of terminal values were then discounted to present values, as of September 30, 2026, using the mid-year discounting convention and discount rates ranging from 9.5% to 11.5%, which Citi derived based on estimates of the Company’s weighted average cost of capital, to derive ranges of implied enterprise value for the Company. Citi adjusted the range of implied enterprise values it derived for the Company for the Company’s net debt, as of September 30, 2026, as provided by the Company’s management, and divided the results by the fully diluted number of shares of Company common stock calculated using the treasury stock method, based on equity information as of October 26, 2026 as provided by the Company’s management. This analysis indicated an approximate implied per share equity value reference range for the Company of $9.95 to $15.20, as compared to the closing share price of the common stock as of October 27, 2026, of $6.87, and the merger consideration of $10.00.
Illustrative Present Value of Future Share Price Analysis
Citi conducted an illustrative present value of future share price analysis of the Company using the Financial Forecasts. Citi calculated illustrative future share prices as of December 31 of each of 2026 through 2029 based on (i) a multiple of enterprise value to next-twelve-month estimated adjusted EBITDA of 4.7x, reflecting the Company’s current trading multiple, and (ii) an adjusted free cash flow yield of 15.6%, reflecting the Company’s estimated 2027 adjusted free cash flow divided by its current equity value. Citi discounted the resulting illustrative future share prices to present values using a discount rate of 13.9%, reflecting the Company’s cost of equity. This analysis indicated an approximate implied per share equity value reference range for the Company of $6.75 to $10.25, as compared to the closing share price of the common stock as of October 27, 2026, of $6.87, and the merger consideration of $10.00.
Certain Additional Information
Citi observed certain other information with respect to the Company that was not considered part of its financial analyses with respect to its opinion, but was noted for reference purposes only, including the following:
Illustrative Discounted Cash Flow Sensitivity Analysis
Citi conducted an illustrative discounted cash flow sensitivity analysis of the Company using the same methodology as described in the section above under the caption “—Discounted Cash Flow Analysis”, based on the Financial Forecasts excluding certain initiatives. This analysis indicated an approximate implied per share equity value reference range for the Company of $6.85 to $11.15, as compared to the closing share price of the common stock as of October 27, 2026, of $6.87, and the merger consideration of $10.00.
52-Week Trading Range
Citi reviewed the range of intraday trading prices of the common stock during the 52-week period ended October 27, 2026. The intraday trading prices during that period ranged from a low of $6.03 on October 1, 2026 to a high of $8.89 on November 3, 2025, as compared to the merger consideration of $10.00.
Discounted Analyst Price Targets
Citi reviewed publicly available analyst price targets for the common stock, which ranged from $7.00 to $9.00. Citi discounted these price targets to present values as of October 27, 2026 using a cost of equity of 13.9%. This analysis indicated an approximate discounted per share reference range of $6.35 to $8.15, as compared to the merger consideration of $10.00.
Premiums Paid Analysis
Citi reviewed premiums paid in all-cash acquisitions of North American target companies with enterprise values between $5 billion and $20 billion from January 1, 2021 through October 27, 2026. Citi reviewed the median unaffected one-day premiums for those transactions, which indicated an overall median of 33%. Premiums were based on the announcement date unless the target company had confirmed a sale process or merger talks or rumors had surfaced within the preceding six months. Citi applied an illustrative premium range of 20% to 50% to the closing share price of the common stock on October 27, 2026 of $6.87. This analysis indicated an approximate implied per share equity value reference range for the Company of $8.25 to $10.30, as compared to the merger consideration of $10.00.
Selected Public Companies Analysis
Citi reviewed certain publicly available financial and stock market information of the Company and the selected companies listed below (collectively, the “selected companies”):
Verisure plc
S-1 Corporation
Alarm.com Holdings, Inc.
Arlo Technologies, Inc.
Although none of the selected companies is directly comparable to the Company, the companies included were chosen because they have operations that, for purposes of Citi’s analysis and based on its experience and professional judgment, may be considered generally relevant in evaluating those of the Company based on business sector participation, operational characteristics and financial metrics. The quantitative information used in this analysis, to the extent that it is based on market data, was based on market data as of October 27, 2026, except that the figures for Verisure and S-1 Corporation reflected unaffected share prices preceding the October 21, 2026 announcement of CVC’s interest in Verisure and the October 14, 2026 tender offer announcement relating to S-1 Corporation, respectively.
For each of the selected companies, and for the Company for reference, Citi calculated and reviewed, among other information, firm value as a multiple of 2027 calendar year EBITDA (such multiple, “FV / 2027E EBITDA”). Financial data of the selected companies were based on company filings and FactSet. Financial data of the Company were based on publicly available information and information provided by the Company’s management. Peer data were presented on a U.S. GAAP basis.
Based on its professional judgment and experience, and taking into consideration the observed multiples for the selected companies, Citi then applied an illustrative FV / 2027E EBITDA multiple reference range of 5.2x to 7.4x to an estimate of the Company’s 2027 calendar year adjusted EBITDA based on the Financial Forecasts, to derive ranges of implied firm value for the Company. Citi adjusted the range of implied firm values it derived for the Company for the Company’s net debt, as of September 30, 2026, as provided by the Company’s management, and
divided the results by the fully diluted number of shares of Company common stock calculated using the treasury stock method, based on equity information as of October 26, 2026 as provided by the Company’s management. This analysis indicated an approximate implied per share equity value reference range for the Company of $8.65 to $16.30, as compared to the closing share price of the common stock as of October 27, 2026, of $6.87, and the merger consideration of $10.00.
Selected Precedent Transactions Analysis
Using publicly available information, Citi performed an analysis of selected precedent transactions relevant to the Company and/or the transaction contemplated by the merger agreement, during which Citi reviewed financial data relating to the three selected transactions listed in the table below that Citi considered generally relevant for purposes of analysis (collectively, the “selected transactions”):
Although none of the target companies in the selected transactions are directly comparable to the Company and none of the selected transactions are directly comparable to the transactions contemplated by the merger agreement, the selected transactions were chosen because they involved businesses with financial, operational or business characteristics that, in Citi’s view, based on its professional judgment and experience, made them sufficiently comparable to the Company and/or the transaction contemplated by the merger agreement or otherwise relevant for purposes of analysis.
For each of the selected transactions, Citi reviewed, among other information, the ratio of the target company’s firm value (calculated as the publicly disclosed transaction value) to the target company’s EBITDA for the specified prior 12 month period disclosed at the time the transaction was announced (“FV / LTM EBITDA”). Financial data of the selected transactions were based on public filings and other publicly available information.
| | | | | | | | | | | | | | | | | | | | |
| Target | | Acquiror | | Month / Year Announced | | Firm Value / LTM EBITDA |
| ADT UK Residential | | Intelligent Monitoring Group Ltd | | July 2026 | | 4.2x |
| The ADT Corporation | | Apollo Global Management, LLC | | February 2016 | | 6.8x |
| Vivint Smart Home, Inc. | | NRG Energy, Inc. | | December 2022 | | 7.1x |
Based on its professional judgment and experience and taking into consideration the observed multiples for the selected transactions, Citi then applied FV / LTM EBITDA multiples of 4.2x, 6.8x and 7.1x to the estimated 2026 calendar year adjusted EBITDA of the Company based on the Financial Forecasts, to derive implied firm values for the Company. Citi adjusted these implied firm values to account for the Company’s net debt as of September 30, 2026 and as provided by the Company’s management, and divided the results by the fully diluted number of shares of Company common stock calculated using the treasury stock method, based on equity information as of October 26, 2026 and as provided by the Company’s management. This analysis indicated approximate implied per share equity values for the Company of $4.90, $13.95 and $15.00 based on the ADT UK, ADT and Vivint transactions, respectively, as compared to the closing share price of the common stock as of October 27, 2026, of $6.87, and the merger consideration of $10.00.
Miscellaneous
For its services in connection with the merger, the Company agreed to pay Citi an aggregate fee estimated based on information available as of the date of this proxy statement to be approximately $69 million, which is contingent upon the consummation of the merger. In addition, the Company agreed to reimburse Citi for certain expenses and to indemnify Citi against certain liabilities arising from Citi’s engagement.
As the Board was aware, Citi and its affiliates in the past have provided, currently are providing and in the future may provide, certain investment banking, commercial banking and other similar services to the Company and/or its affiliates unrelated to the merger, for which services Citi and such affiliates have received and expect to receive compensation, including, without limitation, during the two-year period prior to the date of Citi’s opinion, having acted as joint bookrunning manager with respect to certain secondary public offerings and as joint lead arranger, joint bookrunner and lender with respect to certain credit facilities and debt offerings of the Company and having provided
or providing certain markets and securities services, treasury and trade solutions services and corporate portfolio management services. For the services described above for the Company, Citi and its affiliates received, during the two-year period prior to the date of Citi’s opinion, aggregate fees of approximately $5.1 million from the Company and/or certain of its affiliates. As the Board was further aware, Citi and its affiliates have not, during the two-year period prior to the date of Citi’s opinion, provided investment banking, commercial banking or other similar financial services to Thrive Capital or Thrive Holdings, or their affiliates for which Citi and its affiliates have received or expect to receive compensation, although Citi and its affiliates in the future may provide such services, for which they would expect to receive compensation. In the ordinary course of its business, Citi and its affiliates may actively trade or hold the securities or financial instruments (including loans and other obligations) of the Company, Thrive Capital, Thrive Holdings and their respective affiliates for Citi’s own account or for the account of Citi’s customers and, accordingly, may at any time hold a long or short position or otherwise effect transactions in such securities or financial instruments. In addition, Citi and its affiliates (including Citigroup Inc. and its affiliates) may maintain relationships with the Company, Thrive Capital, Thrive Holdings and their respective affiliates. As of October 26, 2026, Citi held, on a proprietary basis, less than 1.0% of the outstanding equity securities of the Company and no equity securities of Thrive Capital and Thrive Holdings.
The Company selected Citi to act as its financial advisor in connection with the merger based on Citi’s reputation, experience and familiarity with the Company and its business. Citi is an internationally recognized investment banking firm that regularly engages in the valuation of businesses and their securities in connection with mergers and acquisitions, negotiated underwritings, competitive bids, secondary distributions of listed and unlisted securities, private placements and valuations for estate, corporate and other purposes.
Opinion of Goldman Sachs & Co. LLC
Goldman Sachs delivered its opinion to the Board that, as of October 29, 2026, and based upon and subject to the factors and assumptions set forth therein, the $10.00 in cash per share of Company common stock to be paid to the holders (other than Parent and its affiliates) of shares of Company common stock, taken in the aggregate, pursuant to the merger agreement was fair from a financial point of view to such holders of shares of Company common stock, taken in the aggregate.
The full text of the written opinion of Goldman Sachs, dated October 29, 2026, which sets forth assumptions made, procedures followed, matters considered and limitations on the review undertaken in connection with the opinion, is attached as Annex C. Goldman Sachs provided advisory services and its opinion for the information and assistance of the Board in connection with its consideration of the merger. Goldman Sachs’ opinion is not a recommendation as to how any holder of shares of Company common stock should vote with respect to the merger or any other matter.
In connection with rendering the opinion described above and performing its related financial analyses, Goldman Sachs reviewed, among other things:
•the merger agreement;
•annual reports to stockholders and Annual Reports on Form 10-K of the Company for the five years ended December 31, 2025;
•certain interim reports to stockholders and Quarterly Reports on Form 10-Q of the Company;
•certain other communications from the Company to its stockholders;
•certain publicly available research analyst reports for the Company; and
•certain internal financial analyses and forecasts for the Company prepared by its management, as approved for Goldman Sachs’ use by the Company, which are referred to as the “Financial Forecasts”.
Goldman Sachs also held discussions with members of the senior management of the Company regarding their assessment of the past and current business operations, financial condition, and future prospects of the Company; reviewed the reported price and trading activity for the shares of common stock; compared certain financial and
stock market information for the Company with similar information for certain other companies the securities of which are publicly traded; reviewed the financial terms of certain recent business combinations; and performed such other studies and analyses, and considered such other factors, as it deemed appropriate.
For purposes of rendering this opinion, Goldman Sachs, with the Board’s consent, relied upon and assumed the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by it, without assuming any responsibility for independent verification thereof. In that regard, Goldman Sachs assumed with the Board’s consent that the Financial Forecasts were reasonably prepared on a basis reflecting the best currently available estimates and judgments of the management of the Company. In rendering its opinion, Goldman Sachs did not take into account any differential voting or other rights between the shares of common stock and the shares of Class B common stock. Goldman Sachs did not make an independent evaluation or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance-sheet assets and liabilities) of the Company or any of its subsidiaries and it was not furnished with any such evaluation or appraisal. Goldman Sachs assumed that all governmental, regulatory or other consents and approvals necessary for the consummation of the merger will be obtained without any adverse effect on the expected benefits of the merger in any way meaningful to its analysis. Goldman Sachs assumed that the merger will be consummated on the terms set forth in the merger agreement, without the waiver or modification of any term or condition the effect of which would be in any way meaningful to its analysis.
Goldman Sachs’ opinion does not address the underlying business decision of the Company to engage in the merger, or the relative merits of the merger as compared to any strategic alternatives that may be available to the Company; nor does it address any legal, regulatory, tax or accounting matters. Goldman Sachs was not requested to solicit, and did not solicit, interest from other parties with respect to an acquisition of, or other business combination with, the Company or any other alternative transaction. Goldman Sachs’ opinion addresses only the fairness from a financial point of view to the holders (other than Parent and its affiliates) of shares of Company common stock, as of the date of the opinion, of the $10.00 in cash per share of Company common stock to be paid to such holders, taken in the aggregate, pursuant to the merger agreement. Goldman Sachs’ opinion does not express any view on, and does not address, any other term or aspect of the merger agreement or the merger or any term or aspect of any other agreement or instrument contemplated by the merger agreement or entered into or amended in connection with the merger, including the fairness of the merger to, or any consideration received in connection therewith by, the holders of any other class of securities, creditors, or other constituencies of the Company, nor as to the fairness of the amount or nature of any compensation to be paid or payable to any of the officers, directors or employees of the Company, or class of such persons, in connection with the merger, whether relative to the $10.00 in cash per share of Company common stock to be paid to the holders (other than Parent and its affiliates) of shares of Company common stock, taken in the aggregate, pursuant to the merger agreement or otherwise. Goldman Sachs expresses no opinion with respect to the allocation of the aggregate consideration payable pursuant to the merger agreement, including among the holders of various classes of Company stock pursuant to the merger agreement. In addition, Goldman Sachs does not express any opinion as to the prices at which the shares of Company common stock will trade at any time or as to the potential effects of volatility in the credit, financial and stock markets on the Company, Parent or the merger, or as to the impact of the merger on the solvency or viability of the Company or Parent or the ability of the Company or Parent to pay their respective obligations when they come due. Goldman Sachs’ opinion is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to Goldman Sachs as of, the date of its opinion, and Goldman Sachs assumes no responsibility for updating, revising or reaffirming its opinion based on circumstances, developments or events occurring after the date of its opinion. Goldman Sachs’ opinion was approved by a fairness committee of Goldman Sachs.
The following is a summary of the material financial analyses delivered by Goldman Sachs to the Board in connection with rendering the opinion described above. The following summary, however, does not purport to be a complete description of the financial analyses performed by Goldman Sachs, nor does the order of analyses described represent relative importance or weight given to those analyses by Goldman Sachs. Some of the summaries of the financial analyses include information presented in tabular format. The tables must be read together with the full text of each summary and are alone not a complete description of Goldman Sachs’ financial analyses. Except as otherwise noted, the following quantitative information, to the extent that it is based on market
data, is based on market data as it existed on or before October 27, 2026, the trading day prior to the day the Board approved the merger, and is not necessarily indicative of current market conditions.
Historical Stock Trading Analysis.
Goldman Sachs reviewed the historical trading prices and volumes for the common stock, for the period from January 1, 2021 through October 27, 2026. In addition, Goldman Sachs analyzed the $10.00 per share of Company common stock to be paid to holders of shares of Company common stock pursuant to the merger agreement in relation to the latest twelve-month intraday high price of the common stock and latest 60-day volume-weighted average price of the common stock.
This analysis indicated that the price per share to be paid to Company stockholders pursuant to the merger agreement represented:
•a premium of 12.5% based on the latest twelve month intraday high market price of $8.89 per share;
•a premium of 43.2% based on the latest 60-day volume-weighted average price of $6.98 per share.
Illustrative Discounted Cash Flow Analysis.
Using the Financial Forecasts, Goldman Sachs performed an illustrative discounted cash flow analysis on the Company to derive a range of illustrative present values per share of Company common stock. Using the mid-year convention for discounting cash flows and discount rates ranging from 8.5% to 12.0%, reflecting estimates of the Company’s weighted average cost of capital, Goldman Sachs discounted to present value as of September 30, 2026 (i) estimates of unlevered free cash flow for the Company for the fourth quarter of fiscal year 2026 and for fiscal years 2027 through 2030 as reflected in the Financial Forecasts and (ii) a range of illustrative terminal values for the Company, which were calculated by applying last twelve month (“LTM”) enterprise value (“EV”) to adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) less capitalized subscriber acquisition costs (“Cap. SAC”) multiples (which are referred to in this section as “LTM EV/adjusted EBITDA – Cap. SAC” multiples) ranging from 8.0x to 10.0x to a terminal year estimate of the adjusted EBITDA less Cap. SAC to be generated by the Company, as reflected in the Financial Forecasts (which implied perpetuity growth rates ranging from 0.0% to 4.8%). The range of terminal year exit LTM EV/adjusted EBITDA – Cap. SAC multiples was estimated by Goldman Sachs utilizing its professional judgment and experience, taking into account current and historical trading multiples of the Company. Goldman Sachs derived such discount rates by application of the Capital Asset Pricing Model, which requires certain company-specific inputs, including the Company’s target capital structure weightings, the cost of long-term debt, after-tax yield on permanent excess cash, if any, future applicable marginal cash tax rate and a beta for the Company, as well as certain financial metrics for the United States financial markets generally.
Goldman Sachs derived ranges of illustrative enterprise values for the Company by adding the ranges of present values it derived above. Goldman Sachs then subtracted from the range of illustrative enterprise values it derived for the Company the amount of the Company’s net debt, as provided by and approved for Goldman Sachs’ use by the management of the Company, to derive a range of illustrative equity values for the Company. Goldman Sachs then divided the range of illustrative equity values it derived by the number of fully diluted outstanding shares of the Company, as provided by and approved for Goldman Sachs’ use by the management of the Company, using the treasury stock method, to derive a range of illustrative present values per share ranging from $9.90 to $16.50.
Illustrative Present Value of Future Share Price Analysis.
Using the Financial Forecasts, Goldman Sachs performed an illustrative analysis of the implied present value of an illustrative future value per share of Company common stock. For this analysis, Goldman Sachs first calculated the implied enterprise value for the Company for each of the fiscal years 2026 through 2029, by applying a range of illustrative last twelve month (“LTM”) EV to adjusted EBITDA – Cap. SAC multiples (which are referred to in this section as “LTM EV/adjusted EBITDA – Cap. SAC” multiples) of 8.0x to 10.0x to estimates of the Company’s LTM adjusted EBITDA less Cap. SAC for each of the fiscal years 2026 through 2029. This illustrative range of LTM EV/adjusted EBITDA – Cap. SAC multiples was estimated by Goldman Sachs utilizing its professional
judgment and experience, taking into account current and historical LTM EV/adjusted EBITDA – Cap. SAC multiples for the Company.
Goldman Sachs then subtracted the amount of the Company’s net debt for each of the fiscal years 2026 to 2029, each as provided by and approved for Goldman Sachs’ use by the management of the Company, from the respective implied enterprise values in order to derive a range of illustrative equity values for the Company as of December 31 of each of the fiscal years 2026 to 2029. Goldman Sachs then divided these implied equity values by the projected year-end number of fully diluted outstanding shares of Company common stock in each of the fiscal years 2026 to 2029, calculated using information provided by and approved for Goldman Sachs’ use by the management of the Company, to derive a range of implied future values per share of Company common stock. Goldman Sachs then discounted these implied future equity values per share of Company common stock and dividends earned during the fourth quarter of fiscal year 2026 through fiscal year 2029 to October 27, 2026, using an illustrative discount rate of 12.0%, reflecting an estimate of the Company’s cost of equity. Goldman Sachs derived such discount rate by application of the Capital Asset Pricing Model, which requires certain company-specific inputs, including a beta for the Company, as well as certain financial metrics for the United States financial markets generally. This analysis resulted in a range of implied present values of $6.60 to $13.65 per share of Company common stock.
Selected Transactions Analysis.
Goldman Sachs analyzed certain information relating to the following selected transactions in the security and alarm monitoring services industry since 2016. For each of the selected transactions, Goldman Sachs calculated and compared the implied enterprise value of the applicable target company based on the consideration paid in the merger as a multiple of the target company’s adjusted EBITDA in the twelve months prior to announcement of the merger based on information in public filings, press releases and investor relations documents. While none of the companies that participated in the selected transactions are directly comparable to the Company, the companies that participated in the selected transactions are companies with operations that, for the purposes of analysis, may be considered similar to certain of the Company’s results, market sizes and product profile.
The following table presents the results of this analysis:
| | | | | | | | | | | | | | | | | | | | |
Announcement Date | | Selected Transactions | | LTM EV / EBITDA |
| Acquiror | | Target | |
February 16, 2016 | | Apollo Global Management, LLC | | The ADT Corporation | | 5.5x |
December 6, 2022 | | NRG Energy, Inc. | | Vivint Smart Home, Inc. | | 7.1x |
July 2, 2026 | | Intelligent Monitoring Group Ltd | | ADT UK Residential | | 4.2x |
Based on the results of the foregoing calculations and Goldman Sachs’ professional judgment and experience, Goldman Sachs applied a reference range of LTM EV to adjusted EBITDA multiples of 4.2x to 7.1x to the Company’s fiscal year 2026 estimated adjusted EBITDA, as provided by and approved for Goldman Sachs’ use by the management of the Company, to derive a range of implied enterprise values for the Company. Goldman Sachs then subtracted the net debt of the Company as of September 30, 2026, as provided by and approved for Goldman Sachs’ use by the management of the Company, and divided the result by the number of fully diluted outstanding shares of Company common stock as of October 26, 2026, as provided by and approved for Goldman Sachs’ use by the management of the Company, to derive implied values per share of Company common stock of $4.90 to $15.00.
Premia Paid Analysis.
Goldman Sachs reviewed and analyzed, using publicly available information, the acquisition premia for 123 all-cash acquisition transactions announced from January 1, 2021 through October 27, 2026 involving a public company based in North America as the target where the disclosed enterprise values were between $5 billion and $20 billion. For the entire period, Goldman Sachs calculated the median, 10th percentile and 90th percentile premiums of the prices paid relative to each target’s last undisturbed closing stock price and 52-week high stock price prior to announcement of the merger. This analysis indicated median, 10th percentile and 90th percentile premiums of 36%, 27% and 44%, respectively, relative to the targets’ last undisturbed closing stock prices, and 4%, 0% and 13%, respectively, relative to the targets’ 52-week high stock prices. Using this analysis, Goldman Sachs
applied reference ranges of illustrative premiums of 25% to 45% to the Company’s undisturbed closing price per share of common stock of $6.87 as of October 27, 2026, and 0% to 15% to the Company’s 52-week high price per share of common stock of $8.89, resulting in ranges of implied equity values per share of Company common stock of $8.60 to $9.95 and $8.90 to $10.20, respectively.
The preparation of a fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description. Selecting portions of the analyses or of the summary set forth above, without considering the analyses as a whole, could create an incomplete view of the processes underlying Goldman Sachs’ opinion. In arriving at its fairness determination, Goldman Sachs considered the results of all of its analyses and did not attribute any particular weight to any factor or analysis considered by it. Rather, Goldman Sachs made its determination as to fairness on the basis of its experience and professional judgment after considering the results of all of its analyses. No company or transaction used in the above analyses as a comparison is directly comparable to the Company or Parent or the merger.
Goldman Sachs prepared these analyses for purposes of Goldman Sachs providing its opinion to the Board as to the fairness from a financial point of view of the $10.00 in cash per share of Company common stock to be paid to the holders (other than Parent and its affiliates) of shares of Company common stock, taken in the aggregate, pursuant to the merger agreement, was fair from a financial point of view to such holders of shares of Company common stock, taken in the aggregate. These analyses do not purport to be appraisals nor do they necessarily reflect the prices at which businesses or securities actually may be sold. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by these analyses. Because these analyses are inherently subject to uncertainty, being based upon numerous factors or events beyond the control of the parties or their respective advisors, none of the Company, Parent, Goldman Sachs or any other person assumes responsibility if future results are materially different from those forecast.
The merger consideration was determined through arm’s-length negotiations between the Company and Parent and was approved by the Board. Goldman Sachs provided advice to the Company during these negotiations. Goldman Sachs did not, however, recommend any specific amount of consideration to the Company or the Board or that any specific amount of consideration constituted the only appropriate consideration for the merger.
As described above, Goldman Sachs’ opinion to the Board was one of many factors taken into consideration by the Board in making its determination to approve the merger agreement. The foregoing summary does not purport to be a complete description of the analyses performed by Goldman Sachs in connection with the fairness opinion and is qualified in its entirety by reference to the written opinion of Goldman Sachs attached as Annex C.
Goldman Sachs and its affiliates (collectively, “Goldman Sachs Affiliated Entities”) are engaged in advisory, underwriting, lending and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the Company, Parent, any of their respective affiliates and third parties, including State Farm, Thrive Holdings and Thrive Capital and any of their respective affiliates and, as applicable, portfolio companies or any currency or commodity that may be involved in the merger. Goldman Sachs Investment Banking has an existing lending relationship with the Company and with Thrive Holdings, or majority-owned subsidiaries (excluding, if applicable, portfolio companies) or funds of Thrive Holdings. Goldman Sachs acted as financial advisor to the Company in connection with, and participated in certain of the negotiations leading to, the merger. During the two-year period ended October 29, 2026, Goldman Sachs Investment Banking had not been engaged by the Company or its affiliates to provide financial advisory or underwriting services for which Goldman Sachs had recognized compensation. During the two-year period ended October 29, 2026, Goldman Sachs Investment Banking had not been engaged by Thrive Capital or its Related Entities to provide financial advisory or underwriting services for which Goldman Sachs had recognized compensation. As of October 29, 2026, Goldman Sachs was mandated by Thrive Capital and/or its Related Entities to provide financial advisory and/or underwriting services unrelated to the merger with respect to one or more matters and expected that, if all such matters were consummated, Goldman Sachs Investment Banking would recognize compensation in an aggregate amount less than the merger fee expected
in connection with the merger. In addition, as is typical for investment banks, Goldman Sachs Investment Banking was, as of October 29, 2026, soliciting Thrive Capital and/or its Related Entities to work on financial advisory and/or underwriting matters unrelated to the merger on which it had not been, and may not be, mandated. Goldman Sachs Investment Banking was not in a position to estimate the amount of compensation, if any, it expected to recognize with respect to such matters, but it expected that, were it to be mandated on such matters, the mandates would provide for customary compensation. The status, timing and likelihood of consummation of such matters will change over time. During the two-year period ended October 29, 2026, Goldman Sachs Investment Banking had not been engaged by Thrive Holdings or its Related Entities to provide financial advisory or underwriting services for which Goldman Sachs had recognized compensation. As of October 29, 2026, Goldman Sachs was not mandated by Thrive Holdings and/or its Related Entities to provide financial advisory and/or underwriting services. In addition, as is typical for investment banks, Goldman Sachs Investment Banking was, as of October 29, 2026, soliciting Thrive Holdings and/or its Related Entities to work on financial advisory and/or underwriting matters unrelated to the merger on which it had not been, and may not be, mandated. Goldman Sachs Investment Banking was not in a position to estimate the amount of compensation, if any, it expected to recognize with respect to such matters, but it expected that, were it to be mandated on such matters, the mandates would provide for customary compensation. The status, timing and likelihood of consummation of such matters will change over time. During the two-year period ended October 29, 2026, Goldman Sachs Investment Banking had not been engaged by State Farm or its affiliates to provide financial advisory or underwriting services for which Goldman Sachs had recognized compensation. As of October 29, 2026, Goldman Sachs Investment Banking was not mandated by State Farm and/or its Related Entities to provide to any such person financial advisory and/or underwriting services. In addition, Goldman Sachs was, as of October 29, 2026, not soliciting State Farm and/or its Related Entities to work on financial advisory and/or underwriting matters for any such persons on which it had not been mandated. Goldman Sachs may also in the future provide financial advisory and/or underwriting services to the Company, Parent, State Farm, Thrive Capital, Thrive Holdings and their respective affiliates, and, as applicable, portfolio companies, for which Goldman Sachs Investment Banking may receive compensation.
As of October 29, 2026, Goldman Sachs Affiliated Entities had (i) no direct GS Principal Investment (as defined below) in the Company and/or its affiliates (excluding State Farm and its other affiliates), (ii) no direct GS Principal Investment in Thrive Holdings and/or its Related Entities (as defined below) (excluding State Farm and its other affiliates), (iii) an aggregate direct GS Principal Investment of approximately $2.7 million in Thrive Capital and/or its Related Entities (as defined below) (excluding State Farm and its other affiliates), and (iv) no direct GS Principal Investment (as defined below) in State Farm and/or its Related Entities (as defined below) (excluding Thrive Capital, Thrive Holdings, the Company or their other respective affiliates). As of October 29, 2026, funds managed by affiliates of Goldman Sachs Investment Banking were not co-invested with Thrive Capital and/or its affiliates and were invested in equity interests of funds managed by affiliates of Thrive Capital. Such funds managed by affiliates of Goldman Sachs Investment Banking may co-invest with, and invest in equity interests of, Thrive Capital and/or its affiliates or funds managed thereby in the future. As of October 29, 2026, funds managed by affiliates of Goldman Sachs Investment Banking were not co-invested with State Farm and/or its affiliates and were not invested in equity interests of funds managed by affiliates of State Farm. Such funds managed by affiliates of Goldman Sachs Investment Banking may co-invest with State Farm, and invest in equity interests of, funds managed by State Farm and/or its affiliates in the future.
On the public side of Goldman Sachs’ informational wall (the “Public Side”) and in the ordinary course of its various business activities, Goldman Sachs Affiliated Entities may also own equity securities in the Company, Thrive Capital, Thrive Holdings, State Farm and/or their respective affiliates arising from engaging in market making, trade execution, clearing, custody, margin lending and other similar financing transactions, securities lending, and related activities (including by acting as agent for third parties executing their transactions or as principal supplying liquidity to market participants, and any related hedging, other risk management or inventory management) (collectively, “Market Making Activities”), which positions change frequently. Regulatory, informational and operational barriers separate the Public Side from Goldman Sachs Investment Banking.
For purposes of this section of the proxy, (x) Goldman Sachs relied on its books and records to (i) unless otherwise indicated, calculate all amounts and (ii) determine whether an entity is an affiliate, portfolio company,
subsidiary or majority-owned subsidiary of another entity, and (y) the following terms have the definitions set forth below:
GS Principal Investments (including any associated commitments) are (i) direct balance sheet investments in equity interests or equity securities held by Goldman Sachs Affiliated Entities for its own account or (ii) direct investments in equity interests held by a fund managed by a Goldman Sachs Affiliated Entity which fund is primarily for the benefit of Goldman Sachs Affiliated Entities and/or its current and former employees and not third party clients. GS Principal Investments do not include equity interests arising from Market Making Activities, equity derivatives, convertible debt instruments, or warrants or equity kickers received in connection with senior secured loans, mezzanine loans, warehouse loans, preferred equity with a fixed rate of return or other similar types of financing transactions (which may also be subject to hedging or other risk-mitigating instruments). GS Principal Investments also do not include investments by funds managed by Goldman Sachs Affiliated Entities which funds are almost entirely for the benefit of third party clients (“GS Client Funds”), which funds can co-invest alongside, and/or make Investments in, the Related Entities. As investment managers for GS Client Funds, Goldman Sachs Affiliated Entities are required to fulfill a fiduciary responsibility to GS Client Funds in making decisions to purchase, sell, hold or vote on, or take any other action with respect to, any financial instrument.
Related Entities are, as applicable, a person or entity’s affiliates, portfolio companies and/or funds managed thereby.
The Board selected Goldman Sachs as its financial advisor because it is an internationally recognized investment banking firm that has substantial experience in transactions similar to the merger. Pursuant to a letter agreement dated September 24, 2026, the Company engaged Goldman Sachs to act as its financial advisor in connection with the contemplated merger. For its services in connection with the merger, the Company agreed to pay Goldman Sachs a transaction fee that is estimated, based on information available as of the date of this proxy statement, at approximately $69 million, all of which is contingent upon consummation of the merger. In addition, the Company has agreed to reimburse Goldman Sachs for certain of its expenses, including attorneys’ fees and disbursements, and to indemnify Goldman Sachs and related persons against various liabilities, including certain liabilities under the federal securities laws.
Certain Effects of the Merger
If the Company stockholder approval is obtained, the other conditions to the closing of the merger are either satisfied or (to the extent permitted by applicable law) waived and the merger is consummated, Merger Sub will be merged with and into the Company upon the terms set forth in the merger agreement and in accordance with the DGCL, with the Company as the surviving corporation in the merger. As the surviving corporation in the merger, the Company will continue to exist following the merger as a wholly owned subsidiary of Parent.
At the effective time, each share of Company common stock that is issued and outstanding as of immediately prior to the effective time (other than excluded shares and appraisal shares) will be converted automatically into the right to receive an amount in cash equal to $10.00 per share, without interest and subject to any applicable withholding taxes. Company stockholders who properly exercise and do not withdraw their appraisal rights will have a right to receive payment of the “fair value” of their shares of Company common stock as determined pursuant to an appraisal proceeding, as contemplated by the DGCL. For more information, please see the section of this proxy statement titled “—Appraisal Rights” beginning on page 88. Following the merger, all of the Company common stock will be beneficially owned by Parent, and none of the current holders of Company common stock will, by virtue of the merger, have any ownership interest in, or be a stockholder of, the Company, the surviving corporation or Parent. As a result, the current holders of common stock will no longer benefit from any increase in the value, nor will they bear the risk of any decrease in the value, of the Company following the merger. Following the merger, Parent will benefit from any increase in the Company’s value and also will bear the risk of any decrease in the Company’s value.
Please see the section of this proxy statement titled “The Merger Agreement—Consideration To Be Received in the Merger” beginning on page 85.
For information regarding the effects of the merger on the Company’s outstanding long-term incentive awards, please see the sections below titled “—Interests of the Company’s Directors and Executive Officers in the Merger” beginning on page 75 and “The Merger Agreement—Treatment of Company Long-Term Incentive Awards” beginning on page 86.
Shares of common stock are currently registered under the Exchange Act and listed on the NYSE under the trading symbol “ADT”. Shares of Class B common stock are currently not registered under the Exchange Act. Following the consummation of the merger, shares of common stock are expected to be delisted and will no longer be traded on the NYSE or any other public market. In addition, the registration of common stock under the Exchange Act is expected to be terminated, and, upon such termination, the Company will no longer be required to file periodic and other reports with the SEC with respect to the common stock.
Effects on the Company if the Merger Is Not Consummated
In the event that Company stockholder approval is not obtained or if the merger is not consummated for any other reason, Company stockholders will not receive any payment for their shares of Company common stock in connection with the merger. Instead, the Company will remain an independent public company, the common stock will continue to be listed and traded on the NYSE, the common stock will continue to be registered under the Exchange Act, the Company will continue to file periodic reports with the SEC, and Company stockholders will continue to own their shares of Company common stock and will continue to be subject to the same general risks and opportunities as they currently are with respect to ownership of the Company common stock.
If the merger is not consummated, there is no assurance as to the effect of these risks and opportunities on the future value of your Company common stock, including the risk that the market price of Company common stock may decline to the extent that the current market price of the Company common stock reflects a market assumption that the merger will be consummated. If the merger is not consummated, there is no assurance that any other transaction acceptable to the Company will be offered or that the business, operations, financial condition, earnings or prospects of the Company will not be adversely impacted. Pursuant to the merger agreement, under certain circumstances the Company is permitted to terminate the merger agreement in order to enter into an alternative transaction. Please see the section of this proxy statement titled “The Merger Agreement—Termination of the Merger Agreement” beginning on page 105.
Under certain circumstances, if the merger is not consummated, the Company may be obligated to pay to Parent a $227,000,000 termination fee (or $114,000,000 if the merger agreement is terminated by the Company to enter into an acquisition agreement with respect to a superior proposal with any person prior to the expiration of the go-shop period (including any extension thereof)). Under certain other specified circumstances, Parent will be required to pay the Company a termination fee of $473,000,000. Please see the section of this proxy statement titled “The Merger Agreement—Termination Fees” beginning on page 107.
Financing of the Merger
The total amount of funds necessary to consummate the merger (including amounts needed to pay the aggregate merger consideration, pay all fees, costs and expenses required to be paid by Parent or Merger Sub at or prior to the closing of the merger in connection with the transactions and repay existing indebtedness in accordance with the merger agreement) is expected to be funded via equity financing, debt financing and preferred equity financing as described below, and available cash on our balance sheet. Parent has received an equity commitment for the equity financing from Thrive Holdings as described below in the section titled “—Equity Financing”, debt commitments for the debt financing from the debt financing sources as described below in the section titled “—Debt Financing” and preferred equity commitments for the preferred equity financing from preferred equity financing sources as described below in the section titled “—Preferred Equity Financing”.
The consummation of the merger is not conditioned on Parent’s receipt of any financing.
Equity Financing
Pursuant to the equity commitment letter, Thrive Holdings has committed to contribute, directly or indirectly, to Parent, as equity capital, an amount of cash in immediately available funds equal to up to $4,895,000,000, solely for the purpose of funding, and to the extent necessary to fund, together with the debt financing proceeds and other available funding amounts, at the closing of the merger, the obligations of Parent pursuant to the merger agreement to pay the aggregate cash payments required thereunder at the closing of the merger, including the aggregate merger consideration and the amounts required to prepay, repay or redeem indebtedness required to be paid at closing and pay all fees and expenses and other payment obligations required to be paid by Parent or Merger Sub at closing as set forth in the merger agreement. Parent may reduce the equity commitment to the amount sufficient to satisfy those obligations in full if the full commitment is not required at the time of funding.
Funding of the equity commitment by Thrive Holdings is subject to the terms, conditions and limitations set forth in the equity commitment letter, which includes (i) the satisfaction in full or, to the extent permissible, waiver by Parent, of all of the conditions precedent to the obligations of Parent and Merger Sub (other than those conditions that by their nature are to be satisfied at the closing of the merger, so long as such conditions would be satisfied if the closing were to occur at such time), (ii) Parent being required to consummate the closing of the merger pursuant to the merger agreement and (iii) the prior or substantially simultaneous funding of the debt financing (or alternative financing) and the preferred equity financing.
The obligation of Thrive Holdings to fund the equity financing will terminate automatically upon the earliest to occur of (i) the consummation of the closing of the merger and the payment in full by Parent of all amounts required to be paid by Parent in connection therewith pursuant to, and in accordance with, the merger agreement, (ii) the valid termination of the merger agreement in accordance with its terms (unless the Company has previously commenced an action to enforce its third party beneficiary rights under the equity commitment letter, in which case the equity commitment letter will terminate upon the final, nonappealable resolution of such action by a court of competent jurisdiction) and (iii) any claim directly or indirectly asserted by the Company or certain Company-related parties acting on their behalf and at their direction (excluding any affiliate not controlled by, or acting at the direction of, such persons) against Parent, Merger Sub, Thrive Holdings or its related parties under the equity commitment letter, the limited guarantee or the merger agreement or otherwise in connection with the transactions, except in the case of this clause (iii) for (a) claims by the Company for specific performance under, and in accordance with, the equity commitment letter, (b) claims by the Company against the Guarantor (as defined below) under and in accordance with the limited guarantee, subject to the remedies provisions described in the section of this proxy statement entitled “The Merger Agreement—Specific Enforcement”, (c) claims by the Company for specific performance against Parent and/or Merger Sub under and in accordance with the provisions described in the section of this proxy statement entitled “The Merger Agreement—Specific Enforcement” or (d) claims against the parties to the nondisclosure agreement between the Company and certain affiliates of Thrive Holdings under and in accordance with the terms thereof.
Pursuant to the terms and conditions of the merger agreement, Parent and Merger Sub shall (and shall cause their affiliates to) use commercially reasonable efforts to obtain and consummate the equity financing.
The Company will be a third party beneficiary of certain of the rights granted to Parent under the equity commitment letter and will be entitled to rights to specific performance of Thrive Holdings to fund all or any portion of its equity financing obligations under the equity commitment letter, subject to the terms thereof, in circumstances in which the Company is entitled to specific performance of Parent’s obligation to cause the equity commitment to be funded pursuant to the merger agreement.
Debt Financing
In connection with entering into the merger agreement, Parent received debt commitment letters from the debt financing sources. Pursuant to the debt commitment letters, the debt financing sources have committed to provide the applicable credit facilities in respect of the debt financing.
The commitments of the debt financing sources under the debt commitment letters are subject to the satisfaction (or waiver by the debt financing sources) of certain conditions precedent, including, without limitation:
•since October 29, 2026, there not having occurred any Material Adverse Effect (as defined in the merger agreement) that is continuing and that would give Parent or Merger Sub the right, taking into account any notice and cure provisions, to terminate its obligations pursuant to the terms of the merger agreement;
•the merger, substantially simultaneously with the initial funding of the applicable credit facilities, having been consummated in accordance in all material respects with the terms and conditions of the merger agreement, as from time to time waived, amended, supplemented or otherwise modified; provided that certain waivers, amendments, supplements, consents or other modifications shall not have been effected without the consent of the debt financing sources;
•the equity financing having been consummated substantially simultaneously with, or prior to, the initial funding of the applicable credit facilities;
•prior to, or substantially concurrently with, the initial funding of the applicable credit facilities, the Company having (i) repaid all indebtedness for borrowed money outstanding under that certain (x) Twenty-First Amended and Restated First Lien Credit Agreement, dated as of July 1, 2015, by and among Prime Security Services Borrower, LLC, The ADT Security Corporation, Barclays Bank PLC, as administrative agent and the other parties party thereto and (y) Term Loan Credit Agreement, dated as of October 28, 2025, by and among Prime Security Services Holdings, LLC, Prime Security Services Borrower, LLC, The ADT Security Corporation, Fifth Third Bank, National Association, as administrative agent and the other parties party thereto, and the termination of all commitments, liens, security interests and guarantees thereunder (other than with respect to any cash collateral arrangement applicable to any outstanding letter of credit) and (ii) redeemed, defeased or satisfied and discharged (or caused the foregoing in respect of) all of the outstanding 3.375% First-Priority Senior Secured Notes due 2027 issued pursuant to that certain Indenture, dated as of August 20, 2020, by and among Prime Security Services Borrower, LLC, Prime Finance Inc., as co-issuers, the guarantors party thereto and Wells Fargo Bank, National Association, as trustee, and any guarantees and security interests in connection therewith shall be terminated and/or released; and
•the Company having satisfied other customary conditions precedent set forth in the applicable debt commitment letter.
The commitments under the debt commitment letters terminate automatically in the event that the closing of the merger and the initial funding of the applicable credit facilities do not occur on or before the Debt Commitment Expiration Date (as defined below), unless the debt financing sources, in their sole discretion, agree to an extension. “Debt Commitment Expiration Date” means the earliest to occur of (i) five business days after July 29, 2027 unless the closing date and the initial funding of the applicable credit facilities shall have occurred on or prior to such date, (ii) the closing of the merger with or without the use of the applicable credit facilities and (iii) the termination prior to closing of the merger of the merger agreement in accordance with its terms.
Preferred Equity Financing
In connection with entering into the merger agreement, an indirect parent entity of Parent received a preferred equity commitment letter from the preferred equity financing sources. Pursuant to the preferred equity commitment letter, the preferred equity financing sources have committed to purchase from an indirect parent entity of Parent preferred equity interests with an aggregate initial liquidation preference of up to $1.625 billion.
The commitments of the preferred equity financing sources under the preferred equity commitment letter are subject to the satisfaction (or waiver by the preferred equity financing sources) of certain conditions precedent, including, without limitation:
•since October 29, 2026, there not having occurred any Material Adverse Effect (as defined in the merger agreement);
•the merger, substantially simultaneously with the purchase of the preferred equity interests, having been consummated in accordance in all material respects with the terms and conditions of the merger agreement,
as from time to time waived, amended, supplemented or otherwise modified; provided that certain waivers, amendments, supplements, consents or other modifications shall not have been effected without the consent of the preferred equity financing sources;
•the equity financing and the initial funding of the credit facilities having been consummated substantially simultaneously with, or prior to, the purchase of the preferred equity interests;
•prior to, or substantially concurrently with, the initial funding of the credit facilities, the Company having (i) repaid all indebtedness for borrowed money outstanding under that certain (x) Twenty-First Amended and Restated First Lien Credit Agreement, dated as of July 1, 2015, by and among Prime Security Services Borrower, LLC, The ADT Security Corporation, Barclays Bank PLC, as administrative agent and the other parties party thereto and (y) Term Loan Credit Agreement, dated as of October 28, 2025, by and among Prime Security Services Holdings, LLC, Prime Security Services Borrower, LLC, The ADT Security Corporation, Fifth Third Bank, National Association, as administrative agent and the other parties party thereto, and the termination of all commitments, liens, security interests and guarantees thereunder (other than with respect to any cash collateral arrangement applicable to any outstanding letter of credit) and (ii) redeemed, defeased or satisfied and discharged (or caused the foregoing in respect of) all of the outstanding 3.375% First-Priority Senior Secured Notes due 2027 issued pursuant to that certain Indenture, dated as of August 20, 2020, by and among Prime Security Services Borrower, LLC, Prime Finance Inc., as co-issuers, the guarantors party thereto and Wells Fargo Bank, National Association, as trustee, and any guarantees and security interests in connection therewith shall be terminated and/or released; and
•the issuer of the preferred equity interests having satisfied other customary conditions precedent set forth in the preferred equity commitment letter.
The commitments under the preferred equity commitment letter terminate automatically in the event that the closing of the merger and the purchase of the preferred equity interests do not occur on or before the Preferred Commitment Expiration Date (as defined below), unless the preferred equity financing sources, in their sole discretion, agree to an extension. “Preferred Commitment Expiration Date” means the earliest to occur of (i) five business days after July 29, 2027 unless the closing date and the purchase of the preferred equity interests shall have occurred on or prior to such date, (ii) the closing of the merger with or without the purchase of the preferred equity interests and (iii) the termination prior to closing of the merger of the merger agreement in accordance with its terms.
Limited Guarantee
Subject to the terms and conditions set forth in the limited guarantee provided by Thrive Holdings (in such capacity, the “Guarantor”), the Guarantor has guaranteed certain payment obligations of Parent under the merger agreement, subject to an aggregate maximum cap of $481,000,000 for payment of the guaranteed obligations (it being understood that the Company may not receive both a grant of specific performance resulting in the closing and monetary damages, including the Parent termination fee). The Company may not collect under the limited guarantee on more than one occasion. To the extent Parent is relieved of any guaranteed obligations by satisfaction, waiver or agreement with the Company before closing, the cap and the Guarantor’s corresponding obligations will be reduced by the same amount.
The limited guarantee is irrevocable, and will not terminate until the earliest to occur of (i) the closing of the merger in accordance with the merger agreement and (ii) payment by Parent or the Guarantor of the guaranteed obligations in full, subject to the cap, in accordance with the limited guarantee and the merger agreement. Notwithstanding the foregoing, all obligations of the Guarantor under the limited guarantee will expire automatically 60 days after the valid termination of the merger agreement in accordance with its terms without any further obligations of the Guarantor under the limited guarantee, except with respect to claims arising from any proceeding, claim or similar action filed by the Company against Parent or the Guarantor prior to the end of such 60-day period alleging that the Company is owed the guaranteed obligations under the limited guarantee (limited, if the Parent termination fee is not payable, to financing cooperation costs and expenses, subject to the applicable cap), in which case the limited guarantee will survive solely with respect to amounts claimed or alleged in such proceeding, claim
or similar action to be so owing; provided, that in such event, the Guarantor will not have any further liability or obligation under the limited guarantee from and after the earliest of (x) the entry of a final, nonappealable order of a court of competent jurisdiction and satisfaction by Parent or the Guarantor of any amounts finally determined pursuant to such order to be owed, subject to the applicable cap, or (y) the satisfaction in full of the guaranteed obligations by Parent or the Guarantor, subject to the applicable cap. The Guarantor’s obligation will also terminate if the Company or certain related parties assert that the cap or the non-recourse provisions are unenforceable, or assert claims other than permitted claims.
Pursuant to the limited guarantee, the Company’s and certain Company-related parties’ sole and exclusive remedy against the Guarantor and certain Guarantor-related parties with respect to matters, liabilities or obligations arising under or in connection with the merger agreement, the limited guarantee, the equity commitment letter or the transactions contemplated by each of the foregoing is recourse against (i) the Guarantor with respect to (x) claims under the limited guarantee following termination of the merger agreement and before termination of the limited guarantee, subject to the cap, and (y) third party beneficiary rights to specific performance pursuant to the equity commitment letter before termination of the merger agreement, (ii) Parent and Merger Sub with respect to claims pursuant to, and in accordance with, the merger agreement and (iii) the counterparties to the nondisclosure agreement between the Company and certain affiliates of Thrive Holdings with respect to claims thereunder.
Appraisal Rights
If the merger is consummated, holders of record and beneficial owners of Company common stock who do not wish to accept the merger consideration are entitled to seek appraisal of their shares of Company common stock under Section 262 and, if all procedures described in Section 262 are strictly complied with, to receive payment in cash for the fair value of their shares of Company common stock exclusive of any element of value arising from the accomplishment or expectation of the merger, as determined by the Delaware Court, together with interest, if any, to be paid upon the amount determined to be the fair value. The “fair value” of your shares of Company common stock as determined by the Delaware Court may be more or less than, or the same as, the merger consideration that you are otherwise entitled to receive under the merger agreement. These rights are known as “appraisal rights”. This proxy statement serves as a notice of such appraisal rights pursuant to Section 262.
Persons who exercise appraisal rights under Section 262 will not receive the merger consideration they would otherwise be entitled to receive pursuant to the merger agreement. They will instead receive an amount determined to be the “fair value” of their shares of Company common stock following petition to, and an appraisal by, the Delaware Court. Persons considering seeking appraisal should recognize that the fair value of their shares of Company common stock determined under Section 262 could be more than, the same as or less than the merger consideration they would otherwise be entitled to receive pursuant to the merger agreement. Strict compliance with the procedures set forth in Section 262 is required. Failure to comply strictly with all of the procedures set forth in Section 262 may result in the withdrawal, loss or waiver of appraisal rights. Consequently, and in view of the complexity of the provisions of Section 262, persons wishing to exercise appraisal rights are urged to consult their legal and financial advisors before attempting to exercise such rights.
A copy of Section 262 may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. The following summary is not a complete statement of the law relating to appraisal rights and is qualified in its entirety by reference to Section 262 and any amendments thereto after the date of this proxy statement. Any person who desires to exercise his, her or its appraisal rights should review carefully Section 262 and is urged to consult his, her or its legal and financial advisors before electing or attempting to exercise such rights. The following summary does not constitute legal or other advice, nor does it constitute a recommendation that persons seek to exercise their appraisal rights under Section 262. A person who loses his, her or its appraisal rights will be entitled to receive the merger consideration under the merger agreement.
A holder of record or a beneficial owner of shares of Company common stock who (i) continuously holds such shares through the effective time, (ii) has not consented to or otherwise voted in favor of the merger or otherwise withdrawn, lost or waived appraisal rights, (iii) strictly complies with the procedures under Section 262, (iv) does not thereafter withdraw his, her or its demand for appraisal of such shares and (v) in the case of a beneficial owner, a
person who (A) reasonably identifies in his, her or its demand the holder of record of the shares for which the demand is made, (B) provides documentary evidence of such beneficial owner’s beneficial ownership and a statement that such documentary evidence is a true and correct copy of what it purports to be and (C) provides an address at which such beneficial owner consents to receive notices given by the Company and to be set forth on the Chancery List (as defined below), will be entitled to receive the fair value of his, her or its shares of Company common stock exclusive of any element of value arising from the accomplishment or expectation of the merger, as determined by the Delaware Court, together with interest, if any, to be paid upon the amount determined to be the fair value.
Section 262 requires that where a merger agreement is to be submitted for adoption at a meeting of stockholders, the stockholders be notified that appraisal rights will be available not less than twenty days before the meeting to vote on the merger. Such notice must include either a copy of Section 262 or information directing the stockholders to a publicly available electronic resource at which Section 262 may be accessed without subscription or cost. This proxy statement constitutes the Company’s notice to our stockholders that appraisal rights are available in connection with the merger, in compliance with the requirements of Section 262. If you wish to consider exercising your appraisal rights, you should carefully review the text of Section 262, which may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. Failure to comply timely and properly with the requirements of Section 262 may result in the withdrawal, loss or waiver of your appraisal rights under the DGCL.
If you elect to demand appraisal of your shares of Company common stock, you must satisfy each of the following conditions: you must deliver to the Company a written demand for appraisal of your shares of Company common stock before the taking of the vote on the merger, which demand must reasonably inform us of the identity of the holder of record of shares of Company common stock who intends to demand appraisal of his, her or its shares of Company common stock and, for beneficial owners only, such demand must be accompanied by documentary evidence of such beneficial owner’s beneficial ownership and a statement that such documentary evidence is a true and correct copy of what it purports to be, and must provide an address at which such beneficial owner consents to receive notices given by the Company and to be set forth on the Chancery List; you must not vote or submit a proxy in favor of the proposal to adopt the merger agreement; you must hold your shares of Company common stock continuously through the effective time; and you must comply with the other applicable requirements of Section 262. A proxy or vote against the merger shall not constitute such a demand.
A Company stockholder who elects to exercise appraisal rights must deliver his, her or its written demand for appraisal to the following address:
| | | | | | | | |
| ADT Inc. |
| 1501 Yamato Road |
| Boca Raton, Florida 33431 |
| Attention: David W. Smail, Esq. |
| Executive Vice President, Chief Legal Officer and Secretary |
A record holder who holds shares of Company common stock as a nominee for others, such as a broker, fiduciary, depositary or other nominee, may exercise appraisal rights with respect to the shares held for all or less than all beneficial owners of shares as to which such person is the record owner. In such case, the demand must set forth the number of shares of Company common stock covered by such demand. Where the number of shares of Company common stock is not expressly stated, the demand will be presumed to cover all shares of Company common stock outstanding in the name of such record owner.
Within ten days after the effective time, the surviving corporation must give written notice that the merger has become effective to each of (i) each Company stockholder who has properly delivered a written demand for appraisal and who did not vote in favor of the proposal to adopt the merger agreement and (ii) any beneficial owner who has demanded appraisal under Section 262. At any time within sixty days after the effective time, any person who has not commenced an appraisal proceeding or joined a proceeding as a named party may withdraw the demand and accept the merger consideration specified by the merger agreement for that person’s shares of Company
common stock by delivering to the surviving corporation a written withdrawal of the demand for appraisal. After such sixty-day period, a demand for appraisal may be withdrawn only with the written approval of the surviving corporation and, once an appraisal proceeding has been commenced, no appraisal proceeding shall be dismissed as to any person without the approval of the Delaware Court.
Within one hundred twenty days after the effective time, but not thereafter, the surviving corporation and any person who has properly and timely demanded appraisal and otherwise complied with Section 262 may commence an appraisal proceeding by filing a petition in the Delaware Court, with a copy served on the surviving corporation in the case of a petition filed by a person, demanding a determination of the fair value of the shares of Company common stock held by all persons that have demanded appraisal. There is no present intent on the part of the Company or the surviving corporation to file an appraisal petition and persons seeking to exercise appraisal rights should assume that the Company and the surviving corporation will not file such a petition or initiate any negotiations with respect to the fair value of shares of Company common stock. Accordingly, persons who desire to have their shares of Company common stock appraised should initiate any petitions necessary for the perfection of their appraisal rights within the time periods and in the manner prescribed in Section 262. If, within one hundred twenty days after the effective time, no petition has been filed as provided above, all rights to appraisal will cease and any person that previously demanded appraisal will become entitled only to the merger consideration under the merger agreement.
In addition, within one hundred twenty days after the effective time, any person who has theretofore complied with the applicable provisions of Section 262 will be entitled, upon written request, to receive from the surviving corporation a statement setting forth the aggregate number of shares of Company common stock not voted in favor of the merger and with respect to which demands for appraisal were received by the surviving corporation and the aggregate number of holders of such shares. Such statement must be given within ten days after the written request therefor has been received by the surviving corporation or within ten days after the expiration of the period for the delivery of demands as described above, whichever is later.
Upon the filing of a petition by a person, service of a copy of such petition shall be made upon the surviving corporation. The surviving corporation shall be required to, within twenty days after such service, file in the office of the Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of all persons who have demanded appraisal of their shares of Company common stock and with whom the surviving corporation has not reached agreements as to the value of such shares (the “Chancery List”). The Register in Chancery, if so ordered by the Delaware Court, shall give notice of the time and place fixed for the hearing of such petition by registered or certified mail to the surviving corporation and to all such persons set forth on the Chancery List.
If a petition for an appraisal is timely filed by a person, at the hearing on such petition, the Delaware Court will determine which persons have complied with Section 262 and have become entitled to appraisal rights provided thereby. The Delaware Court may require the persons who have demanded an appraisal of their shares of Company common stock and who hold shares represented by certificates to submit their certificates of shares of Company common stock to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings; and if any person fails to comply with such direction, the Delaware Court may dismiss the proceedings as to such person. If immediately before the merger, the shares of the class or series of stock of the Company were listed on a national securities exchange, the Delaware Court will dismiss the appraisal proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (i) the total number of shares entitled to appraisal exceeds 1% of the outstanding shares of the class or series eligible for appraisal or (ii) the value of the consideration provided in the merger for such total number of shares exceeds $1,000,000. Because the Class B common stock is not listed on a securities exchange, these thresholds do not apply to holders of Class B common stock.
Upon application by the surviving corporation or any person entitled to participate in the appraisal proceedings, the Delaware Court may, in its discretion, proceed to trial upon the appraisal prior to the final determination of the persons entitled to appraisal. Any person whose name appears on the Chancery List may participate fully in all proceedings until it is finally determined that such person is not entitled to appraisal rights under Section 262.
Where proceedings are not dismissed, the appraisal proceeding shall be conducted in accordance with the rules of the Delaware Court, including any rules specifically governing appraisal proceedings. Through such proceedings the Delaware Court shall determine the fair value of shares of Company common stock taking into account all relevant factors, exclusive of any element of value arising from the accomplishment or expectation of the merger, together with interest, if any, to be paid upon the amount determined to be the fair value. Unless the Delaware Court, in its discretion, determines otherwise for good cause shown, interest on an appraisal award will accrue and compound quarterly from the effective time through the date the judgment is paid at five percent (5%) over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the effective time and the date of payment of the judgment. At any time before the entry of judgment in the proceedings, the surviving corporation may pay to each person entitled to appraisal an amount in cash, in which case interest shall accrue after such payment only on the sum of (i) the difference, if any, between the amount so paid and the fair value of the shares of Company common stock as determined by the Delaware Court, and (ii) interest theretofore accrued, unless paid by the surviving corporation as part of the pre-judgment payment to the person.
When the fair value of the shares of Company common stock is determined, the Delaware Court will direct the payment of such value, with interest thereon, if any, to the persons entitled to receive the same.
Although the Company believes that the merger consideration is fair, no representation is made as to the outcome of the appraisal of fair value as determined by the Delaware Court and persons should recognize that such an appraisal could result in a determination of a value higher or lower than, or the same as, the merger consideration. Moreover, the surviving corporation does not anticipate offering more than the merger consideration to any person exercising appraisal rights and reserves the right to assert, in any appraisal proceeding, that, for purposes of Section 262, the “fair value” of the relevant shares of Company common stock is less than the merger consideration.
In determining “fair value”, the Delaware Court is required to take into account all relevant factors. In Weinberger v. UOP, Inc., the Delaware Supreme Court discussed the factors that could be considered in determining fair value in an appraisal proceeding, stating that “proof of value by any techniques or methods which are generally considered acceptable in the financial community and otherwise admissible in court” should be considered and that “[f]air price obviously requires consideration of all relevant factors involving the value of a company.” The Delaware Supreme Court has stated that in making this determination of fair value, the court must consider market value, asset value, dividends, earnings prospects, the nature of the enterprise and any other facts which were known or could be ascertained as of the date of the merger which throw any light on future prospects of the merged corporation. Section 262 provides that fair value is to be “exclusive of any element of value arising from the accomplishment or expectation of the merger.” In Cede & Co. v. Technicolor, Inc., the Delaware Supreme Court stated that such exclusion is a “narrow exclusion [that] does not encompass known elements of value”, but which rather applies only to the speculative elements of value arising from such accomplishment or expectation.
In Weinberger, the Delaware Supreme Court construed Section 262 to mean that “elements of future value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the merger and not the product of speculation, may be considered.” In addition, the Delaware courts have decided that the statutory appraisal remedy, depending on factual circumstances, may or may not be a person’s exclusive remedy.
The cost of the appraisal proceeding may be determined by the Delaware Court and taxed upon the parties as the Delaware Court deems equitable in the circumstances. However, costs do not include attorneys’ and expert witness fees. Each person is responsible for his, her or its attorneys’ and expert witness fees, although, upon application of a person whose name appears on the Chancery List who participated in the proceeding and incurred expenses in connection therewith, the Delaware Court may order that all or a portion of such expenses, including, without limitation, reasonable attorneys’ and expert witness fees, be charged pro rata against the value of all shares of Company common stock entitled to appraisal not dismissed pursuant to Section 262(k) of the DGCL or subject to such an award pursuant to a reservation of jurisdiction under Section 262(k) of the DGCL. Determinations by the Delaware Court are subject to appellate review by the Delaware Supreme Court.
Any person who has duly demanded appraisal in compliance with Section 262 will not be entitled to vote for any purpose any shares of Company common stock subject to such demand or to receive payment of dividends or
other distributions on such shares, except for dividends or distributions payable to Company stockholders of record at a date prior to the effective time.
No appraisal proceeding in the Delaware Court shall be dismissed as to any person without the approval of the Delaware Court, and such approval may be conditioned upon such terms as the Delaware Court deems just, including without limitation, a reservation of jurisdiction for any application to the Delaware Court made under Section 262(j) of the DGCL; provided, however, that the foregoing shall not affect the right of any person who has not commenced an appraisal proceeding or joined such a proceeding as a named party to withdraw such person’s demand for appraisal and to accept the terms offered upon the merger within sixty days after the effective time. If no petition for appraisal is filed with the Delaware Court within one hundred twenty days after the effective time, all rights to appraisal will cease and any person that previously demanded appraisal will become entitled only to the merger consideration under the merger agreement.
To the extent there are any inconsistencies between the foregoing summary, on the one hand, and Section 262, on the other hand, Section 262 will govern.
Interests of the Company’s Directors and Executive Officers in the Merger
The Company’s directors and executive officers have financial interests in the merger that may be different from, or in addition to, the interests of the Company’s stockholders generally. The Board was aware of and carefully considered these interests, among other matters, in evaluating and negotiating the merger agreement, in approving the merger agreement and in determining to recommend that the Company’s stockholders approve the merger agreement proposal and the advisory compensation proposal.
The Company’s executive officers for purposes of the discussion below are:
•James D. DeVries (Chairman of the Board, President and Chief Executive Officer);
•Jeffrey A. Likosar (President, Corporate Development and Transformation, and Chief Financial Officer);
•Fawad Ahmad (Executive Vice President and Chief Operating and Customer Officer);
•Todd Dernberger (Executive Vice President and Chief Growth Officer);
•Omar Khan (Executive Vice President and Chief Business Officer);
•Kimberly Miller (Executive Vice President and Chief Marketing and Communications Officer);
•David Scott (Executive Vice President and Chief People and Administration Officer); and
•David W. Smail (Executive Vice President, Chief Legal Officer and Secretary).
In accordance with SEC rules, this discussion also covers former directors and executive officers of the Company who served in such capacity at any time since January 1, 2025, which includes (i) Donald Young (former Executive Vice President and Chief Operating Officer), (ii) DeLu Jackson (former Executive Vice President and Chief Marketing Officer) and (iii) Nicole Bonsignore, Marques Coleman, Benjamin Honig and Reed Rayman (each, a former non-employee director, and collectively, the “former directors”). Mr. Young continues to hold stock options, which are reflected below, while Mr. Jackson and the former directors, to the Company’s knowledge, do not have any interests in the merger that are different from those of the Company’s stockholders, and have therefore been omitted from the discussion below.
Treatment of Company Long-Term Incentive Awards
For information regarding beneficial ownership of shares of Company common stock by each of the Company’s current directors and named executive officers and all of such directors and executive officers as a group, please see the section titled “Security Ownership of Certain Beneficial Owners and Management” beginning on page 111. Each of the Company’s directors and executive officers will be entitled to receive, for each share of Company common
stock he or she holds, the same per share merger consideration in cash in the same manner as other Company stockholders.
As described further in the section titled “The Merger Agreement—Treatment of Company Long-Term Incentive Awards” beginning on page 86, each unvested Company long-term incentive award outstanding as of immediately prior to the effective time will be converted into a cash-based award based on the per share value of the merger consideration (less the exercise price in the case of any stock options) and subject to the same terms and conditions, including vesting terms, as applied to the long-term incentive award prior to the effective time. Amounts in respect of fully vested awards, such as vested stock options, will be payable at the effective time. Stock options with an exercise price in excess of the value of the merger consideration will be canceled for no consideration. In the event of an award holder’s termination without cause or due to a resignation for good reason, in each case, within two years following the effective time, such holder, including any executive officer, will vest in all then outstanding and unvested cash-based awards.
The following table sets forth, by type of long-term incentive award, for each director and each executive officer, an estimate of the aggregate value of such long-term incentive awards that may be held by each such individual at the effective time. Mr. Jackson and the former directors have been excluded because they no longer hold any long-term incentive awards. The amounts set forth in the table below have been determined based on the number of long-term incentive awards held by each such individual as of November 18, 2026, the latest practicable date to determine such amounts before the filing of this proxy statement, and assuming that (i) the effective time occurs on February 1, 2027, which is the assumed closing date only for purposes of this compensation-related disclosure, and (ii) the individuals included in the table below do not receive any additional grants of long-term incentive awards or forfeit any long-term incentive awards prior to the effective time. None of the long-term incentive awards held by the individuals included in the table below are scheduled to vest prior to February 1, 2027.
| | | | | | | | | | | | | | | | | | | | | | | |
| Vested Stock Options(1) ($) | | Unvested Stock Options(1) ($) | | Unvested RSUs ($) | | Total ($) |
Non-Employee Directors |
| |
| |
| |
|
Thomas Gartland | — | | | — | | | 267,986 | | | 267,986 | |
Tracey Griffin | — | | | — | | | 267,986 | | | 267,986 | |
Daniel Houston | — | | | — | | | 267,986 | | | 267,986 | |
Paul Smith | — | | | — | | | 267,986 | | | 267,986 | |
Danielle Tiedt | — | | | — | | | 267,986 | | | 267,986 | |
Matthew Winter | — | | | — | | | 267,986 | | | 267,986 | |
Suzanne Yoon | — | | | — | | | 267,986 | | | 267,986 | |
Sigal Zarmi | — | | | — | | | 267,986 | | | 267,986 | |
|
| |
| |
| |
|
Executive Officers |
| |
| |
| |
|
James D. DeVries(2) | 34,042,749 | | | 15,625,395 | | | — | | | 49,668,144 | |
Jeffrey A. Likosar(2) | 11,781,851 | | | 3,627,598 | | | — | | | 15,409,449 | |
Fawad Ahmad | 248,440 | | | 1,947,918 | | | 2,156,240 | | | 4,352,598 | |
Todd Dernberger | 443,123 | | | 2,086,089 | | | 126,882 | | | 2,656,094 | |
Omar Khan | 1,120,843 | | | 3,692,760 | | | — | | | 4,813,603 | |
Kimberly Miller | — | | | 1,451,036 | | | 527,760 | | | 1,978,796 | |
David Scott | 1,121,655 | | | 2,488,168 | | | — | | | 3,609,823 | |
David W. Smail(2) | 5,038,569 | | | 1,813,796 | | | — | | | 6,852,365 | |
Donald Young(3) | 7,573,154 | | | — | | | — | | | 7,573,154 | |
__________________
(1)Excludes any stock options for which the exercise price is equal to or greater than the merger consideration value of $10.00.
(2)Each of Messrs. DeVries, Likosar and Smail is retirement-eligible, meaning that upon a termination of employment other than for “cause,” the executive would be entitled to retain any long-term incentive awards that have been outstanding for at least one year. As a result, any
long-term incentive awards held by Messrs. DeVries, Likosar and Smail that have been outstanding for at least one year (which consist solely of stock options) are treated as vested awards for purposes of this table.
(3)Mr. Young retired as Executive Vice President and Chief Operating Officer on June 6, 2025, but continues to hold vested stock options. This includes certain stock options that are continuing to vest in accordance with their terms as a result of Mr. Young’s retirement, but which are treated as vested awards for purposes of this table, consistent with the treatment for retirement eligible current executive officers.
Severance Entitlements
The Company maintains the ADT Inc. Change in Control Severance Plan (referred to as the “severance plan”). To ensure uniformity of treatment of executive officers, in connection with the entry into the merger agreement, the only executive officers who were not previously participants in the severance plan, Messrs. DeVries, Likosar and Smail, were added as participants in the severance plan, which replaced any entitlement to severance benefits they were eligible for under their pre-existing individual arrangements. As a result, all executive officers currently participate in the severance plan.
The severance plan provides for the following severance payments and benefits in the event an executive officer’s employment is terminated without cause or for good reason (each, as defined in the severance plan) within the period beginning 60 days prior to and ending 24 months following a change in control, which the merger will constitute (any such termination, a “qualifying termination”), subject to the executive officer’s execution and non-revocation of a general release of claims and compliance with certain covenants:
•cash severance, payable in a lump sum, equal to two times the sum of the executive officer’s base salary and target bonus amount;
•a pro-rated target bonus for the year of termination;
•52 weeks of continued health insurance coverage at the premium rates available to active employees for similar coverage, and a lump sum payment equal to the employer portion of the value of an additional 52 weeks of coverage; and
•12 months of outplacement benefits.
The value of the severance payments and benefits that the named executive officers would receive under the severance plan is set forth in the section titled “—Quantification of Payments and Benefits” below. In the case of the executive officers who are not named executive officers, the aggregate value of the severance payments and benefits that such executive officers would receive, based on the assumptions used for valuing such payments and benefits described in the section titled “—Quantification of Payments and Benefits”, including the assumption that a qualifying termination occurs immediately following the effective time (but not including the value of the accelerated vesting of long-term incentive awards, which is quantified in the section titled “—Treatment of Company Long-Term Incentive Awards” above), would be $5,642,105.
Retention Program
In connection with the entry into the merger agreement, in order to help retain and incentivize certain key employees and/or recognize the additional efforts required of certain key employees in connection with the transactions contemplated by the merger agreement, the Company established a limited cash retention program. As part of this cash retention program, the Company provided Mr. Likosar with a cash retention bonus of $1 million. The retention bonus is payable in two equal installments, with the first installment payable upon the effective time and the second installment payable on the date that is three months following the effective time. Payment of either installment is subject to Mr. Likosar’s continued employment through the applicable retention date, provided that if Mr. Likosar’s employment is terminated without cause following the effective time but prior to the final retention date, he will receive any then-unpaid portion of the retention bonus.
Non-Qualified Deferred Compensation
The Company maintains the ADT LLC Supplemental Savings and Retirement Plan (the “SSRP”), under which the Company makes matching contributions equal to a portion of eligible pay contributed by eligible employees,
which includes the executive officers. Matching contributions generally vest after a participant has completed three years of service from the date of hire, subject to full vesting upon death, disability, retirement, or the occurrence of a change in control (including the merger). As of the date of this proxy statement, no executive officer has an unvested balance in the SSRP.
Section 280G Mitigation Actions
The severance plan contains a “best net cutback” provision, which provides that, if any payment or benefit to a participant in the plan would trigger the adverse tax consequences of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), then the payments and benefits will either (a) be paid in full or (b) be reduced to avoid triggering such consequences, whichever results in the greater after-tax payments to the participant.
The Company, in consultation with Parent, is also permitted to take certain actions before the effective time to mitigate the exposure under Section 280G and reduce or eliminate the likelihood that the best net cutback provisions would be relevant. These actions include accelerating the payment of compensation or the vesting and settlement of time-based Company RSU awards that, in each case, are scheduled to be paid or to vest and settle, respectively, between January 1 and April 1, 2027 so that such compensation is instead paid or such Company RSU awards instead vest and settle in December 2026, subject to a clawback if the compensation would not have been earned under the original terms, which has the effect of increasing the threshold to trigger Section 280G. As of the date of this proxy statement, no such actions have been approved as the Company’s analysis is ongoing, but the Company expects that such actions will be implemented for one or more executive officers. No tax or other gross-ups have been, or will be, provided to any executive officer as a result of Section 280G.
Arrangements with Parent
As of the date of this proxy statement, none of the Company’s directors or executive officers has entered into any agreement, arrangement or understanding with Parent regarding employment or other services, or providing for any compensation or benefits, following the effective time, and the merger is not conditioned upon any such agreement, arrangement or understanding being entered into.
Continuing Employee Benefits
The merger agreement provides for certain customary protections regarding the compensation and benefits of continuing employees, including the executive officers, during their employment with the surviving corporation following the effective time. The relevant provisions are described in more detail in the section titled “The Merger Agreement—Employee Benefits Matters” beginning on page 104 of this proxy statement.
Director and Officer Indemnification
Pursuant to the terms of the merger agreement, each current or former director or officer of the Company will be entitled to certain ongoing indemnification and coverage under directors’ and officers’ liability insurance policies following the merger. For a more detailed description of the provisions of the merger agreement relating to director and officer indemnification, please see the section of this proxy statement titled “The Merger Agreement—Indemnification and Insurance” beginning on page 102.
Quantification of Payments and Benefits
In accordance with Item 402(t) of Regulation S-K, the table below sets forth for each of the Company’s named executive officers estimates of the amounts of compensation that are payable in connection with or otherwise relate to the merger. The Company’s stockholders are being asked to approve, on a non-binding, advisory basis, such compensation. Because the vote to approve such compensation is advisory only, it will not be binding on any of the Company, the Board, Parent or the surviving corporation. Accordingly, if the merger agreement proposal is approved by the Company stockholders and the merger is consummated, the compensation will be payable regardless of the outcome of the vote to approve such compensation, subject only to the conditions applicable thereto, which are described in the footnotes to the table below and above under “—Interests of the Company’s Directors and Executive Officers in the Merger”.
The potential payments in the table below are quantified in accordance with Item 402(t) of Regulation S-K. The estimated values are based on (i) an assumption that the merger is consummated on February 1, 2027, (ii) the per share merger consideration of $10.00, (iii) the named executive officers’ base salaries and target bonus amounts as in effect as of the date of this proxy statement, (iv) the number of unvested equity awards held by the named executive officers as of November 18, 2026, the latest practicable date to determine such amounts before the filing of this proxy statement, excluding any awards that would remain outstanding and continue vesting in connection with an executive officer’s retirement on or prior to February 1, 2027, and assuming no additional grants or forfeitures of Company long-term incentive awards will be made prior to February 1, 2027 and (v) an assumption that each named executive officer experiences a qualifying termination of employment immediately following the effective time. As such, the amounts indicated below are estimates based on multiple assumptions that may or may not actually occur, and do not reflect certain compensation actions that may occur before the consummation of the merger. As a result, the actual amounts, if any, to be received by a named executive officer may materially differ from the amounts set forth below.
Potential Payments to Named Executive Officers
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| Name | | Cash ($)(1) | | Company Equity Awards ($)(2) | | Perquisites/ Benefits ($)(3) | | Total ($) |
| James D. DeVries | | 6,008,288 | | | 15,625,395 | | | 52,000 | | | 21,685,683 | |
| Jeffrey A. Likosar | | 4,337,904 | | | 3,627,598 | | | 52,000 | | | 8,017,502 | |
| David W. Smail | | 2,614,413 | | | 1,813,796 | | | 52,000 | | | 4,480,209 | |
| Fawad Ahmad | | 2,562,560 | | | 4,104,158 | | | 52,000 | | | 6,718,718 | |
| Omar Khan | | 2,571,380 | | | 3,692,760 | | | 52,000 | | | 6,316,140 | |
__________________
(1)The amounts shown in this column represent the estimated value of the cash severance each named executive officer is eligible to receive upon a termination without cause or a resignation for good reason in connection with a change in control pursuant to the terms of the severance plan, and consist of (i) two times the sum of base salary and target bonus, (ii) a pro-rated target bonus for the year of termination, and (iii) a cash amount equal to the employer portion of the value of 52 weeks of continued medical coverage (estimated at $3,500 per month) (as described above in the section titled “—Severance Entitlements”). These cash severance amounts are “double-trigger,” as such payments will not be payable solely as a result of the occurrence of the effective time but would also require a qualifying termination. For Mr. Likosar, the amount also includes his retention bonus of $1,000,000, half of which is “single-trigger”, as such payment will be payable solely as a result of the occurrence of the effective time, and half of which is “double-trigger”. The table below provides a breakdown of the cash severance and retention bonus amounts.
| | | | | | | | | | | | | | | | | | | | |
| Name | | Cash Severance ($) | | Retention Bonus ($) | | Total ($) |
| James D. DeVries | | 6,008,288 | | | — | | | 6,008,288 | |
| Jeffrey A. Likosar | | 3,337,904 | | | 1,000,000 | | | 4,337,904 | |
| David W. Smail | | 2,614,413 | | | — | | | 2,614,413 | |
| Fawad Ahmad | | 2,562,560 | | | — | | | 2,562,560 | |
| Omar Khan | | 2,571,380 | | | — | | | 2,571,380 | |
(2)The amounts shown in this column represent the estimated aggregate value of each named executive officer’s unvested long-term incentive awards in connection with the consummation of the merger. The treatment of outstanding long-term incentive awards held by the named executive officers is described above in the section titled “—Treatment of Company Long-Term Incentive Awards.” Each of Messrs. DeVries, Likosar and Smail is retirement-eligible under the terms of the long-term incentive awards, which entitle each such individual to continued vesting upon retirement for grants outstanding for at least one year. Therefore, for purposes of this disclosure, such long-term incentive awards are treated as vested and amounts in respect of such awards have been excluded. Each named executive officer’s unvested long-term incentive awards are “double-trigger,” as such payments will not be payable solely as a result of the occurrence of the effective time but would also require a qualifying termination. The table below provides a breakdown of each award by type.
| | | | | | | | | | | | | | | | | | | | |
| Name | |
RSUs ($) | |
Stock Options ($) | | Total ($) |
| James D. DeVries | | — | | | 15,625,395 | | | 15,625,395 | |
| Jeffrey A. Likosar | | — | | | 3,627,598 | | | 3,627,598 | |
| David W. Smail | | — | | | 1,813,796 | | | 1,813,796 | |
| Fawad Ahmad | | 2,156,240 | | | 1,947,918 | | | 4,104,158 | |
| Omar Khan | | — | | | 3,692,760 | | | 3,692,760 | |
(3)The amounts shown in this column include (i) the estimated aggregate value of the employer portion of 52 weeks of continued health insurance coverage (estimated at $3,500 per month) and (ii) 12 months of outplacement benefits (estimated at $10,000) payable under the severance plan, as described more fully in the section titled “—Severance Entitlements.” These benefits are “double-trigger,” as such payments will not be payable solely as a result of the occurrence of the effective time but would also require a qualifying termination.
Material U.S. Federal Income Tax Consequences of the Merger
The following discussion summarizes certain material U.S. federal income tax consequences to holders with respect to the disposition of Company common stock pursuant to the merger. It is not intended to be a complete analysis or description of all potential U.S. federal income tax consequences of the merger. This discussion is based upon the provisions of the Internal Revenue Code of 1986, as amended (the “Code”), applicable U.S. Treasury Regulations, rulings and judicial decisions as of the date hereof, all of which are subject to change or varying interpretation, possibly with retroactive effect. Any such changes could affect the accuracy of the statements and conclusions set forth herein. The Internal Revenue Service (“IRS”) may not agree with the tax consequences described in this discussion.
This discussion assumes that holders of Company common stock hold their shares as capital assets within the meaning of Section 1221 of the Code (generally, property held for investment). This discussion does not address all aspects of U.S. federal income taxation that may be relevant to a holder of Company common stock in light of such holder’s particular circumstances, nor does it discuss the special considerations applicable to holders of Company common stock subject to special treatment under the U.S. federal income tax laws (e.g., financial institutions or broker-dealers, mutual funds, partnerships or other pass-through entities and their partners or members, tax-exempt organizations, retirement or other tax-deferred accounts, insurance companies, dealers in securities or non-U.S. currencies, traders in securities who elect mark-to-market method of accounting, controlled foreign corporations, passive foreign investment companies, U.S. expatriates, holders who acquired their shares of Company common stock through vesting of units or otherwise as compensation, holders subject to the alternative minimum tax, holders who hold their shares of Company common stock as part of a hedge, straddle, constructive sale or conversion transaction, U.S. holders (as defined below) whose functional currency is not the U.S. dollar, accrual method holders who prepare an “applicable financial statement” (as defined in Section 451 of the Code) and holders who own or have owned (directly, indirectly or constructively) 5% or more of the Company common stock (by vote or value) outstanding). In addition, this discussion does not address any tax consequences arising under the laws of any state, local or non-U.S. jurisdiction or U.S. federal non-income tax consequences (e.g., the federal estate or gift tax) or the application of the Medicare tax on net investment income under Section 1411 of the Code.
If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds Company common stock, the tax treatment of a partner in such partnership generally will depend on the status of the partner and activities of the partnership. If you are a partner of a partnership holding Company common stock, you should consult your own tax advisor.
All holders should consult their own tax advisor to determine the particular tax consequences to them (including the application and effect of any state, local or non-U.S. income and other tax laws) of the receipt of cash in exchange for shares of Company common stock pursuant to the merger.
For purposes of this discussion, the term “U.S. holder” means a beneficial owner of Company common stock, that is, for U.S. federal income tax purposes:
•an individual citizen or resident of the United States;
•a corporation (including any entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia;
•a trust if (1) its administration is subject to the primary supervision of a court within the United States and one or more U.S. persons (within the meaning of Section 7701(a)(30) of the Code) have the authority to control all substantial decisions of the trust or (2) it has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person for U.S. federal income tax purposes; or
•an estate, the income of which is subject to U.S. federal income tax regardless of its source.
A “non-U.S. holder” is a beneficial owner (other than a partnership or an entity classified as a partnership that is subject to U.S. federal income tax reporting) of Company common stock that is not a U.S. holder.
U.S. Holders
The receipt of cash pursuant to the merger will be a taxable transaction for U.S. federal income tax purposes. A U.S. holder generally will recognize gain or loss for U.S. federal income tax purposes equal to the difference, if any, between the amount of cash received pursuant to the merger and such U.S. holder’s adjusted tax basis in the shares of Company common stock converted into cash pursuant to the merger. Such gain or loss generally will be capital gain or loss and will be long-term capital gain or loss if the holder’s holding period for such shares exceeds one year as of the date of the merger. Long-term capital gains for certain non-corporate U.S. holders, including individuals, are generally eligible for a reduced rate of U.S. federal income taxation. The deductibility of capital losses is subject to limitations. If a U.S. holder acquired different blocks of Company common stock at different times or at different prices, such U.S. holder must determine their tax basis, holding period, and gain or loss separately with respect to each block of Company common stock.
A U.S. holder may, under certain circumstances, be subject to information reporting and backup withholding (currently at a rate of 24%) with respect to the cash received pursuant to the merger, unless such holder properly establishes an exemption or provides their correct tax identification number and otherwise complies with the applicable requirements of the backup withholding rules. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules can be refunded or credited against a U.S. holder’s U.S. federal income tax liability, if any; provided that such U.S. holder furnishes the required information to the IRS in a timely manner.
Non-U.S. Holders
Subject to the discussion of information reporting and backup withholding below, any gain recognized on the receipt of cash pursuant to the merger by a non-U.S. holder generally will not be subject to U.S. federal income tax unless:
•the gain is effectively connected with a U.S. trade or business of such non-U.S. holder (and, if required by an applicable income tax treaty, is attributable to a permanent establishment or, in the case of an individual, a fixed base in the United States maintained by such non-U.S. holder), in which case the non-U.S. holder generally will be subject to tax on such gain in the same manner as a U.S. holder and, if the non-U.S. holder is a corporation, the holder may be subject to branch profits tax at the rate of 30% on the effectively connected gain (or such lower rate as may be specified by an applicable income tax treaty);
•the non-U.S. holder is a nonresident alien individual who is present in the United States for 183 days or more in the taxable year of the merger and certain other conditions are met, in which case the non-U.S. holder generally will be subject to tax at a 30% rate (or a lower applicable income tax treaty rate) on any gain derived from the disposition of the Company common stock pursuant to the merger (other than gain effectively connected with a U.S. trade or business), which may be offset by U.S. source capital losses; or
•the Company common stock constitutes a “United States real property interest” (“USRPI”) for U.S. federal income tax purposes under the Foreign Investment in Real Property Tax Act of 1980 (“FIRPTA”).
If the Company common stock constitutes a USRPI under FIRPTA, a non-U.S. holder will be subject to U.S. federal income tax on any gain recognized on the receipt of cash in exchange for their shares of Company common stock in the merger on a net basis at applicable U.S. graduated rates in the same manner as a U.S. holder. The Company common stock will constitute a USRPI if we have been a “United States real property holding corporation” (“USRPHC”) for U.S. federal income tax purposes at any time within the shorter of (x) the five-year period ending with the effective date of the merger and (y) the non-U.S. holder’s holding period for the shares of Company common stock. Although there can be no assurances in this regard, we believe we have not been a USRPHC at any time during the five-year period preceding the merger. The determination of USRPHC status depends on the fair market value of our USRPIs relative to the fair market value of our other trade or business assets and our non-U.S. real property interests. In the event that we are, or have been, a USRPHC, a non-U.S. holder’s shares of the Company common stock nevertheless will not constitute a USRPI if the shares of the Company
common stock are “regularly traded” (within the meaning of applicable U.S. Treasury Regulations) on an established securities market at the effective time and the non-U.S. holder held 5% or less of the total fair market value of such class of shares at all times during the shorter of (x) the five-year period ending with the effective date of the merger and (y) the non-U.S. holder’s holding period for the shares.
Non-U.S. holders should consult their own tax advisors regarding the application of the foregoing rules in light of their particular facts and circumstances, the procedures for claiming tax treaty benefits or otherwise establishing an exemption from U.S. tax with respect to any portion of the cash consideration payable to them pursuant to the merger.
A non-U.S. holder will be subject to information reporting and, in certain circumstances, backup withholding (currently at a rate of 24%) will apply with respect to the cash received by such holder pursuant to the merger, unless such non-U.S. holder certifies under penalties of perjury that it is a non-U.S. holder (and the payor does not have actual knowledge or reason to know that the holder is a U.S. person) or such holder otherwise establishes an exemption from backup withholding. Backup withholding is not an additional tax and any amounts withheld under the backup withholding rules may be refunded or credited against a non-U.S. holder’s U.S. federal income tax liability, if any, provided that such non-U.S. holder furnishes the required information to the IRS in a timely manner.
The foregoing summary does not discuss all aspects of U.S. federal income taxation that may be relevant to particular holders of Company common stock. It is for general information only and is not tax advice. All holders should consult their own tax advisor to determine the particular tax consequences to them (including the application and effect of any state, local or non-U.S. income and other tax laws) of the receipt of cash in exchange for shares of Company common stock pursuant to the merger.
Regulatory Approvals in Connection with the Merger
The parties to the merger agreement intend to, and are obligated to, cooperate with each other and use their respective reasonable best efforts to, as promptly as reasonably practicable, among other things, (i) obtain all approvals, consents, registrations, waivers, permits, authorizations, exemptions, clearances, orders and other confirmations from any governmental authority or third party necessary, proper or advisable to consummate the transactions and (ii) defend or contest in good faith any action or judgment that could otherwise prevent or impede, interfere with, hinder or delay in any material respect the consummation of the transactions, in each case, as described in the section of this proxy statement titled “The Merger Agreement—Reasonable Best Efforts” beginning on page 99. The management of each of the Company and Parent currently believes that the necessary regulatory approvals can be obtained by year-end 2026; however, there can be no assurances that such approvals will be obtained in accordance with this timing or at all.
HSR Act Clearance
Consummation of the merger is subject to the requirements of the HSR Act and the rules promulgated by the FTC, which prevent transactions such as the merger from being consummated until (i) certain information and materials are furnished to the DOJ and the FTC and (ii) the applicable waiting period under the HSR Act has expired or been terminated. Both the Company and Parent filed their respective Notification and Report Forms with the FTC and the Antitrust Division of the DOJ on November 13, 2026. The waiting period applicable to the consummation of the merger under the HSR Act is scheduled to expire at 11:59 p.m. Eastern Time on December 14, 2026.
At any time before or after consummation of the merger, notwithstanding the termination or expiration of the waiting period under the HSR Act, the FTC or the DOJ could take such action under the antitrust laws as it deems necessary or desirable in the public interest, including seeking to enjoin the completion of the merger, seeking divestiture of substantial assets of the parties, or requiring the parties to license or hold separate assets or terminate existing relationships and contractual rights. At any time before or after the completion of the merger, any state could take such action under the antitrust laws as it deems necessary or desirable in the public interest. Such action could include seeking to enjoin the completion of the merger or seeking divestiture of substantial assets of the parties. Private parties may also seek to take legal action under the antitrust laws under certain circumstances. We cannot be certain that a challenge to the merger will not be made or that, if a challenge is made, we will prevail.
Additional Approvals
The Company and Parent intend to make all required filings under the Exchange Act relating to the merger and obtain all other approvals and consents that may be necessary to give effect to the merger.
Delisting and Deregistration of the Common Stock
If the merger is consummated, Parent will use its reasonable best efforts to cause shares of common stock to be delisted from the NYSE and deregistered under the Exchange Act as soon as reasonably practicable following the effective time.
THE MERGER AGREEMENT
Explanatory Note Regarding the Merger Agreement
The following summarizes the material provisions of the merger agreement. This summary does not purport to be complete, may not contain all of the information about the merger agreement that is or may be important to you, and is qualified in its entirety by reference to the full merger agreement, a copy of which is attached to this proxy statement as Annex A. We strongly recommend that you read the merger agreement and documents related thereto carefully and in their entirety, as the rights and obligations of the parties are governed by the express terms of the merger agreement and such documents and not by this summary or any other information contained in this proxy statement.
The merger agreement is included with this proxy statement only to provide you with information regarding the terms of the merger agreement and not to provide you with any other factual information regarding the Company, Parent, Merger Sub or their respective subsidiaries, affiliates or businesses. The merger agreement contains representations and warranties by each of the parties to the merger agreement. These representations and warranties have been made solely for the benefit of the other parties to the merger agreement and:
•have been made only for purposes of the merger agreement;
•have been qualified by certain documents filed with, or furnished to, the SEC by the Company, from and after January 1, 2024, and prior to October 29, 2026;
•have been qualified by confidential disclosures made by the Company in connection with the merger agreement;
•are subject to materiality qualifications contained in the merger agreement that may differ from what may be viewed as material by investors;
•are subject to knowledge qualifiers contained in the merger agreement, which qualifiers are tied to the actual knowledge of certain persons;
•were made only as of the date of the merger agreement or such other date as is specified in the merger agreement; and
•have been included in the merger agreement for the purpose of allocating risk between the Company, on the one hand, and Parent and Merger Sub, on the other hand, rather than establishing matters as facts.
You should not rely on the representations and warranties or any descriptions thereof as characterizations of the actual state of facts or conditions of the Company, Parent, Merger Sub or any of their respective subsidiaries, affiliates or businesses. Moreover, information concerning the subject matter of the representations and warranties may have changed (and may continue to change) after the date of the merger agreement, which subsequent information may or may not be fully reflected in the Company’s public disclosures.
Accordingly, the representations and warranties and other provisions of the merger agreement should not be read alone, but instead should be read together with the information provided elsewhere in this proxy statement and in the documents incorporated by reference into this proxy statement. The Company will provide additional disclosure in its public reports of any material information necessary to provide the Company stockholders with a materially complete understanding of the disclosures relating to the merger agreement. See “Where You Can Find Additional Information” beginning on page 117 of this proxy statement.
The summary of the material terms of the merger agreement below and elsewhere in this proxy statement is qualified in its entirety by reference to the full merger agreement, a copy of which is attached to this proxy statement as Annex A and which we incorporate by reference into this proxy statement.
Effects of the Merger
Upon the terms and subject to the conditions set forth in the merger agreement, at the effective time, Merger Sub, a wholly owned subsidiary of Parent, will be merged with and into the Company, the separate corporate existence of Merger Sub will thereupon cease, and the Company will be the surviving corporation in the merger.
Closing and Effective Time of the Merger
Unless Parent and the Company agree in writing otherwise, the closing of the merger will take place at 10:00 a.m. (New York City time) on the second business day following the satisfaction or waiver (to the extent permitted by applicable law) of the conditions set forth in the merger agreement (other than those conditions that by their nature are to be satisfied at the closing, but subject to the satisfaction or waiver of those conditions at the closing); provided that, the closing will not occur prior to the third business day following the final day of the Marketing Period (as defined in the merger agreement) (or such other business day prior to the final day of the Marketing Period as specified by Parent in its sole discretion on no fewer than three business days’ notice to the Company (unless a shorter period is agreed to by the Company and Parent)) (subject to the satisfaction or waiver of the conditions set forth in the merger agreement as of such date).
The merger will become effective at the time that the certificate of merger is filed with the Secretary of State of the State of Delaware or, to the extent permitted by applicable law, at such later time as is agreed to by the parties prior to the filing of such certificate of merger and specified therein.
At the effective time, the certificate of incorporation of the Company, as in effect immediately prior to the effective time, will be amended and restated to read in its entirety as set forth on Exhibit A to the merger agreement, and as so amended and restated will be the certificate of incorporation of the surviving corporation until thereafter amended in accordance with applicable law and the certificate of incorporation and by-laws of the surviving corporation (and subject to compliance with the requirements of the merger agreement described under the section titled “—Indemnification and Insurance” below). The by-laws of Merger Sub, as in effect immediately prior to the effective time, will be the by-laws of the surviving corporation, except that references to Merger Sub’s name will be replaced with references to the surviving corporation’s name, until thereafter amended in accordance with applicable law and the certificate of incorporation and by-laws of the surviving corporation (and subject to compliance with the requirements of the merger agreement described under the section titled “—Indemnification and Insurance” below). The Company and Parent currently expect to consummate the merger during the first quarter of 2027, subject to receipt of the Company stockholder approval and the required regulatory approvals and the satisfaction or waiver (to the extent permitted by applicable law) of the other conditions to the merger described under the section titled “—Conditions of the Merger” below. For additional information, please see the section of this proxy statement titled “The Merger—Regulatory Approvals in Connection with the Merger” beginning on page 82.
Directors and Officers of the Surviving Corporation
The directors of Merger Sub immediately prior to the effective time will be the directors of the surviving corporation immediately following the effective time, until their respective successors are duly elected or appointed and qualified or their earlier death, resignation or removal in accordance with the certificate of incorporation and by-laws of the surviving corporation.
The officers of the Company immediately prior to the effective time will be the officers of the surviving corporation until their respective successors are duly elected and qualified or their earlier death, resignation or removal in accordance with the certificate of incorporation and by-laws of the surviving corporation.
Consideration To Be Received in the Merger
The merger agreement provides that, at the effective time, each share of Company common stock (including each share of Class B common stock of the Company) that is issued and outstanding as of immediately prior to the effective time (other than shares canceled in accordance with Section 2.01(b) of the merger agreement and appraisal shares) will be converted automatically into, and will thereafter represent only, the right to receive an amount in cash equal to $10.00 per share, without interest and subject to any applicable withholding taxes. As of the effective time,
each holder of Company common stock will cease to have any rights with respect thereto, except the right to receive the merger consideration to be paid in consideration therefor.
If, between October 29, 2026, and the effective time, any change in the outstanding shares of Company common stock, or securities exchangeable into or exercisable for shares of Company common stock, occurs as a result of any stock split, reverse share split, dividend (including any dividend or other distribution of securities convertible into shares of Company common stock), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change, then the merger consideration and any other amounts payable pursuant to the merger agreement will be appropriately adjusted to reflect such event.
Excluded Shares
All shares of Company common stock that are held by the Company as treasury shares immediately prior to the effective time or held by Parent or Merger Sub will be canceled and will cease to exist and no consideration will be delivered in exchange therefor.
Treatment of Company Long-Term Incentive Awards
Each long-term incentive award outstanding as of immediately prior to the effective time will be treated as follows:
•each vested Company Stock Option will be canceled and the holder thereof will be entitled to receive an amount in cash equal to the product of the number of shares of Company common stock subject to such vested option, multiplied by the excess of the merger consideration over the exercise price per share, provided that any such option with an exercise price per share equal to or greater than the merger consideration will be canceled for no consideration;
•each unvested Company Stock Option will be canceled and converted into the contingent right to receive an amount in cash, without interest (a “Contingent Cash Award”), equal to the product of (i) the number of shares of Company common stock subject to such unvested option immediately prior to the effective time and (ii) the excess, if any, of (A) the merger consideration over (B) the per share exercise price of such unvested Company Stock Option, which award shall generally have the same terms and conditions (including service-based vesting conditions) that applied to the corresponding unvested Company Stock Option immediately prior to the effective time, provided that any such option with an exercise price per share equal to or greater than the merger consideration will be canceled for no consideration; and
•each unvested Company RSU will be canceled and the holder thereof will be entitled to receive a Contingent Cash Award equal to the merger consideration multiplied by the number of shares subject to such Company RSU (assuming solely for purposes of computing the target amount of cash pursuant to performance-based vesting conditions, the attainment of all applicable performance goals at target), with the same terms and conditions (including service- and/or performance-based vesting conditions) that applied to the corresponding Company RSU immediately prior to the effective time.
With respect to the awards described above, the amounts that are payable as of the effective time will be made by the surviving corporation or any of its subsidiaries through their payroll systems, subject to any applicable withholding taxes, as promptly as reasonably practicable following the effective time (and in no event later than five business days following the effective time), provided, that to the extent that any such amounts relate to an award that is nonqualified deferred compensation subject to Section 409A of the Code, Parent and the surviving corporation shall pay such amounts at the earliest time permitted under the terms of the applicable agreement, plan or arrangement relating to such award and that will not trigger a tax or penalty under Section 409A of the Code. Any amounts payable following the effective time in respect of any portion of a Contingent Cash Award that vests shall be paid by the surviving corporation or any of its subsidiaries through their payroll systems, less applicable tax withholdings, no later than the second regularly scheduled payroll date following the date on which such portion vests.
Payment for Stock
Prior to the closing date, Parent will designate a bank or trust company reasonably acceptable to the Company to act as paying agent for the payment of the merger consideration in accordance with the merger agreement. At or prior to the effective time, Parent will deposit or cause to be deposited with the paying agent an amount in cash sufficient to pay the aggregate merger consideration (other than payments with respect to long-term incentive awards described above under the section titled “—Treatment of Company Long-Term Incentive Awards”).
As promptly as practicable after the effective time (but in no event more than three business days thereafter), Parent and the surviving corporation will cause the paying agent to mail to each person who was, at the effective time, a holder of a share certificate or book-entry shares not held, directly or indirectly, through the DTC (other than excluded shares and appraisal shares) (i) a letter of transmittal and (ii) instructions for use in effecting the surrender of the share certificates or book-entry shares to the paying agent in exchange for payment of the merger consideration as provided in the merger agreement.
Upon delivery of a letter of transmittal, duly completed and validly executed in accordance with such letter’s instructions (and such other customary documents as may reasonably be required by the paying agent) and either (i) the surrender to the paying agent of share certificates (or affidavits of loss in lieu thereof in accordance with the merger agreement) or (ii) the transfer of book-entry shares not held through the DTC, by book receipt of an “agent’s message” in customary form by the paying agent in connection with the surrender of book-entry shares (or such other reasonable evidence, if any, of surrender with respect to such book-entry shares, as the paying agent may reasonably request), in each case as contemplated in the merger agreement, the holder of such share certificates or book-entry shares will be entitled to receive, in exchange therefor, the merger consideration for each share of Company common stock formerly represented by such share certificates or book-entry shares, and the share certificates and book-entry shares so surrendered will forthwith be canceled.
With respect to book-entry shares held, directly or indirectly, through DTC, Parent and the Company will cooperate to establish procedures with the paying agent, DTC, DTC’s nominees and such other necessary third-party intermediaries to ensure that the paying agent will transmit to DTC or its nominees as promptly as practicable after the effective time, upon surrender of book-entry shares held of record by DTC or its nominees, the aggregate merger consideration to which the beneficial owners thereof are entitled to receive as a result of the merger.
HOLDERS OF SHARE CERTIFICATES OR BOOK-ENTRY SHARES NOT HELD, DIRECTLY OR INDIRECTLY, THROUGH DTC, SHOULD NOT FORWARD THEIR STOCK CERTIFICATES TO THE PAYING AGENT WITHOUT A LETTER OF TRANSMITTAL AND SHOULD NOT RETURN THEIR STOCK CERTIFICATES WITH THE ENCLOSED PROXY CARD.
Transfer Books; No Further Ownership Rights
At the effective time, the transfer books of the Company will be closed and thereafter there will be no further registration of transfers on the transfer books of the surviving corporation of the shares of Company common stock that were outstanding immediately prior to the effective time. From and after the effective time, the holders of the shares of Company common stock outstanding immediately prior to the effective time will cease to have any rights with respect to such shares, except as otherwise provided for herein or by applicable law. If, at any time after the effective time, share certificates or book-entry shares are presented to the surviving corporation, for any reason, they will be canceled and exchanged as provided in the merger agreement.
Lost, Stolen or Destroyed Certificates
A holder of a share certificate that has been lost, stolen or destroyed will have to make an affidavit of that fact and, if required by the surviving corporation, post a bond, in such reasonable amount as Parent may direct, as indemnity against any claim that may be made against it with respect to such share certificate, upon which the paying agent will pay, in exchange for such lost, stolen or destroyed share certificate, the applicable aggregate merger consideration.
Termination of Exchange Fund
At any time following the first anniversary of the closing date, the surviving corporation will be entitled to require the paying agent to deliver to it any portion of the exchange fund (including any interest received with respect thereto) which has not been disbursed to holders of share certificates or book-entry shares, and thereafter such holders will be entitled to look only to Parent and the surviving corporation, as applicable, for, and Parent and the surviving corporation will remain liable for, payment of their claims for the merger consideration. Any amounts remaining unclaimed by such holders at such time at which such amounts would otherwise escheat to or become property of any governmental authority will become, to the extent permitted by applicable law, the property of Parent or its designee, free and clear of all claims or interest of any person previously entitled thereto.
No Liability
Notwithstanding any provision of the merger agreement to the contrary, none of the Company, Parent or Merger Sub, the surviving corporation or the paying agent will be liable to any person for merger consideration properly delivered to a public official pursuant to any applicable state, federal or other abandoned property, escheat or similar law. Any amounts remaining unclaimed by holders of the Company common stock immediately prior to the time at which such amounts would otherwise escheat to, or become the property of, any governmental authority will, to the extent permitted by applicable law, become the property of the surviving corporation, free and clear of any claims or interest of any person previously entitled thereto.
Appraisal Rights
Shares of Company common stock that are outstanding immediately prior to the effective time and that are held by any person who is entitled to demand and properly demands appraisal of such shares of Company common stock pursuant to, and who complies in all respects with, Section 262 of the DGCL will not be converted into the right to receive the merger consideration as provided in the merger agreement, but instead will be canceled and will represent the right to receive only those rights provided under Section 262 of the DGCL. For additional information, please see “The Merger—Appraisal Rights”. Prior to the effective time, the Company will not, without the prior written consent of Parent (such consent not to be unreasonably withheld, delayed or conditioned), make any payment with respect to, or settle or offer to settle, any demands for appraisal of any shares of Company common stock or related notices, waive any failures or approve any withdrawal of any such demands or notices or propose or otherwise agree to do any of the foregoing. Parent will not, without the prior written consent of the Company (such consent not to be unreasonably withheld, delayed or conditioned), require the Company to make any payment with respect to any demands for appraisal or offer to settle or compromise (or actually settle or compromise) any such demands or notices.
Representations and Warranties
The merger agreement contains representations and warranties that the Company, on the one hand, and Parent and Merger Sub, on the other hand, have made to one another, which are qualified in many cases by knowledge, materiality or Material Adverse Effect standards and with respect to the disclosures made by the Company, by (i) certain exceptions and qualifications set forth in the merger agreement, (ii) confidential disclosures made by the Company to Parent and Merger Sub and (iii) certain sections of documents filed with, or furnished to, the SEC by the Company, from and after January 1, 2024, and prior to October 29, 2026.
The representations and warranties in the merger agreement do not survive the closing or termination of the merger agreement.
For purposes of the merger agreement, a “Material Adverse Effect” with respect to the Company and its subsidiaries means any effect, change, event or occurrence that has, or would be reasonably expected to have, a material adverse effect on the business, assets, results of operations or condition (financial or otherwise) of the Company and its subsidiaries, taken as a whole; provided, however, that none of the following, and no effect, change, event or occurrence arising out of, or resulting from, the following, will constitute or be taken into account in determining whether a Material Adverse Effect has occurred, is continuing or would reasonably be expected to occur: any effect, change, event or occurrence (A) generally affecting the industry in which the Company and its
subsidiaries operate or the economy, credit or financial or capital markets, in the U.S. or elsewhere in the world, including changes in interest or exchange rates, monetary policy, inflation, tariffs, sanctions, trade policies or trade wars, or (B) to the extent arising out of, resulting from or attributable to (1) any change in law or in GAAP, or any change in the interpretation or enforcement of any of the foregoing, in each case, after October 29, 2026, or any change in general legal, regulatory, political or social conditions, (2) the negotiation, execution, announcement or performance of the merger agreement or the consummation of the transactions (other than for purposes of certain representations and conditions as set forth in the merger agreement), including the impact thereof on relationships, contractual or otherwise, with customers, suppliers, landlords, distributors, partners, employees or regulators, or any litigation arising from allegations of breach of fiduciary duty or violation of law relating to the merger agreement or the transactions, (3) acts of war (whether or not declared), military activity, sabotage, civil disobedience, social unrest, protests, terrorism (including cyberterrorism or cyberattacks not specifically directed at the Company or its subsidiaries), or any escalation or worsening of any such acts of war (whether or not declared), military activity, sabotage, civil disobedience, social unrest, protests or terrorism, (4) earthquakes, fires, floods, hurricanes, tornados or other natural disasters, weather-related events, casualty events or other force majeure events, (5) (x) any action taken by the Company or its subsidiaries that is expressly required by the merger agreement, (y) any action taken by the Company or its subsidiaries with Parent’s express written consent or at Parent’s express written request or (z) the failure to take any action by the Company or its subsidiaries if that action is expressly prohibited by the merger agreement (provided that clause (z) will not apply to any action omitted to be taken pursuant to the Company’s obligations described under the section titled “—Covenants Regarding Conduct of Business by the Company Pending the Effective Time” unless the Company has requested to take an action that is prohibited thereby and Parent has unreasonably withheld, delayed or conditioned its written consent to such action), (6) any change or prospective change in the Company’s credit ratings, (7) any decline in the market price, or change in trading volume, of the shares of the Company, (8) any failure to meet any internal or public projections, forecasts, guidance, estimates, milestones, budgets or internal or published financial or operating predictions of revenue, earnings, cash flow or cash position (it being understood that the exceptions in clauses (6), (7) and (8) will not prevent or otherwise affect a determination that the underlying cause of any such change, decline or failure referred to therein (if not otherwise falling within any of the exceptions provided by clause (A) and clauses (B)(1) through (8)) is a Material Adverse Effect) or (9) any epidemic, pandemic or disease outbreak; provided further, however, that any effect, change, event or occurrence referred to in clause (A) or clauses (B)(1), (3), (4) or (9) may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect to the extent such effect, change, event or occurrence has a disproportionate adverse effect on the Company and its subsidiaries, taken as a whole, as compared to other participants in the industry in which the Company and its subsidiaries operate (in which case only the incremental disproportionate impact or impacts may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect).
A Material Adverse Effect with respect to Parent and Merger Sub means any effect, change, event or occurrence that would or would reasonably be expected to prevent or materially delay, interfere with, hinder or impair the consummation by Parent or Merger Sub of any of the transactions in accordance with the terms of the merger agreement.
The representations and warranties made by the Company relate to, among other topics, the following:
•the organization, valid existence, good standing, authority and qualification to conduct business with respect to the Company and each subsidiary;
•capitalization;
•authority to enter into the merger and the binding nature of the merger agreement;
•governmental approvals;
•compliance with SEC filing requirements;
•conformity with GAAP and SEC requirements of financial statements filed with the SEC;
•no undisclosed liabilities;
•existence of internal controls and disclosure controls and procedures;
•the absence of certain actions or circumstances, and absence of any material adverse effect, in each case, since June 30, 2026;
•the absence of certain legal proceedings;
•compliance with applicable laws, including anti-corruption laws and sanctions, and holding of required permits;
•certain tax matters;
•certain employee benefits matters;
•certain labor matters;
•certain environmental matters;
•intellectual property;
•certain data privacy laws and technology and information security matters;
•matters relating to owned and leased real property;
•material contracts;
•insurance coverage;
•absence of rights agreements and inapplicability of anti-takeover laws;
•receipt of opinions from the Company’s financial advisors regarding the fairness, from a financial point of view, of the merger consideration to be received by holders of shares of Company common stock;
•brokers and other advisors; and
•top vendors.
The representations and warranties made by Parent and Merger Sub relate to, among other topics, the following:
•the organization, valid existence, good standing, authority and qualification to conduct their respective businesses;
•authority to enter into the merger agreement and to consummate the transactions contemplated by the merger agreement;
•governmental approvals;
•ownership and operations of Merger Sub;
•the debt, preferred equity and equity commitment letters delivered by Parent to the Company (including the enforceability thereof) and the related fee letters;
•the guarantee delivered by Parent to the Company (including the enforceability thereof);
•the solvency of Parent and the surviving corporation as of the effective time and immediately after the consummation of the applicable transactions, including the merger and the financing;
•the absence of certain arrangements with Company management, the Board or any beneficial owner of shares of Company common stock;
•brokers and other advisors;
•the accuracy of information supplied for inclusion in this proxy statement;
•the absence of certain legal proceedings;
•non-ownership of Company common stock; and
•foreign person status.
Covenants Regarding Conduct of Business by the Company Pending the Effective Time
Under the merger agreement, in general, subject to certain exceptions and unless Parent otherwise consents in writing (such consent not to be unreasonably withheld, delayed or conditioned), the Company has agreed to, and to cause each of its subsidiaries to, use commercially reasonable efforts to carry on its and their respective businesses in all material respects in the ordinary course and, to the extent consistent therewith, to (i) preserve its and each of its subsidiaries’ current business organizations substantially intact, (ii) retain the services of its and their respective officers and key employees and (iii) preserve its and each of its subsidiaries’ material business relationships.
The Company has also agreed under the merger agreement, subject to certain exceptions (including as required by applicable law, judgment or a government authority, as expressly permitted or required by the merger agreement and as set forth in the confidential disclosure schedules to the merger agreement) and unless Parent otherwise consents in writing (such consent not to be unreasonably withheld, delayed or conditioned, except in specified cases that remain subject to Parent’s sole discretion) to certain restrictions on its activities during the period from October 29, 2026, to the effective time or earlier termination of the merger agreement. These restrictions on the Company’s activities are summarized below. In general, subject to certain exceptions, the Company will not, and will not permit any of its subsidiaries to, without Parent’s prior written consent (such consent not to be unreasonably withheld, delayed or conditioned, except in specified cases that remain subject to Parent’s sole discretion):
•issue, grant, sell, pledge, dispose of or encumber (or authorize any of the foregoing with respect to) any shares of its capital stock or other equity or voting interests, or any securities convertible into, or exchangeable or exercisable for, any shares of its capital stock or other equity or voting interests (including any rights, warrants or options to purchase any shares of its capital stock or other equity or voting interests), with certain specified exceptions;
•other than transactions solely between and among the Company and its wholly owned subsidiaries, redeem, purchase or otherwise acquire any shares of the Company’s capital stock or other equity or voting interests, any capital stock of, or other equity or voting interests in, any subsidiary of the Company or any securities convertible into, or exchangeable or exercisable for, any shares of its capital stock or other equity or voting interests (including any rights, warrants or options to purchase any shares of its capital stock or other equity or voting interests) (other than pursuant to the forfeiture of, withholding of taxes with respect to or the net settlement or cashless exercise of equity-based awards outstanding as of October 29, 2026, in accordance with the terms of such awards and the applicable Company benefit plan as in effect on October 29, 2026, or the cancellation, retirement and elimination of shares of Class B common stock of the Company converted into shares of common stock of the Company);
•other than transactions solely between and among the Company and its wholly owned subsidiaries, establish a record date for, approve, declare, set aside for payment or pay any dividend on, or make any other distribution in respect of, any shares of its capital stock or other equity or voting interests (whether in cash, securities or otherwise);
•split, combine, subdivide or reclassify any shares of its capital stock or other equity or voting interests, except for any such transaction by a wholly owned subsidiary of the Company which remains a wholly owned subsidiary following such transaction;
•incur, create, refinance, prepay, repay, replace or assume any indebtedness for borrowed money, issue, create, refinance, replace or sell any debt securities or warrants or other rights to acquire any debt securities
of the Company or any of its subsidiaries, guarantee any such indebtedness or debt securities of another person or enter into any “keep well” or other agreement to maintain any financial condition of another person, except for (i) intercompany indebtedness among the Company and its subsidiaries in the ordinary course of business that is not reasonably expected to have an adverse impact on Parent’s ability to obtain any portion of the financing on the terms set forth in the commitment letters in any material respect, (ii) letters of credit, bank guarantees, security or performance bonds or similar credit support instruments, overdraft facilities or cash management programs, in each case issued, made or entered into but not drawn, in the ordinary course of business, (iii) indebtedness incurred under the Company’s existing revolving credit facility in an aggregate principal amount not to exceed $50 million, (iv) indebtedness incurred under the Company’s existing receivables facility in the ordinary course of business and on terms existing as of October 29, 2026, subject to certain conditions, including that the Company’s uncommitted available borrowing capacity thereunder not be less than $50 million, (v) additional indebtedness incurred after October 29, 2026 in an aggregate principal amount not to exceed $5 million and (vi) prepayments and repayments of existing indebtedness at stated maturity, in the ordinary course of business or in connection with any refinancing permitted under the merger agreement;
•enter into any swap or hedging transaction or other derivative agreements in an amount in excess of $20 million in the aggregate;
•make any loans, capital contributions or advances to any person, group or entity other than to the Company or any subsidiary of the Company in the ordinary course of business or pursuant to an acquisition permitted under the merger agreement;
•transfer, assign, dispose of, license, sell or lease to any person, in a single transaction or series of related transactions, any of its material properties or assets (excluding intellectual property of the Company), except (i) transfers, sales, leases, subleases or licenses between and among the Company and its subsidiaries, (ii) dispositions of properties or assets that are obsolete, worn out, surplus or no longer used or useful in the conduct of the business of the Company or any of its subsidiaries, (iii) expirations, terminations or surrenders of real property leases, subleases or licenses in accordance with their terms, (iv) transfers, sales, leases, subleases or licenses in the ordinary course of business and (v) sales, leases, subleases or licenses of properties or assets for consideration not to exceed $25 million in the aggregate;
•transfer, assign, sell, lease, license, subject to an encumbrance (other than encumbrances permitted under the merger agreement), cancel, abandon, allow to lapse or expire, or otherwise dispose of any material intellectual property owned or purported to be owned by the Company or any of its subsidiaries, except for (i) non-exclusive licenses granted to third parties in the ordinary course of business, (ii) any such transfer, assignment, sale or license required pursuant to certain material contracts and (iii) the expiration of any registered intellectual property at the end of its full statutory life;
•grant any encumbrance (other than encumbrances permitted under the merger agreement) on any of its assets having a value of more than $1 million (excluding intellectual property of the Company) other than (i) to secure indebtedness and other obligations permitted under the applicable terms of the merger agreement or (ii) to the Company or to a wholly owned subsidiary of the Company;
•acquire (including by merger) any capital stock or a material portion of the assets of any other person, business or division thereof, except for (i) purchases or acquisitions of inventory, supplies and other similar assets (excluding acquisitions of customer accounts) in the ordinary course of business, (ii) acquisitions in the amounts set forth in the confidential disclosure schedules to the merger agreement or (iii) certain acquisitions of customer accounts set forth in the confidential disclosure schedules to the merger agreement;
•except as required pursuant to the terms of any Company benefit plan, multiemployer plan or collective bargaining agreement, in each case, in effect on October 29, 2026 or adopted, established, entered into or amended after October 29, 2026 not in violation of the merger agreement, (i)(A) grant to any member of the Company board or employee of the Company or its subsidiaries classified as “Band 2” or above
(collectively, the “senior service providers”) any increase in compensation or benefits, or (B) grant to any current or former director, officer, employee or other individual service provider of the Company or its subsidiaries who is not a senior service provider any increase in compensation or benefits, except, in the case of this clause (B), annual merit-based increases to base salary or base wage rate (and corresponding increases to annual cash bonus opportunities) made in the ordinary course of business consistent with past practice that do not, on an aggregate basis, exceed 3.5% of the base salaries or base wage rates for all such individuals as of October 29, 2026, (ii) grant to any director, officer, employee or other individual service provider any increase in (or new) cash or equity-based incentive, bonus, severance, retention, change of control or termination or similar compensation or benefits, (iii) terminate, enter into or modify, extend or amend any collective bargaining agreement (other than successor collective bargaining agreements entered into in the ordinary course of business that do not result in material economic or operational changes and do not increase the hourly base wage rate by more than 5%) or material Company benefit plan, (iv) incur any obligation or liability, including any withdrawal liability, under any multiemployer plan, (v) take any action to accelerate the funding, payment or vesting of any rights, compensation or benefits under any Company benefit plan, (vi) hire, terminate, promote or engage, or otherwise enter into any employment or consulting agreement with, any senior service provider, or (vii) terminate any senior service provider, other than for cause (as determined by the Company in its reasonable discretion);
•make any changes in financial accounting methods, principles or practices affecting the consolidated assets, liabilities or results of operations of the Company and its subsidiaries except insofar as may be required by GAAP (or any binding interpretation thereof), by an applicable law, including Regulation S-X under the Securities Act of 1933, as amended, or by any governmental authority or quasi-governmental authority (including the Financial Accounting Standards Board or any similar organization);
•make, change or revoke any tax election, adopt or change any tax accounting method or change any tax accounting period, file any amended tax return, settle any tax claim or assessment, or consent to any extension or waiver of the limitations period applicable to any tax claim or assessment outside of the ordinary course of business, in each case, that is material to the Company or any of its subsidiaries;
•amend the Company’s certificate of incorporation and by-laws, as amended, or the comparable organizational documents of any subsidiary of the Company (other than immaterial amendments to the organizational documents of any subsidiary of the Company);
•settle or compromise any pending or threatened action against the Company or any of its subsidiaries (or any of their respective officers, directors or employees, in their capacity as such), other than settlements or compromises (i) in the ordinary course of business, (ii) reflected or reserved against in the Company’s balance sheet as of June 30, 2026, for an amount not materially in excess of the amount so reflected or reserved (excluding any amount that may be paid under insurance policies or indemnification agreements) or (iii) in an amount not exceeding $2.5 million, after taking into account any amounts that may be paid under insurance policies or indemnification agreements; provided that no such settlement may involve any material injunctive or equitable relief or impose ongoing restrictions on the business activities of the Company or any of its subsidiaries or on any of their respective assets, properties or rights that are material to the business of the Company and its subsidiaries, taken as a whole;
•recognize or certify any labor union, labor organization, works council, or group of employees as the bargaining representative for any employees of the Company or its subsidiaries, in each case, except as required by law;
•waive or release any noncompetition, nonsolicitation, nondisclosure, noninterference, nondisparagement, or other restrictive covenant obligation of any senior service provider;
•implement or announce any employee layoffs, plant closings, reductions in force, collective redundancies, furloughs, temporary layoffs, salary or wage reductions, work schedule changes or other such actions that could trigger any liability or notice requirement under the WARN Act;
•make, commit to or authorize any capital expenditures (including expenditures in connection with or relating to acquisitions of subscriber system assets and customer accounts), other than capital expenditures not to exceed the amounts set forth in the confidential disclosure schedules to the merger agreement and certain other specified capital expenditures;
•(i) modify, amend or extend any material contract in a manner adverse to the Company or its subsidiaries in any material respect, (ii) voluntarily terminate or cancel any material contract, (iii) waive, release or assign any material rights or claims under any material contract or (iv) enter into any contract that would have been a material contract had it been entered into prior to October 29, 2026, in each case, other than in the ordinary course of business and subject to certain exceptions;
•modify, amend, supplement or extend (other than renewals and extensions pursuant to the terms thereof), voluntarily terminate or cancel (other than expirations or redemptions pursuant to the terms thereof), waive or release any rights or claims under, consent to any waiver, modification or amendment of, or assign any rights or claims under, any of the indentures governing the Company’s outstanding notes; or
•commit, resolve or agree, in writing or otherwise, to take any of the foregoing actions.
Except as expressly permitted or expressly required by the merger agreement or as required by applicable law, judgment or a governmental authority, during the period from October 29, 2026, to the effective time (or such earlier date on which the merger agreement is terminated), neither Parent nor Merger Sub will, without the prior written consent of the Company, (i) take any action, or fail to take any action, in either case, that would reasonably be expected to result in any of the conditions to the merger set forth in the merger agreement to not be satisfied, (ii) take any action, or fail to take any action, in either case the result of which would reasonably be expected to materially impair or materially delay the consummation of the transactions or (iii) authorize any of, or commit or agree, in writing or otherwise, to take any of the foregoing actions.
Nothing contained in the merger agreement is intended to give Parent or Merger Sub, directly or indirectly, the right to control or direct the Company’s or its subsidiaries’ operations prior to the effective time. Prior to the effective time, the Company will exercise, consistent with the other terms and conditions of the merger agreement, complete control and supervision over its and its subsidiaries’ respective operations.
Go Shop; No Solicitation; Change in Board Recommendation
The merger agreement provides that, from October 29, 2026, until 11:59 p.m. New York City time, on November 28, 2026 (the “go-shop period”), which may be extended, solely with respect to excluded parties (as defined below), by written notice to Parent for a period of time not to exceed ten calendar days (the “go-shop extension period”), the Company and its subsidiaries and their respective representatives may, directly or indirectly:
•initiate, solicit, cause, encourage or facilitate, whether publicly or otherwise, takeover proposals (as defined below) (or inquiries, proposals or offers or other efforts or attempts that may reasonably be expected to lead to a takeover proposal);
•provide access to non-public information concerning the Company or any of its subsidiaries (provided that the Company will promptly provide to Parent any non-public information concerning the Company or its subsidiaries that is provided to any person given such access which was not previously provided to Parent or its representatives substantially concurrently with the time it is provided to such person);
•enter into, engage in and maintain discussions or negotiations with any persons or groups of persons with respect to takeover proposals (or inquiries, proposals or offers or other efforts or attempts that may reasonably be expected to lead to a takeover proposal); and
•cooperate with or assist or participate in, or facilitate any such inquiries, proposals, offers, efforts, attempts, discussions or negotiations.
However, non-public information relating to the Company and its subsidiaries provided to any such person during the go-shop period (or the go-shop extension period) must be provided pursuant to an acceptable
confidentiality agreement (as defined below). In addition, the Company may, in its sole discretion, waive or release any preexisting standstill provisions or similar agreements with any person or group of persons only if (i) the Board, after consultation with its outside legal counsel, has determined that the failure to waive or release such standstill would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable law and (ii) the Company notifies Parent prior to granting such waiver or release and provides the identity of the counterparty to whom it intends to grant such waiver or release.
In addition, from one minute after the termination of the go-shop period (i.e., 12:00 a.m., New York City time, on November 29, 2026) (the “no-shop period start date”) (or, with respect to any excluded party (solely for as long as such person or group is an excluded party), from the expiration of the go-shop extension period (if any)), the Company agreed that it will, and will cause each of its subsidiaries and its and their respective employees, officers and directors to, and will instruct and use its reasonable best efforts to cause its other representatives retained by it and acting on its behalf to, immediately cease and cause to be terminated any solicitation, discussions or negotiations (including promptly terminating each person’s and its representatives’ access to any physical or electronic data room and promptly requesting the return or destruction of all non-public information of the Company or any of its subsidiaries) that may be ongoing with respect to, or which would reasonably be expected to lead to, a takeover proposal and, from the no-shop period start date until the effective time or, if earlier, the termination of the merger agreement, not, directly or indirectly:
•initiate, solicit, cause or knowingly encourage or facilitate (including by way of furnishing non-public information) the submission of any inquiries regarding, or the making of any proposal or offer that constitutes, or would reasonably be expected to lead to, a takeover proposal;
•enter into, engage in, continue or otherwise participate in any discussions or negotiations regarding (except to notify any person of the provisions of the merger agreement described in this section) a takeover proposal or any inquiry or proposal that would reasonably be expected to lead to a takeover proposal, or furnish to any other person any non-public information or afford any person access to the business, employees, officers, contracts, properties, assets or books and records of the Company or its subsidiaries, in each case in connection with, or for the purpose of, knowingly encouraging or facilitating, a takeover proposal or any inquiry or proposal that would reasonably be expected to lead to a takeover proposal;
•approve, endorse or recommend any takeover proposal or submit a takeover proposal or any matter related thereto for the approval of the Company stockholders;
•enter into any letter of intent, memorandum of understanding, agreement in principle, merger agreement, acquisition agreement or other similar agreement (i) providing for or relating to a takeover proposal or (ii) requiring the Company to abandon, terminate or fail to consummate the transactions or breach the merger agreement; or
•authorize or commit to do any of the foregoing.
No later than two business days after the no-shop period start date, the Company is required to notify Parent in writing of the identity of each excluded party and provide to Parent the material terms and conditions of such takeover proposal, inquiry, request, proposal or offer and a copy of any written takeover proposal received therefrom. The parties to the merger agreement have agreed that the Company and its subsidiaries and their respective representatives may continue to engage in the activities described in the first paragraph of this section with respect to each excluded party (solely for as long as any such person or group is an excluded party) on and after the no-shop period start date until the expiration of the go-shop extension period (if any), including with respect to any amended or revised proposal submitted by such excluded party on or after the no-shop period start date and prior to the expiration of the go-shop extension period (if any).
On and after the no-shop period start date and prior to receipt of the Company stockholder approval, if the Company or any of its representatives receives a takeover proposal that did not result from any material breach of the obligations under the merger agreement described in this section, (i) the Company and its representatives may contact and engage in discussions with such person or group of persons making such takeover proposal or its or their representatives and financing sources solely to clarify the terms and conditions thereof or to request that any
takeover proposal made orally be made in writing or to notify such persons or group of persons or its or their representatives and financing sources of the Company’s obligations described above, and (ii) if the Board or any duly authorized committee thereof determines in good faith, after consultation with its financial advisors and outside legal counsel, that such takeover proposal constitutes, or would reasonably be expected to result in, a superior proposal (as defined below) and the failure to take such action would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable law, then the Company and any of its representatives may:
•enter into an acceptable confidentiality agreement with such person or group of persons making such takeover proposal and furnish, pursuant to an acceptable confidentiality agreement, information (including non-public information) with respect to the Company and its subsidiaries to the person or group of persons that has made such takeover proposal and its or their representatives and financing sources (provided that the Company will provide to Parent any non-public information concerning the Company or any of its subsidiaries that is provided to any such person or persons which was not previously provided to Parent or its representatives prior to, or substantially concurrently with, the time it is provided to such person or persons); and
•subject to the execution of an acceptable confidentiality agreement and compliance with applicable provisions of the merger agreement described in this section, engage in or otherwise participate in discussions or negotiations with the person or group of persons making such takeover proposal.
From and after the no-shop period start date (or, in the case of any excluded party (for so long as such person or group is an excluded party), following the expiration of the go-shop extension period (if any)) and prior to receipt of the Company stockholder approval, the Company must promptly (and in any event within 24 hours) notify Parent, in writing, in the event that the Company or any of its subsidiaries or its or their representatives receives a takeover proposal, and must disclose to Parent the material terms and conditions of any such takeover proposal and the identity of the person or group of persons making such takeover proposal. Furthermore, the Company must, upon the request of Parent, keep Parent reasonably informed of any material developments with respect to any such takeover proposal (including any material changes thereto) on a prompt basis (and in any event within 24 hours), including by providing Parent with any material documents or correspondence that identify or set forth any additional material terms or conditions thereof.
The Board has agreed that neither it, nor any duly authorized committee thereof, will:
•(i) fail to include the Company’s recommendation in this proxy statement, (ii) withdraw, withhold (or modify or qualify in a manner adverse to Parent), or publicly propose to withdraw or withhold (or modify or qualify in a manner adverse to Parent) or make other public statements inconsistent with, the Company’s recommendation, (iii) recommend the approval or adoption of, or approve or adopt, or publicly propose to recommend, approve or adopt, or publicly declare advisable, any takeover proposal, (iv) fail to publicly reaffirm the Company’s recommendation within ten business days following written request therefor from Parent or (v) commit, agree or resolve to take any action set forth in the foregoing clauses, subject to certain specified qualifications (any such action, an “adverse recommendation change”); or
•execute or enter into (or cause or permit the Company or any of its subsidiaries to execute or enter into) any contract, letter of intent, memorandum of understanding, agreement in principle, merger agreement, acquisition agreement or other similar agreement providing for a takeover proposal, other than any acceptable confidentiality agreement (each, a “Company acquisition agreement”).
Prior to adoption of the Company merger agreement proposal by Company stockholders, but not after, the Board or any duly authorized committee thereof may (i) in response to an intervening event (as defined below), make an adverse recommendation change or (ii) solely in response to a takeover proposal that did not result from a breach of the obligations described in this section, either or both (x) make an adverse recommendation change or (y) cause the Company to enter into a Company acquisition agreement providing for a takeover proposal and terminate the merger agreement in accordance with the terms thereof only if, in either case, the Board or any duly authorized
committee thereof has determined in good faith, after consultation with its financial advisors and outside legal counsel that:
•in respect of any adverse recommendation change in response to an intervening event, that the failure to make such adverse recommendation change would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable law (after taking into account all revisions to the terms of the merger agreement committed to by Parent in writing); provided that the Board may not make such adverse recommendation change unless (i) the Company has given Parent at least three business days’ prior written notice of its intention to take such action, specifying in reasonable detail the intervening event and the reasons that the Board is proposing to effect an adverse recommendation change, (ii) the Company has negotiated, and caused its representatives to negotiate, in good faith with Parent during such notice period, to the extent Parent wishes to negotiate, to enable Parent to commit in writing to effect revisions to the terms of the merger agreement, the commitment letters or the guarantee as would permit the Board to determine that it would not reasonably be expected to be required by its fiduciary duties to effect an adverse recommendation change and (iii) following the end of such notice period, the Board or any duly authorized committee thereof shall have considered in good faith such written commitment to effect revisions, and shall have, after consultation with its financial advisors and outside legal counsel, determined that the failure to make an adverse recommendation change would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable law if the revisions to which Parent has committed in writing were to be given effect; provided, further that, in the event of any material change regarding any intervening event, the Company will be required to deliver a new notice as described above and provide a new two-business-day notice period; and
•in respect of any such action in response to a takeover proposal, that such takeover proposal constitutes a superior proposal and that the failure to take such action would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable law (after taking into account all revisions to the terms of the merger agreement committed to by Parent in writing); provided that the Board and the Company may not take any such action unless (i) the Company has given Parent at least three business days’ prior written notice of its intention to take such action (which notice will specify the identity of the party making such superior proposal and the material terms and conditions thereof and include a copy of the most current version of the proposed agreement under which such superior proposal is to be consummated), (ii) the Company has negotiated, and caused its representatives to negotiate, in good faith with Parent during such notice period, to the extent Parent wishes to negotiate, to enable Parent to commit in writing to effect revisions to the terms of the merger agreement, the commitment letters or the guarantee such that it would cause such superior proposal to no longer constitute a superior proposal and (iii) following the end of such notice period, the Board or any duly authorized committee thereof shall have considered in good faith such written commitment to effect revisions, and shall have, after consultation with its financial advisors and outside legal counsel, determined that such superior proposal would continue to constitute a superior proposal if the revisions to which Parent has committed in writing were to be given effect and that the failure to take any such action would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable law; provided, further that, in the event of any change to pricing or any other material amendment or revision to the terms of any such takeover proposal, the Company will be required to deliver a new notice as described above and provide a new two-business-day notice period.
Any termination of the merger agreement in connection with the Company’s entry into a Company acquisition agreement with respect to a takeover proposal will be void and of no force and effect unless the termination is in accordance with the termination provisions described in the section below titled “—Termination of the Merger Agreement” and, to the extent required under the terms of the merger agreement, the Company pays to Parent (or Parent’s designee) the applicable Company termination fee.
For purposes of the merger agreement, “acceptable confidentiality agreement” means (i) any confidentiality agreement entered into by the Company from and after October 29, 2026, that (A) contains confidentiality provisions that are not materially less favorable in the aggregate to the Company than those contained in the nondisclosure agreement between the Company and an affiliate of Thrive Holdings, except that such confidentiality agreement need not include explicit or implicit standstill provisions or otherwise restrict the making of or
amendment or modification to takeover proposals and (B) does not prohibit the Company from complying with its obligations described in this section or contain terms that would restrict in any manner the Company’s ability to consummate the merger, or (ii) any confidentiality agreement entered into prior to October 29, 2026; provided, however, that, (x) in the case of clause (i), any such confidentiality agreements may not contain any provision requiring the Company or any of its subsidiaries to pay or reimburse the counterparty’s expenses and (y) in each case, any such confidentiality agreement may not contain any provision that would prevent the Company from complying with its obligations described in this section.
For purposes of the merger agreement, “takeover proposal” means any inquiry, proposal or offer from any person, entity or group (other than Parent and its subsidiaries) relating to, in a single transaction or series of related transactions, any direct or indirect (including through any derivative, hedging or option transactions):
•acquisition of 20% or more of the consolidated assets of the Company and its subsidiaries (based on the fair market value thereof, as determined in good faith by the Board or any duly authorized committee thereof), including through the acquisition of one or more subsidiaries of the Company owning such assets;
•acquisition of securities representing 20% or more of the voting power of the then outstanding Company common stock;
•tender offer or exchange offer that if consummated would result in any person, entity or group beneficially owning securities representing 20% or more of the voting power of the then outstanding Company common stock;
•merger, consolidation, share exchange, business combination, recapitalization, liquidation, dissolution, spin-off, joint-venture or similar transaction involving the Company pursuant to which such person, entity or group (or the stockholders thereof) would acquire, directly or indirectly, 20% or more of the consolidated assets of the Company and its subsidiaries (based on the fair market value thereof, as determined in good faith by the Board or any duly authorized committee thereof) or securities representing 20% or more of the aggregate voting power of the Company’s then outstanding securities or of the surviving entity in a merger, consolidation, share exchange or other business combination involving the Company or the resulting direct or indirect parent of the Company or such surviving entity; or
•any public announcement of a proposal or plan or intention to do any of the foregoing or any agreement to engage in any of the foregoing, in each case, other than the merger; provided that the merger agreement and the merger will not be deemed a takeover proposal.
For purposes of the merger agreement, “superior proposal” means any bona fide written takeover proposal made by a third party after October 29, 2026 and that did not result from a breach of, and was not solicited in violation of the merger agreement, and that the Board or any duly authorized committee thereof has determined in its good faith judgment, after consultation with its financial advisors and outside legal counsel, has terms and conditions that (i) would be more favorable to the stockholders of the Company than the merger from a financial point of view (after taking into account any revisions to the terms of the merger agreement and the merger committed to by Parent in writing) and (ii) is reasonably capable of being completed on the terms set forth in such takeover proposal, taking into account (a) the identity of the person or group of persons making such takeover proposal and (b) all legal, regulatory, financial, financing and other aspects of such proposal (including the financing arrangements, the form of consideration and the timing of and conditions to consummating such transaction) and of the merger agreement (provided that, for purposes of the definition of “superior proposal”, the references to “20%” in the definition of takeover proposal will be deemed to be references to “50%”).
For purposes of the merger agreement, an “intervening event” means any effect, change, event, fact, circumstance, occurrence or development with respect to the Company and its subsidiaries, taken as a whole, that, irrespective of when such effect, change, event, fact, circumstance, occurrence or development occurred, was not known or reasonably foreseeable by the Board (or if known to the Board, the consequences of which were not known or reasonably foreseeable as of October 29, 2026) as of or prior to October 29, 2026, which becomes known prior to the special meeting of the Company stockholders; provided that, in no event will any of the following constitute an intervening event: (a) the receipt, existence or terms of any takeover proposal or offer, inquiry or
proposal that could reasonably lead to a takeover proposal, (b) any change in the market price, trading volume or ratings of any securities or indebtedness of the Company or any of its subsidiaries and (c) the fact that the Company meets or exceeds, or fails to meet or exceed, internal or public projections, forecasts, guidance, estimates, milestones, budgets or internal or published financial or operating predictions of revenue, earnings, cash flow or cash position (it being understood that the exceptions in clauses (b) and (c) will not prevent or otherwise affect a determination that the underlying cause of any such change, decline or failure referred to therein that is not otherwise excluded from the definition of “intervening event” may be taken into account) or the consequences of any of the foregoing.
For purposes of the merger agreement, an “excluded party” means any person, group of persons or group that includes any person (so long as such person, together with all other members of such group, if any, who were members of such group or another group that included such person immediately prior to the no-shop period start date, represents at least 50% of the equity financing of such group at all times following the no-shop period start date and prior to the termination of the merger agreement) from whom the Company or any of its representatives has received, after the execution of the merger agreement and prior to the expiration of the go-shop period (for the avoidance of doubt, not including during any go-shop extension period), a takeover proposal that the Board or any committee thereof determines, in good faith and after consultation with its financial advisor and outside legal counsel, constitutes or would reasonably be expected to lead to a superior proposal; provided, however, that any person will immediately and irrevocably cease to be an excluded party if, at any time after the no-shop period start date, the takeover proposal submitted by such person is withdrawn or terminated or the Board (or any committee thereof) determines that such takeover proposal no longer is, or no longer would reasonably be expected to lead to, a superior proposal. A person or group shall cease to be an excluded party when the condition set forth in the parenthetical in the immediately preceding sentence is no longer satisfied with respect to such person or group and the Board receives written notice thereof.
Reasonable Best Efforts
Each of the parties to the merger agreement has agreed to cooperate with the other parties and use (and cause their respective controlled affiliates to use) their reasonable best efforts (unless, with respect to any action, another standard of performance is expressly provided for in the merger agreement) to:
•take, or cause to be taken, all actions, and do, or cause to be done, and assist and cooperate with the other parties in doing, all things necessary, proper or advisable to cause the conditions to closing to be satisfied and to consummate and make effective, prior to the outside date, the transactions, including preparing and filing all documentation to effect all necessary, proper and advisable filings, notices, petitions, statements, registrations, declarations, submissions of information, applications, reports and other documents;
•obtain all approvals, consents, registrations, waivers, permits, authorizations, exemptions, clearances, orders and other confirmations from any governmental authority or third party reasonably necessary, proper or advisable to consummate the transactions;
•execute and deliver any additional instruments reasonably necessary to consummate the transactions; and
•defend or contest in good faith any action brought by any person (including any governmental authority) or any judgment that could otherwise prevent or impede, interfere with, hinder or delay in any material respect the consummation of the transactions.
The Company and Parent also agreed to use reasonable best efforts to (i) take all action necessary to ensure that no anti-takeover law is or becomes applicable to any of the transactions and refrain from taking any actions that would cause the applicability of such laws, and (ii) if the restrictions of any anti-takeover law become applicable to any of the transactions, take all action necessary to ensure that such transactions may be consummated prior to the outside date on the terms contemplated by the merger agreement and otherwise lawfully minimize the effect of such anti-takeover laws on such transactions.
Parent will (i) control, lead and direct all actions, decisions and the timing and strategy for, and make all final determinations as to the timing and appropriate course of action with respect to, making and obtaining any
approvals, consents, registrations, waivers, permits, authorizations, exemptions, clearances, orders and other confirmations from any governmental authority in connection with the transactions and (ii) control, direct, lead and coordinate the overall development and strategy of the positions to be taken and the actions and positions to be requested or taken in any filing or submission with any governmental authority in connection with the transactions and in connection with any investigation, action or other inquiry or litigation by or before, or any negotiations with, any governmental authority relating to the transactions and of all other regulatory matters incidental thereto; provided that Parent will consult in good faith with the Company and its representatives and consider in good faith the Company’s perspective and input in respect of any of the foregoing.
On November 13, 2026, the Company and Parent each filed a Notification and Report Form under the HSR Act with respect to the merger. The waiting period under the HSR Act with respect to the merger is scheduled to expire at 11:59 p.m. Eastern Time on December 14, 2026, unless earlier terminated or extended. Each of the parties will use its reasonable best efforts to supply (and cause their respective affiliates to supply) any additional information and documentary material that may be reasonably requested by the relevant governmental authority with respect to such filings. Parent will pay, or cause to be paid, all filing fees payable to the governmental authority in connection with such filings under the HSR Act.
Subject to the limitations described below, Parent will take (and will cause its controlled affiliates and the subsidiaries of Thrive Holdings to take) all actions necessary to secure the expiration or termination of any applicable waiting period under the HSR Act and resolve any objections asserted with respect to, and avoid and eliminate each and every impediment to the consummation of, the transactions prior to the outside date under any applicable law raised by any governmental authority. Such actions include (A) executing settlements, national security agreements, undertakings, consent decrees, stipulations or other agreements with any governmental authority or other person, (B) agreeing to sell, divest or otherwise convey or hold separate any particular assets or categories of assets or businesses of the Company and its subsidiaries contemporaneously with or subsequent to the effective time, (C) terminating existing relationships, contractual rights or obligations of the Company or its subsidiaries, (D) creating any relationship, contractual right or obligation of the Company or its subsidiaries, (E) effectuating any other change or restructuring of the Company or any of its affiliates and (F) defending through litigation any claim asserted in court or administrative or other tribunal by any person (including any governmental authority) in order to avoid the entry of, or to have vacated or terminated, any restraint that would prevent the closing (each, a “remedial action”), in each case subject to the limitations described below, including with respect to burdensome conditions, and provided that Parent will consult in good faith with the Company and consider in good faith the Company’s perspective and input with respect to any such remedial action. Each of the Company, Parent and Merger Sub will not take (and each of the Company and Parent will cause their respective controlled affiliates (and, in the case of Parent, Thrive Holdings and its subsidiaries) not to take) any action or enter into any transaction acquiring or merging with any business, person or division thereof, or enter into a definitive agreement with respect thereto, with the intention to, or that would reasonably be expected to, (1) materially delay the expiration or termination of any waiting period under the HSR Act or the obtaining of approval of the DOJ or FTC as necessary, (2) materially increase the risk of any governmental authority entering an order or otherwise seeking to enjoin or prohibit the consummation of the transactions or (3) otherwise materially delay the consummation of the transactions. Neither Parent nor the Company will commit (and will cause their respective affiliates not to commit) to or agree with any governmental authority to stay, toll or extend any applicable waiting period under the HSR Act or enter into a timing agreement, understanding or commitment with any governmental authority without the prior written consent of the other party (such consent not to be unreasonably withheld, delayed or conditioned).
Notwithstanding the foregoing, none of Thrive Holdings, Parent, Merger Sub or their respective subsidiaries and affiliates is required to take or agree to take, or refrain from taking, actions that would or would reasonably be expected to impose a burdensome condition (as defined below) or involve their businesses, assets, equity interests or properties (other than those of the Company and its subsidiaries following closing). The Company and its subsidiaries and affiliates are not required to take or agree to take, or refrain from taking, actions unless conditioned upon closing and not effective before closing. Without Parent’s prior written consent, the Company and its subsidiaries may not take, offer or agree to take, or refrain from taking, any remedial action or other action that would or would reasonably be expected to impose a burdensome condition. At Parent’s written request, the Company and its affiliates will agree to remedial actions conditioned upon closing and not effective before closing.
A “burdensome condition” means any undertakings, terms, conditions, liabilities, obligations, commitments, sanctions or other measures (including remedial actions) that would or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the business, assets, results of operations or condition (financial or otherwise) of Parent, Thrive Holdings, the Company and their respective subsidiaries and affiliates, taken as a whole, deemed for this purpose to be a consolidated group equal in size and scale to 100% of the Company and its subsidiaries, taken as a whole, as of October 29, 2026. The parties have also agreed to use (and to cause their respective controlled affiliates (and, in the case of Parent, Thrive Holdings and its subsidiaries) to use) reasonable best efforts to: (i) cooperate in all respects with each other in connection with any necessary, proper or advisable submissions, consents, approvals, filings, petitions, statements, licenses, permits, authorizations, declarations, notifications, registrations, submissions of information, applications, reports, waivers, exemptions, clearances, orders, confirmations and other documents with the FTC, the DOJ or any other governmental authority in connection with the transactions and in connection with any investigation or other inquiry by or before the FTC, the DOJ or any other governmental authority relating to the transactions or any proceeding initiated by a private person, entity or group; (ii) keep the other parties informed in all material respects and on a reasonably timely basis of any material written or verbal communication received by such party from, or given by such party to, the FTC, the DOJ or any other governmental authority and of any material written or verbal communication received or given in connection with any proceeding by a private person, entity or group, (iii) subject to applicable law, the nondisclosure agreement identified in Section 5.05 of the confidential disclosure schedules to the merger agreement, and to the extent reasonably practicable, consult with the other parties with respect to information relating to the other parties to the merger agreement and their respective subsidiaries, as the case may be, that appears in any filing made with, or written materials submitted to, any third person or entity or the FTC, the DOJ, or any governmental authority in connection with the transactions, other than “4(c) documents” as that term is used in the rules and regulations under the HSR Act, (iv) to the extent permitted by the FTC, the DOJ or such other applicable governmental authority or other person, give the other parties to the merger agreement the opportunity to attend and participate in any meetings or conferences in connection with the transactions and (v) obtain prior to the outside date all consents, registrations, waivers, exemptions, approvals, confirmations, clearances, permits, certificates, orders, and authorizations necessary, proper or advisable to be obtained from, or renewed with, the FTC, the DOJ and any other governmental authority.
Financing
Efforts
The merger agreement provides that each of Parent and Merger Sub will use, and will cause their affiliates to use, commercially reasonable efforts to consummate the equity financing, preferred equity financing and debt financing, including using commercially reasonable efforts to:
•maintain in effect the commitment letters (other than any commitment letter terminated or reduced as permitted by the merger agreement);
•negotiate and enter into definitive agreements with respect to the debt financing on the terms and subject only to the conditions set forth in the applicable debt commitment letter and the fee letters delivered in connection therewith or on other terms and subject to other conditions not materially less favorable to Parent or Merger Sub than the terms and conditions set forth in the applicable debt commitment letter and related fee letter;
•satisfy (and cause its affiliates to satisfy) on a timely basis all conditions applicable to Parent (or its affiliates) in the applicable commitment letter and the definitive agreements related thereto;
•consummate the applicable debt financing at or prior to the closing of the merger;
•enforce its rights under the applicable commitment letters and the definitive agreements related thereto; and
•comply with its covenants and other obligations under the commitment letters and the definitive agreements relating to the financing.
Parent and Merger Sub may not, without the prior written consent of the Company, agree to or permit any termination of or amendment or modification to be made to, or grant any waiver of any provision under, the commitment letters or the associated fee letters or the definitive agreements relating to the financing if such termination, amendment, modification or waiver would (i) reduce (or could have the effect of reducing) the aggregate amount of the financing (including by increasing the amount of fees to be paid or original issue discount) below the amount required to satisfy the financing uses on the closing date (after taking into consideration certain other available funding amounts, including the equity financing, the preferred equity financing and available cash of the Company and its subsidiaries), unless there is a corresponding increase in the equity or preferred equity commitments, (ii) impose any new or additional conditions precedent to the availability of the financing or otherwise expand, amend or modify any existing conditions precedent to the financing, or otherwise expand, amend or modify any other provision of the commitment letters or the fee letters in a manner that would reasonably be expected to delay or prevent or make less likely to occur the funding of the financing (or satisfaction of the conditions to the financing) on or prior to the closing date, (iii) amend or modify or grant any consent under or otherwise waive any provision in the debt commitment letters if the effect of such amendment, modification, consent or waiver would be to modify the requirements of certain syndication provisions in the debt commitment letters, each as in effect on the signing date, (iv) amend or modify the backstop commitment letter if the effect of such amendment or modification would be to reduce the commitment of Apollo or Atlas in respect of each of the debt facilities contemplated below 100% of the aggregate commitments thereunder in respect of each debt facility, (v) amend or modify the syndicated commitment letter in order to join any additional debt financing source to the syndicated commitment letter unless such debt financing source constitutes an Approved Financing Source (as defined in the merger agreement) (provided that the aggregate number of additional debt financing sources joined to the syndicated commitment letter after the signing date shall not exceed twenty (20)) or (vi) adversely impact the ability of Parent, Merger Sub or the Company to enforce its rights against the parties to the commitment letters or the definitive agreements with respect to the financing.
The Company has agreed that, prior to the closing date, it will use commercially reasonable efforts to provide, and to cause its subsidiaries and their respective representatives to provide, to Parent and Merger Sub, in each case at Parent’s sole expense, all cooperation reasonably requested by Parent, as more fully set forth in the merger agreement, as is customary and reasonably necessary in connection with the consummation of the debt financing.
Parent or its affiliates obtaining financing, including any alternative financing, is not a condition to the consummation of the merger.
Indemnification and Insurance
The merger agreement provides that for a period of six years from and after the effective time, each of Parent and the surviving corporation will, and Parent will cause the surviving corporation to, in each case to the fullest extent permitted by applicable law, (i) indemnify and hold harmless each current or former director or officer of the Company or its subsidiaries and each other person, group or entity who at the effective time is, or at any time prior to the effective time was, indemnified or entitled to be indemnified by the Company or its subsidiaries pursuant to the Company’s certificate of incorporation and other organizational documents and the organizational documents of the Company’s subsidiaries in effect on October 29, 2026 or in any agreement in existence on October 29, 2026 providing for indemnification or advancement of expenses between the Company or any of its subsidiaries and any such person, group or entity (each, an “indemnitee” and, collectively, “indemnitees”) with respect to all claims, liabilities, losses, damages, judgments, fines, penalties, costs (including amounts paid in settlement or compromise) and expenses (including fees and expenses of legal counsel) in connection with any legal or administrative proceeding, suit, investigation, arbitration or action (whether civil, criminal, administrative or investigative), whenever asserted, based on or arising out of, in whole or in part, (A) the fact that an indemnitee is or was a member, director, manager, officer, employee or agent of the Company or such subsidiary or (B) acts or omissions by an indemnitee in the indemnitee’s capacity as a member, director, manager, officer, employee or agent of the Company or such subsidiary or taken at the request of the Company or such subsidiary (including in connection with serving at the request of the Company or such subsidiary as a representative of another person (including any employee benefit plan)), in each case of (A) or (B), at, or at any time prior to, the effective time (including any legal or administrative proceeding, suit, investigation, arbitration or action relating in whole or in part to the transactions or relating to the enforcement of the indemnification provisions of the merger agreement or any other
indemnification or expense advancement right of any indemnitee), subject in each case to certain limitations as set forth in the merger agreement, and (ii) assume (in the case of the surviving corporation, in the merger without any further action) all obligations of the Company and such subsidiaries to the indemnitees in respect of indemnification, advancement of expenses and exculpation from liabilities for acts or omissions occurring at or prior to the effective time as provided in the Company charter and the organizational documents of such subsidiaries as in effect on October 29, 2026 or in any agreement in existence as of October 29, 2026 providing for indemnification or advancement of expenses between the Company or any of its subsidiaries and any indemnitee.
From and after the effective time, to the fullest extent permissible by applicable law, Parent will cause, unless otherwise required by law, the certificate of incorporation and by-laws of the surviving corporation, and the surviving corporation will cause the organizational documents of its subsidiaries, to contain provisions no less favorable to the indemnitees with respect to limitation of liabilities, indemnification, advancement of expenses and exculpation, in each case, of members, managers, directors and officers than are set forth as of October 29, 2026 in the Company’s certificate of incorporation and the organizational documents of such subsidiaries as in effect on October 29, 2026, which provisions will not be amended, repealed or otherwise modified in a manner that would adversely affect the rights thereunder of any of the indemnitees, and Parent will, and will cause the surviving corporation to, without requiring a preliminary determination of entitlement to indemnification, advance any expenses (including fees and expenses of legal counsel) of any indemnitee (including in connection with enforcing the indemnity and other obligations described in this section), as incurred to the fullest extent permitted under applicable law.
None of Parent, the surviving corporation or any of their respective subsidiaries are permitted to settle, compromise or consent to the entry of any judgment in any threatened or actual litigation, claim or proceeding relating to any acts or omissions (each, a “claim”) for which indemnification could be sought by an indemnitee under the merger agreement, unless such settlement, compromise or consent includes an unconditional release of such indemnitee from all liability arising out of such claim or such indemnitee otherwise consents in writing to such settlement, compromise or consent. From and after the effective time, each of Parent, the surviving corporation and their respective subsidiaries is required to cooperate in the defense of any claim and provide access to properties and individuals as reasonably requested and furnish or cause to be furnished records, information and testimony, and attend such conferences, discovery proceedings, hearings, trials or appeals, as may be reasonably requested in connection therewith, subject in each case to certain limitations as set forth in the merger agreement.
The merger agreement requires that, for the six-year period commencing immediately after the effective time, the surviving corporation maintain in effect the Company’s current directors’ and officers’ liability insurance covering acts or omissions occurring at or prior to the effective time with respect to those individuals who are currently (and any additional individuals who prior to the effective time become) covered by the Company’s directors’ and officers’ liability insurance policies, on terms and scope with respect to such coverage, and in an amount, no less favorable to such individuals than those of such policy in effect on October 29, 2026 (or Parent may substitute therefor policies, issued by reputable insurers, of at least the same coverage with respect to matters existing or occurring prior to the effective time, including a “tail” policy); provided that the surviving corporation will not be required to pay an annual premium for such insurance in excess of 300% of the current annual premium paid by the Company for such insurance. The Company has the right, prior to the effective time, to purchase a six-year prepaid “tail policy” on terms and conditions providing at least substantially equivalent benefits as the current policies of directors’ and officers’ liability insurance maintained by the Company and its subsidiaries with respect to matters existing or occurring prior to the effective time, covering, without limitation, the transactions, subject to the same cap on the annual premium. If such tail policy has been obtained by the Company, it will be deemed to satisfy all obligations to obtain such insurance under the merger agreement, and the surviving corporation will use reasonable best efforts to cause such policy to be maintained in full force and effect, for its full term, and to perform all of its obligations thereunder.
From and after the effective time, the obligations of Parent and the surviving corporation with respect to indemnification under the merger agreement will not be terminated or modified in such a manner as to adversely affect the rights of any indemnitee to whom such provisions apply unless (x) such termination or modification is required by applicable law or (y) the affected indemnitee will have consented in writing to such termination or modification. In the event that (i) Parent, the surviving corporation or any of their respective successors or assigns
(A) consolidates with or merges into any other person, entity or group and is not the continuing or surviving corporation or entity of such consolidation or merger or (B) transfers or conveys all or substantially all of its properties and assets to any person, entity or group, or (ii) Parent or any of its successors or assigns dissolves the surviving corporation, then, in each case, proper provisions will be made so that the successors and assigns of Parent or the surviving corporation assume all of the obligations thereof with respect to indemnification set forth in the merger agreement. If any claim is brought against an indemnitee on or prior to the sixth anniversary of the effective time, the indemnification provisions of the merger agreement will continue in effect until the full and final resolution of such claim.
Employee Benefits Matters
The merger agreement provides that for a period of at least 12 months following the effective time, Parent will, and will cause the surviving corporation and its subsidiaries to, provide (i) a base salary or hourly base wage rate and target annual cash bonus opportunities to each person who is an employee of the Company or any of its subsidiaries immediately prior to the effective time (each, a “continuing employee”) that are no less favorable, in each case, than those in effect immediately prior to the effective time, (ii) severance benefits to each continuing employee that are no less favorable than those that would have been provided to such continuing employee under certain severance benefit plans, programs, policies, agreements and arrangements of the Company as in effect immediately prior to the effective time (after giving effect to any provisions relating to a “change in control,” “change of control” or other terms of similar import), and (iii) employee benefits (other than base salary, wage rate, incentive, bonus, equity and long-term incentive opportunities, retention, change in control, transaction, nonqualified deferred compensation, defined benefit pension and post-retirement welfare benefits) to each continuing employee that are substantially comparable in the aggregate to those benefits (subject to the same exclusions) provided to such continuing employee immediately prior to the effective time.
From and after the effective time, Parent will, or will cause the surviving corporation and their respective subsidiaries to, honor in accordance with their terms all Company benefit plans as in effect at the effective time and continue to be bound by the terms of each collective bargaining agreement in effect as of immediately prior to the effective time. Parent and the Company have acknowledged that the consummation of the transactions constitutes a “change in control,” “change of control” or other term of similar import for purposes of any Company benefit plan that contains such a definition.
With respect to all employee benefit plans of Parent, the surviving corporation and their respective subsidiaries in which continuing employees are eligible to participate from and after the effective time (including any vacation, paid time-off and severance plans), for purposes of determining eligibility to participate, level of paid time off and severance benefits, and vesting (other than vesting of equity or equity-based compensation), each continuing employee’s service with the Company or any of its subsidiaries (and any predecessor employer, to the extent such service was recognized by the Company or such subsidiary) will be treated as service with Parent, the surviving corporation or any of their respective subsidiaries, except that such service need not be recognized with respect to any defined benefit pension plan or post-retirement welfare benefits or to the extent such recognition would result in any duplication of benefits for the same period of service.
Parent will, or will cause the surviving corporation and its subsidiaries to, use commercially reasonable efforts to (i) waive, or cause to be waived, any pre-existing condition limitations, exclusions, actively-at-work requirements and waiting periods under any welfare benefit plan in which continuing employees (and their eligible dependents) will be eligible to participate from and after the effective time, except to the extent such pre-existing condition limitations, exclusions, actively-at-work requirements and waiting periods would not have been satisfied or waived under the comparable Company benefit plan immediately prior to the effective time, and (ii) recognize the dollar amount of all co-payments, deductibles and similar expenses incurred by each continuing employee (and his or her eligible dependents) during the calendar year in which the effective time occurs for purposes of satisfying such year’s deductible and co-payment limitations under the relevant welfare benefit plans.
Certain Additional Covenants and Agreements
The merger agreement also contains additional covenants between the Company, Parent and Merger Sub relating to, among other things, (i) public announcements with respect to the transactions; (ii) access to information and confidentiality; (iii) coordination with respect to stockholder litigation relating to the merger; (iv) covenants relating to the de-listing of the shares of Company common stock from the NYSE and deregistering such Company common stock under the Exchange Act; (v) the filing of this proxy statement and the holding of the special meeting; (vi) the treatment of the Company’s outstanding notes; (vii) the delivery of payoff letters with respect to certain existing indebtedness of the Company; (viii) Section 16 matters; and (ix) the payment of transfer taxes.
Conditions of the Merger
Each party’s obligations to effect the merger are subject to the satisfaction (or waiver, if permissible under applicable law), on or prior to the closing date, of certain conditions, including:
•no judgment enacted, promulgated, issued, entered, amended or enforced by any governmental authority of competent jurisdiction or any applicable law in the United States will be in effect enjoining, restraining or otherwise making illegal, preventing or prohibiting the consummation of the merger (the “restraints”);
•the expiration or early termination of the waiting period (and any extension thereof) applicable to the consummation of the merger under the HSR Act; and
•the receipt of the Company stockholder approval.
The obligations of Parent and Merger Sub to consummate the merger are subject to the satisfaction (or written waiver by Parent, if permissible under applicable law) on or prior to the closing of the following additional conditions:
•the accuracy of representations and warranties of the Company to the extent specified in the merger agreement, subject to certain materiality qualifications;
•the Company having complied with or performed in all material respects the obligations required to be complied with or performed by the Company and its subsidiaries at or prior to the effective time under the merger agreement; and
•the absence of a Material Adverse Effect with respect to the Company and its subsidiaries since October 29, 2026.
The obligations of the Company to consummate the merger are subject to the satisfaction (or written waiver by the Company, if permissible under applicable law) at or prior to the closing of the following additional conditions:
•the accuracy of representations and warranties of Parent and Merger Sub to the extent specified in the merger agreement, subject to certain materiality qualifications; and
•Parent and Merger Sub having complied with or performed, in all material respects, the obligations required to be complied with or performed by them at or prior to the effective time under the merger agreement.
The consummation of the merger and the transactions is not conditioned upon Parent’s receipt of financing. Each party may waive any of the conditions to its obligations to consummate the merger except where waiver is not permitted by law.
Termination of the Merger Agreement
The merger agreement may be terminated, and the transactions abandoned, at any time prior to the effective time, whether before or after receipt of the Company stockholder approval, by the mutual written consent of the Company and Parent.
Termination by Either the Company or Parent
In addition, the Company, on the one hand, or Parent, on the other hand, may terminate the merger agreement and abandon the transactions at any time prior to the effective time, whether before or after receipt of the Company stockholder approval, if:
•the effective time has not occurred on or before July 29, 2027 (the “outside date”); provided that this right to terminate the merger agreement (i) will not be available to any party if the breach by such party of its representations and warranties set forth in the merger agreement or the failure of such party to perform any of its obligations under the merger agreement has been a principal cause of or principally responsible for the failure of the effective time to occur on or before such date (it being understood that Parent and Merger Sub are deemed a single party for such purpose) and (ii) is subject to the proviso described in the third bullet in the section titled “—Termination by the Company”;
•any restraint in the U.S. having the effect set forth in the first bullet described above in the section titled “—Conditions of the Merger” is in effect and has become final and nonappealable; provided that the party seeking to terminate the merger agreement pursuant to this right to terminate has used the required efforts to prevent the entry of and to remove such restraint in accordance with its obligations under the merger agreement; or
•the special meeting of Company stockholders (including any adjournments or postponements thereof) has concluded and Company stockholder approval is not obtained.
Termination by Parent
Parent may also terminate the merger agreement and abandon the transactions by written notice to the Company at any time prior to the effective time, whether before or after receipt of the Company stockholder approval, if:
•the Company has breached any of its representations or warranties or failed to perform or comply with any of its covenants or agreements in the merger agreement, which breach or failure to perform or comply (i) would give rise to the failure of any of the conditions set forth under the fourth and fifth bullets described above in the section titled “—Conditions of the Merger” and (ii) which is incapable of being cured, or, if capable of being cured by the outside date, has not been cured by the earlier of (x) the outside date and (y) the date that is 45 calendar days following receipt by the Company of written notice from Parent of such breach or failure to perform or comply stating Parent’s intention to terminate the merger agreement pursuant to this right to terminate and the basis for such termination; provided that Parent will not have the right to terminate the merger agreement pursuant to this right to terminate if Parent or Merger Sub is then in material breach of any of its representations, warranties, covenants or agreements under the merger agreement; or
•the Board or a duly authorized committee thereof will have made an adverse recommendation change or the Company will have materially breached its no-shop obligations described above in the section titled “—Go Shop; No Solicitation; Change in Board Recommendation”.
Termination by the Company
The Company may also terminate the merger agreement and abandon the transactions by written notice to Parent at any time prior to the effective time, whether before or after receipt of the Company stockholder approval (except as otherwise noted), if:
•either of Parent or Merger Sub has breached any of its representations or warranties or failed to perform or comply with any of its covenants or agreements in the merger agreement, which breach or failure to perform or comply (i) (A) would give rise, individually or in the aggregate, to a Material Adverse Effect with respect to Parent and Merger Sub, or (B) would give rise to the failure of any of the conditions set forth under the seventh and eighth bullets described above in the section titled “—Conditions of the Merger” and (ii) which is incapable of being cured, or, if capable of being cured by the outside date, has
not been cured by the earlier of (x) the outside date and (y) the date that is 45 calendar days following receipt by Parent of written notice from the Company of such breach or failure to perform or comply stating the Company’s intention to terminate the merger agreement pursuant to this right to terminate and the basis for such termination; provided that the Company will not have the right to terminate the merger agreement pursuant to this right to terminate if the Company is then in material breach of any of its representations, warranties, covenants or agreements under the merger agreement;
•prior to receipt of Company stockholder approval, if the Company has received a superior proposal and the Board has authorized the Company to enter into a definitive agreement to consummate a superior proposal (after complying with the procedures described above in the eighth and ninth paragraphs and the bullets thereto of the section titled “—Go Shop; No Solicitation; Change in Board Recommendation”), in order to accept a superior proposal and enter into a Company acquisition agreement substantially concurrently with such termination in accordance with the applicable terms of the merger agreement; provided that prior to or concurrently with (and as a condition to) such termination the Company pays or causes to be paid the applicable termination fee in the manner provided for in the merger agreement; or
•all of the conditions under the first, second, third, fourth, fifth and sixth bullets described above in the section titled “—Conditions of the Merger” have been satisfied or waived in writing (to the extent such waiver is permitted by applicable law) (other than those conditions that by their nature are to be satisfied at the closing of the merger), the Company has irrevocably confirmed in writing to Parent that all conditions under the seventh and eighth bullets described above in the section titled “—Conditions of the Merger” have been satisfied (other than those conditions that by their nature are to be satisfied at the closing of the merger) or that, to the extent permitted by law, it has irrevocably waived any such unsatisfied conditions, the merger is required to be consummated, and the Company is ready, willing and able to consummate the merger on the date such notice is delivered and through the end of the next succeeding three business days, and the merger is not consummated by the later of (x) three business days after delivery of such notice to Parent and (y) the date the merger was required to be consummated as described above in the section titled “—Closing and Effective Time of the Merger” (provided that no party will be permitted to terminate the merger agreement pursuant to the first bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by Either the Company or Parent” during such three-business-day period).
Termination Fees
The Company will be required to pay to Parent the Company termination fee if:
•the Company or Parent terminates the merger agreement pursuant to the provisions described in the first or third bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by Either the Company or Parent” or the first bullet of “—Termination of the Merger Agreement—Termination by Parent”; provided that (i) at the time of termination neither Parent nor Merger Sub is then in material breach of its representations, warranties, covenants or agreements under the merger agreement such that the Company would be entitled to terminate the merger agreement pursuant to the provision described in the first bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by the Company”, (ii) a bona fide takeover proposal will have been publicly made, publicly proposed or otherwise publicly communicated by a third party after October 29, 2026 and not publicly withdrawn at least three business days prior to the time the merger agreement is terminated or, in the case of a termination pursuant to the provision described in the third bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by Either the Company or Parent”, the date of the special meeting of the Company stockholders and (iii) within 12 months of the date the merger agreement is terminated, the Company enters into a definitive agreement with respect to a takeover proposal and such takeover proposal is subsequently consummated (regardless of whether such consummation occurs within the 12-month period) or consummates a takeover proposal; provided, that for purposes of clauses (ii) and (iii), the references to “20%” in the definition of “takeover proposal” are deemed to be references to “50%”; or
•Parent terminates the merger agreement pursuant to the provision described in the second bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by Parent” or the Company terminates the merger agreement pursuant to the provision described in the second bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by the Company”.
For purposes of the merger agreement, “Company termination fee” means a cash amount equal to $227,000,000, except that it means a cash amount equal to $114,000,000 if the merger agreement is terminated by the Company pursuant to the second bullet described above in the section titled “—Termination of the Merger Agreement—Termination by the Company” in connection with entering into a Company acquisition agreement with (i) any person at any time before expiration of the go-shop period, (ii) any excluded party following the expiration of the go-shop period but before termination of the go-shop extension period (if any) or (iii) any excluded party within one business day following the expiration of the notice period for Parent’s match right described above in the section titled “—Go Shop; No Solicitation; Change in Board Recommendation” if such excluded party submitted the takeover proposal (or amendment or modification to a predecessor takeover proposal) giving rise to such match right less than five business days prior to the expiration of the go-shop extension period.
Parent will be required to pay to the Company the Parent termination fee of $473,000,000 if (i) the Company terminates the merger agreement pursuant to the provisions described in the first or third bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by the Company” or (ii) if Parent terminates the merger agreement pursuant to the provisions described in the first bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by Either the Company or Parent” and at such time the Company could have terminated the merger agreement pursuant to the provisions described in the first or third bullet point described above in the section titled “—Termination of the Merger Agreement—Termination by the Company”.
Limitation of Liability
Notwithstanding anything in the merger agreement to the contrary, the Parent termination fee, together with certain enforcement expenses (subject to a cap of $5,000,000) and certain financing cooperation expenses (subject to a cap of $3,000,000), will be the maximum aggregate monetary liability of Parent, Merger Sub and certain Parent-related parties in the event that Parent or Merger Sub fails to consummate the transactions contemplated by the merger agreement, including the merger, or otherwise fails to comply with or breaches any covenant or other obligation or representation and warranty in the merger agreement, and the Company on behalf of itself and certain Company-related parties has agreed to irrevocably waive and relinquish any right to seek or recover any monetary damages in excess of such amount.
In addition, other than in circumstances in which Parent is entitled to receive the Company termination fee (in which case such fee, together with certain enforcement expenses, will be Parent’s sole and exclusive monetary remedy, except in the case of the Company’s knowing and intentional breach of the merger agreement or fraud), Parent has agreed, on behalf of itself and certain Parent-related parties, that, except in the case of the Company’s knowing and intentional breach of the merger agreement or fraud, the maximum aggregate monetary liability of the Company and certain Company-related parties will be limited to the amount of the Company termination fee. Although the merger agreement provides that damages for a knowing and intentional breach of the merger agreement or fraud may include damages based on loss of the economic benefit of the transactions to the parties and the Company’s stockholders, from and after any termination of the merger agreement, the monetary liability of Parent, Merger Sub and certain Parent-related parties (including in respect of any knowing and intentional breach) will in no event exceed the Parent termination fee, if and when payable, together with the enforcement expenses and financing cooperation expenses described above, subject to the applicable caps.
Fees and Expenses
Whether or not the transactions are consummated, all fees and expenses incurred in connection with the merger agreement and the transactions will be paid by the party incurring or required to incur such fees or expenses, except as otherwise expressly set forth in the merger agreement.
Withholding Taxes
Each of Parent, Merger Sub, the Company, the surviving corporation, the paying agent and their respective affiliates will be entitled to deduct and withhold (or cause to be deducted and withheld) from any amounts otherwise payable pursuant to the merger agreement such amounts as are required to be deducted or withheld under applicable tax law. To the extent that amounts are so deducted or withheld and paid over to the relevant governmental authority, such amounts will be treated for all purposes of the merger agreement as having been paid to the person in respect of which such deduction or withholding was made.
Amendment or Supplement
Subject to compliance with applicable law, at any time prior to the effective time, the merger agreement may be amended, modified or supplemented in any and all respects only by written agreement of the parties thereto; provided that (i) following receipt of the Company stockholder approval, there will be no amendment or change to the provisions of the merger agreement which by law would require further approval by the Company stockholders without such approval, and (ii) any modification or amendment of specified sections of the merger agreement that is adverse to the interests of the debt financing sources or their affiliates will not be effective against such parties without their prior written consent.
Extension of Time, Waiver, etc.
At any time prior to the effective time, either Parent or the Company may, subject to applicable law, (i) waive any inaccuracies in the representations and warranties of the other party contained in the merger agreement or in any document delivered pursuant to the merger agreement, (ii) extend the time for the performance of any of the obligations or acts of the other party or (iii) waive compliance by the other party with any of the agreements contained in the merger agreement applicable to such party or, except as otherwise provided in the merger agreement, waive any of such party’s conditions (it being understood that Parent and Merger Sub will be deemed a single party for purposes of the foregoing clauses (i) through (iii)); provided that, following receipt of Company stockholder approval, there may be no waiver or extension of the merger agreement that would require further approval of the Company stockholders without such approval having first been obtained.
Governing Law; Jurisdiction
The merger agreement and all disputes, controversies or other actions arising out of or relating to the merger agreement or the transactions, including matters of validity, construction, effect, performance and remedies, are governed by, and will be construed in accordance with, the laws of the State of Delaware applicable to contracts executed in and to be performed entirely within that state, regardless of the laws that might otherwise govern under any applicable conflict of laws principles. Any legal, regulatory or administrative proceeding, suit, investigation, arbitration or action arising out of or relating to the merger agreement or the transactions will be heard and determined in the Court of Chancery of the State of Delaware (or, if the Court of Chancery of the State of Delaware declines to accept jurisdiction over any action, any state or federal court of competent jurisdiction within the State of Delaware).
Notwithstanding anything to the contrary in the merger agreement, the parties to the merger agreement have agreed that any legal action, whether at law or in equity, whether in contract or in tort or otherwise, against any debt financing sources or their affiliates arising out of or relating to the merger agreement or to the debt commitment letters, will be subject to the exclusive jurisdiction of the Supreme Court of the State of New York, County of New York, or, if under applicable law exclusive jurisdiction is vested in federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof), and that, except to the extent relating to the interpretation of any provisions in the merger agreement (other than those applicable to the debt financing sources) or the equity commitment letter, any legal action, whether at law or in equity, whether in contract or in tort or otherwise, against any debt financing sources or their affiliates will be governed by, and construed in accordance with, the laws of the State of New York.
Specific Enforcement
The parties agreed that irreparable damage for which monetary relief (including the termination fees described above in the section titled “—Termination Fees”), even if available, would not be an adequate remedy, would occur in the event that any provision of the merger agreement is not performed in accordance with its specific terms or is otherwise breached, including if the parties fail to take any action required of them to consummate the merger agreement and the transactions, subject to the terms and conditions of the merger agreement.
Subject to certain limitations, the parties acknowledged and agreed that the parties are entitled to an injunction or injunctions, specific performance or other equitable relief to prevent breaches of the merger agreement; that the termination fees described above in the section titled “—Termination Fees” will not be construed to diminish or otherwise impair a party’s right to specific enforcement; and that the right of specific enforcement is an integral part of the transactions and without that right neither the Company nor Parent would have entered into the merger agreement. The parties agreed not to assert that a remedy of specific enforcement is invalid or contrary to law for any reason, and not to assert that a remedy of monetary damages would provide an adequate remedy or that the parties otherwise have an adequate remedy at law.
Notwithstanding the foregoing, the Company will be entitled to seek specific performance of Parent’s obligation to cause the equity financing to be funded to fund the merger consideration and Parent’s and Merger Sub’s obligations to effect the closing only if (i) all of the conditions to Parent’s and Merger Sub’s obligations to consummate the merger have been satisfied or waived (other than those conditions that by their nature are to be satisfied at the closing, each of which is capable of being satisfied at such time) at the time when the closing would have been required to occur, (ii) the debt financing and the preferred equity financing have been funded or will be funded at the closing if the equity financing is funded at the closing, (iii) the Company has irrevocably confirmed in writing to Parent that all of the conditions to the Company’s obligations to consummate the merger have been satisfied or waived and that, if specific performance is granted and the equity financing, the preferred equity financing and the debt financing are funded, the Company stands ready, willing and able to consummate the transactions and (iv) Parent and Merger Sub have failed to consummate the closing prior to the third business day following the delivery of such confirmation.
Notwithstanding the foregoing, the parties agreed that no debt financing source will have any liability for any claims or damages to the Company, Parent or any of their related parties (other than Parent, Merger Sub and their respective affiliates in respect of any rights, claims or causes pursuant to the debt commitment letters) in its capacity as a debt financing source in connection with the merger agreement, the debt commitment letter or the debt financing or the transactions contemplated thereby, whether at law, in equity, in contract, in tort or otherwise, in each case, whether arising, in whole or in part, out of comparative, contributory or sole negligence by any debt financing source or otherwise.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information regarding the beneficial ownership of Company common stock as of November 19, 2026 by:
•each director;
•each current named executive officer;
•all of our current executive officers and directors as a group; and
•all stockholders known to us to be beneficial owners of five percent or more of Company common stock.
Except as otherwise set forth below, the address of each beneficial owner is: c/o ADT Inc., 1501 Yamato Road, Boca Raton, Florida 33431.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Beneficial Ownership |
| Name | | Vested Options (convertible into common stock on a 1:1 basis) (#) | | Common Stock (#) | | Common Stock and Vested Options Beneficially Owned | | Percent of Total(1) (%) |
| Non-Employee Directors | | | | | |
| |
|
Matthew E. Winter | | — | | | 126,225 | | | 126,225 | | | * |
Thomas Gartland | | — | | | 25,182 | | | 25,182 | | | * |
Tracey R. Griffin | | — | | | 126,996 | | | 126,996 | | | * |
Daniel Houston | | — | | | 74,812 | | | 74,812 | | | * |
Paul J. Smith | | — | | | 18,228 | | | 18,228 | | | * |
Danielle Tiedt | | — | | | 38,362 | | | 38,362 | | | * |
Suzanne Yoon | | — | | | 33,866 | | | 33,866 | | | * |
Sigal Zarmi | | — | | | 81,454 | | | 81,454 | | | * |
| Named Executive Officers | | | | | |
| |
|
James D. DeVries(2) | | 8,850,132 | | | 5,143,865 | | | 13,993,997 | | | 1.89 | % |
Jeffrey A. Likosar (3) | | 3,997,503 | | | 3,097,749 | | | 7,095,252 | | | * |
Fawad Ahmad | | 124,842 | | | 88,412 | | | 213,254 | | | * |
Omar Khan | | 465,080 | | | 7,280 | | | 472,360 | | | * |
David W. Smail | | 961,317 | | | 385,284 | | | 1,346,601 | | | * |
Donald M. Young(4) | | 2,847,299 | | | 3,095,288 | | | 5,942,587 | | | * |
| All executive officers and directors as a group (19 persons) | | 18,017,834 | | | 12,447,432 | | | 30,465,266 | | | 4.17 | % |
*Represents beneficial ownership of less than one percent of the outstanding Company common stock.
_______________
(1)Based on 730,531,112 shares, consisting of 675,786,587 shares of common stock and 54,744,525 shares of Class B common stock (as converted to common stock on a one-to-one basis), outstanding as of October 27, 2026, as disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the SEC on November 3, 2026. Share amounts are rounded to the nearest whole share; amounts do not include shares underlying options or restricted stock units that do not vest or become exercisable within 60 days of November 19, 2026.
(2)Consists of (a) 1,577,928 shares of common stock held by Mr. DeVries, (b) 3,565,937 shares of common stock held indirectly by Bethel Ventures LLC, of which Mr. DeVries is the manager and a member and (c) 8,850,132 options to purchase common stock held indirectly by Bethel Ventures LLC, of which Mr. DeVries is the manager and a member.
(3)Consists of (a) 3,997,503 options to purchase common stock held by MTCF LLC, (b) 623,195 shares of common stock held by Mr. Likosar, (c) 1,899,274 shares of common stock held by JSKC LLC and (d) 575,280 shares of common stock held by MTCF LLC. Mr. Likosar is a manager and a member of MTCF LLC and JSKC LLC.
(4)Reported amounts consistent with the Company’s Definitive Proxy Statement on Schedule 14A for its 2026 annual meeting of Company stockholders; total of 2,947,342 shares of common stock and 2,847,299 options to purchase common stock are held indirectly by Sweet Yourself LLC, of which Mr. Young is the manager and sole member. As disclosed in the Current Report on Form 8-K filed by the Company on March 11, 2025, Mr. Young retired from his position as Executive Vice President and Chief Operating Officer, effective as of
June 6, 2025. Following Mr. Young’s retirement from the Company, he is no longer subject to reporting requirements pursuant to Section 16 of the Exchange Act. As a result, the Company cannot independently verify this information.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Name | | Common Stock Number of Shares (#) | | Percent of Common Stock(2) (%) | | Class B Common Stock Number of Shares (#) | | Percent of Class B(3) (%) | | Percent of Total Company Common Stock(4) (%) |
Beneficial Owner (5%+)(1) | | | | | | | | | | |
State Farm Mutual Automobile Insurance Company(5) | | 133,333,333 | | | 19.7 | % | | — | | | — | % | | 18.3 | % |
BlackRock, Inc.(6) | | 69,300,803 | | | 10.3 | % | | — | | | — | % | | 9.5 | % |
Vanguard Portfolio Management, LLC(7) | | 57,175,389 | | | 8.5 | % | | — | | | — | % | | 7.8 | % |
Google LLC(8) | | — | | | — | % | | 54,744,525 | | | 100 | % | | 7.5 | % |
Dimensional Fund Advisors LP(9) | | 43,322,385 | | | 6.4 | % | | — | | | — | % | | 5.9 | % |
AQR Capital Management, LLC(10) | | 34,020,399 | | | 5.0 | % | | — | | | — | % | | 4.7 | % |
_______________
(1)Includes each person known to the Company to beneficially own 5% or more of the outstanding common stock or more than 5% of the outstanding Class B common stock, each measured as a separate class.
(2)Based on 675,786,587 shares of common stock outstanding as of October 27, 2026, as disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the SEC on November 3, 2026. Each holder of common stock is entitled to one vote per share on all matters submitted to the Company’s stockholders for a vote. Each share of common stock is entitled to receive dividends when, as, and if declared by the Board out of funds legally available for that purpose.
(3)Based on 54,744,525 shares of Class B common stock (as converted to common stock on a one-to-one basis), outstanding as of October 27, 2026, as disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the SEC on November 3, 2026. Class B common stock is convertible into common stock on a one-for-one basis, subject to certain conditions and adjustments and is entitled to one vote per share on all matters submitted to the Company’s stockholders for a vote; provided, however, that holders of Class B common stock are not entitled to vote on the election, appointment, or removal of directors of the Company. Each share of Class B common stock (i) is entitled to receive dividends when, as, and if declared by the Board out of funds legally available for that purpose and (ii) has equal status and rights to dividends as a share of common stock.
(4)Based on 730,531,112 shares, consisting of 675,786,587 shares of common stock and 54,744,525 shares of Class B common stock (as converted to common stock on a one-to-one basis), outstanding as of October 27, 2026, as disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the SEC on November 3, 2026.
(5)Based solely on information provided by State Farm Mutual Automobile Insurance Company (“State Farm”) in Amendment No. 5 to Schedule 13D filed with the SEC on August 11, 2026. The shares are held directly by State Farm Fire and Casualty Company (“State Farm Fire”). State Farm and State Farm Fire have shared voting power and shared dispositive power with respect to all 133,333,333 shares. The address of State Farm is One State Farm Plaza, Bloomington, Illinois 61710.
(6)Except for information pertaining to the percent of shares of common stock held, which is computed based on shares outstanding as of October 27, 2026, based solely on information provided by BlackRock, Inc. in a Schedule 13G/A filed with the SEC on August 6, 2026. BlackRock, Inc. possesses sole power to vote or to direct the vote of 68,047,053 shares and sole power to dispose or to direct the disposition of 69,300,803 shares. BlackRock, Inc. reported that iShares Core S&P Small-Cap ETF has an interest in more than five percent of the outstanding common stock. The address of BlackRock, Inc. is 50 Hudson Yards, New York, New York 10001.
(7)Except for information pertaining to the percent of shares of common stock held, which is computed based on shares outstanding as of October 27, 2026, based solely on information provided by Vanguard Portfolio Management, LLC in a Schedule 13G/A filed with the SEC on October 30, 2026. Vanguard Portfolio Management, LLC possesses sole power to vote or to direct the vote of 654,296 shares and sole power to dispose or to direct the disposition of 57,175,389 shares. Following an internal realignment on January 12, 2026, The Vanguard Group, Inc. reported in a Schedule 13G/A filed with the SEC on March 26, 2026 that it no longer beneficially owns any shares, with such holdings now reported on a disaggregated basis. The address of Vanguard Portfolio Management, LLC is 100 Vanguard Blvd., Malvern, Pennsylvania 19355.
(8)Except for information pertaining to the percent of shares held, which is computed based on shares outstanding as of October 27, 2026, based solely on information provided by Google LLC (“Google”) in a Schedule 13G filed with the SEC on September 23, 2020. Google holds all 54,744,525 outstanding shares of Class B common stock, which are convertible into common stock on a one-for-one basis, subject to certain conditions and adjustments. Google possesses sole power to vote or to direct the vote of, and sole power to dispose or to direct the disposition of, 54,744,525 shares; provided, however, that holders of Class B common stock are not entitled to vote on the election, appointment, or removal of directors of the Company. The address of Google is 1600 Amphitheatre Parkway, Mountain View, California 94043.
(9)Except for information pertaining to the percent of shares of common stock held, which is computed based on shares outstanding as of October 27, 2026, based solely on information provided by Dimensional Fund Advisors LP (“Dimensional”) in a Schedule 13G/A filed with the SEC on October 8, 2026. Dimensional possesses sole power to vote or to direct the vote of 42,559,587 shares and sole power to dispose or to direct the disposition of 43,322,385 shares. All securities reported are owned by funds advised by Dimensional, and Dimensional disclaims beneficial ownership of such securities. The address of Dimensional is 6300 Bee Cave Road, Building One, Austin, Texas 78746.
(10)Except for information pertaining to the percent of shares of common stock held, which is computed based on shares outstanding as of October 27, 2026, based solely on information provided by AQR Capital Management, LLC (“AQR”) and AQR Capital Management
Holdings, LLC (“AQR Holdings”) in a Schedule 13G filed with the SEC on November 13, 2026. Each of AQR and AQR Holdings possesses shared power to vote or to direct the vote of 33,174,815 shares and shared power to dispose or to direct the disposition of 34,020,399 shares. AQR is a wholly owned subsidiary of AQR Holdings. The address of each of AQR and AQR Holdings is One Greenwich Plaza, Suite 130, Greenwich, Connecticut 06830.
To our knowledge, except as noted above, no person or entity is the beneficial owner of five percent or more of the outstanding shares of any class of the Company’s voting securities.
MARKET PRICE AND DIVIDEND INFORMATION
Shares of common stock are listed on the NYSE under the trading symbol “ADT”. The $10.00 per share to be paid for each share of Company common stock pursuant to the merger agreement represents a 45.6% premium to the Company’s unaffected closing stock price of $6.87 on October 27, 2026, the last full trading day prior to the publication of a media report on the evening of October 27, 2026 regarding a potential transaction involving the Company. The $10.00 per share to be paid for each share of Company common stock pursuant to the merger agreement represents a premium of approximately 35.0% to the $7.41 per share closing price for shares of common stock on October 28, 2026, the last full trading day prior to the public announcement of the signing of the merger agreement. On November [ ], 2026, the latest practicable trading day before the filing of this proxy statement, the reported closing price for shares of common stock on the NYSE was $[ ]. You are encouraged to obtain current market quotations for shares of common stock in connection with voting your common stock.
As of the close of business on the record date, there were [ ] shares of common stock outstanding and entitled to vote, held by [ ] Company stockholders of record, and [54,744,525] shares of Class B common stock outstanding and entitled to vote, held by one Company stockholder of record, Google LLC. The number of holders is based upon the actual number of holders registered in our records at such date and excludes holders of shares in “street name” or persons, partnerships, associations, corporations or other entities identified in security positions listings maintained by depository trust companies.
During fiscal year 2026, the Company paid quarterly cash dividends of $0.055 per share of Company common stock on January 8, 2026, April 2, 2026, July 7, 2026 and October 1, 2026. During fiscal year 2025, the Company paid quarterly cash dividends of $0.055 per share of Company common stock on January 9, 2025, April 3, 2025, July 8, 2025 and October 2, 2025. Under the terms of the merger agreement, from the date of the merger agreement until the effective time, the Company is prohibited from establishing a record date for, approving, declaring, setting aside for payment or paying any dividend on, or making any other distribution in respect of, any shares of its capital stock or other equity or voting interests (whether in cash, securities or otherwise), other than dividends or distributions solely between and among the Company and its wholly owned subsidiaries, without Parent’s prior written consent, which Parent may grant or withhold in its sole discretion. Accordingly, the Company does not expect to declare or pay any further dividends on shares of Company common stock prior to the effective time of the merger.
HOUSEHOLDING
The SEC has approved rules that permit companies to deliver a single copy of proxy materials (or annual report, as applicable) to multiple stockholders sharing an address unless a company has received contrary instructions from one or more of the stockholders at that address. This means that only one copy of this proxy statement may have been sent to multiple stockholders in your household. This process, which is commonly referred to as “householding”, potentially means extra convenience for Company stockholders and cost savings for companies.
If you would prefer to opt out of or into householding in the future, or would like to receive a separate copy of the proxy materials, please contact our transfer agent, Broadridge (either by calling toll-free at 1-866-540-7095, or by writing to Broadridge, Householding Department, 51 Mercedes Way, Edgewood, New York 11717). Upon written or oral request, Broadridge will promptly provide you with a separate copy of this proxy statement. Our householding process does not include accounts that are maintained at a brokerage firm or bank. Stockholders who hold their shares in street name can request information about householding from their banks, brokers or other nominees.
STOCKHOLDER PROPOSALS
If the merger is consummated, we will not have public stockholders and there will be no public participation in any future stockholder meetings. Until the merger is consummated, you will continue to be entitled to attend and participate in stockholders’ meetings, including the Company’s annual meetings of Company stockholders, and we will provide notice of or otherwise publicly disclose the date on which the 2027 annual meeting of Company stockholders will be held, if at all.
Company stockholders are entitled to present proposals for action and director nominations at the 2027 annual meeting of Company stockholders, if held, only if they comply with the applicable requirements of the proxy rules established by the SEC and the applicable provisions of the Company’s bylaws. To be considered for inclusion in next year’s proxy statement and form of proxy, stockholder proposals for the 2027 annual meeting of stockholders must be received at our principal executive offices no later than the close of business on December 15, 2026, unless the date of the 2027 annual meeting of stockholders is more than 30 days before or after May 27, 2027, in which case the proposal must be received within a reasonable time before we begin to print and mail our proxy materials.
For any proposal or director nomination that is not submitted for inclusion in next year’s proxy statement pursuant to the process set forth above, but is instead sought to be presented directly at the 2027 annual meeting of stockholders, stockholders are advised to review our bylaws as they contain requirements with respect to advance notice of stockholder proposals and director nominations. To be timely, in accordance with our bylaws, the notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary of the preceding year’s annual meeting. Accordingly, any such stockholder proposal or director nomination must be received between January 27, 2027 and February 26, 2027 for the 2027 annual meeting of stockholders. In the event that the date of the 2027 annual meeting of stockholders is more than 30 days before or more than 60 days after May 27, 2027, notice by the stockholder, to be timely, must be so delivered not earlier than the close of business on the 120th day prior to the 2027 annual meeting of stockholders and no later than the close of business on the 90th day prior to the date of such annual meeting. If the public announcement of the date of the 2027 annual meeting of stockholders is less than 100 days prior to such meeting, then to be timely, the notice by the stockholder must be received by us not later than the close of business on the tenth day following the day on which the first public announcement of the date of the 2027 annual meeting of stockholders is made by the Company. All such proposals should be sent to our Secretary at ADT Inc., 1501 Yamato Road, Boca Raton, Florida 33431. In addition to satisfying the deadlines and other requirements set forth in our bylaws, stockholders who intend to solicit proxies in support of director nominees other than the Board’s nominees must provide notice that also sets forth the information required by Rule 14a-19 under the Exchange Act no later than March 29, 2027. This deadline under Rule 14a-19 does not supersede or replace any of the timing requirements for advance notice under our bylaws.
We advise you to review our bylaws for additional stipulations relating to the process for identifying and nominating directors, including advance notice of director nominations and stockholder proposals. Copies of the pertinent bylaw provisions are available on request to our Secretary at the address set forth above.
WHERE YOU CAN FIND ADDITIONAL INFORMATION
We are subject to the information and reporting requirements of the Exchange Act, and, accordingly, file annual, quarterly and periodic reports, proxy statements and other information with the SEC. Our SEC filings are available over the Internet at the SEC’s website at www.sec.gov.
Statements contained in this proxy statement, or in any document incorporated in this proxy statement by reference, regarding the contents of any contract or other document, are not necessarily complete and each such statement is qualified in its entirety by reference to that contract or other document filed as an exhibit with the SEC. The SEC allows us to “incorporate by reference” information into this proxy statement. This means that we can disclose important information by referring to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this proxy statement. This proxy statement and the information that we later file with the SEC may update and supersede the information incorporated by reference, and the information that we later file with the SEC may update and supersede the information in this proxy statement. This proxy statement incorporates by reference the following documents filed by us with the SEC under the Exchange Act and any documents filed by us pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this proxy statement and before the date of the special meeting (provided that we are not incorporating by reference any information furnished to, but not filed with, the SEC):
•our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (filed with the SEC on March 2, 2026);
•the portions of our Definitive Proxy Statement on Schedule 14A for our 2026 annual meeting of Company stockholders filed with the SEC on April 14, 2026 that are incorporated by reference in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025;
•our Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2026, June 30, 2026, and September 30, 2026 (filed with the SEC on April 30, 2026, July 30, 2026 and November 3, 2026, respectively); and
•our Current Reports on Form 8-K filed on February 24, 2026, April 24, 2026, May 8, 2026, May 28, 2026, August 31, 2026, October 29, 2026 (Accession No. 0001193125-26-437123) and October 29, 2026 (Accession No. 0001193125-26-437964).
Information furnished under Item 2.02 or Item 7.01 of any Current Report on Form 8-K, including related exhibits, is not and will not be incorporated by reference into this proxy statement, unless expressly stated otherwise therein.
The information contained in this proxy statement speaks only as of the date indicated on the cover of this proxy statement unless the information specifically indicates that another date applies.
You may obtain any of the documents we file with the SEC (not including exhibits to the information that is incorporated by reference unless such exhibits are specifically incorporated by reference into the information that this proxy statement incorporates), without charge, by requesting them in writing or by telephone from us:
ADT Inc.
Attention: Investor Relations
1501 Yamato Road
Boca Raton, FL 33431
(561) 988-3600
In order for you to receive timely delivery of documents in advance of the special meeting, you must make such request no later than [ ]. If you request any documents from us, we will mail them to you by first class mail or another equally prompt method, within one business day after we receive your request. Please note that you will be able to obtain the documents (if and when available) free of charge on the SEC’s website at www.sec.gov. In addition, as soon as reasonably practicable after such materials are furnished to the SEC, we make copies of these
documents available to the public, free of charge, through our website. Our website address is https://investor.adt.com.
We have not authorized anyone to give you any information or to make any representation about the proposed merger or the Company that is different from or adds to the information contained in this proxy statement or in the documents we have publicly filed with the SEC. Therefore, if anyone does give you any different or additional information, you should not rely on it.
EXECUTION VERSION
CONFIDENTIAL
AGREEMENT AND PLAN OF MERGER
By and Among
ABODE PARENT, LLC,
ABODE MERGER SUB, INC.
and
ADT INC.
Dated as of October 29, 2026
TABLE OF CONTENTS
| | | | | | | | |
Page |
ARTICLE I |
| | |
The Merger |
| | |
SECTION 1.01. | The Merger | 2 |
SECTION 1.02. | Closing | 2 |
SECTION 1.03. | Effective Time | 2 |
SECTION 1.04. | Effects of the Merger | 3 |
SECTION 1.05. | Certificate of Incorporation and Bylaws of the Surviving Corporation | 3 |
SECTION 1.06. | Directors and Officers of the Surviving Corporation | 3 |
| | |
ARTICLE II |
| | |
Effect of the Merger on Capital Stock; Exchange of Certificates; |
Equity-Based Awards |
| | |
SECTION 2.01. | Effect on Capital Stock | 4 |
SECTION 2.02. | Exchange Matters | 4 |
SECTION 2.03. | Treatment of Equity-Based Awards | 7 |
SECTION 2.04. | Payments with Respect to Equity-Based Awards | 8 |
SECTION 2.05. | Adjustments | 9 |
SECTION 2.06. | Appraisal Rights | 9 |
| | |
ARTICLE III |
| | |
Representations and Warranties of the Company |
| | |
SECTION 3.01. | Organization; Standing | 10 |
SECTION 3.02. | Capitalization | 11 |
SECTION 3.03. | Authority; Noncontravention | 12 |
SECTION 3.04. | Governmental Approvals | 13 |
SECTION 3.05. | Company SEC Documents; Undisclosed Liabilities | 14 |
SECTION 3.06. | Absence of Certain Changes | 16 |
SECTION 3.07. | Legal Proceedings | 16 |
SECTION 3.08. | Compliance with Laws; Permits | 16 |
SECTION 3.09. | Tax Matters | 17 |
SECTION 3.10. | Employee Benefits | 18 |
SECTION 3.11. | Labor Matters | 19 |
SECTION 3.12. | Environmental Matters | 19 |
SECTION 3.13. | Intellectual Property | 20 |
SECTION 3.14. | Data Privacy and Technology; Information Security | 21 |
SECTION 3.15. | Property | 21 |
SECTION 3.16. | Contracts | 22 |
TABLE OF CONTENTS
(continued)
| | | | | | | | |
SECTION 3.17. | Insurance | 24 |
SECTION 3.18. | No Rights Agreement; Anti-Takeover Provisions | 24 |
SECTION 3.19. | Opinion of Financial Advisors | 24 |
SECTION 3.20. | Brokers and Other Advisors | 25 |
SECTION 3.21. | Top Vendors | 25 |
SECTION 3.22. | No Other Representations or Warranties | 25 |
| | |
ARTICLE IV |
| | |
Representations and Warranties of Parent and Merger Sub |
| | |
SECTION 4.01. | Organization; Standing | 26 |
SECTION 4.02. | Authority; Noncontravention | 26 |
SECTION 4.03. | Governmental Approvals | 27 |
SECTION 4.04. | Ownership and Operations of Merger Sub | 28 |
SECTION 4.05. | Financing | 28 |
SECTION 4.06. | Guarantee | 31 |
SECTION 4.07. | Solvency | 31 |
SECTION 4.08. | Certain Arrangements | 32 |
SECTION 4.09. | Brokers and Other Advisors | 32 |
SECTION 4.10. | Information Supplied | 32 |
SECTION 4.11. | Legal Proceedings | 33 |
SECTION 4.12. | Ownership of Equity of the Company | 33 |
SECTION 4.13. | Foreign Person Status | 33 |
SECTION 4.14. | No Other Company Representations or Warranties | 33 |
SECTION 4.15. | Non-Reliance on Company Estimates, Projections, Forecasts, Forward-Looking Statements and Business Plans | 34 |
| | |
ARTICLE V |
| | |
Additional Covenants and Agreements |
| | |
SECTION 5.01. | Conduct of Business | 35 |
SECTION 5.02. | Solicitation; Change in Recommendation | 40 |
SECTION 5.03. | Efforts | 46 |
SECTION 5.04. | Public Announcements | 50 |
SECTION 5.05. | Access to Information; Confidentiality | 51 |
SECTION 5.06. | Indemnification and Insurance | 52 |
SECTION 5.07. | Employee Matters | 54 |
SECTION 5.08. | Notification of Certain Matters; Stockholder Litigation | 56 |
SECTION 5.09. | Merger Sub | 56 |
SECTION 5.10. | Parent Vote | 56 |
SECTION 5.11. | Stock Exchange De-listing | 56 |
SECTION 5.12. | Preparation of the Proxy Statement; Stockholders’ Meeting | 56 |
SECTION 5.13. | Section 16 Matters | 58 |
TABLE OF CONTENTS
(continued)
| | | | | | | | |
SECTION 5.14. | Financing | 58 |
SECTION 5.15. | Treatment of Company Notes | 66 |
SECTION 5.16. | Payoff of Company Existing Indebtedness | 67 |
SECTION 5.17. | Transfer Taxes | 68 |
| | |
ARTICLE VI |
| | |
Conditions to the Merger |
| | |
SECTION 6.01. | Conditions to Each Party’s Obligation To Effect the Merger | 68 |
SECTION 6.02. | Conditions to the Obligations of Parent and Merger Sub | 68 |
SECTION 6.03. | Conditions to the Obligations of the Company | 69 |
SECTION 6.04. | Frustration of Closing Conditions | 69 |
| | |
ARTICLE VII |
| | |
Termination |
| | |
SECTION 7.01. | Termination | 70 |
SECTION 7.02. | Effect of Termination | 72 |
SECTION 7.03. | Termination Fee | 72 |
| | |
ARTICLE VIII |
| | |
Miscellaneous |
| | |
SECTION 8.01. | No Survival of Representations and Warranties | 76 |
SECTION 8.02. | Amendment or Supplement | 76 |
SECTION 8.03. | Extension of Time, Waiver, Etc | 77 |
SECTION 8.04. | Assignment | 77 |
SECTION 8.05. | Counterparts | 77 |
SECTION 8.06. | Entire Agreement; No Third-Party Beneficiaries | 77 |
SECTION 8.07. | Governing Law; Jurisdiction | 78 |
SECTION 8.08. | Specific Enforcement | 80 |
SECTION 8.09. | WAIVER OF JURY TRIAL | 81 |
SECTION 8.10. | Notices | 81 |
SECTION 8.11. | Severability | 83 |
SECTION 8.12. | Definitions | 83 |
SECTION 8.13. | Fees and Expenses | 98 |
SECTION 8.14. | Performance Guaranty | 98 |
SECTION 8.15. | No Recourse | 99 |
SECTION 8.16. | Interpretation | 99 |
TABLE OF CONTENTS
(continued)
| | | | | | | | |
| | Page |
Exhibits | | |
| | |
Exhibit A | Certificate of Incorporation of the Surviving Corporation | |
This AGREEMENT AND PLAN OF MERGER, dated as of October 29, 2026 (this “Agreement”), is by and among Abode Parent, LLC, a Delaware limited liability company (“Parent”), Abode Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and ADT Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 8.12.
WHEREAS, the parties intend that, upon the terms and subject to the conditions set forth in this Agreement and in accordance with the Delaware General Corporation Law (the “DGCL”), Merger Sub will be merged with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent, and pursuant to the Merger each share of common stock of the Company, par value $0.01 per share (the “Common Stock”), and each share of Class B Common Stock of the Company, par value $0.01 per share (the “Class B Common Stock” and, together with the Common Stock, the “Company Common Stock”) (other than (i) shares of Company Common Stock canceled pursuant to Section 2.01(b) and (ii) Appraisal Shares, which shall be treated in accordance with Section 2.06), will be converted into the right to receive the Merger Consideration;
WHEREAS, the Board of Directors of the Company has (i) determined that it is in the best interests of the Company and the stockholders of the Company, and declared it advisable, that the Company enter into this Agreement and consummate the Merger, (ii) approved this Agreement and the consummation of the Merger, (iii) recommended that the stockholders of the Company entitled to vote adopt this Agreement (this clause (iii), the “Company Board Recommendation”) and (iv) directed that this Agreement be submitted to the stockholders of the Company entitled to vote for adoption;
WHEREAS, the Board of Directors of Parent has (i) determined that it is in the best interests of Parent and the stockholders of Parent, and declared it advisable, that Parent enter into this Agreement and consummate the Transactions and (ii) approved this Agreement and the consummation of the Transactions, including the Merger;
WHEREAS, the Board of Directors of Merger Sub has (i) determined that it is in the best interests of Merger Sub and the sole stockholder of Merger Sub, and declared it advisable, that Merger Sub enter into this Agreement and consummate the Transactions, (ii) approved this Agreement and the consummation of the Transactions, including the Merger, (iii) recommended that the sole stockholder of Merger Sub entitled to vote adopt this Agreement and (iv) directed that this Agreement be submitted for consideration at a meeting or by unanimous written consent of the sole stockholder of Merger Sub;
WHEREAS, Parent, in its capacity as sole stockholder of Merger Sub, will adopt this Agreement and the consummation by Merger Sub of the Transactions by written consent in accordance with the provisions of the DGCL immediately following the execution of this Agreement;
WHEREAS, concurrently with the execution and delivery of this Agreement, and as a condition and inducement to the Company’s willingness to enter into this Agreement, Thrive Holdings (the “Equity Commitment Party”) has entered into and delivered the Equity Commitment Letter;
WHEREAS, concurrently with the execution and delivery of this Agreement, and as a condition and inducement to the Company’s willingness to enter into this Agreement, the Equity Commitment Party (in such capacity, the “Guarantor”) has entered into and delivered the Guarantee with respect to the obligations of Parent and Merger Sub under this Agreement; and
WHEREAS, the Company, Parent and Merger Sub desire to make certain representations, warranties, covenants and agreements in connection with this Agreement.
NOW, THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and agreements contained in this Agreement, and intending to be legally bound hereby, the Company, Parent and Merger Sub hereby agree as follows:
ARTICLE I
The Merger
SECTION 1.01.The Merger. Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the provisions of the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, the separate corporate existence of Merger Sub shall thereupon cease, and the Company shall be the surviving corporation in the Merger. The Company, as the surviving corporation after the Merger, is hereinafter referred to as the “Surviving Corporation”.
SECTION 1.02.Closing. The closing of the Merger (the “Closing”) shall take place at 10:00 a.m. (New York City time) on the second Business Day following the satisfaction or waiver (to the extent such waiver is permitted by applicable Law) of the conditions set forth in Article VI (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at the Closing), at the offices of Cravath, Swaine & Moore LLP, 375 Ninth Avenue, New York, New York 10001 or remotely by exchange of documents and signatures (or their electronic counterparts), unless another date, time or place is agreed to in writing by Parent and the Company; provided that, the Closing shall not occur prior to the third Business Day following the final day of the Marketing Period (or such other Business Day prior to the final day of the Marketing Period as specified by Parent in its sole discretion on no fewer than three Business Days’ notice to the Company (unless a shorter period shall be agreed to by the Company and Parent)) (subject to the satisfaction or waiver of the conditions set forth in Article VI as of such date). The date on which the Closing occurs is herein referred to as the “Closing Date”.
SECTION 1.03.Effective Time. Subject to the provisions of this Agreement, as soon as practicable on the Closing Date after or concurrently with the Closing, the parties hereto shall cause the Merger to be consummated by filing a certificate of merger executed in accordance with, and in such form as is required by, the relevant provisions of the DGCL (the “Certificate of Merger”), and shall make all other filings, recordings or publications required under the DGCL in connection with the Merger. The Merger shall become effective at the time that the Certificate of Merger is filed with the Secretary of State of the State of Delaware (the “Secretary of State of Delaware”) or, to the extent permitted by applicable Law, at such later time as is agreed to by the parties hereto prior to the filing of the Certificate of Merger and
specified in the Certificate of Merger (the time at which the Merger becomes effective is herein referred to as the “Effective Time”).
SECTION 1.04.Effects of the Merger. The Merger shall have the effects provided in this Agreement and as set forth in the applicable provisions, including Section 259, of the DGCL.
SECTION 1.05.Certificate of Incorporation and Bylaws of the Surviving Corporation.
(a)At the Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub, the Company or any holder of any Company Common Stock or any shares of capital stock of Merger Sub, the certificate of incorporation of the Company as in effect immediately prior to the Effective Time shall be amended and restated to read in its entirety as set forth on Exhibit A hereto, and as so amended and restated shall be the certificate of incorporation of the Surviving Corporation, until thereafter amended in accordance with applicable Law and the certificate of incorporation and bylaws of the Surviving Corporation (and subject to Section 5.06).
(b)Subject to Section 5.06, the parties shall take the actions necessary so that, at the Effective Time, the bylaws of Merger Sub as in effect immediately prior to the Effective Time shall be the bylaws of the Surviving Corporation, except that references to Merger Sub’s name shall be replaced with references to the Surviving Corporation’s name, until thereafter amended in accordance with applicable Law and the certificate of incorporation and bylaws of the Surviving Corporation (and subject to Section 5.06).
SECTION 1.06.Directors and Officers of the Surviving Corporation.
(a)The directors of Merger Sub immediately prior to the Effective Time shall be the directors of the Surviving Corporation immediately following the Effective Time, until their respective successors are duly elected or appointed and qualified, subject, however, to such director’s earlier death, resignation or removal in accordance with the certificate of incorporation and bylaws of the Surviving Corporation.
(b)The officers of the Company immediately prior to the Effective Time shall be the officers of the Surviving Corporation until their respective successors are duly elected and qualified, subject, however, to such officer’s earlier death, resignation or removal in accordance with the certificate of incorporation and bylaws of the Surviving Corporation.
ARTICLE II
Effect of the Merger on Capital Stock; Exchange of Certificates;
Equity-Based Awards
SECTION 2.01.Effect on Capital Stock. At the Effective Time, by virtue of the Merger and without any action on the part of the Company, Parent, Merger Sub or the holders of any shares of Company Common Stock or any shares of capital stock of Merger Sub:
(a)Capital Shares of Merger Sub. Each issued and outstanding share of capital stock of Merger Sub as of immediately prior to the Effective Time shall be converted into and become one validly issued, fully paid and nonassessable share of common stock, $0.01 par value per share, of the Surviving Corporation.
(b)Cancelation of Certain Shares. All shares of Company Common Stock that are owned by the Company as treasury shares immediately prior to the Effective Time shall be canceled and shall cease to exist and no consideration shall be delivered in exchange therefor. All shares of Company Common Stock then held by Parent or Merger Sub shall be canceled and shall cease to exist and no consideration shall be delivered in exchange therefor.
(c)Conversion of Company Common Stock. Each issued and outstanding share of Company Common Stock as of immediately prior to the Effective Time (other than (i) shares of Company Common Stock to be canceled in accordance with Section 2.01(b) and (ii) Appraisal Shares, which shall be treated in accordance with Section 2.06) shall be converted automatically into and shall thereafter represent only the right to receive an amount in cash equal to $10.00 per share, without interest (the “Merger Consideration”). As of the Effective Time, all such shares of Company Common Stock shall no longer be outstanding and shall automatically be canceled and shall cease to exist, and each holder of a certificate which immediately prior to the Effective Time represented any such share of Company Common Stock (each, a “Share Certificate”) or non-certificated shares of Company Common Stock held in book-entry form (each, a “Book-Entry Share”) shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration to be paid in consideration therefor.
SECTION 2.02.Exchange Matters.
(a)Paying Agent. Prior to the Closing Date, Parent shall designate a bank or trust company reasonably acceptable to the Company to act as agent (the “Paying Agent”) for the payment of the Merger Consideration in accordance with this Article II and, in connection therewith, prior to the Closing Date, shall enter into an agreement with the Paying Agent in a form reasonably acceptable to the Company. At or prior to the Effective Time, Parent shall deposit or cause to be deposited with the Paying Agent an amount in cash sufficient to pay the aggregate Merger Consideration, other than any amounts payable in respect of each Equity-Based Award in accordance with Section 2.04 (such cash being hereinafter referred to as the “Exchange Fund”). The Exchange Fund shall not be used for any purpose other than a purpose expressly provided for in this Agreement. Pending its disbursement in accordance with this Section 2.02, the Exchange Fund shall be invested by the Paying Agent as directed by Parent, including in (i) short-term direct obligations of the United States of America (“U.S.”) or
(ii) short-term obligations for which the full faith and credit of the U.S. is pledged to provide for the payment of principal and interest. Parent shall or shall cause the Surviving Corporation to promptly replace or restore the cash in the Exchange Fund so as to ensure that the Exchange Fund is at all times maintained at a level sufficient for the Paying Agent to make all payments of Merger Consideration in accordance herewith. No investment losses resulting from investment of the funds deposited with the Paying Agent shall diminish the rights of any holder of shares of Company Common Stock to receive the Merger Consideration as provided herein and any interest earned thereon shall be paid to the Surviving Corporation.
(b)Payment Procedures.
(i)As promptly as practicable after the Effective Time (but in no event more than three Business Days thereafter), Parent and the Surviving Corporation shall cause the Paying Agent to mail to each Person who was, at the Effective Time, a holder of a Share Certificate or Book-Entry Shares not held, directly or indirectly, through The Depository Trust Company (“DTC”) (other than a Share Certificate or Book-Entry Shares representing (A) shares of Company Common Stock to be canceled in accordance with Section 2.01(b) and (B) Appraisal Shares, which shall be treated in accordance with Section 2.06) (x) a letter of transmittal (which shall specify that delivery shall be effected, and risk of loss and title to such Share Certificate or such Book-Entry Shares, as applicable, shall pass, only upon delivery of such Share Certificate (or affidavits in lieu thereof in accordance with Section 2.02(d))) to the Paying Agent or, in the case of such Book-Entry Shares, upon adherence to the procedures set forth in the letter of transmittal, which shall be in such form and shall have such other customary provisions as Parent and the Company may reasonably agree prior to the Closing Date and (y) instructions for use in effecting the surrender of such Share Certificate or such Book-Entry Shares to the Paying Agent, as applicable, in exchange for payment of the Merger Consideration as provided in Section 2.01(c).
(ii)Upon delivery of a letter of transmittal, duly completed and validly executed in accordance with such letter’s instructions (and such other customary documents as may reasonably be required by the Paying Agent), and either (A) surrender to the Paying Agent of Share Certificates (or affidavits in lieu thereof) in accordance with Section 2.02(d) or (B) transfer of Book-Entry Shares not held through DTC by book receipt of an “agent’s message” in customary form by the Paying Agent in connection with the surrender of Book-Entry Shares (or such other reasonable evidence, if any, of surrender with respect to such Book-Entry Shares as the Paying Agent may reasonably request), in each case as contemplated in subsection (i) of this Section 2.02(b), the holder of such Share Certificates or Book-Entry Shares shall be entitled to receive in exchange therefor, the Merger Consideration for each share of Company Common Stock formerly represented by such Share Certificates or Book-Entry Shares, and the Share Certificates or Book-Entry Shares so surrendered shall forthwith be canceled. Until surrendered as contemplated by this Section 2.02, each Share Certificate or Book-Entry Share (other than a Share Certificate or Book-Entry Shares representing (A) shares of Company Common Stock to be canceled in accordance with Section 2.01(b) and (B) Appraisal Shares, which shall be treated in accordance with Section 2.06) shall be deemed at any time after the Effective Time to represent only the right to receive the Merger Consideration as contemplated by this Article II.
(iii)The Persons who were, at the Effective Time, holders of Book-Entry Shares (other than (i) shares of Company Common Stock to be canceled in accordance with Section 2.01(b) or (ii) Appraisal Shares, which shall be treated in accordance with Section 2.06) held, directly or indirectly, through DTC shall not be required to take any action with respect to the exchange of their Book-Entry Shares for the Merger Consideration that such holder is entitled to receive pursuant to this Section 2.02. With respect to such Book-Entry Shares held, directly or indirectly, through DTC, Parent and the Company shall cooperate to establish procedures with the Paying Agent, DTC, DTC’s nominees and such other necessary third-party intermediaries to ensure that the Paying Agent will transmit to DTC or its nominees as promptly as practicable after the Effective Time, upon surrender of Book-Entry Shares held of record by DTC or its nominees in accordance with DTC’s customary surrender procedures and such other procedures as agreed by Parent, the Company, the Paying Agent, DTC, DTC’s nominees and such other necessary third-party intermediaries, the aggregate Merger Consideration to which the beneficial owners thereof are entitled to receive as a result of the Merger pursuant to this Section 2.02.
(iv)If payment of the Merger Consideration is to be made to a Person other than the Person in whose name the surrendered Share Certificate is registered, Parent may cause the Paying Agent to pay the Merger Consideration to such Person only if such Share Certificate (if applicable) is presented to the Paying Agent, accompanied by all documents required to evidence and effect such transfer and to evidence to the reasonable satisfaction of the Paying Agent that any applicable stock transfer or similar Taxes required by reason of the payment of the Merger Consideration to a Person other than the Person in whose name the surrendered Share Certificate is registered have been paid or are not applicable. Payment of the Merger Consideration with respect to Book-Entry Shares shall only be made to the Person in whose name such Book-Entry Shares are registered in the stock transfer records of the Company.
(c)Transfer Books; No Further Ownership Rights. The Merger Consideration paid in respect of the shares of Company Common Stock in accordance with the terms of this Article II shall be deemed to have been paid in full satisfaction of all ownership rights in such common stock, and at the Effective Time, the transfer books of the Company shall be closed and thereafter there shall be no further registration of transfers on the transfer books of the Surviving Corporation of the shares of Company Common Stock that were outstanding immediately prior to the Effective Time. From and after the Effective Time, the holders of the shares of Company Common Stock outstanding immediately prior to the Effective Time shall cease to have any rights with respect to such shares except as otherwise provided for herein or by applicable Law. Subject to the last sentence of Section 2.02(e), if, at any time after the Effective Time, Share Certificates or Book-Entry Shares are presented to the Surviving Corporation, for any reason, they shall be canceled and exchanged as provided in this Article II.
(d)Lost, Stolen or Destroyed Certificates. If any Share Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Share Certificate to be lost, stolen or destroyed and, if required by the Surviving Corporation, the posting by such Person of a bond, in such reasonable amount as Parent may direct, as indemnity against any claim that may be made against Parent with respect to such Share Certificate, the Paying Agent will pay, in exchange for such lost, stolen or destroyed Share Certificate, the applicable aggregate Merger Consideration to be paid in respect of the shares of
Company Common Stock formerly represented by such Share Certificate as contemplated by this Article II.
(e)Termination of Exchange Fund. At any time following the first anniversary of the Closing Date, the Surviving Corporation shall be entitled to require the Paying Agent to deliver to it any portion of the Exchange Fund (including any interest received with respect thereto) which has not been disbursed to holders of Share Certificates or Book-Entry Shares, and thereafter such holders who have not theretofore complied with this Article II shall be entitled to look only to Parent and the Surviving Corporation, as applicable, for, and Parent and the Surviving Corporation shall remain liable for, payment of such holders’ claims for the Merger Consideration pursuant to the provisions of this Article II. Any amounts remaining unclaimed by such holders at such time at which such amounts would otherwise escheat to or become property of any Governmental Authority shall become, to the extent permitted by applicable Law, the property of Parent or its designee, free and clear of all claims or interest of any Person previously entitled thereto.
(f)No Liability. Notwithstanding any provision of this Agreement to the contrary, none of the parties hereto, the Surviving Corporation or the Paying Agent shall be liable to any Person for Merger Consideration properly delivered to a public official pursuant to any applicable state, federal or other abandoned property, escheat or similar Law. Any amounts remaining unclaimed by holders of Company Common Stock immediately prior to the time at which such amounts would otherwise escheat to, or become the property of, any Governmental Authority shall, to the extent permitted by applicable Law, become the property of the Surviving Corporation, free and clear of any claims or interest of any Person previously entitled thereto.
(g)Withholding. Each of Parent, Merger Sub, the Company, the Surviving Corporation, the Paying Agent and their respective Affiliates shall be entitled to deduct and withhold (or cause to be deducted and withheld) from any amounts otherwise payable pursuant to this Agreement such amounts as are required to be deducted or withheld under applicable Tax Law. To the extent that amounts are so deducted or withheld and paid over to the relevant Governmental Authority, such amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction or withholding was made. Other than amounts that are treated as compensatory for U.S. federal income tax purposes, Parent and the Company shall use commercially reasonable efforts to cooperate to reduce or eliminate any such deduction and withholding, including by soliciting any Tax forms requested by any other party hereto that are necessary to establish any exemption from, or reduction of, such deduction or withholding.
SECTION 2.03.Treatment of Equity-Based Awards. Prior to the Effective Time, the Board of Directors of the Company (or, if appropriate, any duly authorized committee thereof administering the Equity Plans) shall adopt such resolutions and take such other actions as may be required to provide for the following:
(a)Each vested Company Stock Option outstanding immediately prior to the Effective Time shall, as of the Effective Time, be canceled and the holder thereof shall then become entitled to receive solely, in full satisfaction of the rights of such holder with respect thereto, a lump-sum cash payment, without interest, equal to the product of (i) the number of
shares of Company Common Stock subject to such vested Company Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (A) the Merger Consideration over (B) the per share exercise price of such vested Company Stock Option. Any Company Stock Option with a per share exercise price that is equal to or greater than the Merger Consideration shall be canceled for no consideration.
(b)Each unvested Company Stock Option outstanding immediately prior to the Effective Time shall, as of the Effective Time, be canceled and converted into the contingent right to receive an amount in cash, without interest (a “Contingent Cash Award”), equal to the product of (i) the number of shares of Company Common Stock subject to such unvested Company Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (A) the Merger Consideration over (B) the per share exercise price of such unvested Company Stock Option. Each such Contingent Cash Award shall have the same terms and conditions (including service-based vesting conditions) that applied to the corresponding unvested Company Stock Option immediately prior to the Effective Time, except for terms rendered inoperative by reason of the Transactions or administrative or ministerial changes. Any unvested Company Stock Option with a per share exercise price that is equal to or greater than the Merger Consideration shall be canceled for no consideration.
(c)Notwithstanding anything in this Agreement to the contrary, each Company RSU outstanding immediately prior to the Effective Time shall, as of the Effective Time, be cancelled and converted into a Contingent Cash Award with respect to an amount equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time (assuming solely for purposes of computing the target amount of cash pursuant to performance-based vesting conditions, the attainment of all applicable performance goals at target), with the same terms and conditions (including service- and/or performance-based vesting conditions) that applied to the corresponding Company RSU immediately prior to the Effective Time, except for terms rendered inoperative by reason of the transactions contemplated by this Agreement or administrative or ministerial changes.
SECTION 2.04.Payments with Respect to Equity-Based Awards. Notwithstanding anything in this Agreement to the contrary, all amounts payable as of the Effective Time pursuant to this Article II in respect of Equity-Based Awards shall be paid as promptly as reasonably practicable after the Effective Time, but in no event later than five Business Days following the Effective Time, by the Surviving Corporation or any of its Subsidiaries through their payroll systems, less applicable Tax withholdings, to the holders of the Equity-Based Awards; provided, however, that to the extent that any such amounts relate to an Equity-Based Award that is nonqualified deferred compensation subject to Section 409A of the Code, Parent, the Surviving Corporation or the applicable Subsidiary shall pay such amounts at the earliest time permitted under the terms of the applicable agreement, plan or arrangement relating to such Equity-Based Award and that will not trigger a Tax or penalty under Section 409A of the Code. Any amounts payable following the Effective Time in respect of any portion of a Contingent Cash Award that vests shall be paid by the Surviving Corporation or any
of its Subsidiaries through their payroll systems, less applicable Tax withholdings, no later than the second regularly scheduled payroll date following the date on which such portion vests.
SECTION 2.05.Adjustments. If between the date of this Agreement and the Effective Time, any change in the outstanding shares of Company Common Stock, or securities exchangeable into or exercisable for shares of Company Common Stock, shall occur as a result of any stock split, reverse share split, dividend (including any dividend or other distribution of securities convertible into shares of Company Common Stock), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change, the Merger Consideration and any other amounts payable pursuant to this Article II shall be appropriately adjusted to reflect such stock split, reverse share split, dividend (including any dividend or other distribution of securities convertible into shares of Company Common Stock), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change.
SECTION 2.06.Appraisal Rights.
(a)Notwithstanding anything in this Agreement to the contrary, shares of Company Common Stock that are outstanding immediately prior to the Effective Time and that are held by any Person who is entitled to demand and properly demands appraisal of such shares pursuant to, and who complies in all respects with, Section 262 of the DGCL (such shares, “Appraisal Shares”) shall not be converted into the right to receive the Merger Consideration as provided in Section 2.01(c), but instead shall be canceled and shall represent the right to receive only those rights provided under Section 262 of the DGCL; provided, however, that, if any such Person shall fail to perfect or otherwise shall waive, withdraw or lose the right to appraisal under Section 262 of the DGCL or if a court of competent jurisdiction determines that such holder is not entitled to the relief provided by Section 262 of the DGCL, then the right of such Person to receive those rights under Section 262 of the DGCL shall cease and such Appraisal Shares shall be deemed to have been converted as of the Effective Time into, and shall represent only the right to receive, the Merger Consideration as provided in Section 2.01(c), without interest thereon.
(b)The Company shall give prompt written notice to Parent of any demands received by the Company for appraisal of any shares of Company Common Stock (and any withdrawals or attempted withdrawals of such demands) as well as copies of any instruments, notices or demands served pursuant to Section 262 of the DGCL. Parent shall have the right to participate in, and, after the Effective Time, direct all negotiations and Actions with respect to such demands. Prior to the Effective Time, the Company shall not, without the prior written consent of Parent (such consent not to be unreasonably withheld, delayed or conditioned), make any payment with respect to, or settle or offer to settle, any such demands or notices, waive any failures or approve any withdrawal of any such demands or notices or propose or otherwise agree to do any of the foregoing. Parent shall not, except with the prior written consent of the Company (such consent not to be unreasonably withheld, delayed or conditioned), require the Company to make any payment with respect to any demands for appraisal or offer to settle or compromise (or actually settle or compromise) any such demands or notices.
ARTICLE III
Representations and Warranties of the Company
The Company represents and warrants to Parent and Merger Sub that, except as (A) set forth in the confidential disclosure letter delivered by the Company to Parent and Merger Sub concurrently with or prior to the execution of this Agreement (the “Company Disclosure Letter”) (it being understood that any information, item or matter set forth in one section or subsection of the Company Disclosure Letter shall be deemed disclosure with respect to, and shall be deemed to apply to and qualify, the section or subsection of this Agreement to which it corresponds in number and each other section or subsection of this Agreement to the extent that it is reasonably apparent based upon the face of such disclosure that such information, item or matter is relevant to such other section or subsection); provided, however, that only items disclosed on Sections 3.02(a), 3.02(b) and 3.06(b) of the Company Disclosure Letter shall be deemed disclosed with respect to Sections 3.02(a), 3.02(b) and 3.06(b), as applicable, or (B) disclosed in any report, schedule, form, statement or other document (including exhibits) filed with, or furnished to, the SEC from and after the Lookback Date by the Company and publicly available on the SEC’s EDGAR system prior to the execution of this Agreement (the “Filed SEC Documents”), other than any risk factor disclosure (other than any statements of fact or other statements that are not forward looking and cautionary in nature) in any such Filed SEC Document contained in the “Risk Factors” section thereof or other similarly cautionary, forward-looking or predictive statements in such Filed SEC Documents; provided, that nothing in the Filed SEC Documents shall be deemed to be disclosures against Sections 3.02(a), 3.02(b) and 3.06(b).
SECTION 3.01.Organization; Standing. (a) The Company is a corporation duly organized and validly existing under the laws of the State of Delaware, is in good standing with the Secretary of State of Delaware and each of it and its Subsidiaries has all requisite corporate power and corporate authority necessary to carry on its business as it is now being conducted, except (other than with respect to the Company’s due organization and valid existence) as would not, individually or in the aggregate, have a Material Adverse Effect or reasonably be expected to prevent, materially delay or materially impair the consummation by the Company of the Merger in accordance with the terms hereof. The Company is duly licensed or qualified to do business and is in good standing (where such concept is recognized under applicable Law) in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so licensed, qualified or in good standing would not, individually or in the aggregate, have a Material Adverse Effect or reasonably be expected to prevent, materially delay or materially impair the consummation by the Company of the Merger in accordance with the terms hereof. True and complete copies of the Company Charter Documents are included in the Filed SEC Documents.
(b)Each of the Company’s Subsidiaries is duly organized, validly existing and in good standing (where such concept is recognized under applicable Law) under the Laws of the jurisdiction of its organization, except where the failure to be so organized, existing and in good standing would not, individually or in the aggregate, have a Material Adverse Effect. Each of the Company’s Subsidiaries is duly licensed or qualified to do business, and is in good standing
(where such concept is recognized under applicable Law) in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so licensed, qualified or in good standing would not, individually or in the aggregate, have a Material Adverse Effect. True and complete copies of the organizational documents of each of the Company’s Subsidiaries have been made available to Parent prior to the date of this Agreement. No Subsidiary of the Company is in violation in any material respect of its organizational documents.
SECTION 3.02.Capitalization. (a) The authorized shares of the Company consist of 4,100,000,000 shares of capital stock, of which (i) 3,999,000,000 shares are Common Stock, (ii) 100,000,000 shares are Class B Common Stock and (iii) 1,000,000 shares are preferred stock, par value $0.01 per share (“Company Preferred Stock”). At the close of business on October 26, 2026 (the “Capitalization Date”), 675,786,587 shares of Common Stock were issued and outstanding, 54,744,525 shares of Class B Common Stock were issued and outstanding and no shares of Company Preferred Stock were issued and outstanding. As of the Capitalization Date, 96,427,056 shares of Common Stock were reserved and available for issuance pursuant to the Equity Plans, of which amount (1) 10,969,717 shares of Common Stock were subject to outstanding Company RSUs solely subject to time-based vesting, (2) 4,462,054 shares of Common Stock were subject to Company RSUs subject to performance-based vesting, assuming full achievement of the applicable performance conditions, and (3) 43,327,058 shares of Common Stock were subject to outstanding Company Stock Options having a weighted average exercise price of $8.22. From the Capitalization Date through the date of this Agreement, neither the Company nor any of its Subsidiaries has issued any Company Securities (as defined below) other than pursuant to the vesting or settlement of Company RSUs and Company Stock Options. All outstanding shares of Company Common Stock have been duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights.
(b)Except as described in Section 3.02(a), as of the Capitalization Date, there were (i) no outstanding shares of capital stock of, or other equity or voting interests in, the Company, (ii) no outstanding securities of the Company convertible into or exchangeable for shares of capital stock of, or other equity or voting interests in, the Company, (iii) no outstanding options, warrants, puts, stock appreciation rights, “phantom” stock rights, profit participation or similar equity based rights or other commitments, agreements or Contracts to acquire from the Company, or that obligate the Company to issue, any capital stock of, or other equity or voting interests in, or any securities convertible into or exchangeable for shares of capital stock of, or other equity or voting interests in, the Company, (iv) no obligations of the Company to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security or other similar agreement or commitment relating to any capital stock of, or other equity or voting interests in, the Company (the items in clauses (i), (ii), (iii) and (iv) being referred to collectively as “Company Securities”) and (v) no other obligations by the Company or any of its Subsidiaries to make any payments based on the price or value of any Company Securities. There are no outstanding agreements of any kind which obligate the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any Company Securities (other than pursuant to the forfeiture of, or withholding of Taxes with respect to, Company RSUs and Company Stock Options), or obligate the Company to grant, extend or enter into any such agreements relating to any Company Securities, including any agreements granting any preemptive rights, subscription
rights, anti-dilutive rights, rights of first refusal or similar rights with respect to any Company Securities. No direct or indirect Subsidiary of the Company owns any Company Common Stock.
(c)None of the Company or any Subsidiary of the Company is a party to any stockholders’ agreement, voting trust agreement, registration rights agreement or other similar agreement or understanding relating to any Company Securities or other agreement relating to the disposition, voting or dividends with respect to any Company Securities.
(d)All of the outstanding shares of capital stock of, or other equity or voting interests in, each Subsidiary of the Company are owned directly or indirectly, beneficially and of record, by the Company or its Subsidiaries free and clear of all Liens and transfer restrictions, except for Permitted Liens and other Liens and transfer restrictions of general applicability as may be provided under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the “Securities Act”) or other applicable securities Laws (including any restriction on the right to vote, sell or otherwise dispose of such shares of capital stock or other equity or voting interests). Each outstanding share of capital stock of each Subsidiary of the Company is duly authorized, validly issued, fully paid, nonassessable and free of preemptive rights, subscription rights, anti-dilutive rights, rights of first refusal or similar rights, and there are no subscriptions, options, warrants, rights, calls, Contracts or other commitments, understandings, restrictions or arrangements relating to the issuance, acquisition, redemption, repurchase or sale of any shares of capital stock or other equity or voting interests of any Subsidiary, including any right of conversion or exchange under any outstanding security, instrument or agreement, any agreements granting any preemptive rights, subscription rights, anti-dilutive rights, rights of first refusal or similar rights with respect to any securities of any Subsidiary.
(e)Section 3.02(e) of the Company Disclosure Letter sets forth a true and complete list as of the Capitalization Date of all outstanding Equity-Based Awards, including with respect to each such award, as applicable, (i) the holder thereof, (ii) the number of shares of Common Stock subject thereto (with respect to any Company RSUs, assuming target and full achievement of the applicable performance conditions), (iii) any dividend equivalents credited in respect of such Equity-Based Award, (iv) in the case of any Company Stock Options, the exercise price and any early exercise feature (as applicable) and expiration date, (v) the date of grant, (vi) the vesting schedule and current vesting status and (vii) in the case of Company Stock Options, whether such Equity-Based Award is intended to constitute an “incentive stock option” within the meaning of Section 422 of the Code.
SECTION 3.03.Authority; Noncontravention. (a) The Company has all necessary corporate power and corporate authority to execute and deliver this Agreement and to perform its obligations hereunder and, assuming the representations and warranties set forth in Section 4.12 (Ownership of Equity of the Company) are true and correct and, subject to the receipt of the Company Stockholder Approval, to consummate the Merger. The execution, delivery and performance by the Company of this Agreement, and, assuming the representations and warranties set forth in Section 4.12 (Ownership of Equity of the Company) are true and correct, the consummation by it of the Merger, have been duly authorized by the Board of Directors of the Company and, except for obtaining the Company Stockholder Approval and filing the Certificate of Merger with the Secretary of State of Delaware pursuant to the
provisions of the DGCL, no other corporate action on the part of the Company is necessary to authorize the execution, delivery and performance by the Company of this Agreement and the consummation by it of the Merger. This Agreement has been duly executed and delivered by the Company and, assuming due authorization, execution and delivery hereof by the other parties hereto, constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except that such enforceability (i) may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar Laws of general application affecting or relating to the enforcement of creditors’ rights generally and (ii) is subject to general principles of equity, whether considered in a proceeding at law or in equity (clauses (i) and (ii), collectively, the “Bankruptcy and Equity Exception”).
(b)The Board of Directors of the Company, at a meeting duly called and held, adopted resolutions (i) determining that it is in the best interests of the Company and the stockholders of the Company, and declaring it advisable, that the Company enter into this Agreement and consummate the Merger, (ii) approving this Agreement and the consummation of the Merger, (iii) making the Company Board Recommendation and (iv) directing that this Agreement be submitted to the stockholders of the Company entitled to vote for adoption.
(c)Assuming the representations and warranties set forth in Section 4.12 (Ownership of Equity of the Company) are true and correct, the affirmative vote (in person or by proxy) of the holders of a majority of the outstanding shares of Company Common Stock, voting together as a single class, entitled to vote thereon (such approval, the “Company Stockholder Approval”) at the Company Stockholders’ Meeting or any adjournment or postponement thereof, is the only vote of the holders of any class or series of shares of the Company necessary to adopt this Agreement.
(d)Neither the execution and delivery of this Agreement by the Company, nor the consummation by the Company of the Merger, nor performance or compliance by the Company with any of the terms or provisions hereof, will (i) subject to the receipt of the Company Stockholder Approval, conflict with or violate any provision of the Company Charter Documents or (ii) assuming that the consents, approvals, filings, licenses, permits, authorizations, declarations, notifications and registrations referred to in Section 3.04 and the Company Stockholder Approval are obtained prior to the Effective Time and the filings referred to in Section 3.04 are made and any waiting periods thereunder have terminated or expired prior to the Effective Time, (x) violate any Law or Judgment applicable to the Company or any of its Subsidiaries, (y) violate or constitute a default under (or a Default or an Event of Default (as defined in the applicable Indenture) under any Indenture) or create a right of termination or acceleration of any of the terms or provisions of any Material Contract or (z) result in the creation of any Lien (other than a Permitted Lien) on any properties or assets of the Company or any of its Subsidiaries, except, in the case of clause (ii), as would not, individually or in the aggregate, have a Material Adverse Effect or reasonably be expected to prevent, materially delay or materially impair the consummation by the Company of the Merger in accordance with the terms hereof.
SECTION 3.04.Governmental Approvals. Except for (a) compliance with the applicable requirements of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (the “Exchange Act”), including the filing with the
Securities and Exchange Commission (the “SEC”) of a proxy statement relating to the Company Stockholders’ Meeting (as amended or supplemented from time to time, the “Proxy Statement”), (b) compliance with the rules and regulations of the New York Stock Exchange (“NYSE”), (c) the filing of the Certificate of Merger with the Secretary of State of Delaware pursuant to the provisions of the DGCL, (d) filings required under, and compliance with other applicable requirements of the HSR Act, and (e) compliance with any applicable state securities or blue sky laws, no consent, approval, license, permit or authorization of, or filing, declaration, notification or registration with, any Governmental Authority is necessary for the execution and delivery of this Agreement by the Company, the performance by the Company of its obligations hereunder and the consummation by the Company of the Merger, other than such other consents, approvals, licenses, permits, authorizations, filings, declarations, notifications or registrations that, if not obtained, made or given, would not, individually or in the aggregate, have a Material Adverse Effect or reasonably be expected to prevent, materially delay or materially impair the consummation by the Company of the Merger in accordance with the terms hereof.
SECTION 3.05.Company SEC Documents; Undisclosed Liabilities. (a) The Company has timely filed with the SEC all material reports, schedules, forms, statements and other documents required to be filed by the Company with the SEC pursuant to the Securities Act or the Exchange Act, in each case, since January 1, 2024 (the “Lookback Date”) (collectively, the “Company SEC Documents”). As of their respective effective dates (in the case of Company SEC Documents that are registration statements filed pursuant to the requirements of the Securities Act) and as of their respective SEC filing dates or, if amended or supplemented prior to the date of this Agreement, the date of the filing of such amendment or supplement with respect to the portions that are amended or supplemented (in the case of all other Company SEC Documents), the Company SEC Documents complied as to form in all material respects with the requirements of the Securities Act or the Exchange Act, as the case may be, applicable to such Company SEC Documents, and none of the Company SEC Documents as of such respective dates (or, if amended or supplemented prior to the date of this Agreement, the date of the filing of such amendment or supplement with respect to the disclosures that are amended or supplemented) contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. As of the date of this Agreement, (i) there are no material outstanding or unresolved comments received from the SEC with respect to any Company SEC Documents and (ii) to the Company’s Knowledge, none of the Company SEC Documents is the subject of ongoing SEC review or outstanding SEC investigation.
(b)The consolidated financial statements of the Company (including all related notes or schedules) included or incorporated by reference in the Company SEC Documents, as of their respective dates of filing with the SEC (or, if such Company SEC Documents were amended or supplemented prior to the date of this Agreement, the date of the filing of such amendment or supplement, with respect to the consolidated financial statements that are amended, supplemented or restated therein), complied as to form in all material respects with the published rules and regulations of the SEC with respect thereto, have been prepared in all material respects in accordance with GAAP (except, in the case of unaudited quarterly statements, as permitted by Form 10-Q of the SEC or other rules and regulations of the SEC) applied on a consistent basis during the periods involved (except (i) as may be indicated in the
notes thereto or (ii) as permitted by Regulation S-X) and fairly present in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated statements of operations and consolidated statements of cash flows for the periods shown (subject, in the case of unaudited quarterly financial statements, to normal year‑end adjustments and absence of footnote disclosure permitted by GAAP, none of which, individually or in the aggregate, is material to the Company and its consolidated Subsidiaries, taken as a whole).
(c)Neither the Company nor any of its consolidated Subsidiaries has any liabilities of a type required to be disclosed in the liabilities column of a balance sheet prepared in accordance with GAAP, except liabilities (i) reflected or reserved against on the face of the consolidated balance sheet (or indicated in the notes thereto) of the Company as of June 30, 2026 (the “Balance Sheet Date”) included in the Filed SEC Documents, (ii) incurred after the Balance Sheet Date in the ordinary course of business (none of which is a liability for breach of contract, tort, misappropriation, or infringement), (iii) as contemplated by this Agreement or otherwise incurred in connection with the Transactions or (iv) as would not, individually or in the aggregate, have a Material Adverse Effect.
(d)The Company has established and maintains disclosure controls and procedures and a system of internal controls over financial reporting (as such terms are defined in paragraphs (e) and (f), respectively, of Rule 13a-15 under the Exchange Act) reasonably designed to meet the requirements of Rule 13a-15 under the Exchange Act. From the Lookback Date to the date of this Agreement, neither the Company nor, to the Company’s Knowledge, the Company’s independent registered public accounting firm has identified or been made aware of (i) “significant deficiencies” or “material weaknesses” (as defined by the Public Company Accounting Oversight Board) in the design or operation of the Company’s internal controls over financial reporting which would reasonably be expected to adversely affect in any material respect the Company’s ability to record, process, summarize and report financial data, in each case, which has not been subsequently remediated or (ii) any fraud, whether or not material, that involved management or other employees of the Company or any of its Subsidiaries that have a significant role in the Company’s internal control over financial reporting.
(e)The Proxy Statement (including any amendment or supplement thereto), at the time first sent or given to the stockholders of the Company and at the time of the Company Stockholders’ Meeting, will comply as to form in all material respects with the requirements of the Exchange Act and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, the Company makes no representation or warranty with respect to statements made or incorporated by reference in the Proxy Statement based on information supplied by or on behalf of Parent, Merger Sub or any of their respective Representatives for inclusion or incorporation by reference therein.
(f)There are no off-balance sheet arrangements of any type pursuant to any off-balance sheet arrangement required to be disclosed pursuant to Item 303(a)(4) of Regulation S-K (or similar Contracts where the purpose is to avoid disclosure of any material transaction
involving the Company or any of its Subsidiaries) that have not been so described in the Company SEC Documents.
SECTION 3.06.Absence of Certain Changes.
(a)Since the Balance Sheet Date through the date of this Agreement, except for the execution and performance of this Agreement and the discussions, negotiations and transactions related thereto and to any transaction of the type contemplated by this Agreement, the business of the Company and its Subsidiaries has been carried on and conducted in all material respects in the ordinary course of business.
(b)Since the Balance Sheet Date through the date of this Agreement, there has not been, individually or in the aggregate, any Material Adverse Effect.
(c)Since the Balance Sheet Date through the date of this Agreement, the Company and its Subsidiaries have not taken any action that, if taken after the date of this Agreement, would constitute a breach of, or otherwise require the consent of Parent under, any of the covenants set forth in clauses (ii) (redemptions, purchases or other acquisitions of equity interests), (vi) (hedging transactions), (vii) (loans, capital contributions or advances), (viii) (sales/dispositions), (xi) (acquisitions), or (xiii) (accounting changes) of Section 5.01(b) (or Section 5.01(b)(xxiii) with respect to any of the foregoing).
SECTION 3.07.Legal Proceedings. Except as would not, individually or in the aggregate, have a Material Adverse Effect, since the Lookback Date, there has been no (a) pending or, to the Knowledge of the Company, threatened legal or administrative proceeding, claim, charge, complaint, audit, inquiry, litigation, investigation, suit, arbitration or action before or by any Governmental Authority (an “Action”) by or against the Company or any of its Subsidiaries or any of their respective directors or officers (in their capacity as such), or (b) outstanding order, judgment, injunction, directive, determination, ruling, writ, award or decree of any Governmental Authority (a “Judgment”) imposed upon the Company or any of its Subsidiaries, in each case, by or before any Governmental Authority.
SECTION 3.08.Compliance with Laws; Permits.
(a)The Company and each of its Subsidiaries are, and have been since the Lookback Date, (i) in compliance with all local, foreign, state or federal laws (including common law), statutes, ordinances, codes, rules, acts, orders or regulations (“Laws”) or Judgments, applicable to the Company or any of its Subsidiaries, and (ii) not in receipt from any Governmental Authority of any written or, to the Knowledge of the Company, oral notice or communication of any non-compliance with any such Laws or Judgments, except, in each case, as would not, individually or in the aggregate, have a Material Adverse Effect.
(b)The Company and each of its Subsidiaries hold all licenses, franchises, permits, certificates, consents, approvals and authorizations from Governmental Authorities (collectively, “Permits”) necessary for the lawful conduct of their respective businesses, except where the failure to hold the same would not, individually or in the aggregate, have a Material Adverse Effect.
(c)Except as would not, individually or in the aggregate, have a Material Adverse Effect, the Company, each of its Subsidiaries and each of its and their respective directors, officers and employees acting in such capacity are, and, to the Knowledge of the Company, each of its and their other agents acting on its or their behalf is, and have been since the Lookback Date, in compliance with the Foreign Corrupt Practices Act of 1977 and any rules and regulations promulgated thereunder or any other applicable Laws relating to bribery, corruption or money laundering or any other applicable Anti-Corruption Laws including Sanctions.
SECTION 3.09.Tax Matters. (a) Except as would not, individually or in the aggregate, have a Material Adverse Effect:
(i)The Company and each of its Subsidiaries have prepared (or caused to be prepared) and timely filed (taking into account valid extensions of time within which to file) all Tax Returns required to be filed by it, and all such filed Tax Returns (taking into account all amendments thereto) are true and complete.
(ii)All Taxes owed by the Company or any of its Subsidiaries that are due (whether or not shown on any Tax Return) have been timely paid or have been adequately reserved against in accordance with GAAP, except for Taxes being contested in good faith by appropriate proceedings.
(iii)Neither the Company nor any of its Subsidiaries has received written notice of any pending audits, examinations, investigations, proposed adjustments, claims or other proceedings in respect of any Taxes.
(iv)Neither the Company nor any of its Subsidiaries has been a “controlled corporation” or a “distributing corporation” (within the meaning of Section 355(a)(1)(A) of the Code) in any distribution of stock occurring during the two-year period ending on the date of this Agreement that was purported or intended to be governed by Section 355 or 361 of the Code (or any similar provision of state, local or non-U.S. Law).
(v)Neither the Company nor any of its Subsidiaries has been a member of an affiliated group of corporations filing a consolidated U.S. federal income Tax Return (other than a group the common parent of which is the Company or an Affiliate of the Company).
(vi)Neither the Company nor any of its Subsidiaries is a party to, or bound by, or has any obligation under, any Tax sharing Contract other than (i) Contracts solely among the Company and its Subsidiaries and (ii) customary Tax indemnification provisions in any Contract the primary purpose of which does not relate to Taxes.
(vii)Neither the Company nor any of its Subsidiaries has waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to an assessment or deficiency for Taxes (other than pursuant to extensions of time to file Tax Returns obtained in the ordinary course).
(viii)Neither the Company nor any of its Subsidiaries has participated in any “listed transaction” within the meaning of U.S. Treasury Regulations Section 1.6011-4(b).
(b)Notwithstanding anything to the contrary in this Agreement, nothing in this Agreement (including this Section 3.09) shall be construed as providing a representation or warranty with respect to Tax assets, or the existence, amount, availability or usability of, or limitations on any Tax attribute (including net operating loss carryforwards), in each case with respect to the Company or any of its Subsidiaries.
SECTION 3.10.Employee Benefits. (a) Section 3.10(a) of the Company Disclosure Letter contains a true and complete list, as of the date of this Agreement, of each material Company Plan. With respect to each material Company Plan, the Company has made available to Parent true and complete copies (to the extent applicable) of (i) the plan document or a written description thereof (or, if appropriate, a form thereof), including any amendments thereto, (ii) the most recent annual report on Form 5500 filed with the IRS and the most recent actuarial valuation or similar report and (iii) each insurance or group annuity contract or other funding vehicle.
(b)Each Company Plan has been administered in compliance with its terms and applicable Laws, including ERISA and the Code, as applicable, other than instances of noncompliance that would not, individually or in the aggregate, have a Material Adverse Effect. Except as would not, individually or in the aggregate, have a Material Adverse Effect, each Company Plan intended to be “qualified” within the meaning of Section 401(a) of the Code has received a favorable determination letter from the IRS or is entitled to rely upon a favorable opinion issued by the IRS, and to the Knowledge of the Company, there are no existing circumstances or any events that have occurred that could reasonably be expected to cause the loss of any such qualification status. There are no pending, or to the Knowledge of the Company, threatened claims (other than routine claims for benefits) by, on behalf of or against any Company Plan or any trust related thereto and no audit or other proceeding by a Governmental Authority is pending, or to the Knowledge of the Company, threatened with respect to any Company Plan, in each case, except as would not, individually or in the aggregate, have a Material Adverse Effect.
(c)No liability under Title IV of ERISA has been or is expected to be incurred by the Company or any of its Subsidiaries with respect to any ongoing, frozen or terminated “single-employer plan”, within the meaning of Section 4001(a)(15) of ERISA, currently or formerly maintained by any of them, or the single-employer plan of any entity which is considered one employer with the Company under Section 4001 of ERISA or Section 414 of the Code (a “Company ERISA Affiliate”), except as would not, individually or in the aggregate, have a Material Adverse Effect.
(d)Each Multiemployer Plan maintained, sponsored or contributed to by the Company or any of its Subsidiaries or any Company ERISA Affiliate (a “Company Multiemployer Plan”), as of the date of this Agreement, is listed in Section 3.10(d) of the Company Disclosure Letter. With respect to any Company Multiemployer Plan, (i) neither the Company nor any Company ERISA Affiliate has incurred any withdrawal liability under Title IV of ERISA which remains unsatisfied, except as would not, individually or in the aggregate, have a Material Adverse Effect, and (ii) a complete withdrawal from all such Multiemployer Plans at the Effective Time, individually or in the aggregate, would not have a Material Adverse Effect.
(e)No Company Plan provides benefits or coverage in the nature of health, life or disability insurance following retirement, other than benefits or coverage (i) required to be provided under Part 6 of Title I of ERISA or Section 4980(B)(f) of the Code or any other applicable Law or (ii) the full cost of which is borne by the recipient (or any of their beneficiaries).
(f)Except as set forth in this Agreement, the consummation of the Merger will not, either alone or in combination with another event, (i) accelerate the time of payment or vesting, or increase the amount of compensation due to any director, officer or employee of the Company or any of its Subsidiaries under any material Company Plan, (ii) cause the Company to transfer or set aside any assets to fund any benefits under any material Company Plan, (iii) limit or restrict the right to amend, terminate or transfer the assets of any material Company Plan on or following the Effective Time or (iv) result in any payment that could constitute an “excess parachute payment” within the meaning of Section 280G of the Code.
(g)Neither the Company nor any of its Subsidiaries is a party to or has any obligation under any Company Plan to gross up or indemnify any Person for excise Taxes payable pursuant to Section 409A or 4999 of the Code.
SECTION 3.11.Labor Matters. (a) Section 3.11(a) of the Company Disclosure Letter contains a true and complete list, as of the date of this Agreement, of each Collective Bargaining Agreement, excluding any national, industry or similar generally applicable Contract or arrangement. Except as would not, individually or in the aggregate, have a Material Adverse Effect, there is no pending or, to the Knowledge of the Company, threatened labor strike, lockout, slowdown or work stoppage by or with respect to the employees of the Company or any of its Subsidiaries.
(b)The Company and each of its Subsidiaries are, and have been since the Lookback Date, in compliance with all applicable Laws relating to labor and employment matters, including occupational safety and health standards, terms and conditions of employment, payment of wages, classification of employees, employment equality, human rights, pay equity and workers’ compensation, except as would not, individually or in the aggregate, have a Material Adverse Effect.
(c)Since the Lookback Date through the date of this Agreement, (i) none of the Company and its Subsidiaries have received or been involved in or been subject to any material written complaints, allegations, claims or Actions, or to the Knowledge of the Company, unwritten formal allegations or complaints, relating to alleged or actual sexual harassment by any employee of the Company or its Subsidiaries at or above the level of senior vice president, and (ii) none of the Company or its Subsidiaries have entered into a settlement Contract with any employee of the Company or any other Person that involves material allegations of sexual harassment by any employee of the Company or its Subsidiaries at or above the level of senior vice president.
SECTION 3.12.Environmental Matters. Except as would not, individually or in the aggregate, have a Material Adverse Effect, (a) the Company and each of its Subsidiaries are, and have been since the Lookback Date, in compliance with all applicable Laws relating to
pollution or the protection of the environment or natural resources (“Environmental Laws”), and the Company has not received any written notice since the Lookback Date alleging that the Company or any of its Subsidiaries is in violation of any Environmental Law, (b) the Company and each of its Subsidiaries possess and are, and have been since the Lookback Date, in compliance with all Permits required under Environmental Laws for the operation of their respective businesses, (c) there is no Action under or pursuant to any Environmental Law that is pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries, and (d) neither the Company nor any of its Subsidiaries is conducting or funding any cleanup or other remedial activities pursuant to Environmental Laws as a result of any release, spill or disposal of any Hazardous Substances at, in or under any real property owned or leased by the Company or any of its Subsidiaries.
SECTION 3.13.Intellectual Property. (a) Section 3.13(a) of the Company Disclosure Letter lists, as of the date of this Agreement, all material Registered Company Intellectual Property. Except as would not, individually or in the aggregate, have a Material Adverse Effect, (i) the Company and its Subsidiaries own the Registered Company Intellectual Property free and clear of any Liens (other than Permitted Liens) and (ii) the Registered Company Intellectual Property is subsisting, and, to the extent issued or registered, valid and enforceable.
(b)Except as would not, individually or in the aggregate, have a Material Adverse Effect, the Company or one of its Subsidiaries exclusively owns the Registered Company Intellectual Property and is licensed or otherwise has the right to use all other Intellectual Property reasonably necessary to conduct the business of the Company and its Subsidiaries (taken as a whole) as conducted as of the date of this Agreement; provided that nothing in this Section 3.13(b) shall be interpreted or construed as a representation or warranty with respect to whether there is any infringement of any Intellectual Property, which is the subject of Section 3.13(d) and Section 3.13(e).
(c)Except as would not, individually or in the aggregate, have a Material Adverse Effect, the Company and its Subsidiaries have used commercially reasonable efforts to protect the confidentiality of Trade Secrets included in the Owned Company Intellectual Property.
(d)Except as would not, individually or in the aggregate, have a Material Adverse Effect, all current and former employees and other service providers of the Company and its Subsidiaries who have developed within the scope of their employment any Owned Company Intellectual Property have entered into appropriate assignment agreements, presently assigning all of their right, title and interest in any such Owned Company Intellectual Property to the Company or any of its Subsidiaries, or all such right, title and interest has vested in the Company or one of its Subsidiaries by operation of law.
(e)Except as would not, individually or in the aggregate, have a Material Adverse Effect, no adverse third-party Actions are pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries (i) challenging the ownership, validity or use by the Company or any of its Subsidiaries of any Owned Company Intellectual Property or (ii) alleging that the operation of the business of the Company or any of
its Subsidiaries is infringing, violating or misappropriating, the Intellectual Property of any other Person.
(f)Except as would not, individually or in the aggregate, have a Material Adverse Effect, to the Knowledge of the Company, since the Lookback Date, (i) no Person has infringed, violated or misappropriated the rights of the Company or any of its Subsidiaries with respect to any Owned Company Intellectual Property and (ii) the operation of the business of the Company and its Subsidiaries has not misappropriated, violated or infringed the Intellectual Property of any other Person.
SECTION 3.14.Data Privacy and Technology; Information Security. (a) Except as would not, individually or in the aggregate, have a Material Adverse Effect, since the Lookback Date, the Company and its Subsidiaries (i) have been in compliance with all applicable Privacy Laws and the publicly posted written policies of the Company and its Subsidiaries relating to privacy, data protection, data security or privacy breach notification and Personal Information, (ii) have not received written notice of any Action with respect to their compliance with applicable Privacy Laws and (iii) have not been legally required to provide any notices to Governmental Authorities, data owners or individuals in connection with a loss or disclosure of, or unauthorized access to or processing of, Personal Information. Since the Lookback Date, the Company and its Subsidiaries have used commercially reasonable measures aimed to protect and maintain the privacy and security of Personal Information within the possession or control of, or otherwise processed by or for, the Company or any of its Subsidiaries.
(b)Except as would not, individually or in the aggregate, have a Material Adverse Effect, since the Lookback Date, (i) the Company and its Subsidiaries have used commercially reasonable efforts to implement procedures aimed to protect and maintain the performance and security of the Company IT Assets, (ii) the Company IT Assets have not failed or, to the Knowledge of the Company, been subject to any breach or unauthorized access by any third party and, to the Knowledge of the Company, the data that they process has not been corrupted or compromised during the same period and (iii) neither the Company nor any of its Subsidiaries has received any written notice or complaint from any third party or any Governmental Authority relating to incidents of breaches or unauthorized access of the Company IT Assets or any Personal Information.
SECTION 3.15.Property. (a) Section 3.15(a) of the Company Disclosure Letter lists, as of the date of this Agreement, the street address of each Owned Real Property. Except as would not, individually or in the aggregate, have a Material Adverse Effect, (i) the Company or one of its Subsidiaries has good and valid fee simple title in each Owned Real Property, free and clear of all Liens (other than Permitted Liens) and (ii) neither the Company nor any of its Subsidiaries has received written notice of any pending Actions in eminent domain, and, to the Knowledge of the Company, there are no such Actions threatened, in each case, affecting any Owned Real Property.
(b)Section 3.15(b) of the Company Disclosure Letter lists, as of the date of this Agreement, the street address of each Leased Real Property. Except as would not, individually or in the aggregate, have a Material Adverse Effect, (i) the Company or one of its Subsidiaries
has a good and valid leasehold, subleasehold or license interest (as tenant, subtenant or licensee) in each Leased Real Property, free and clear of all Liens (other than Permitted Liens) and each such Company Lease is valid, binding and in full force and effect, subject to the terms of the applicable Company Lease, and (ii) neither the Company nor any of its Subsidiaries has received written notice of any pending Actions in eminent domain, and, to the Knowledge of the Company, there are no such Actions threatened, in each case, affecting any Leased Real Property.
(c)The Owned Real Property and the Leased Real Property comprise all of the material real property currently used in, or otherwise related to, the business of the Company.
SECTION 3.16.Contracts. (a) Section 3.16(a) of the Company Disclosure Letter sets forth a true and complete list, as of the date of this Agreement, of each Material Contract. For purposes of this Agreement, “Material Contract” means any Contract (but excluding any Company Plan, any Company Multiemployer Plan and any Collective Bargaining Agreement) to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries or any of their respective properties or assets is bound, whether executed on, prior to, or after the date of this Agreement, that:
(i)is or would be required to be filed as an exhibit to the Company’s Annual Report on Form 10-K or is otherwise a “material contract” (as such term is defined in Item 601(b)(10) of Regulation S-K under the Securities Act);
(ii)is a joint venture, strategic alliance, partnership or other similar arrangement that is material to the business of the Company and its Subsidiaries, taken as a whole, other than with respect to any partnership that is wholly owned by the Company or any of its Subsidiaries;
(iii)provides for indebtedness for borrowed money of the Company or any of its Subsidiaries having an outstanding or committed amount in excess of $25 million or requiring repayment at the Closing, other than (A) indebtedness solely between or among any of the Company and its Subsidiaries, (B) letters of credit, bank guarantees, security or performance bonds or similar credit support instruments, overdraft facilities or cash management programs, in each case issued, made or entered into in the ordinary course of business, in each case of this clause (B), in amounts that do not exceed $2 million individually or $5 million in the aggregate or (C) ordinary course hedging, swap and other derivative arrangements entered into for non-speculative risk management purposes, in each case of this clause (C), in amounts that do not exceed $20 million;
(iv)relates to the acquisition or disposition of any business, assets or properties (whether by merger, sale of stock, sale of assets or otherwise) for aggregate consideration under such Contract in excess of $20 million that was entered into after the Lookback Date, excluding (x) acquisitions or dispositions in the ordinary course of business, (y) acquisitions or dispositions of assets that are obsolete, worn out, surplus or no longer used or useful in the conduct of business of the Company or its Subsidiaries or (z) repurchases by the Company of Company Common Stock;
(v)is a Company Lease that obligates the Company to make base rental payments in excess of $2 million per annum;
(vi)includes remaining obligations for the Company to make any capital expenditure in an amount in excess of $20 million in any calendar year;
(vii)is a Contract that is with any Governmental Authority where (A) the Governmental Authority is the customer and (B) the Contract is material to the business of the Company and its Subsidiaries, taken as a whole;
(viii)contains provisions that (x) prohibit in a material respect the Company or any of its Subsidiaries from competing in or conducting any line of business, restrict the use or enforcement of any material Owned Company Intellectual Property or grant a right of exclusivity to any Person that prevents the Company or any of its Subsidiaries from entering into any business or any geographic territory or (y) grant any rights of first refusal, first negotiation, or “most favored nation” or similar rights to any third party, in each case, other than (A) Contracts that can be terminated (including such restrictive provisions) by the Company or any of its Subsidiaries on less than 180 days’ notice without payment by the Company or any of its Subsidiaries of any penalty, (B) non-exclusive license agreements for Intellectual Property limiting the Company’s and its Subsidiaries’ use of such Intellectual Property to specified fields of use and (C) Contracts pertaining to real property;
(ix)is a settlement agreement pursuant to which the Company or any of its Subsidiaries has material continuing obligations or involves the payment of more than $5 million;
(x)grants any third party the right to use any material Owned Company Intellectual Property, or grants the Company or any of its Subsidiaries the right to use any Intellectual Property owned by a third party that is material to the Company and its Subsidiaries, taken as a whole, other than (A) non-disclosure and confidentiality agreements, (B) Contracts for any off-the-shelf, or other software commercially available on generally standard terms and conditions (including shrink wrap or click wrap agreements), (C) Contracts granting non-exclusive licenses of Intellectual Property entered into in the ordinary course of business and (D) Contracts in which the grant of rights to Intellectual Property is incidental or ancillary to the primary purpose of such Contract;
(xi)is a Contract with an authorized dealer for the Company or any of its Subsidiaries pursuant to which more than $3 million of revenue was generated for the year ended December 31, 2025;
(xii)requires aggregate payments by the Company or any of its Subsidiaries in excess of $20 million in any twelve-month period; or
(xiii)any agreement with a Top Vendor.
(b)Except (x) with respect to any Contract that has expired in accordance with its terms, been terminated, restated or replaced or (y) as would not, individually or in the aggregate, have a Material Adverse Effect, (i) subject to the Bankruptcy and Equity Exception, each
Material Contract is valid and binding on the Company and/or any of its Subsidiaries to the extent such Person is a party thereto, as applicable, and to the Knowledge of the Company, each other party thereto, and is in full force and effect, (ii) the Company and each of its Subsidiaries, and, to the Knowledge of the Company, any other party thereto, have performed all obligations required to be performed by it under each Material Contract, (iii) neither the Company nor any of its Subsidiaries have received written notice of the existence of any breach or default under any Material Contract nor are there events or conditions which constitute a breach or default on the part of the Company or any of its Subsidiaries under any Material Contract and (iv) to the Knowledge of the Company, no counterparty under any Material Contract intends to terminate or adversely amend such Material Contract or is in breach or default thereof and there is not any material Action with the counterparty in respect of any Material Contract.
(c)As of the date of this Agreement, the Company has made available to Parent true and complete copies of the Material Contracts.
SECTION 3.17.Insurance. Except as would not, individually or in the aggregate, have a Material Adverse Effect, (a) the Company and its Subsidiaries own or hold policies of insurance, or are self-insured, in amounts providing reasonably adequate coverage against all risks customarily insured against by companies in similar lines of business as the Company and its Subsidiaries, (b) all such insurance policies are in full force and effect except for any expiration thereof in accordance with the terms thereof, (c) as of the date of this Agreement, no written notice of cancelation or modification has been received other than in connection with ordinary renewals, (d) there is no existing default or event which, with the giving of notice or lapse of time or both, would constitute a default by any insured under such insurance policies and (e) all premiums due and payable thereon have been paid in full.
SECTION 3.18.No Rights Agreement; Anti-Takeover Provisions. (a) As of the date of this Agreement, the Company is not party to a stockholder rights agreement, “poison pill” or similar anti-takeover agreement or plan.
(b)Assuming the accuracy of the representations and warranties set forth in Section 4.12 (Ownership of Equity of the Company), as a result of the approval by the Board of Directors of the Company referred to in Section 3.03(b), no “business combination”, “control share acquisition”, “fair price”, “moratorium” or other anti-takeover Law (each, a “Takeover Law”) applies or will apply to the Company pursuant to this Agreement or the Merger.
SECTION 3.19.Opinion of Financial Advisors. (a) The Board of Directors of the Company has received the written opinion (or an oral opinion to be confirmed in writing) of Citigroup Global Markets Inc. (“Citi”) to the effect that, as of the date of such opinion, and based upon and subject to, among other things, the assumptions made, procedures followed, matters considered and conditions, qualifications, and limitations on the review undertaken by Citi in connection with the opinion, the Merger Consideration to be received by the holders of Company Common Stock in the Merger pursuant to this Agreement is fair, from a financial point of view,
to such holders. It is agreed and understood that such opinion is for the benefit of the Board of Directors of the Company and may not be relied on by Parent or Merger Sub.
(b) The Board of Directors of the Company has also received the written opinion (or an oral opinion to be confirmed in writing) of Goldman Sachs & Co. LLC (“Goldman Sachs”) to the effect that, as of the date of such opinion, and based upon and subject to, among other things, the assumptions made, procedures followed, matters considered and conditions, qualifications, and limitations on the review undertaken by Goldman Sachs in connection with the opinion, the $10.00 in cash per share to be paid to the holders (other than Parent and its Affiliates) of Company Common Stock, taken in the aggregate, pursuant to this Agreement is fair from a financial point of view to such holders of Company Common Stock, taken in the aggregate. It is agreed and understood that such opinion is for the benefit of the Board of Directors of the Company and may not be relied on by Parent or Merger Sub.
SECTION 3.20.Brokers and Other Advisors. Except for Citi and Goldman Sachs, the fees and expenses of which will be paid by the Company, no broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission, in connection with the Merger or following the Closing based upon arrangements made by or on behalf of the Company or any of its Subsidiaries. The Company has provided to Parent the aggregate amount of and the means to calculate such fees and expenses payable to such advisors.
SECTION 3.21.Top Vendors. Section 3.21 of the Company Disclosure Letter sets forth the names of the top 10 vendors (excluding legal, accounting, tax and similar professional service providers) (the “Top Vendors”) of the Company and its Subsidiaries, taken as a whole, based on the aggregate dollar value of purchases made by the Company and its Subsidiaries from such vendor, in each case for the 12 months ended December 31, 2025.
SECTION 3.22.No Other Representations or Warranties. Except for the express representations and warranties made by the Company in this Article III or in any certificate delivered by the Company pursuant to this Agreement, Parent and Merger Sub (each for itself and on behalf of its Affiliates and Representatives) acknowledge that neither the Company nor any of its Subsidiaries, nor any other Person, (a) have made or is making, and each of Parent, Merger Sub and their Affiliates and respective Representatives have not relied on and are not relying on, any other express or implied representation or warranty with respect to the Company or any of its Subsidiaries or their respective businesses, operations, properties, assets, liabilities, condition (financial or otherwise) or prospects, or any estimates, projections, forecasts and other forward-looking information or business and strategic plan information regarding the Company and its Subsidiaries, notwithstanding the delivery or disclosure to Parent, Merger Sub or any of their Affiliates or respective Representatives of any documentation, forecasts or other information (in any form or through any medium) with respect to any one or more of the foregoing or any oral, written, video, electronic or other information developed by Parent, Merger Sub or any of their Affiliates or respective Representatives or (b) will have or be subject to any liability or indemnification obligation to Parent, Merger Sub or any of their Affiliates or respective Representatives resulting from the delivery, dissemination or any other distribution to Parent, Merger Sub or any of
their Affiliates or respective Representatives (in any form whatsoever and through any medium whatsoever), or the use by Parent, Merger Sub or any of their Affiliates or respective Representatives, of any information, documents, estimates, projections, forecasts or other forward-looking information, business plans or other material developed by or provided or made available to Parent, Merger Sub or any of their Affiliates or respective Representatives, including in due diligence materials, “data rooms” or management presentations (formal or informal, in person, by phone, through video or in any other format), in anticipation or contemplation of any of the Transactions. In particular, and without limiting the generality of the foregoing, neither the Company nor any other Person makes or has made any express or implied representation or warranty to Parent or Merger Sub or any of their Affiliates or respective Representatives with respect to (x) any financial projection, forecast, estimate, budget or prospect information relating to the Company, any of its Subsidiaries or their respective businesses or (y) except for the express representations and warranties made by the Company in this Article III and any certificate delivered by the Company pursuant to this Agreement, any oral, written, video, electronic or other information presented to Parent or Merger Sub or any of their Affiliates or respective Representatives in the course of their due diligence investigation of the Company, the negotiation of this Agreement or the course of the Transactions.
ARTICLE IV
Representations and Warranties of Parent and Merger Sub
Parent and Merger Sub jointly and severally represent and warrant to the Company:
SECTION 4.01.Organization; Standing. Parent is a limited liability company duly organized, validly existing and in good standing under the laws of Delaware, and Merger Sub is a corporation duly incorporated, validly existing under the laws of the State of Delaware and is in good standing with the Secretary of State of Delaware. Each of Parent and Merger Sub has all requisite power and authority necessary to carry on its business as it is now being conducted and is duly licensed or qualified to do business and is in good standing (where such concept is recognized under applicable Law) in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so licensed, qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect. Parent has made available to the Company complete and correct copies of Parent’s and Merger Sub’s certificates of incorporation, bylaws or comparable governing documents, as applicable, each as amended to the date of this Agreement.
SECTION 4.02.Authority; Noncontravention. (a) Each of Parent and Merger Sub has all necessary power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the Transactions. The sole member of Parent has adopted resolutions approving the execution, delivery and performance by Parent of this Agreement and the consummation of the Transactions, which resolutions have not been subsequently rescinded, modified or withdrawn. The Board of Directors of Merger Sub has unanimously adopted resolutions (i) approving the execution, delivery and performance by Merger Sub of this Agreement and the consummation by Merger Sub of the Transactions, (ii) declaring that this Agreement and the consummation of the Transactions are advisable and
(iii) directing that this Agreement be submitted for consideration at a meeting or by unanimous written consent of Parent, as the sole stockholder of Merger Sub, which resolutions have not been subsequently rescinded, modified or withdrawn. No vote of holders of capital stock of Parent is necessary to approve this Agreement or the consummation by Parent and Merger Sub of the Merger and the other Transactions. Parent, as the sole stockholder of Merger Sub, will approve this Agreement (which approval shall be provided for by the written consent of Parent) immediately following the execution and delivery of this Agreement. Except as expressly set forth in this Section 4.02(a), no other corporate action (including any stockholder vote or other action) on the part of Parent or Merger Sub is necessary to authorize the execution, delivery and performance by Parent and Merger Sub of this Agreement and the consummation by Parent and Merger Sub of the Transactions. This Agreement has been duly executed and delivered by Parent and Merger Sub and, assuming due authorization, execution and delivery hereof by the Company, constitutes a legal, valid and binding obligation of each of Parent and Merger Sub, enforceable against each of them in accordance with its terms, subject to the Bankruptcy and Equity Exception. No Takeover Laws apply or will apply to Parent or Merger Sub with respect to this Agreement or the Transactions.
(b)Neither the execution and delivery of this Agreement by Parent and Merger Sub, nor the consummation by Parent or Merger Sub of the Transactions, nor performance or compliance by Parent or Merger Sub with any of the terms or provisions hereof, will (i) conflict with or violate any provision of the certificate of incorporation, bylaws or other comparable charter or organizational documents of Parent or Merger Sub or (ii) assuming that the consents, approvals, filings, licenses, permits, authorizations, declarations, notifications and registrations referred to in Section 4.03 are obtained prior to the Effective Time and the filings referred to in Section 4.03 are made and any waiting periods with respect to such filings have terminated or expired prior to the Effective Time, (x) violate any Law or Judgment applicable to Parent, Merger Sub or any of their respective Subsidiaries or (y) violate or constitute a default under any of the terms, conditions or provisions of any Contract to which Parent, Merger Sub or any of their respective Subsidiaries are a party or accelerate Parent’s, Merger Sub’s or any of their respective Subsidiaries’, if applicable, obligations under any such Contract, except, in the case of clause (ii), as would not, individually or in the aggregate, have a Parent Material Adverse Effect.
SECTION 4.03.Governmental Approvals. Except for (a) compliance with the applicable requirements of the Exchange Act, including the filing with the SEC of the Proxy Statement, (b) compliance with the rules and regulations of any national securities exchange, as applicable, (c) the filing of the Certificate of Merger with the Secretary of State of Delaware pursuant to the provisions of the DGCL, (d) filings required under, and compliance with other applicable requirements of, the HSR Act, and (e) compliance with any applicable state securities or blue sky laws, no consent, approval, license, permit or authorization of, or filing, declaration, notification or registration with, any Governmental Authority is necessary for the execution and delivery of this Agreement by each of Parent and Merger Sub, the performance by each of Parent and Merger Sub of its obligations hereunder and the consummation by each of Parent and Merger Sub of the Transactions, other than such other consents, approvals, licenses, permits, authorizations, filings, declarations, notifications or registrations that, if not obtained, made or
given, would not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect.
SECTION 4.04.Ownership and Operations of Merger Sub. Parent owns beneficially and of record all of the issued and outstanding shares of Merger Sub, free and clear of all Liens. Merger Sub was formed solely for the purpose of engaging in the Transactions, has no liabilities or obligations of any nature other than those incident to its formation and pursuant to the Transactions, and as of immediately prior to the Effective Time, will not have engaged in any other business activities other than those relating to the Transactions or those incident to its formation and will have no liabilities other than those contemplated by this Agreement.
SECTION 4.05.Financing.
(a)As of the date of this Agreement, Parent has delivered to the Company true and complete copies of (i) the executed Backstop Commitment Letter and Syndicated Commitment Letter, in each case, dated as of the date of this Agreement, from the Debt Financing Sources party thereto (as amended, modified, supplemented, replaced or extended from time to time after the date of this Agreement in compliance with the terms of this Agreement, including all annexes, exhibits, schedules and other attachments thereto, each a “Debt Commitment Letter” and collectively, the “Debt Commitment Letters”; provided that (x) in the event that the Backstop Trigger Event does not occur, the term “Debt Commitment Letter” shall refer to each of the Backstop Commitment Letter and the Syndicated Commitment Letter, in each case, to the extent then in effect and until such time that the Backstop Commitment Letter is terminated in accordance with its terms and (y) on and after the occurrence of the Backstop Trigger Event, the term “Debt Commitment Letter” shall refer to solely the Backstop Commitment Letter), pursuant to which such Debt Financing Sources have committed, subject to the terms and conditions set forth therein, to provide debt financing of the type contemplated in the Backstop Commitment Letter or Syndicated Commitment Letter, as applicable, to Parent in the aggregate amounts set forth therein for the purposes of funding a portion of the Financing Uses (and references herein to “Debt Financing” shall refer to the financing of the type referred to in each of the Backstop Commitment Letter and/or Syndicated Commitment Letter as the context may require), (ii) an executed preferred equity commitment letter, dated as of the date of this Agreement, from the Preferred Financing Sources party thereto, as amended, modified, supplemented, replaced or extended from time to time after the date of this Agreement in compliance with the terms of this Agreement, including all annexes, exhibits, schedules and other attachments thereto (the “Preferred Commitment Letter”), pursuant to which the Preferred Financing Sources have committed, subject to the terms and conditions set forth therein, to provide preferred equity financing to Parent (or its Affiliate) in the aggregate amount set forth therein for the purposes of funding a portion of the Financing Uses (the “Preferred Financing”) and (iii) the executed equity commitment letter, dated as of the date of this Agreement, from the Equity Commitment Party, including all annexes, exhibits, schedules and other attachments thereto (the “Equity Commitment Letter” and, together with the Debt Commitment Letter and the Preferred Commitment Letter, the “Commitment Letters”), pursuant to which the Equity Commitment Party has committed, subject to the terms and conditions set forth therein, to provide equity financing to Parent in the aggregate amount set forth therein for the purposes of funding a portion of the Financing Uses (the “Equity Financing” and, together with the Debt Financing and Preferred Financing, the “Financing”).
(b)As of the date of this Agreement, Parent has also delivered to the Company true, correct and complete copies of each fee letter executed by Parent (or its Affiliate) in connection with the Debt Financing and the Preferred Financing referred to in each applicable Debt Commitment Letter and the Preferred Commitment Letter, respectively (collectively, the “Fee Letters”), subject, in the case of each Fee Letter, each Debt Commitment Letter and the Preferred Commitment Letter, to redaction solely of fee amounts and the economic, financial, dollar and ratio terms (including related dates) of any “market flex”, “structure flex” or “securities demand” provisions, pricing terms and pricing caps and other terms that are customarily redacted in debt commitment letters, preferred equity commitment letters and fee letters delivered to sellers in connection with transactions of this type, which such redactions shall be made in a manner customary for transactions of this type; provided that no such redactions shall cover terms that would (i) reduce the amount of the Debt Financing or the Preferred Financing below the amount required to satisfy the Financing Uses on the Closing Date (after taking into consideration the amount of the Available Funding Amounts), (ii) impose any new condition or contingency or otherwise adversely amend, modify or expand any conditions precedent to the Debt Financing or the Preferred Financing on the Closing Date or (iii) adversely affect the availability of the Debt Financing or the Preferred Financing.
(c)As of the date of this Agreement, (i) none of the Commitment Letters or the Fee Letters, in the form delivered to the Company, have been amended, supplemented or modified, (ii) no such amendment, supplement or modification is contemplated by Parent or, to the Knowledge of Parent, by the other parties thereto (other than to add Debt Financing Sources who had not executed the Debt Commitment Letters as of the date of this Agreement or to give effect to any “market flex”, “structure flex” or “securities demand” provisions in the Fee Letters), and (iii) the respective commitments contained in the Commitment Letters have not been withdrawn, terminated or rescinded in any respect and, to the Knowledge of Parent, no such withdrawal, termination or rescission is contemplated (other than as expressly contemplated by clauses (iii), (iv) and (v) of the last sentence of Section 5.14(f)). Except for the Fee Letters and customary engagement letters and fee credit letters with respect to the Debt Financing and the Preferred Financing (none of which (x) imposes any new condition or contingency or otherwise adversely amends, modifies or expands any conditions precedent to the Debt Financing or the Preferred Financing or (y) adversely affects the enforceability, availability or termination of the Debt Financing or the Preferred Financing), there are no side letters, Contracts or other arrangements or understandings to which Parent, Merger Sub or any of their Affiliates is a party related to the funding or investing, as applicable, of the Financing or the other Transactions, in each case, other than as expressly set forth in or contemplated by the Commitment Letters and Fee Letters delivered to the Company on or prior to the date of this Agreement, that would (i) reduce the amount of the Debt Financing or the Preferred Financing below the amount required to satisfy the Financing Uses on the Closing Date (after taking into consideration the Available Funding Amounts) or (ii) have the effect set forth in either clause (x) or clause (y) above.
(d)As of the date of this Agreement, Parent has fully paid any and all commitment fees or other fees in connection with the Commitment Letters or the Fee Letters that are payable on or prior to the date of this Agreement pursuant to the terms of the Commitment Letters or the Fee Letters, and Parent will, directly or indirectly, continue to pay in full any such amounts required to be paid pursuant to the terms relating to the Debt Financing and the Preferred Financing as and when they become due and payable prior to the Closing Date.
(e)As of the date of this Agreement, each of the Debt Commitment Letters, the Preferred Commitment Letter and the Equity Commitment Letter is in full force and effect and constitutes legal, valid, binding and enforceable obligations of each party thereto, subject to the Bankruptcy and Equity Exception. There are no conditions precedent or other contingencies related to the funding, availability or investing, as applicable, of the full amount of the Financing required to satisfy the Financing Uses on the Closing Date (including pursuant to any “market flex” provisions in any fee letters), other than those expressly set forth in the Commitment Letters or the Fee Letters. Assuming satisfaction or waiver of the conditions to Parent’s and Merger Sub’s obligation to consummate the Merger, as of the date of this Agreement, no event has occurred which, with or without notice, lapse of time or both, would or would reasonably be expected to (i) constitute a default or breach on the part of Parent, Merger Sub or, to the Knowledge of Parent, any other party thereto under any of the Commitment Letters, (ii) constitute a failure to satisfy a condition on the part of Parent, Merger Sub or, to the Knowledge of Parent, any other party thereto under any of the Commitment Letters or (iii) result in any portion of the Financing being unavailable on the Closing Date (other than, to the extent that the Backstop Trigger Event does not occur, the replacement of the Backstop Commitment Letter (other than the commitments thereunder that backstop the Receivables Facility, but subject to clause (v) of the last sentence of Section 5.14(f))with the Syndicated Commitment Letter as permitted herein). Assuming satisfaction or waiver of the conditions to Parent’s and Merger Sub’s obligation to consummate the Merger, as of the date of this Agreement, Parent has no reason to believe that it or any other party to the Commitment Letters will be unable to satisfy on a timely basis any applicable term or condition thereof, that the conditions thereto will not otherwise be satisfied on the Closing Date or that the Financing required to satisfy the Financing Uses on the Closing Date will not be available in full on or prior to the Closing Date. Parent and Merger Sub will have on the Closing Date, together with the Available Funding Amounts, funds sufficient to (i) pay the aggregate Merger Consideration and the other payments under Article II payable at the Closing, (ii) pay any and all fees and expenses required to be paid at Closing by Parent and Merger Sub in connection with the Merger and the Financing, (iii) prepay, repay or redeem, as appropriate, any outstanding indebtedness of the Company or its Subsidiaries required under this Agreement to be prepaid, repaid or redeemed in connection with the Transactions at the Closing and (iv) satisfy all of the other payment obligations of Parent and Merger Sub required at the Closing (clauses (i) through (iv), the “Financing Uses”). In no event shall the receipt or availability of any funds or financing by or to Parent, Merger Sub or any of their Affiliates or any other financing transaction be a condition to any obligation of Parent or Merger Sub hereunder.
(f)In the case of the Debt Financing and Debt Commitment Letter referred to in this Agreement, (i) for purposes of determining the sufficiency of the Debt Financing under this Agreement (including this Section 4.05), (x) (1) unless and until the Backstop Commitment Letter has been terminated and replaced in accordance with its terms (notice of which will be promptly provided to the Company) as a result of the Debt Financing Sources (which, in the case of any such Debt Financing Source that is not a party to the Syndicated Commitment Letter as of the date hereof, shall be an Approved Financing Source) having committed to provide the aggregate amount of the Debt Financing contemplated by the Syndicated Commitment Letter in an amount (when taken together with the aggregate amount of commitments under the Backstop Commitment Letter that backstop the Receivables Facility and that remain outstanding if the Backstop Trigger Event does not occur) equal to 100% of the aggregate commitments under the
Backstop Commitment Letter as of the date hereof (as such commitments may be reduced or terminated from time to time in accordance with the terms of the Backstop Commitment Letter) (after taking into account the Available Funding Amounts) (the Syndicated Commitment Letter, at such time as such commitments thereunder have become effective in such amounts, the “Fully Committed Syndicated Commitment Letter”), and (2) at all times from and after the occurrence of the Backstop Trigger Event (if it occurs), in all such cases, the Backstop Commitment Letter shall be required to provide for Debt Financing sufficient (after taking into consideration the Available Funding Amounts) to pay the Financing Uses on the Closing Date and (y) if the Backstop Trigger Event does not occur, the Syndicated Commitment Letter shall be required to provide for Debt Financing sufficient (after taking into consideration the Available Funding Amounts and the commitments under the Backstop Commitment Letter that backstop the Receivables Facility and that remain outstanding if the Backstop Trigger Event does not occur) to pay the Financing Uses on the Closing Date, and (ii) any reference in this Agreement to the Debt Financing being funded (including in Section 8.08(b)) shall refer to the Debt Financing contemplated under each of the Backstop Commitment Letter or Fully Committed Syndicated Commitment Letter, in either case, as in effect at such time.
SECTION 4.06.Guarantee. Concurrently with the execution of this Agreement, Parent has delivered to the Company the duly executed guarantee, duly executed by the Guarantor, dated as of the date of this Agreement, in favor of the Company in respect of Parent’s obligation to pay the Parent Termination Fee, if and when due under Section 7.03(b), any Enforcement Expenses payable pursuant to Section 7.03(c) (subject to the Enforcement Expenses Cap) and Financing Cooperation Expenses payable pursuant to Section 5.14(d) and Section 5.15(d) (subject to the Financing Cooperation Expenses Cap), in each case subject to the terms of this Agreement (the “Guarantee”). The Guarantee is (a) a legal, valid and binding obligation of the Guarantor, (b) enforceable against the Guarantor in accordance with its terms, except as such enforceability may be limited by the Bankruptcy and Equity Exception and (c) in full force and effect. As of the date of this Agreement, no event has occurred which, with or without notice, lapse of time or both, would or would reasonably be expected to constitute a default, breach or failure to satisfy a condition on the part of the Guarantor under the Guarantee. The Guarantor has, and at all times will have, access to sufficient cash, available lines of credit, capital commitments or other sources of immediately available funds to satisfy in full the full amount of its obligations under the Guarantee if and when due pursuant to the terms thereof. There are no side letters, contracts or other agreements, arrangements or understandings (whether oral or written) to which the Guarantor, Parent, Merger Sub or any of their respective Affiliates is a party related to the Guarantee other than as expressly set forth in the Guarantee and the Commitment Letters, in each case as delivered to the Company on or prior to the date of this Agreement, that could adversely affect the conditionality, amount, timing, availability or termination of the Guarantee. As of the date of this Agreement, assuming the accuracy of the representations and warranties set forth in Article III, the performance in all material respects by the Company and its Subsidiaries of their obligations hereunder and the satisfaction of the conditions set forth in Section 6.01 and Section 6.02, Parent has no reason to believe that any of the conditions to the Guarantor’s obligations under the Guarantee will not be satisfied on a
timely basis or that the full amount of the Guarantee will not be available pursuant to the terms thereof.
SECTION 4.07.Solvency. Neither Parent nor Merger Sub is entering into this Agreement (and the Guarantor is not entering into the Guarantee) with the actual intent to hinder, delay or defraud any present or future creditors of the Company or any of its Subsidiaries. Assuming the satisfaction or waiver of the conditions to Parent’s obligation to consummate the Merger, the accuracy in all material respects of the representations and warranties of the Company set forth in Article III and after giving effect to the Transactions and the payment of the aggregate Merger Consideration, any other repayment or refinancing of debt contemplated by this Agreement or the Commitment Letters, the payment of all amounts required to be paid in connection with the consummation of the Transactions (including all amounts payable in respect of Equity-Based Awards under this Agreement) and the payment of all related fees and expenses, each of (x) Parent and (y) the Surviving Corporation and its Subsidiaries, on a consolidated basis, will be Solvent as of, and immediately following, the Effective Time and immediately after the consummation of the Transactions. For purposes of this Agreement, “Solvent,” when used with respect to any Person, means that, as of any date of determination, (a) the amount of the “fair saleable value” of the assets of such Person and its Subsidiaries, taken as a whole, will, as of such date, exceed the sum of (i) the value of all “liabilities of such Person and its Subsidiaries, taken as a whole, including contingent and other liabilities”, and (ii) the amount that will be required to pay the probable liabilities of such Person and its Subsidiaries, taken as a whole, as of such date, on its existing debts (including contingent and other liabilities) as such debts become absolute and mature, (b) such Person and its Subsidiaries, taken as a whole, will not have, as of such date, an unreasonably small amount of capital for the operation of the businesses in which they are engaged or proposed to be engaged following such date and (c) such Person and its Subsidiaries, taken as a whole, will be able to pay their liabilities, including contingent and other liabilities, as they mature. For purposes of this definition, “not have an unreasonably small amount of capital for the operation of the businesses in which it is engaged or proposed to be engaged” and “able to pay its liabilities, including contingent and other liabilities, as they mature” mean that such Person will be able to generate enough cash from operations, asset dispositions or refinancings, or any combination thereof, to meet its obligations as they become due.
SECTION 4.08.Certain Arrangements. As of the date of this Agreement, there are no Contracts or other arrangements or understandings (whether oral or written and whether or not legally binding) or commitments to enter into Contracts or other arrangements or understandings (whether oral or written and whether or not legally binding) between Parent, Merger Sub or any of their Affiliates, on the one hand, and any member of the Company’s management or Board of Directors of the Company or any beneficial owner of shares of Company Common Stock, on the other hand, that relate in any way to the Company or any of its businesses or Subsidiaries (including those businesses and Subsidiaries following the Closing) or the Transactions (including as to continuing employment or equity roll-over).
SECTION 4.09.Brokers and Other Advisors. Other than Evercore Group L.L.C., no broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission, in connection with the Transactions based upon arrangements made by or on behalf of Parent, Merger Sub or any of
their respective Subsidiaries, except for Persons, if any, whose fees and expenses will be paid by Parent.
SECTION 4.10.Information Supplied. None of the information supplied or to be supplied by or on behalf of Parent or Merger Sub for inclusion or incorporation by reference in the Proxy Statement (including any amendments or supplements thereto) will, at the time the Proxy Statement (or any amendment or supplement thereto) is first sent or given to the stockholders of the Company or at the time of the Company Stockholders’ Meeting, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, Parent and Merger Sub make no representation or warranty with respect to statements made or incorporated by reference in the Proxy Statement based on information supplied by or on behalf of the Company or any Affiliates thereof for inclusion or incorporation by reference therein.
SECTION 4.11.Legal Proceedings. Except as would not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect, as of the date of this Agreement, there is no (a) pending or, to the Knowledge of Parent and Merger Sub, threatened Action against Parent or Merger Sub or any of their respective Affiliates or (b) Judgment imposed upon or affecting Parent or Merger Sub or any of their respective Affiliates, in each case, by or before any Governmental Authority.
SECTION 4.12.Ownership of Equity of the Company. Neither Parent nor Merger Sub nor any of their Affiliates owns any shares of Company Common Stock or is or has been an “interested stockholder” (as defined in Section 203 of the DGCL) of the Company during the three years prior to the date of this Agreement.
SECTION 4.13.Foreign Person Status. Neither Parent nor Merger Sub is, or is acting on behalf of, a “foreign person”, as such term is defined in Section 721 of the Defense Production Act of 1950 (as amended, including all implementing regulations thereof, the “DPA”). None of Parent, Merger Sub or the Equity Commitment Party is permitting any “foreign person” (as such term is defined in the DPA) affiliated with Parent, Merger Sub or the Equity Commitment Party to obtain any of the following with respect to the Company or any of its Subsidiaries: (a) access to any “material nonpublic technical information” (as such term is defined in the DPA) in the possession of the Company or any of its Subsidiaries; (b) membership or observer rights on, or the right to nominate an individual to a position on, the Board of Directors or equivalent governing body of the Company or any of its Subsidiaries; (c) any involvement, other than through voting of shares, in substantive decision-making of the Company or any of its Subsidiaries regarding (i) the use, development, acquisition, safekeeping or release of “sensitive personal data” (as such term is defined in the DPA) of U.S. citizens maintained or collected by the Company or any of its Subsidiaries, (ii) the use, development, acquisition or release of any “critical technologies” (as such term is defined in the DPA) or (iii) the management, operation, manufacture or supply of “covered investment critical
infrastructure” (as such term is defined in the DPA); or (d) “control” (as such term is defined in the DPA) of the Company or any of its Subsidiaries.
SECTION 4.14.No Other Company Representations or Warranties. Each of Parent and Merger Sub acknowledges that it and its Representatives have received access to such books and records, facilities, equipment, Contracts and other assets of the Company which it and its Representatives have desired or requested to review, and that it and its Representatives have had full opportunity to meet with the management of the Company and to discuss the business and assets of the Company. Except for the express representations and warranties made by the Company in Article III or in any certificate delivered by the Company pursuant to this Agreement, Parent and Merger Sub (each for itself and on behalf of its Affiliates and Representatives) acknowledge that neither the Company nor any of its Subsidiaries, nor any other Person, (a) have made or are making, and each of Parent, Merger Sub and their Affiliates and respective Representatives have not relied on and are not relying on, any other express or implied representation or warranty with respect to the Company or any of its Subsidiaries or their respective businesses, operations, properties, assets, liabilities, condition (financial or otherwise) or prospects, or any estimates, projections, forecasts and other forward-looking information or business and strategic plan information regarding the Company and its Subsidiaries, notwithstanding the delivery or disclosure to Parent, Merger Sub or any of their Affiliates or respective Representatives of any documentation, forecasts or other information (in any form or through any medium) with respect to any one or more of the foregoing or any oral, written, video, electronic or other information developed by Parent, Merger Sub or any of their Affiliates or respective Representatives or (b) will have or be subject to any liability or indemnification obligation to Parent, Merger Sub or any of their Affiliates or respective Representatives resulting from the delivery, dissemination or any other distribution to Parent, Merger Sub or any of their Affiliates or respective Representatives (in any form whatsoever and through any medium whatsoever), or the use by Parent, Merger Sub or any of their Affiliates or respective Representatives, of any information, documents, estimates, projections, forecasts or other forward-looking information, business plans or other material developed by or provided or made available to Parent, Merger Sub or any of their Affiliates or respective Representatives, including in due diligence materials, “data rooms” or management presentations (formal or informal, in person, by phone, through video or in any other format), in anticipation or contemplation of any of the Transactions. Parent, on behalf of itself and on behalf of its Affiliates, expressly waives any such claim relating to the foregoing matters. Parent and Merger Sub hereby acknowledge (each for itself and on behalf of its Affiliates and Representatives) that they have conducted, to their satisfaction, their own independent investigation of the business, operations, assets and financial condition of the Company and its Subsidiaries and, in making their determination to proceed with the Transactions, each of Parent, Merger Sub and their Affiliates and respective Representatives have relied on the results of their own independent investigation and have not relied on any express or implied representations or warranties other than those expressly set forth in Article III or in any certificate delivered by the Company pursuant to this Agreement. Notwithstanding the foregoing, nothing in this Section 4.14 shall affect, modify or otherwise limit any Action for Fraud.
SECTION 4.15.Non-Reliance on Company Estimates, Projections, Forecasts, Forward-Looking Statements and Business Plans. In connection with the due diligence investigation of the Company by Parent and Merger Sub and their Affiliates and respective
Representatives, the negotiations of this Agreement or the course of the Transactions, Parent, Merger Sub and their Affiliates and respective Representatives have received and may continue to receive from the Company certain estimates, projections, forecasts and other forward-looking information, as well as certain business and strategic plan information, regarding the Company and its Subsidiaries and their respective businesses and operations. Parent and Merger Sub hereby acknowledge (each for itself and on behalf of its Affiliates and Representatives) that there are uncertainties inherent in attempting to make such estimates, projections, forecasts and other forward-looking statements, as well as in such business and strategic plans, with which Parent and Merger Sub are familiar, that Parent and Merger Sub (each for itself and on behalf of its Affiliates and Representatives) are taking full responsibility for making their own evaluation of the adequacy and accuracy of all estimates, projections, forecasts and other forward-looking information, as well as such business plans, so furnished to them (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, forward-looking information or business plans), and that except for the representations and warranties expressly set forth in Article III or in any certificate delivered by the Company pursuant to this Agreement, Parent, Merger Sub, their Affiliates and respective Representatives have not relied on such information and will have no claim against the Company or any of its Subsidiaries, or any of their respective Representatives, with respect thereto or, except for the representations and warranties expressly set forth in Article III or in any certificate delivered by the Company pursuant to this Agreement, any rights hereunder with respect thereto.
ARTICLE V
Additional Covenants and Agreements
SECTION 5.01.Conduct of Business. (a) Except as required by applicable Law, Judgment or a Governmental Authority, as expressly required or expressly permitted by this Agreement or as set forth in Section 5.01(a) of the Company Disclosure Letter, during the period from the date of this Agreement until the Effective Time (or such earlier date on which this Agreement is terminated pursuant to Section 7.01), unless Parent otherwise consents in writing (such consent not to be unreasonably withheld, delayed or conditioned), the Company shall, and shall cause each of its Subsidiaries to, use its and their commercially reasonable efforts to carry on its business in all material respects in the ordinary course of business and, to the extent consistent with the foregoing, to (i) preserve its and each of its Subsidiaries’ current business organizations substantially intact, (ii) retain the services of its and their respective officers and key employees and (iii) preserve its and each of its Subsidiaries’ material business relationships; provided that no action by the Company or any of its Subsidiaries with respect to matters specifically addressed by Section 5.01(b) shall be deemed to be a breach of this Section 5.01(a) unless such action would constitute a breach of Section 5.01(b).
(b)Except as required by applicable Law, Judgment or a Governmental Authority, as expressly required or expressly permitted by this Agreement or as set forth in Section 5.01(b) of the Company Disclosure Letter, during the period from the date of this Agreement until the Effective Time (or such earlier date on which this Agreement is terminated pursuant to Section 7.01), unless Parent otherwise consents in writing (such consent not to be unreasonably withheld, delayed or conditioned; provided, that any consent with respect to
Section 5.01(b)(i) (issuances of capital stock), (ii) (redemptions, purchases or other acquisitions of equity interests), (iii) (dividends or distributions), (iv) (splits, combinations and reclassifications of capital stock), (v) (indebtedness), (vi) (hedging transactions), (vii) (sales/dispositions), (viii) (acquisitions) and (ix) (organizational document amendments) shall be at Parent’s sole discretion; provided that any consent with respect to the matter set forth on Item 1 under Section 5.01(b) of the Company Disclosure Letter shall not be unreasonably withheld, conditioned or delayed), the Company shall not, and shall not permit any of its Subsidiaries to:
(i)issue, grant, sell, pledge, dispose of or encumber, (or authorize the foregoing with respect to) any Company Securities or any capital stock of, or other equity or voting interests in, any Subsidiary of the Company or any securities convertible into, or exchangeable or exercisable for, any shares of its capital stock or other equity or voting interests (including any rights, warrants, options to purchase any shares of its capital stock or other equity or voting interests) other than (A) transactions solely between and among the Company and its wholly owned Subsidiaries, (B) refinancings of Indebtedness otherwise expressly permitted under Section 5.01(b)(v), (C) the issuance of shares of Company Common Stock as required pursuant to equity awards outstanding under the Company Plans in effect on the date of this Agreement or (D) the issuance of shares of Company Common Stock upon the conversion, at the option of the holder thereof, of any shares of Class B Common Stock, into shares of Common Stock pursuant to and in accordance with Section 4.02(d) of the Amended and Restated Certificate of Incorporation of the Company as in effect on the date of this Agreement;
(ii)other than transactions solely between and among the Company and its wholly owned Subsidiaries, redeem, purchase or otherwise acquire any Company Securities or any capital stock of, or other equity or voting interests in, any Subsidiary of the Company or any securities convertible into, or exchangeable or exercisable for, any shares of its capital stock or other equity or voting interests (including any rights, warrants or options to purchase any shares of its capital stock or other equity or voting interests), other than (A) pursuant to the forfeiture of, withholding of Taxes with respect to or the net settlement or cashless exercise of Equity-Based Awards outstanding as of the date of this Agreement in accordance with the terms of such awards and applicable Company Plan as in effect on the date of this Agreement or (B) the cancellation, retirement and elimination of shares of Class B Common Stock converted into shares of Common Stock in accordance with clause (i) above;
(iii)other than transactions solely between and among the Company and its wholly owned Subsidiaries, establish a record date for, approve, declare, set aside for payment or pay any dividend on, or make any other distribution in respect of, any shares of its capital stock or other equity or voting interests (whether in cash, securities or otherwise);
(iv)split, combine, subdivide or reclassify any shares of its capital stock or other equity or voting interests, except for any such transaction by a wholly owned Subsidiary of the Company which remains a wholly owned Subsidiary after consummation of such transaction;
(v)incur, create, refinance, prepay, repay, replace or assume any indebtedness for borrowed money, issue, create, refinance, replace or sell any debt securities or warrants or other rights to acquire any debt securities of the Company or any of its Subsidiaries, guarantee any such indebtedness or debt securities of another Person or enter into any “keep well” or other
agreement to maintain any financial condition of another Person (collectively, “Indebtedness”), except for (A) intercompany Indebtedness among the Company and its Subsidiaries in the ordinary course of business and that is not reasonably expected to have an adverse impact on Parent’s ability to obtain any portion of the Financing on the terms set forth in the Commitment Letters in any material respect, (B) letters of credit, bank guarantees, security or performance bonds or similar credit support instruments, overdraft facilities or cash management programs, in each case issued, made, entered into but not drawn, in each case, in the ordinary course of business, (C) Indebtedness incurred under the Revolving Credit Facility in an aggregate principal amount not to exceed $50 million, (D) Indebtedness incurred under the Receivables Facility in the ordinary course of business and on terms existing as of the date of this Agreement; provided that (x) the Company’s uncommitted available borrowing capacity under the Receivables Facility shall not be less than $50 million and (y) each borrowing or other extension of credit under the Receivables Facility shall be supported by one or more specifically identified receivables of the Company or its applicable Subsidiaries and (E) additional Indebtedness incurred after the date of this Agreement in an aggregate principal amount not to exceed $5 million; and (F) prepayments and repayments of existing Indebtedness at stated maturity, in the ordinary course of business or in connection with any refinancing permitted pursuant to this Section 5.01(b)(v) (including as set forth on Section 5.01(b)(v) of the Company Disclosure Letter);
(vi)enter into any swap or hedging transaction or other derivative agreements in an amount in excess of $20 million in the aggregate;
(vii)make any loans, capital contributions or advances to any Person other than (A) to the Company or any Subsidiary of the Company, in the ordinary course of business or (B) pursuant to Section 5.01(b)(xi);
(viii)transfer, assign, dispose of, license, sell or lease to any Person, in a single transaction or series of related transactions, any of its material properties or assets (other than Intellectual Property), except (A) transfers, sales, leases, subleases or licenses between and among the Company and its Subsidiaries, (B) dispositions of properties or assets that are obsolete, worn out, surplus or no longer used or useful in the conduct of the business of the Company or any of its Subsidiaries, (C) expirations, terminations or surrenders of real property leases, subleases or licenses in accordance with their terms, (D) transfers, sales, leases, subleases or licenses in the ordinary course of business and (E) sales, leases, subleases or licenses of properties or assets for consideration not to exceed $25 million in the aggregate;
(ix)transfer, assign, sell, lease, license, subject to any Lien (other than a Permitted Lien), cancel, abandon, allow to lapse or expire, or otherwise dispose of any material Owned Company Intellectual Property, except, in each case, (A) non-exclusive licenses granted to third parties in the ordinary course of business, or (B) any such transfer, assignment, sale or license required pursuant to a Material Contract in effect as of the date of this Agreement or entered into in compliance with this Section 5.01 (other than entering into Material Contracts of the type identified in Section 3.16(a)(ii)), or (C) the expiration of any Registered Company Intellectual Property at the end of its full statutory life;
(x)grant any Lien (other than a Permitted Lien) on any of its assets having a value of more than $1 million (excluding Intellectual Property) other than (A) to secure Indebtedness and other obligations permitted under Section 5.01(b)(v) or (B) to the Company or to a wholly owned Subsidiary of the Company;
(xi)acquire (including by merger) any capital stock or a material portion of the assets of any other Person or business, or division thereof, except for (A) purchases or acquisitions of inventory, supplies and other similar assets (excluding acquisitions of customer accounts) in the ordinary course of business, (B) in the amounts set forth on Section 5.01(b)(xi)(B) of the Company Disclosure Letter or (C) acquisitions of customer accounts set forth on Section 5.01(b)(xi)(C) of the Company Disclosure Letter;
(xii)except as required pursuant to the terms of any Company Plan, Company Multiemployer Plan or Collective Bargaining Agreement, in each case, in effect on the date of this Agreement or adopted, established, entered into or amended after the date of this Agreement not in violation of this Agreement, (A)(1) grant to any member of the Board of Directors of the Company or employee of the Company or its Subsidiaries classified as “Band 2” or above (collectively, the “Senior Service Providers”) any increase in compensation or benefits, or (2) grant to any current or former director, officer, employee or other individual service provider of the Company or its Subsidiaries who is not a Senior Service Provider any increase in compensation or benefits, except, in the case of this clause (2), annual merit-based increases to base salary or base wage rate (and corresponding increases to annual cash bonus opportunities) made in the ordinary course of business, consistent with past practice, that do not, on an aggregate basis, exceed 3.5% of the base salaries or base wage rates for all such individuals as of the date hereof, (B) grant to any director, officer, employee or other individual service provider any increase in (or new) cash or equity-based incentive, bonus, severance, retention, change of control or termination or similar compensation or benefits, (C) terminate, enter into or modify, extend or amend any Collective Bargaining Agreement (other than successor Collective Bargaining Agreements entered into in the ordinary course of business that do not result in material economic or operational changes and do not increase the hourly base wage rate by more than five percent) or material Company Plan, (D) incur any obligation or liability, including any withdrawal liability, under any Multiemployer Plan, (E) take any action to accelerate the funding, payment or vesting of any rights, compensation or benefits under any Company Plan, (F) hire, terminate, promote or engage, or otherwise enter into any employment or consulting agreement with, any Senior Service Provider, or (G) terminate any Senior Service Provider, other than for cause (as determined by the Company in its reasonable discretion);
(xiii)make any changes in financial accounting methods, principles or practices affecting the consolidated assets, liabilities or results of operations of the Company and its Subsidiaries, except insofar as may be required by (A) GAAP (or any binding interpretation thereof), (B) any applicable Law, including Regulation S-X under the Securities Act, or (C) any Governmental Authority or quasi-governmental authority (including the Financial Accounting Standards Board or any similar organization);
(xiv)make, change or revoke any Tax election, adopt or change any Tax accounting method or change any Tax accounting period, file any amended Tax Return, settle any Tax claim or assessment, or consent to any extension or waiver of the limitations period
applicable to any Tax claim or assessment outside of the ordinary course of business, in each case, that is material to the Company or any of its Subsidiaries;
(xv)amend (A) the Company Charter Documents or (B) the comparable organizational documents of any Subsidiary of the Company (other than, in the case of clause (B) for immaterial amendments);
(xvi)make, commit to or authorize any capital expenditures (including expenditures in connection with or relating to acquisitions of subscriber system assets and customer accounts), except for (A) such capital expenditures not to exceed the amounts set forth on Section 5.01(b)(xvi)(A) of the Company Disclosure Letter and (B) capital expenditures in connection with the transactions set forth on Section 5.01(b)(xvi)(B) of the Company Disclosure Letter;
(xvii)(A) modify, amend or extend (other than renewals and extensions pursuant to the terms thereof, except with respect to Material Contracts referenced in Section 3.16(a)(ii); provided that any nondiscretionary renewal or extension of a Material Contract referenced in Section 3.16(a)(ii) pursuant to the terms thereof shall be permitted) any Material Contract, in each case in a manner adverse to the Company or its Subsidiaries in any material respect, (B) voluntarily terminate or cancel (other than expirations pursuant to the terms thereof) any Material Contract, (C) waive or release any material rights or claims under any Material Contract, (D) assign any material rights or claims under any Material Contract or (E) enter into any Contract that would have been a Material Contract had it been entered into prior to or as of the date of this Agreement, in each case, other than in the ordinary course of business (except, in the case of this clause (E), with respect to Material Contracts referenced in Section 3.16(a)(ii));
(xviii)(A) modify, amend, supplement or extend (other than renewals and extensions pursuant to the terms thereof) any Indenture, (B) voluntarily terminate or cancel (other than expirations or redemptions pursuant to the terms thereof) any Indenture, (C) waive or release any rights or claims under any Indenture, or consent to any waiver, modification or amendment thereof or (D) assign any rights or claims under any Indenture;
(xix)settle or compromise any pending or threatened Action against the Company or any of its Subsidiaries (or any of their respective officers, directors or employees, in their capacity as such of the Company), other than settlements or compromises of any pending or threatened Action (A) in the ordinary course of business, (B) reflected or reserved against in the balance sheet (or the notes thereto) of the Company as of the Balance Sheet Date included in the Filed SEC Documents for an amount not materially in excess of the amount so reflected or reserved (excluding any amount that may be paid under insurance policies or indemnification agreements) or (C) if the amount of any such settlement does not exceed $2.5 million, taken as a whole, after taking into account any amounts that may be paid under insurance policies or indemnification agreements; provided that no settlement of any pending or threatened Action may (x) involve any material injunctive or equitable relief or (y) impose ongoing restrictions on the business activities of the Company or any of its Subsidiaries or on any of their respective assets, properties or rights that are material to the business of the Company and its Subsidiaries, taken as a whole;
(xx)recognize or certify any labor union, labor organization, works council, or group of employees of the Company or its Subsidiaries as the bargaining representative for any employees of the Company or its Subsidiaries, in each case, except as required by Law;
(xxi)implement or announce any employee layoffs, plant closings, reductions in force, collective redundancies, furloughs, temporary layoffs, salary or wage reductions, work schedule changes, or other such actions, in each case that could trigger any liability or notice requirement under the WARN Act;
(xxii)waive or release any noncompetition, nonsolicitation, nondisclosure, noninterference, nondisparagement, or other restrictive covenant obligation of any Senior Service Provider; or
(xxiii)commit or agree, in writing or otherwise, to take any of the foregoing actions.
(c)Except as expressly permitted or expressly required by this Agreement or as required by applicable Law, Judgment or a Governmental Authority, during the period from the date of this Agreement to the Effective Time (or such earlier date on which this Agreement is terminated pursuant to Section 7.01), neither Parent nor Merger Sub shall, without the prior written consent of the Company, (i) take any action, or fail to take any action, in either case, that would reasonably be expected to result in any of the conditions to the Merger set forth in Article VI to not be satisfied, (ii) take any action, or fail to take any action, in either case the result of which would reasonably be expected to materially impair or materially delay the consummation of the Transactions or (iii) authorize any of, or commit or agree, in writing or otherwise, to take any of the foregoing actions.
(d)Nothing contained in this Agreement is intended to give Parent or Merger Sub, directly or indirectly, the right to control or direct the Company’s or its Subsidiaries’ operations prior to the Effective Time. Prior to the Effective Time, the Company shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its and its Subsidiaries’ respective operations.
SECTION 5.02.Solicitation; Change in Recommendation.
(a)Notwithstanding anything to the contrary contained in this Agreement, during the period beginning on the date of this Agreement and continuing until 11:59 p.m., New York City time, November 28, 2026 (the “Go-Shop Period”), which may be extended by the Go-Shop Extension solely with respect to Excluded Parties, the Company and its Subsidiaries and their respective Representatives shall have the right to directly or indirectly (i) initiate, solicit, cause, encourage or facilitate, whether publicly or otherwise, Takeover Proposals (or inquiries, proposals or offers or other efforts or attempts that may reasonably be expected to lead to a Takeover Proposal), including by providing access to non-public information pursuant to one or more Acceptable Confidentiality Agreements; provided that the Company shall promptly provide to Parent any non-public information concerning the Company or any of its Subsidiaries that is provided to any Person given such access which was not previously provided to Parent or its Representatives substantially concurrently with the time it is provided to such Person; and (ii)
enter into, engage in and maintain discussions or negotiations with any Persons or groups of Persons with respect to Takeover Proposals (or inquiries, proposals or offers or other efforts or attempts that may reasonably be expected to lead to a Takeover Proposal) and otherwise cooperate with or assist or participate in, or facilitate, any such inquiries, proposals, offers, efforts, attempts, discussions or negotiations; provided, further, that the Company may extend the Go-Shop Period with respect to one or more Excluded Parties by written notice to Parent for a period of time not to exceed 10 calendar days (the “Go-Shop Extension”) in order to continue to engage in the activities described in this Section 5.02(a) solely with such Excluded Parties solely during the period of such Go-Shop Extension.
(b)Except (x) as expressly permitted by this Section 5.02 or (y) as expressly permitted with respect to an Excluded Party (for as long as such Person or group of Persons is an Excluded Party) until the expiration of the Go-Shop Extension (if any) but subject to Section 5.02(e), the Company shall and shall cause each of its Subsidiaries and its and their respective employees, officers and directors to, and shall instruct and use its reasonable best efforts to cause its other Representatives retained by it and acting on its behalf to, (i) from one (1) minute after the termination of the Go-Shop Period (the “No-Shop Period Start Date”), immediately cease and cause to be terminated any solicitation, discussions or negotiations (including promptly terminating each Person’s and its Representatives’ access to any physical or electronic data room and promptly requesting the return or destruction of all such non-public information of the Company or any of its Subsidiaries) that may be ongoing with respect to, or which would reasonably be expected to lead to, a Takeover Proposal, and (ii) from the No-Shop Period Start Date until the Effective Time or, if earlier, the termination of this Agreement in accordance with Article VII, not, directly or indirectly, (A) initiate, solicit, cause or knowingly encourage or facilitate (including by way of furnishing non-public information) the submission of any inquiries regarding, or the making of any proposal or offer that constitutes, or would reasonably be expected to lead to, a Takeover Proposal, (B) enter into, engage in, continue or otherwise participate in any discussions or negotiations regarding (except to notify any Person of the provisions of this Section 5.02) a Takeover Proposal or any inquiry or proposal that would reasonably be expected to lead to a Takeover Proposal, (C) furnish to any other Person any non-public information or afford any Person with access to the business, employees, officers, Contracts, properties, assets or books and records of the Company or its Subsidiaries, in each case in connection with, or for the purpose of, knowingly encouraging or facilitating, a Takeover Proposal or any inquiry or proposal that would reasonably be expected to lead to a Takeover Proposal, (D) enter into any letter of intent, memorandum of understanding, agreement in principle, merger agreement, acquisition agreement or other similar agreement or Contract (1) providing for or relating to a Takeover Proposal or (2) requiring the Company to abandon, terminate or fail to consummate the Transactions or breach this Agreement, (E) approve, endorse or recommend any Takeover Proposal or submit a Takeover Proposal or any matter related thereto for the approval of the Company stockholders or (F) authorize or commit to do any of the foregoing. No later than two Business Days after the No-Shop Period Start Date, the Company shall notify Parent in writing of the identity of each Excluded Party and provide to Parent the material terms and conditions of such Takeover Proposal, inquiry, request, proposal or offer and a copy of any written Takeover Proposal received therefrom. Notwithstanding the commencement of the obligations of the Company under this Section 5.02(b) on the No-Shop Period Start Date, the parties hereto agree that the Company and its Subsidiaries and their respective Representatives may continue to engage in the activities described in clauses (i)
and (ii) of Section 5.02(a) with respect to each Excluded Party (solely for as long as any such Person or group of Persons is an Excluded Party) on and after the No-Shop Period Start Date until the expiration of the Go-Shop Extension (if any), including with respect to any amended or revised proposal submitted by such Excluded Party on or after the No-Shop Period Start Date and prior to the expiration of the Go-Shop Extension.
(c)Notwithstanding anything contained in Section 5.02(b) or any other provision of this Agreement to the contrary (and without limiting the Company’s rights hereunder with respect to any Excluded Party until the expiration of the Go-Shop Extension, if any), if at any time on or after the No-Shop Period Start Date and prior to obtaining the Company Stockholder Approval, the Company or any of its Representatives receives a Takeover Proposal, which Takeover Proposal did not result from any material breach of this Section 5.02, (i) the Company and its Representatives may contact and engage in discussions with such Person or group of Persons making such Takeover Proposal or its or their Representatives and financing sources solely to clarify the terms and conditions thereof or to request that any Takeover Proposal made orally be made in writing or to notify such Person or group of Persons or its or their Representatives and financing sources of the provisions of this Section 5.02 and (ii) if the Board of Directors of the Company or any duly authorized committee thereof determines in good faith, after consultation with its financial advisors and outside legal counsel, that (A) such Takeover Proposal constitutes or would reasonably be expected to result in a Superior Proposal and (B) the failure to take such action would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable Law, then the Company and any of its Representatives may (x) enter into an Acceptable Confidentiality Agreement with such Person or group of Persons making such Takeover Proposal and furnish, pursuant to an Acceptable Confidentiality Agreement, information (including non-public information) with respect to the Company and its Subsidiaries to such Person or group of Persons who has made such Takeover Proposal and its or their respective Representatives and financing sources; provided that the Company shall provide to Parent any non-public information concerning the Company or any of its Subsidiaries that is provided to any Person given such access which was not previously provided to Parent or its Representatives prior to, or substantially concurrently with, the time it is provided to such Person, and (y) subject to the execution of an Acceptable Confidentiality Agreement and compliance with this Section 5.02, engage in or otherwise participate in discussions or negotiations with such Person or group of Persons and its or their Representatives and financing sources. The parties hereto acknowledge and agree that any confidential contacts, disclosures, discussions or negotiations permitted under this Section 5.02(c) without violation of this Section 5.02, shall not, in and of itself, constitute an Adverse Recommendation Change or otherwise constitute a basis for Parent to terminate this Agreement pursuant to Section 7.01(c)(ii).
(d)Except as may relate to any Excluded Party (for as long as such Person or group of Persons is an Excluded Party) until the expiration of the Go-Shop Extension (if any), but subject to Section 5.02(e), following the No-Shop Period Start Date and prior to the Company Stockholder Approval, the Company shall promptly (and in any event within 24 hours) notify Parent in writing in the event that the Company or any of its Subsidiaries or its or their Representatives receives a Takeover Proposal and shall disclose to Parent the material terms and conditions of any such Takeover Proposal and the identity of the Person or group of Persons making such Takeover Proposal, and the Company shall, upon the request of Parent, keep Parent reasonably informed of any material developments with respect to any such Takeover Proposal
(including any material changes thereto), on a prompt basis (and in any event within 24 hours), including by providing Parent with any material documents or correspondence that identify or set forth any additional material terms or conditions thereof. For the avoidance of doubt, all information provided to Parent pursuant to this Section 5.02(d) will be subject to the terms of the Nondisclosure Agreement.
(e)None of the Board of Directors of the Company or any duly authorized committee thereof shall (i) (A) fail to include the Company Board Recommendation in the Proxy Statement, (B) withdraw, withhold (or modify or qualify in a manner adverse to Parent), or publicly propose to withdraw, withhold (or modify or qualify in a manner adverse to Parent) or make other public statements inconsistent with, the Company Board Recommendation, (C) recommend the approval or adoption of, or approve or adopt, or publicly propose to recommend, approve or adopt, or publicly declare advisable, any Takeover Proposal, (D) fail to publicly reaffirm the Company Board Recommendation within ten Business Days following written request therefor from Parent or (E) commit, agree or resolve to take any action set forth in the foregoing clauses (A) through (D), it being understood that the Board of Directors of the Company, or any duly authorized committee thereof may, and may cause the Company to (x) make a customary “stop, look and listen” communication or (y) elect to take no position with respect to a Takeover Proposal until the close of business on the tenth Business Day after the commencement of such Takeover Proposal pursuant to Rule 14e-2, Rule 14d-9 or Item 1012(a) of Regulation M-A; provided, however, that (1) neither the Board of Directors of the Company nor any duly authorized committee thereof, shall, except as expressly permitted by, and pursuant to, this Section 5.02(e), effect an Adverse Recommendation Change, including in any disclosure document or communication filed, publicly issued or made in connection with compliance with such requirements and (2) any such disclosure shall be deemed to be an Adverse Recommendation Change unless such disclosure expressly states that the Board of Directors of the Company expressly reaffirms the Company Board Recommendation or states that the Company Board Recommendation has not been changed (each action described in this clause (i), other than the actions set forth in the foregoing clauses (x) and (y), being referred to as an “Adverse Recommendation Change”), or (ii) execute or enter into (or cause or permit the Company or any of its Subsidiaries to execute or enter into) any Contract, letter of intent, memorandum of understanding, agreement in principle, merger agreement, acquisition agreement or other similar agreement providing for a Takeover Proposal, other than any Acceptable Confidentiality Agreement (each, a “Company Acquisition Agreement”). Notwithstanding the foregoing or any other provision of this Agreement to the contrary, prior to obtaining the Company Stockholder Approval, but not after, the Board of Directors of the Company or any duly authorized committee thereof may, solely in accordance with this Section 5.02(e), (I) make an Adverse Recommendation Change in response to an Intervening Event or (II) solely in response to a Takeover Proposal that did not result from a breach of this Section 5.02, either or both (A) make an Adverse Recommendation Change or (B) cause the Company to enter into a Company Acquisition Agreement with respect to a Takeover Proposal and terminate this Agreement pursuant to Section 7.01(d)(ii), only if the Board of Directors of the Company or any duly authorized committee thereof has determined in good faith, after consultation with its financial advisors and outside legal counsel, that (x) in the case of clause (I) where the failure to take such action would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable Law (after taking into account all revisions to the terms of this Agreement committed to by Parent in writing), and (y) in the case of clause (II) (1) such
Takeover Proposal constitutes a Superior Proposal and (2) failure to take such action in response to such Takeover Proposal (as applicable) would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable Law (after taking into account all revisions to the terms of this Agreement committed to by Parent in writing); provided, however, that the Board of Directors of the Company or any duly authorized committee thereof shall not, and shall cause the Company not to, take any action set forth in clause (I) or (II), including in the event such action is proposed to be taken in connection with a Superior Proposal, unless (1) the Company has given Parent at least three Business Days’ prior written notice (the “Notice Period”) of its intention to take such action (which notice shall, in the case of clause (I), specify in reasonable detail the Intervening Event and the reasons that the Board of Directors of the Company or any duly authorized committee thereof is proposing to effect an Adverse Recommendation Change, and in the case of clause (II), (x) specify the identity of the party making such Superior Proposal and the material terms and conditions thereof and (y) provide a copy of the most current version of the proposed agreement under which such Superior Proposal is to be consummated), (2) the Company has negotiated, and has caused its Representatives to negotiate, in good faith with Parent during the Notice Period, to the extent Parent wishes to negotiate, to enable Parent to commit in writing to effect revisions to the terms of this Agreement, the Commitment Letters or the Guarantee, in the case of clause (II), that it would cause such Takeover Proposal to no longer constitute a Superior Proposal or in the case of clause (I), as would permit the Board of Directors of the Company or any duly authorized committee thereof to determine it would not reasonably be expected to be required by their fiduciary duties to effect an Adverse Recommendation Change, and (3) following the end of such Notice Period, the Board of Directors of the Company or any duly authorized committee thereof shall have considered in good faith such written commitment to effect revisions, and shall, after consultation with its financial advisors and outside legal counsel, have determined, in the case of clause (II), that such Takeover Proposal would continue to constitute a Superior Proposal and, in the case of clauses (I) and (II), that the failure to make an Adverse Recommendation Change or terminate this Agreement, as applicable, would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable Law, in each case, if the revisions to which Parent has committed in writing were to be given effect (it being understood and agreed that (x) in the case of clause (II) any change to pricing or any other material amendment or revision to the terms of such Takeover Proposal that was previously the subject of a notice hereunder (after having been determined by the Board of Directors of the Company or any duly authorized committee thereof to no longer constitute a Superior Proposal) and (y) in the case of clause (I), any material change regarding any Intervening Event shall, in each case, require the Company to deliver a new notice as provided above and provide a new notice period, except that such new notice period in connection with any such amendment or revision shall be for two Business Days rather than three Business Days); and provided, further, that any purported termination of this Agreement pursuant to this sentence shall be void and of no force and effect unless the termination is in accordance with Section 7.01 and, to the extent required under the terms of this Agreement, the Company pays or causes to be paid to Parent (or Parent’s designee) the Company Termination Fee in accordance with Section 7.03 (to the extent due and payable thereunder) prior to or concurrently with such termination so long as the Company has requested, and Parent has timely provided the Company with, wire instructions for such payment.
(f)Nothing in this Section 5.02 or elsewhere in this Agreement shall prohibit the Company or the Board of Directors of the Company or any duly authorized committee thereof
from (i) taking and disclosing to the stockholders of the Company a position contemplated by Rule 14e-2(a), Rule 14d-9 or Item 1012(a) of Regulation M-A promulgated under the Exchange Act or (ii) making any customary “stop, look and listen” communication to the stockholders of the Company that is required by applicable Law; provided, that (x) nothing in this Section 5.02(f) shall permit the Board of Directors of the Company to make an Adverse Recommendation Change except to the extent expressly permitted by, and in accordance with, Section 5.02(e), (y) if any disclosure in accordance with this Section 5.02(f) has the effect of an Adverse Recommendation Change (it being understood that neither the Board of Directors of the Company nor any duly authorized committee thereof, shall, except as expressly permitted by, and pursuant to, Section 5.02(e), effect an Adverse Recommendation Change, including in any disclosure document or communication filed, publicly issued or made in connection with compliance with such requirements), Parent shall have the right to terminate this Agreement to the extent set forth in Section 7.01(c)(ii)(A) and (z) any disclosure in accordance with this Section 5.02(f) shall be deemed to be an Adverse Recommendation Change unless such disclosure expressly states that the Board of Directors of the Company expressly reaffirms the Company Board Recommendation or states that the Company Board Recommendation has not been changed.
(g)As used in this Agreement, “Acceptable Confidentiality Agreement” means (x) any confidentiality agreement entered into by the Company from and after the date of this Agreement that (i) contains confidentiality provisions that are not materially less favorable in the aggregate to the Company than those contained in the Nondisclosure Agreement, except that such confidentiality agreement need not include explicit or implicit standstill provisions or otherwise restrict the making of or amendment or modification to Takeover Proposals and (ii) shall not prohibit the Company from complying with this Section 5.02 or contain terms that would restrict in any manner the Company’s ability to consummate the Merger, or (y) any confidentiality agreement entered into prior to the date of this Agreement; provided, that, (A) in the case of clause (x), any such confidentiality agreements may not contain any provision requiring the Company or any of its Subsidiaries to pay or reimburse the counterparty’s expenses and (B) in each case, any such confidentiality agreement may not contain any provision that would prevent the Company from complying with its obligations pursuant to this Section 5.02. Notwithstanding the foregoing, the Company, in its sole discretion, shall be entitled to waive or release any preexisting explicit or implicit standstill provisions or similar agreements with any Person or group of Persons only if (i) the Board of Directors of the Company, after consultation with its outside legal counsel, has determined that the failure to so waive or release such standstill would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable Law and (ii) the Company notifies Parent prior to granting such waiver or release and provides the identity of the counterparty to whom it intends to grant such waiver or release.
(h)As used in this Agreement, “Takeover Proposal” shall mean any inquiry, proposal or offer from any Person or group of Persons (other than Parent and its Subsidiaries) relating to, in a single transaction or series of related transactions, any direct or indirect (including through any derivative, hedging or option transactions) (i) acquisition of 20% or more of the consolidated assets of the Company and its Subsidiaries (based on the fair market value thereof, as determined in good faith by the Board of Directors of the Company or any duly authorized committee thereof), including through the acquisition of one or more Subsidiaries of
the Company owning such assets, (ii) acquisition of securities representing 20% or more of the voting power of the then outstanding Company Common Stock, (iii) tender offer or exchange offer that if consummated would result in any Person or group of Persons beneficially owning securities representing 20% or more of the voting power of the then outstanding Company Common Stock, (iv) merger, consolidation, share exchange, business combination, recapitalization, liquidation, dissolution, spin-off or joint venture or similar transaction involving the Company pursuant to which such Person or group of Persons (or the stockholders of any Person) would acquire, directly or indirectly, 20% or more of the consolidated assets of the Company and its Subsidiaries (based on the fair market value thereof, as determined in good faith by the Board of Directors of the Company or any duly authorized committee thereof) or securities representing 20% or more of the aggregate voting power of the Company’s then outstanding securities or of the surviving entity in a merger, consolidation, share exchange or other business combination involving the Company or the resulting direct or indirect parent of the Company or such surviving entity or (v) any public announcement of a proposal or plan or intention to do any of the foregoing or any agreement, in each case, other than the Merger; provided, however, that this Agreement and the Merger shall not be deemed a Takeover Proposal.
(i)As used in this Agreement, “Superior Proposal” shall mean any bona fide written Takeover Proposal made after the date of this Agreement by a third party and that did not result from a breach of, and was not solicited in violation of, this Section 5.02 and that the Board of Directors of the Company or any duly authorized committee thereof has determined in its good faith judgment, after consultation with its financial advisors and outside legal counsel has terms and conditions that, (i) would be more favorable to the Company’s stockholders than the Merger from a financial point of view (after taking into account any revisions to the terms of this Agreement and the Merger committed to by Parent in writing) and (ii) is reasonably capable of being completed on the terms set forth in such Takeover Proposal, taking into account (a) the identity of the Person or group of Persons making such Takeover Proposal and (b) all legal, regulatory, financial, financing and other aspects of such proposal (including the financing arrangements, the form of consideration and the timing of and conditions to consummating such transaction) and of this Agreement; provided that for purposes of the definition of “Superior Proposal”, the references to “20%” in the definition of Takeover Proposal shall be deemed to be references to “50%”.
(j)The Company agrees that any violation of the restrictions set forth in this Section 5.02 by any Representative of the Company or any of its Subsidiaries acting on behalf of the Company or its Subsidiaries shall be deemed to be a breach of this Agreement by the Company.
SECTION 5.03.Efforts. (a) Subject to the terms and conditions of this Agreement, each of the parties hereto shall cooperate with the other parties and use (and shall cause their respective controlled Affiliates their respective reasonable best efforts (unless, with respect to any action, another standard of performance is expressly provided for herein) to (i) take, or cause to be taken, all actions, and do, or cause to be done, and assist and cooperate with the other parties hereto in doing, all things necessary, proper or advisable to cause the conditions to Closing to be satisfied and to consummate and make effective, prior to the Outside Date, the Transactions, including preparing and filing all documentation to effect all necessary,
proper and advisable filings, notices, petitions, statements, registrations, declarations, submissions of information, applications, reports and other documents, (ii) obtain all approvals, consents, registrations, waivers, permits, authorizations, exemptions, clearances, orders and other confirmations from any Governmental Authority or third party reasonably necessary, proper or advisable to consummate the Transactions (each, a “Consent”), (iii) execute and deliver any additional instruments reasonably necessary to consummate the Transactions and (iv) defend or contest in good faith any Action brought by any Person (including any Governmental Authority) or any Judgment that could otherwise prevent or impede, interfere with, hinder or delay in any material respect the consummation of the Transactions. Notwithstanding anything to the contrary contained in this Agreement, neither the Company nor any of its Subsidiaries or Affiliates (nor Parent nor any of its Affiliates) will be required to (and without the prior written consent of Parent, the Company or any of its Subsidiaries may not) grant or offer to grant any accommodation or concession (financial or otherwise), or make any payment, to any third party in connection with seeking or obtaining its Consent.
(b)In furtherance and not in limitation of the foregoing, the Company and Parent shall each use (and shall cause their respective controlled Affiliates to use) reasonable best efforts to (i) take all action necessary to ensure that no Takeover Law is or becomes applicable to any of the Transactions and refrain from taking any actions that would cause the applicability of such Laws and (ii) if the restrictions of any Takeover Law become applicable to any of the Transactions, take all action necessary to ensure that the Transactions may be consummated prior to the Outside Date on the terms contemplated by this Agreement and otherwise lawfully minimize the effect of such Takeover Law on the Transactions.
(c)Parent shall (i) control, lead and direct all actions, decisions and the timing and strategy for, and make all final determinations as to the timing and appropriate course of action with respect to making and obtaining any approvals, consents, registrations, waivers, permits, authorizations, exemptions, clearances, orders and other confirmations from any Governmental Authority in connection with the Transactions and (ii) control, direct, lead and coordinate the overall development and strategy of the positions to be taken and the actions and positions to be requested or taken in any filing or submission with any Governmental Authority in connection with the Transactions and in connection with any investigation, Action, or other inquiry or litigation by or before, or any negotiations with, any Governmental Authority relating to the Transactions and of all other regulatory matters incidental thereto; provided that Parent shall consult in good faith with the Company and its Representatives and consider in good faith the Company’s perspective and input in respect of any of the foregoing.
(d)In furtherance and not in limitation of the foregoing, each of the parties hereto agrees to make (and cause their respective Affiliates to make) an appropriate filing of a Notification and Report Form pursuant to the HSR Act with respect to the Transactions as promptly as reasonably practicable following the date of this Agreement (and in any event within ten Business Days following the date of this Agreement). Each of the Company, Parent and Merger Sub shall use its reasonable best efforts to supply (and cause their respective Affiliates to supply) any additional information and documentary material that may be reasonably requested by the relevant Governmental Authority with respect to the foregoing filings, notices, applications and notifications following submission thereof (subject, for the avoidance of doubt, to applicable confidentiality obligations). Parent will pay, or cause to be paid, all filing fees
payable to the Governmental Authority in connection with the filing of a Notification and Report Form pursuant to the HSR Act required pursuant to this Section 5.03(d).
(e)Subject to the other terms and conditions of this Section 5.03, including Section 5.03(g), Parent shall take (and shall cause its controlled Affiliates and the Subsidiaries of Thrive Holdings to take) all actions necessary to secure the expiration or termination of any applicable waiting period under the HSR Act and resolve any objections asserted with respect to, and avoid and eliminate each and every impediment to the consummation of, the Transactions prior to the Outside Date under any applicable Law raised by any Governmental Authority, in order to (I) prevent the entry of, or to have vacated, lifted, reversed or overturned, any Restraint that would prevent, prohibit, restrict or delay the consummation of the Transactions; and (II) obtain all approvals, consents, registrations, waivers, permits, authorizations, exemptions, clearances, orders and other confirmations from any Governmental Authority necessary to consummate the Transactions, including, in each case, (A) executing settlements, national security agreements, undertakings, consent decrees, stipulations or other agreements with any Governmental Authority or with any other Person, (B) agreeing to sell, divest or otherwise convey or hold separate any particular assets or categories of assets or businesses of the Company and its Subsidiaries contemporaneously with or subsequent to the Effective Time, (C) terminating existing relationships, contractual rights or obligations of the Company or its Subsidiaries, or any controlled Affiliate of the Company or any of its Affiliates, (D) creating any relationship, contractual right or obligation of the Company or its Subsidiaries, (E) effectuating any other change or restructuring of the Company or any of its Affiliates, in each case, by entering into agreements or stipulating to the entry of any Judgment by, or filing appropriate applications with, the Federal Trade Commission (the “FTC”), the Antitrust Division of the Department of Justice (the “DOJ”) or any other Governmental Authority, in connection with any of the foregoing and, in the case of actions by or with respect to the Company, by consenting to such action by the Company (including any consents required under this Agreement with respect to such action) and (F) defending through litigation any claim asserted in court or administrative or other tribunal by any Person (including any Governmental Authority) in order to avoid the entry of, or to have vacated or terminated, any Restraint, whether temporary, preliminary or permanent, that would prevent the Closing (each of such actions, including the actions set forth in clauses (A)–(F), a “Remedial Action”); provided that any such Remedial Actions shall, for the avoidance of doubt, be subject to the requirements and limitations contemplated by Sections 5.03(c) and 5.03(g); provided, further, that Parent shall consult in good faith with the Company and its Representatives and consider in good faith the Company’s perspective and input with respect to any such Remedial Action. Subject to its obligations under Section 5.03(f) and the other conditions and limitations set forth in this Section 5.03 (including Section 5.03(c) and Section 5.03(g)), Parent shall respond to and seek to resolve any objections asserted by any Governmental Authority with respect to the Transactions. Each of the Company, Parent and Merger Sub shall not take (and each of the Company and Parent shall cause their respective controlled Affiliates (and, in the case of Parent, Thrive Holdings and its Subsidiaries)) not to take any action or enter into any transaction acquiring or merging with any business, Person or division thereof, or entering into a definitive agreement with respect thereto with the intention to, or that would reasonably be expected to: (1) materially delay the expiration or termination of any waiting period under the HSR Act or the obtaining of approval of the DOJ or FTC as necessary; (2) materially increase the risk of any Governmental Authority entering an order or otherwise seeking to enjoin or prohibit the consummation of the Transactions contemplated by this
Agreement or (3) otherwise materially delay the consummation of the Transactions contemplated by this Agreement. Nothing in this Agreement shall require any party hereto to take or agree to take any action with respect to its business or operations unless the effectiveness of such agreement or action is conditioned upon the Closing. Neither Parent nor the Company shall commit (and shall cause their respective Affiliates not to commit) to or agree with any Governmental Authority to stay, toll or extend any applicable waiting period under the HSR Act or enter into a timing agreement, understanding or commitment with any Governmental Authority in connection with the foregoing, without the prior written consent of the other party (such consent not to be unreasonably withheld, delayed or conditioned).
(f)In furtherance and not in limitation of the foregoing, but in any event subject to the limitations set forth in Sections 5.03(c), (e) and (g), each of the parties hereto shall use (and shall cause their respective controlled Affiliates (and, in the case of Parent, Thrive Holdings and its Subsidiaries) to use) reasonable best efforts to (i) cooperate in all respects with each other in connection with any necessary, proper or advisable submissions, consents, approvals, filings, petitions, statements, licenses, permits, authorizations, declarations, notifications, registrations, submissions of information, applications, reports, waivers, exemptions, clearances, orders, confirmations and other documents with the FTC, DOJ, or any other Governmental Authority in connection with the Transactions and in connection with any investigation or other inquiry by or before the FTC, DOJ, or any other Governmental Authority relating to the Transactions or any proceeding initiated by a private Person, (ii) keep the other parties hereto informed in all material respects and on a reasonably timely basis of any material written or verbal communication received by such party from, or given by such party to, the FTC, DOJ, or any other Governmental Authority (including by promptly sending the other parties hereto a copy of all documents, information, correspondence or other communications) and of any material written or verbal communication received or given in connection with any proceeding by a private Person, in each case regarding any of the Transactions, (iii) subject to applicable Laws and the Nondisclosure Agreement relating to the exchange of information, and to the extent reasonably practicable, consult with the other parties hereto with respect to information relating to the other parties hereto and their respective Subsidiaries, as the case may be, that appears in any filing made with, or written materials submitted to, any third Person or the FTC, DOJ or any other Governmental Authority in connection with the Transactions, other than “4(c) documents” as that term is used in the rules and regulations under the HSR Act, (iv) to the extent permitted by the FTC, DOJ or such other applicable Governmental Authority or other Person, give the other parties hereto the opportunity to attend and participate in any meetings or conferences (whether in person, by telephone or otherwise) in connection with the Transactions, and (v) obtain prior to the Outside Date all consents, registrations, waivers, exemptions, approvals, confirmations, clearances, permits, certificates, orders, and authorizations necessary, proper or advisable to be obtained from, or renewed with, the FTC, DOJ, and any other Governmental Authority; provided that materials furnished pursuant to this Section 5.03(f) may be redacted (A) as necessary to address reasonable attorney-client or other privilege concerns, (B) to remove references concerning the valuation of the Company, (C) as necessary to avoid disclosure of competitively sensitive information or (D) as necessary to comply with contractual arrangements or applicable Law. Prior to submitting any document or any information relating to the Transactions or the parties hereto (whether formally or informally, in draft form or final form) to the FTC, DOJ, or any other Governmental Authority, a party shall send the other parties such document or information reasonably in advance of such submission and such document or information shall
not be submitted to the FTC, DOJ, or any other Governmental Authority without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed).
(g)Notwithstanding the foregoing and notwithstanding anything to the contrary elsewhere in this Agreement, (i) Thrive Holdings, Parent, Merger Sub and their respective Subsidiaries and Affiliates shall not be obligated to take or agree to take any, or refrain from taking, any actions (including offering, accepting, consenting to or agreeing to, or committing to offer, accept, consent to or agree to any Remedial Action), including in connection with obtaining any Consent or otherwise pursuant to this Section 5.03 (x) that would (or would reasonably be expected to) impose a Burdensome Condition or (y) involving any businesses, assets, equity interests or properties of Thrive Holdings, Parent or their respective Subsidiaries or Affiliates (other than, for the avoidance of doubt, the Company and its Subsidiaries following the consummation of the transactions contemplated herein subject to the limitations set forth herein), (ii) the Company and its Subsidiaries and Affiliates shall not be obligated to take or agree to take any, or refrain from taking, any actions (including offering, accepting, consenting to or agreeing to, or committing to offer, accept, consent to or agree to any Remedial Action), including in connection with obtaining any Consent or otherwise pursuant to this Section 5.03 that is not conditioned upon, and not effective until, Closing and (iii) in no event shall the Company or any of its Subsidiaries, without the prior written consent of Parent, take or offer or agree to take any, or refrain from taking, any actions (including offering, accepting, consenting to or agreeing to, or committing to offer, accept, consent to or agree to), including in connection with obtaining any Consent or otherwise pursuant to this Section 5.03, any Remedial Action or other action that would (or would reasonably be expected to) impose a Burdensome Condition. Notwithstanding the foregoing, at the written request of Parent, the Company and its Affiliates shall agree to a Remedial Action, so long as such Remedial Action is conditioned upon and will not be effective until Closing.
SECTION 5.04.Public Announcements. Unless and until an Adverse Recommendation Change has occurred, Parent and the Company shall consult (and shall cause their respective Affiliates to consult) with each other before issuing, and give each other the opportunity to review and comment upon (which comments each party shall take into account in good faith), any press release or other public statements with respect to the Transactions, and shall not (and shall cause their respective Affiliates not to) issue any such press release or make any such public statement prior to such consultation, except as may be required by applicable Law, Judgment, court process or the rules and regulations of any national securities exchange or national securities quotation system and except for any matters referred to in Section 5.02. The parties hereto agree that the initial press release to be issued with respect to the Transactions following execution of this Agreement shall be in the form heretofore agreed to by the parties hereto (the “Announcement”). Notwithstanding the foregoing, this Section 5.04 shall not apply to any press release or other public statement made by the Company or Parent (a) (i) in connection with any Takeover Proposal, Superior Proposal or Adverse Recommendation Change or (ii) in connection with, and to the extent relating to, a dispute between the parties regarding the Agreement, (b) which is consistent with the Announcement and the terms of this Agreement and does not contain any information relating to the Company or Parent, as applicable, that has not been previously announced or made public in accordance with the terms of this Agreement or (c) which is made in the ordinary course of business and does not relate specifically to the
signing of this Agreement or the Transactions. Notwithstanding the foregoing or anything to the contrary herein or in the Nondisclosure Agreement, Parent and its Affiliates may provide information regarding the Company and its Subsidiaries, this Agreement and the Transactions to their respective existing or prospective limited partners, equity holders, members, managers and other investors including any Preferred Financing Sources or Debt Financing Sources or prospective Preferred Financing Sources or Debt Financing Sources and other financial institutions and investors that are or may become parties to the Financing and to any underwriters, initial purchasers or placement agents in connection with the Debt Financing or any equity financing in connection with the Transactions (and, in each case, to their respective counsel, advisors and auditors) so long as (i) such information is shared on a confidential basis, (ii) such Persons (x) agree to be bound by confidentiality provisions substantially similar to those in the Nondisclosure Agreement as if parties thereto, or (y) are subject to other confidentiality undertakings reasonably satisfactory to the Company and of which the Company is a beneficiary, and (iii) such information is shared in the ordinary course of business.
SECTION 5.05.Access to Information; Confidentiality. Subject to applicable Law and any applicable Judgment, between the date of this Agreement and the earlier of the Effective Time and the termination of this Agreement pursuant to Section 7.01, upon reasonable notice and solely for the purposes of facilitating the consummation of the Transactions and integration planning with respect thereto, the Company shall, in each case, in connection with the consummation of the Transactions (a) afford to Parent and Parent’s Representatives reasonable access during normal business hours to the Company’s and its Subsidiaries’ officers, employees, agents, facilities, properties, books, Contracts and records and (b) furnish promptly to Parent and Parent’s Representatives such information concerning its and its Subsidiaries’ business, personnel, assets, liabilities and properties as Parent may reasonably request (in the case of the previous clauses (a) and (b), other than any information that the Company determines in its reasonable judgment is in respect of the negotiation and execution of this Agreement, or, except as expressly provided in Section 5.02, to any Takeover Proposal or any other transactions potentially competing with or alternative to the Transactions or proposals from other parties relating to any competing or alternative transactions or relating to any deliberation of the Board of Directors of the Company or any duly authorized committee thereof regarding any Takeover Proposal or Adverse Recommendation Change); provided that Parent and its Representatives shall conduct any such activities in such a manner as not to interfere unreasonably with the business or operations of the Company and its Subsidiaries; provided, however, that the Company shall not be obligated to provide such access or information if the Company determines, in its reasonable judgment, after consultation with counsel, that doing so would reasonably be expected to (i) violate or materially prejudice the rights of its or any of its Subsidiaries’ customers, (ii) result in the disclosure of Trade Secrets or competitively sensitive information to third parties, (iii) violate (A) applicable Law or an applicable Judgment or (B) an obligation of confidentiality owing to a third party under a Contract in effect prior to the date hereof, (iv) result in the loss or waiver of protection of an attorney-client privilege, attorney work product protection or other legal privilege, (v) be materially adverse to the interests of the Company or any of its Subsidiaries in any pending or threatened Action, (vi) expose the Company to risk of material liability for disclosure of sensitive or personal information or (vii) involve any environmental or other sampling or testing (provided that, in the cases of clauses (i)–(vii), the Company shall, to the extent practicable, inform Parent as to the general nature of the access or information being restricted as a result thereof and use commercially
reasonable efforts to provide such information (or portions thereof) in a way that would avoid the consequences described in the foregoing). Until the Effective Time, all information provided will be subject to the terms of the agreement set forth on Schedule 5.05 of the Company Disclosure Letter (the “Nondisclosure Agreement”). Nothing in this Section 5.05 or elsewhere in this Agreement shall be construed to require the Company or any of its Representatives to prepare any reports, analyses, appraisals or opinions that are outside the ordinary course of business and otherwise would be unduly burdensome to prepare (it being understood that the Company shall not be required to prepare any financial projections, forecasts or any other prospective or pro forma financial information).
SECTION 5.06.Indemnification and Insurance. (a) From and after the Effective Time, each of Parent and the Surviving Corporation shall, and Parent shall cause the Surviving Corporation to, in each case to the fullest extent permitted by applicable Law, (i) indemnify and hold harmless each current or former director or officer of the Company or its Subsidiaries and each other Person who at the Effective Time is, or at any time prior to the Effective Time was, indemnified or entitled to be indemnified by the Company or its Subsidiaries pursuant to the Company Charter Documents and the organizational documents of such Subsidiaries as in effect on the date of this Agreement or in any other agreement in existence as of the date of this Agreement providing for indemnification or advancement of expenses between the Company or any of its Subsidiaries and such Person (each, an “Indemnitee”) with respect to all claims, liabilities, losses, damages, judgments, fines, penalties, costs (including amounts paid in settlement or compromise) and expenses (including fees and expenses of legal counsel) in connection with any Action (whether civil, criminal, administrative or investigative), whenever asserted, based on or arising out of, in whole or in part, (A) the fact that an Indemnitee is or was a member, director, manager, officer, employee or agent of the Company or such Subsidiary or (B) acts or omissions by an Indemnitee in the Indemnitee’s capacity as a member, director, manager, officer, employee or agent of the Company or such Subsidiary or taken at the request of the Company or such Subsidiary (including in connection with serving at the request of the Company or such Subsidiary as a representative of another Person (including any employee benefit plan)), in each case under clause (A) or (B), at, or at any time prior to, the Effective Time (including any Action relating in whole or in part to the Transactions or relating to the enforcement of this provision or any other indemnification or expense advancement right of any Indemnitee) and (ii) assume (in the case of the Surviving Corporation, in the Merger without any further action) all obligations of the Company and such Subsidiaries to the Indemnitees in respect of indemnification, advancement of expenses and exculpation from liabilities for acts or omissions occurring at or prior to the Effective Time as provided in the Company Charter Documents and the organizational documents of such Subsidiaries as in effect on the date of this Agreement or in any agreement in existence as of the date of this Agreement providing for indemnification or advancement of expenses between the Company or any of its Subsidiaries and any Indemnitee.
(b)Without limiting the foregoing, from and after the Effective Time, to the fullest extent permitted by applicable Law, Parent shall cause the certificate of incorporation and bylaws of the Surviving Corporation, and the Surviving Corporation shall cause the organizational documents of its Subsidiaries, to contain provisions no less favorable to the Indemnitees with respect to limitation of liabilities, indemnification, advancement of expenses and exculpation, in each case, of members, managers, directors and officers than are set forth as
of the date of this Agreement in the Company Charter Documents and the organizational documents of such Subsidiaries as in effect on the date of this Agreement, which provisions shall not be amended, repealed or otherwise modified in a manner that would adversely affect the rights thereunder of any of the Indemnitees. In addition, from the Effective Time, Parent shall, and shall cause the Surviving Corporation to, without requiring a preliminary determination of entitlement to indemnification, advance any expenses (including fees and expenses of legal counsel) of any Indemnitee under this Section 5.06 (including in connection with enforcing the indemnity and other obligations referred to in this Section 5.06) as incurred to the fullest extent permitted under applicable Law.
(c)None of Parent, the Surviving Corporation or any of their respective Subsidiaries shall settle, compromise or consent to the entry of any judgment in any threatened or actual litigation, claim or proceeding relating to any acts or omissions covered under this Section 5.06 (each, a “Claim”) for which indemnification could be sought by an Indemnitee hereunder, unless such settlement, compromise or consent includes an unconditional release of such Indemnitee from all liability arising out of such Claim or such Indemnitee otherwise consents in writing to such settlement, compromise or consent. Each of Parent, the Surviving Corporation or any of their Subsidiaries shall cooperate in the defense of any Claim and shall provide access to properties and individuals as reasonably requested and furnish or cause to be furnished records, information and testimony, and attend such conferences, discovery proceedings, hearings, trials or appeals, as may be reasonably requested in connection therewith; provided, however, that neither Parent nor the Surviving Corporation or any of their Subsidiaries shall be required to provide such access or information if Parent or the Surviving Corporation determines, in its reasonable judgment, after consultation with counsel, that doing so would reasonably be expected to result in the loss or waiver of the protection of any attorney-client privilege of the Surviving Corporation or its Affiliates.
(d)For the six-year period commencing immediately after the Effective Time, the Surviving Corporation shall maintain in effect the Company’s current directors’ and officers’ liability insurance covering acts or omissions occurring at or prior to the Effective Time with respect to those individuals who are currently (and any additional individuals who prior to the Effective Time become) covered by the Company’s directors’ and officers’ liability insurance policies on terms and scope with respect to such coverage, and in an amount, no less favorable to such individuals than those of such policy in effect on the date of this Agreement (or Parent may substitute therefor policies, issued by reputable insurers, of at least the same coverage with respect to matters existing or occurring prior to the Effective Time, including a “tail” policy); provided, however, that the Surviving Corporation shall not be required to pay an annual premium for such insurance policy in excess of 300% of the current annual premium paid by the Company for such insurance. The Company shall have the right, prior to the Effective Time, to purchase a six-year prepaid “tail policy” on terms and conditions providing at least substantially equivalent benefits as the current policies of directors’ and officers’ liability insurance maintained by the Company and its Subsidiaries with respect to matters existing or occurring prior to the Effective Time, covering without limitation the Transactions, subject to the cap on the annual premium set forth in the preceding sentence. If such prepaid “tail policy” has been obtained by the Company, it shall be deemed to satisfy all obligations to obtain insurance pursuant to this Section 5.06(d) and the Surviving Corporation shall use reasonable best efforts
to cause such policy to be maintained in full force and effect, for its full term, and to perform all of its obligations thereunder.
(e)The provisions of this Section 5.06 are (i) intended to be for the benefit of, and shall be enforceable by, each Indemnitee, his or her heirs and his or her representatives and (ii) in addition to, and not in substitution for, any other rights to indemnification or contribution that any such Indemnitee, his or her heirs and his or her representatives may have under the Company Charter Documents, under the organizational documents of the Company’s Subsidiaries as in effect on the date of this Agreement or by contract or otherwise. The obligations of Parent and the Surviving Corporation under this Section 5.06 shall not be terminated or modified in such a manner as to adversely affect the rights of any Indemnitee to whom this Section 5.06 applies unless (x) such termination or modification is required by applicable Law or (y) the affected Indemnitee shall have consented in writing to such termination or modification (it being expressly agreed that the Indemnitees to whom this Section 5.06 applies and each Indemnitee and such Indemnitee’s representatives shall be third-party beneficiaries of this Section 5.06).
(f)In the event that (i) Parent, the Surviving Corporation or any of their respective successors or assigns (A) consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger or (B) transfers or conveys all or substantially all of its properties and assets to any Person, or (ii) Parent or any of its successors or assigns dissolves the Surviving Corporation, then, in each such case, proper provision shall be made so that the successors and assigns of Parent or the Surviving Corporation shall assume all of the obligations thereof set forth in this Section 5.06.
(g)Nothing in this Agreement is intended to, shall be construed to or shall release, waive or impair any rights to directors’ and officers’ insurance claims under any policy that is or has been in existence with respect to the Company or any of its Subsidiaries for any of their respective directors, officers or other employees, it being understood and agreed that the indemnification provided for in this Section 5.06 is not prior to or in substitution for any such claims under such policies.
(h)Parent’s and the Surviving Corporation’s obligations under this Section 5.06 shall continue in full force and effect for a period of six years from the Effective Time; provided, however, that if any Claim (whether arising before, at or after the Effective Time) is brought against an Indemnitee on or prior to the sixth anniversary of the Effective Time, the provisions of this Section 5.06 shall continue in effect until the full and final resolution of such Claim.
SECTION 5.07.Employee Matters. (a) For a period of at least 12 months following the Effective Time (such period, the “Comparability Period”), Parent shall, and shall cause the Surviving Corporation and its Subsidiaries to, provide (i) a base salary or hourly base wage rate and target annual cash bonus opportunities to each Person who is an employee of the Company or any of its Subsidiaries immediately prior to the Effective Time (each, a “Continuing Employee”) that are no less favorable, in each case, than those in effect immediately prior to the Effective Time, (ii) severance benefits to each Continuing Employee that are no less favorable than those that would have been provided to such Continuing Employee under the applicable severance benefit plans, programs, policies, agreements and arrangements as in effect
immediately prior to the Effective Time (after giving effect to any provisions relating to a “change in control”, “change of control”, or other terms of similar import) and set forth on Section 3.10(a) of the Company Disclosure Letter and (iii) employee benefits (other than base salary, wage rate, incentive, bonus, equity and long-term incentive opportunities, retention, change in control, transaction, nonqualified deferred compensation, defined benefit pension and post-retirement welfare benefits) to each Continuing Employee that are substantially comparable in the aggregate to those benefits (subject to the same exclusions) provided to such Continuing Employee immediately prior to the Effective Time.
(b)Without limiting the generality of Section 5.07(a), from and after the Effective Time, Parent shall, or shall cause the Surviving Corporation and their respective Subsidiaries to, honor in accordance with their terms all the Company Plans as in effect at the Effective Time and continue to be bound by the terms of each Collective Bargaining Agreement in effect as of immediately prior to the Effective Time. Parent and the Company hereby acknowledge that the consummation of the Transactions constitutes a “change in control”, “change of control” or other term of similar import for purposes of any Company Plan that contains a definition of “change in control”, “change of control” or other term of similar import, as applicable.
(c)With respect to all employee benefit plans of Parent, the Surviving Corporation and their respective Subsidiaries in which Continuing Employees are eligible to participate from and after the Effective Time, including any “employee benefit plan” (as defined in Section 3(3) of ERISA) (including any vacation, paid time-off and severance plans), for purposes of determining eligibility to participate, level of paid time off and severance benefits, and vesting (other than vesting of equity or equity-based compensation), each Continuing Employee’s service with the Company or any of its Subsidiaries (as well as service with any predecessor employer of the Company or any such Subsidiary, to the extent service with the predecessor employer was recognized by the Company or such Subsidiary) shall be treated as service with Parent, the Surviving Corporation or any of their respective Subsidiaries; provided, however, that such service need not be recognized with respect to any defined benefit pension plan or post-retirement welfare benefits or to the extent that such recognition would result in any duplication of benefits for the same period of service.
(d)Without limiting the generality of Section 5.07(a), Parent shall, or shall cause the Surviving Corporation and its Subsidiaries to, use commercially reasonable efforts to waive, or cause to be waived, any pre-existing condition limitations, exclusions, actively-at-work requirements and waiting periods under any welfare benefit plan maintained by Parent, the Surviving Corporation or any of their respective Subsidiaries in which Continuing Employees (and their eligible dependents) will be eligible to participate from and after the Effective Time, except to the extent that such pre-existing condition limitations, exclusions, actively-at-work requirements and waiting periods would not have been satisfied or waived under the comparable Company Plan immediately prior to the Effective Time. Parent shall, or shall cause the Surviving Corporation and its Subsidiaries to, use commercially reasonable efforts to recognize the dollar amount of all co-payments, deductibles and similar expenses incurred by each Continuing Employee (and his or her eligible dependents) during the calendar year in which the Effective Time occurs for purposes of satisfying such year’s deductible and co-payment
limitations under the relevant welfare benefit plans in which they will be eligible to participate from and after the Effective Time.
(e)The provisions of this Section 5.07 are solely for the benefit of the parties to this Agreement, and no provision of this Section 5.07 is intended to, or shall constitute the establishment or adoption of, or an amendment to, any employee benefit plan for purposes of ERISA or otherwise and, except as otherwise explicitly provided for in this Agreement, no current or former employee or any other individual associated therewith or any other Person shall be regarded for any purpose as a third-party beneficiary of this Agreement or have the right to enforce the provisions hereof.
SECTION 5.08.Notification of Certain Matters; Stockholder Litigation. The Company shall give Parent prompt written notice of, and the opportunity to participate in the defense and settlement of any stockholder litigation against the Company or the Company’s directors relating to this Agreement or the Transactions, and shall keep Parent reasonably informed with respect to the status thereof. The Company shall not settle any stockholder litigation against the Company or the Company’s directors relating to this Agreement or the Transactions without Parent’s prior written consent (such consent not to be unreasonably withheld, delayed or conditioned).
SECTION 5.09.Merger Sub. (a) From the date of this Agreement until the Effective Time, (x) Merger Sub shall not expend funds other than in connection with the Transactions and the payment of related expenses and (y) Merger Sub shall not declare, set aside, make or pay any dividend or other distribution with respect to any of its capital stock.
(b)Parent shall cause each of Merger Sub and the Surviving Corporation, as applicable, to comply with all of its respective obligations under this Agreement, and Merger Sub shall not engage in any activities of any nature except as provided in or contemplated by this Agreement.
SECTION 5.10.Parent Vote. (a) Parent shall vote or cause to be voted any shares of Company Common Stock beneficially owned by it or any of its Affiliates or with respect to which it or any of its Affiliates has the power (by agreement, proxy or otherwise) to cause to be voted, in favor of the adoption of this Agreement at any meeting of stockholders of the Company at which this Agreement shall be submitted for adoption and at all adjournments or postponements thereof.
(b)Immediately following the execution and delivery of this Agreement, Parent, in its capacity as the sole stockholder of Merger Sub, will execute and deliver to Merger Sub and the Company a written consent adopting this Agreement in accordance with the provisions of the DGCL.
SECTION 5.11.Stock Exchange De-listing. Parent shall use its reasonable best efforts to cause the shares of Company Common Stock to be de-listed from NYSE and de-registered under the Exchange Act as soon as reasonably practicable following the Effective
Time. The Company shall reasonably cooperate with Parent prior to the Effective Time in connection with such de-listing and de-registration.
SECTION 5.12.Preparation of the Proxy Statement; Stockholders’ Meeting. (a) As promptly as reasonably practicable after the execution of this Agreement and in no event later than fifteen (15) Business Days following the date of this Agreement, subject to applicable Law, the Company shall prepare the Proxy Statement in preliminary form and after consultation with, and good faith consideration of any comments made by Parent, file it with the SEC. Subject to Section 5.02, the Board of Directors of the Company shall make the Company Board Recommendation to the Company’s stockholders and shall include such recommendation in the Proxy Statement. Parent shall provide to the Company all information concerning Parent, Merger Sub and their respective Affiliates as may be reasonably requested by the Company in connection with the Proxy Statement and shall otherwise reasonably assist and cooperate with the Company in the preparation and filing of the Proxy Statement and the resolution of any comments thereto received from the SEC. The Company shall cause the Proxy Statement, at the time of mailing of the Proxy Statement or any amendments or supplements thereto, and at the time of the Company Stockholders’ Meeting, not to contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they are made, not misleading and to comply as to form in all material respects with the Exchange Act and any applicable requirements under applicable Law, except that no representation, warranty, covenant or agreement is made by the Company with respect to (i) statements made or incorporated therein relating to Parent or its Affiliates, including Merger Sub, or based on information supplied by or on behalf of Parent, Merger Sub or any Representatives thereof for inclusion or incorporation by reference in the Proxy Statement or (ii) any financial projections or forward-looking statements. Each of the Company, Parent and Merger Sub shall correct any information provided by it for use in the Proxy Statement as promptly as reasonably practicable if and to the extent such information contains any untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company shall notify Parent in writing promptly upon the receipt of any comments from the SEC and of any request by the SEC for amendments or supplements to the Proxy Statement and shall supply Parent with copies of all written correspondence between the Company or any of its Representatives, on the one hand, and the SEC, on the other hand, with respect to the Proxy Statement. The Company shall use its reasonable best efforts to respond as promptly as reasonably practicable to any comments received from the SEC concerning the Proxy Statement and to resolve such comments with the SEC, and shall use its reasonable best efforts to (A) cause the definitive Proxy Statement to be filed with the SEC and disseminated to its stockholders as promptly as reasonably practicable after the earlier of (i) the resolution of any such comments, (ii) receiving notification that the SEC is not reviewing the preliminary Proxy Statement or (iii) the first Business Day that is at least ten days after the filing of the preliminary Proxy Statement if the SEC has not informed the Company that it intends to review the Proxy Statement, (B) conduct a “broker search” in accordance with Rule 14a-13 of the Exchange Act and, in reasonable consultation with Parent, and (C) establish a record date for the Company Stockholders’ Meeting. Notwithstanding the foregoing or anything to the contrary herein, in no event shall the Company be required to file the definitive Proxy Statement with the SEC or mail or otherwise disseminate the definitive Proxy Statement to the Company’s stockholders prior to the date that is one (1) Business Day
after the No-Shop Period Start Date. Prior to any filing of the Proxy Statement (or any amendment or supplement thereto) or any dissemination thereof to the stockholders of the Company, or responding to any comments from the SEC with respect thereto, the Company shall provide Parent with a reasonable opportunity to review and to propose comments on such document or response, which the Company shall consider in good faith.
(b)Notwithstanding any Adverse Recommendation Change but subject to Section 5.12(a) and applicable Law and to the extent not prohibited by any Judgment, the Company shall take all necessary actions in accordance with applicable Law, the Company Charter Documents and the rules of NYSE to duly call, give notice of, convene and hold a meeting of its stockholders (including any adjournment, recess or postponement thereof, the “Company Stockholders’ Meeting”) for the purpose of obtaining the Company Stockholder Approval, as soon as reasonably practicable after the SEC confirms that it has no further comments on the Proxy Statement. Subject to Section 5.02, the Company shall use its reasonable best efforts to obtain the Company Stockholder Approval. Notwithstanding anything to the contrary contained in this Agreement, the Company (x) may, in its sole discretion, adjourn, recess or postpone the Company Stockholders’ Meeting and (y) shall, at the request of Parent in the case of clauses (i) and (iii) below, and on no more than one occasion, adjourn or recess the Company Stockholders’ Meeting, in each case (i) to allow reasonable additional time for the filing or mailing of any supplement or amendment to the Proxy Statement that the Company has determined is reasonably likely to be required under applicable Law and for such supplement or amendment to be disseminated and reviewed by the stockholders of the Company in advance of the Company Stockholders’ Meeting, (ii) to the extent required by a court of competent jurisdiction in connection with any proceedings in connection with this Agreement or the Transactions, (iii) if as of the time for which the Company Stockholders’ Meeting is originally scheduled (as set forth in the Proxy Statement), there are insufficient shares of Company Common Stock represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of the Company Stockholders’ Meeting or (iv) to solicit additional proxies for the purpose of obtaining the Company Stockholder Approval; provided, that in the case of clauses (i), (iii) and (iv), without the written consent of Parent (such consent not to be unreasonably withheld, delayed or conditioned), in no event shall the Company Stockholders’ Meeting (as so postponed, recessed or adjourned) be held on a date that is more than 30 days after the date on which the Company Stockholders’ Meeting was originally scheduled.
(c)Nothing in this Section 5.12 shall be deemed to prevent the Company or the Board of Directors of the Company or any duly authorized committee thereof from taking any action they are permitted or required to take under, and in compliance with, Section 5.02 or applicable Law.
SECTION 5.13.Section 16 Matters. Prior to the Effective Time, the Company shall take all actions reasonably necessary or advisable to cause the disposition of equity securities of the Company (including any derivative securities) pursuant to the Merger and the other Transactions by each individual who is an officer or director of the Company subject to
Section 16 of the Exchange Act to be exempt pursuant to Rule 16b-3 promulgated under the Exchange Act.
SECTION 5.14.Financing.
(a)Prior to the Closing Date, regardless of whether or not the Backstop Trigger Event has occurred, the Company shall use its commercially reasonable efforts to provide, and to cause its Subsidiaries and their respective Representatives to provide, to Parent and Merger Sub, in each case at Parent’s sole expense, all cooperation reasonably requested by Parent as is customary and reasonably necessary in connection with the consummation of the Debt Financing, including using commercially reasonable efforts to:
(i)execute and deliver as of (but not prior to) the Closing any pledge and security documents, other definitive financing documents, or other certificates or documents as may be reasonably requested by Parent or the Debt Financing Sources and otherwise reasonably facilitating the pledging of collateral (including the delivery of all stock or other certificates intended to constitute collateral as contemplated by the applicable Debt Commitment Letter) (it being understood that such documents and pledges will not take effect, and delivery of such stock or other certificates will not be required to be made, prior to the Effective Time);
(ii)prior to or at, and conditioned upon, the occurrence of the Closing, arrange for customary payoff letters, lien terminations and instruments of discharge providing for the payoff, discharge and termination on the Closing Date of all obligations of the Company and its Subsidiaries in respect of the Payoff Indebtedness, in accordance with Section 5.16;
(iii)provide Parent and the Debt Financing Sources, no later than three Business Days in advance of the Closing, with all documentation and other information about the Company and its Subsidiaries as is reasonably requested by Parent that is required in connection with the Debt Financing under applicable “know your customer” and anti-money laundering rules and regulations, including the USA PATRIOT Act, and a beneficial ownership certificate for any entity that qualifies as a “legal entity customer” under the Beneficial Ownership Regulation (31 C.F.R. § 1010.230), in each case to the extent requested in writing at least ten Business Days in advance of the Closing;
(iv)furnish to Parent, as promptly as reasonably practicable, the Backstop Financing Materials;
(v)cause appropriate members of senior management of the Company to participate, upon reasonable advance notice and at mutually agreed times and locations, in a reasonable number of lender meetings, rating agency presentations, “road shows” and meetings with existing or prospective lenders and assist Parent in the preparation of customary bank confidential information memoranda, offering memoranda, investor presentations, materials for rating agency presentations and lender presentations for the syndication of the Debt Financing, and in obtaining public corporate credit and corporate family ratings and public ratings of the Debt Financing; and
(vi)(x) assist in the delivery and preparation of the information described in Paragraph 10 of Exhibit D of the Backstop Commitment Letter in respect of the Existing
Receivables Facility and (y) facilitate the taking of all corporate actions, subject to and only effective upon the occurrence of the Effective Time, reasonably requested by Parent to permit the consummation of the Debt Financing and to permit the proceeds thereof to be made available to Parent (or its Subsidiaries) immediately after; provided, that no such action shall be required of the Board of Directors and/or any committee thereof, in any case, which is effective prior to the Closing.
Notwithstanding anything to the contrary herein, it is understood and agreed that the condition precedent set forth in Section 6.02(b) as applied to the Company’s obligations under this Section 5.14(a) shall be deemed satisfied unless the Debt Financing has not been obtained as a result of the Company’s knowing and intentional breach of its obligations under this Section 5.14(a) to the extent such breach is the primary cause of the unavailability of the Debt Financing.
(b)Prior to the Closing Date, and only so long as a Backstop Trigger Event shall not have occurred (and, for the avoidance of doubt, not at any time on or after the occurrence of a Backstop Trigger Event), the Company shall use its commercially reasonable efforts to provide, and to cause its Subsidiaries and their respective Representatives to provide, to Parent and Merger Sub, in each case at Parent’s sole expense, all cooperation reasonably requested by Parent as is customary and reasonably necessary in connection with the consummation of the Debt Financing pursuant to the Syndicated Commitment Letter (and, solely to the extent of the commitments under the Backstop Commitment Letter that survive in accordance with the terms thereof if a Backstop Trigger Event does not occur, the Backstop Commitment Letter), including using commercially reasonable efforts to:
(i)furnish to Parent, as promptly as reasonably practicable, the Required Financing Information (including any updates as may be necessary for such Required Financing Information to remain Compliant, meet the applicable requirements set forth in the definition of “Required Financing Information” and would not, after giving effect to such update, cause the Marketing Period to cease pursuant to the definition of “Marketing Period”);
(ii)inform Parent if the chief executive officer, chief financial officer, treasurer, controller or comparable officer of the Company shall have knowledge of any fact as a result of which a restatement of any financial statements (or portion thereof) included in the Required Financing Information is reasonably probable or required in order for such financial statements (or portion thereof) to comply with GAAP;
(iii)in connection with any marketing effort for the Debt Financing (including any attempt to access the financing markets pursuant to Section 5.14(h)), furnish to Parent the “flash” or “recent developments” financial information described in clause (b)(ii)(x) of the definition of “Required Financing Information” as if references therein to the commencement of the Marketing Period were references to the commencement of such marketing effort and to the extent reasonably requested by Parent, file a Current Report on Form 8-K in respect of such information that Parent and the Company may reasonably agree; and
(iv)cause the Company’s auditors, to the extent financial statements audited or reviewed by such auditor are included in any offering memorandum to (x) consistent with the
customary practice, furnish customary comfort letters (including customary “negative assurance” comfort and change period comfort) and consents, together with drafts of such comfort letters that such auditors are prepared to deliver, as necessary and customary and (y) attend a reasonable number of accounting due diligence and drafting sessions.
Notwithstanding anything to the contrary herein, it is understood and agreed that the condition precedent set forth in Section 6.02(b) as applied to the Company’s obligations under this Section 5.14(b) shall be deemed satisfied (and, solely to the extent of the commitments under the Backstop Commitment Letter that survive in accordance with the terms thereof if a Backstop Trigger Event does not occur, the Backstop Commitment Letter) unless the Debt Financing of the type contemplated in the Syndicated Commitment Letter has not been obtained as a result of the Company’s knowing and intentional breach of its obligations under this Section 5.14(b) to the extent such breach is the primary cause of the unavailability of the Debt Financing of the type contemplated in the Syndicated Commitment Letter (and, solely to the extent of the commitments under the Backstop Commitment Letter that survive in accordance with the terms thereof if a Backstop Trigger Event does not occur, the Backstop Commitment Letter).
(c)Notwithstanding anything to the contrary contained herein, nothing in this Section 5.14 shall require any such cooperation or assistance to the extent that it could result in the Company or any of its Subsidiaries being required to:
(i)pledge any assets as collateral prior to the Effective Time;
(ii)agree to pay any fee, bear any cost or expense, enter into any definitive agreement, incur any other liability or give any indemnities to any third party or otherwise commit to take any similar action in connection with the Debt Financing prior to the Effective Time, other than the execution of customary authorization letters, representation letters and, to the extent substantially consistent with the Company’s existing ratings coverage, the execution and delivery of customary engagement letters, application letters or similar documentation in connection with any ratings evaluation service, rating assessment service or similar confidential ratings assessments requested by Parent in connection with the Debt Financing contemplated under the Syndicated Commitment Letter (other than as expressly contemplated by Section 5.15);
(iii)take any actions to the extent such actions would, in the Company’s reasonable judgment, (A) unreasonably interfere with the ongoing business or operations of the Company or any of its Subsidiaries or otherwise interfere with the prompt and timely discharge by the Company’s or any of its Subsidiaries’ employees of their normal duties, (B) subject any director, manager, officer or employee of the Company or any of its Affiliates to any actual or potential personal liability, (C) conflict with, or result in any violation or breach of, or default (with or without notice, or lapse of time or both) under, the organizational documents of the Company or any of its Subsidiaries, any applicable Law or Judgment, any obligation of confidentiality owing to a third party or any Contract to which the Company or any of its Subsidiaries is a party or by which any of their respective properties or assets is bound, (D) require any such entity to change any fiscal period or (E) cause (x) any closing condition set
forth in Article VI of this Agreement to fail to be satisfied or (y) any other breach of this Agreement;
(iv)waive or amend any terms of this Agreement;
(v)commit to take any action under any certificate, document or instrument that is not contingent upon the Closing (other than as contemplated by Section 5.15);
(vi)provide access to or disclose information if the Company determines, in its reasonable judgment, that doing so would reasonably be expected to (A) violate or prejudice the rights of its or any of its Subsidiaries’ customers, (B) result in the disclosure of Trade Secrets or competitively sensitive information to third parties, (C) jeopardize the protection of an attorney-client privilege, attorney work product protection or other legal privilege or (D) expose the Company to risk of liability for disclosure of sensitive or personal information;
(vii)cause any director, manager or equivalent, or any officer or employee, in each case of the Company or any of its Subsidiaries to pass resolutions to approve the Debt Financing or authorize the creation of any agreements, documents or actions in connection therewith, or to execute or deliver any certificate in connection with the Debt Financing (other than any director, manager or equivalent, or officer or employee, in each case of the Company or any of its Subsidiaries who will continue in such a position following the Closing and the passing of such resolutions), in each case that are not contingent on the Closing or would be effective prior to the Effective Time;
(viii)deliver any legal opinion or negative assurance letter; or
(ix)provide or prepare (A) any description of all or any component of the Financing, including any such description to be included in liquidity and capital resources disclosure or any “description of notes”, (B) risk factors relating to all or any component of the Financing, (C) “segment reporting”, subsidiary financial statements or any information of the type required by Rule 3-09, Rule 3-10 or 3-16 of Regulation S-X or (D) any information required by Regulation S-K Item 402 or by Items 10 through 14 of Form 10-K.
(d)Parent shall promptly, upon request by the Company, reimburse the Company for all reasonable and documented out-of-pocket costs and expenses (including reasonable, documented and invoiced attorneys’ fees of a single outside counsel) incurred by the Company or any of its Subsidiaries and their respective Representatives in connection with the Financing, including the cooperation of the Company and its Subsidiaries and Representatives contemplated by this Section 5.14; provided, that the Company, and not Parent, shall be responsible for (i) fees, costs and expenses incurred in connection with the preparation of financial statements that are or would be prepared in the ordinary course of business regardless of the Financing, (ii) any ordinary course amounts payable to existing employees, advisors or consultants of the Company and its Subsidiaries and their respective Representatives with respect to services provided prior to Closing and (iii) any amounts that would have been incurred in connection with the transactions contemplated hereby regardless of the Financing. Parent shall indemnify and hold harmless the Company, its Subsidiaries and their respective Representatives from and against any and all losses, damages, claims, costs or expenses suffered or incurred by any of them in
connection with the arrangement of the Financing and the cooperation of the Company and its Subsidiaries and Representatives required by Section 5.14(a) except in the event such losses, damages, claims, costs or expenses arose out of or resulted from the gross negligence, fraud, material breach of this Agreement or willful misconduct by the Company, any of their respective Affiliates or any Representatives of any of the foregoing or from any material misrepresentation of any historical financial information provided in writing by or on behalf of the Company or any of their Representatives for use in connection with the Financing. Notwithstanding the foregoing, Parent’s obligation to reimburse the Company for Financing Cooperation Expenses shall be subject to the Financing Cooperation Expenses Cap.
(e)Parent acknowledges and agrees that the obligations of Parent to consummate the Transactions contemplated by this Agreement are not in any way contingent upon or otherwise subject to Parent’s consummation of any financing arrangement, Parent or any of its Affiliates obtaining any financing (including the Financing) or the availability, grant, provision or extension of any financing to Parent or any of its Affiliates (including the Financing).
(f)Each of Parent and Merger Sub shall use, and shall cause its Affiliates to use, commercially reasonable efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable to consummate and obtain the Financing on the terms and subject only to the conditions (including the market flex provisions) set forth in the Commitment Letters and the Fee Letters, including using commercially reasonable efforts to: (i) maintain in effect and comply with the Commitment Letters (other than any Commitment Letter terminated or reduced as permitted by this Section 5.14(f)); (ii) negotiate and enter into definitive agreements with respect to the Debt Financing on the terms and subject only to the conditions (including the market flex provisions) set forth in the applicable Debt Commitment Letter and the related Fee Letter (or on terms and conditions not materially less favorable to Parent or Merger Sub than the terms and conditions (including market flex provisions) set forth in the applicable Debt Commitment Letter); (iii) satisfy (and cause its Affiliates to satisfy) on a timely basis all conditions applicable to Parent (or its Affiliates) in the applicable Commitment Letter and the definitive agreements related thereto; (iv) consummate the applicable Debt Financing at or prior to the Closing Date; (v) enforce its rights under the Commitment Letters and the definitive agreements relating to the Financing; and (vi) comply with its covenants and other obligations under the Commitment Letters and the definitive agreements relating to the Financing. Parent and Merger Sub shall not, without the prior written consent of the Company, agree to or permit any termination of or amendment or modification to be made to, or grant any waiver of any provision under, the Commitment Letters or the Fee Letters or the definitive agreements relating to the Financing if such termination, amendment, modification or waiver would (A) reduce (or could have the effect of reducing) the aggregate amount of the Financing (including by increasing the amount of fees to be paid or original issue discount), such that the aggregate amount of such Financing would not be sufficient to pay the Financing Uses on the Closing Date (after taking into consideration the Available Funding Amounts), unless, in each case, there is a corresponding increase in any equity commitment under the Equity Commitment Letter or Preferred Commitment Letter (it being understood, for the avoidance of doubt, that any termination of the Backstop Commitment Letter (other than the commitments thereunder that backstop the Receivables Facility, but subject to clause (v) below) upon the effectiveness of the Fully Committed Syndicated Commitment Letter or any reduction as expressly contemplated herein shall not constitute a reduction of the Financing for purposes of this clause (A)),
(B) impose new or additional conditions precedent to the availability of the Financing or otherwise expand, amend or modify any of the conditions to the Financing, or otherwise expand, amend or modify any other provision of the Commitment Letters or the Fee Letters in a manner that could reasonably be expected to delay or prevent or make less likely to occur the funding of the Financing (or satisfaction of the conditions to the Financing) on or prior to the Closing Date, (C) amend or modify or grant any consent under or otherwise waive any provision in the Backstop Commitment Letter or the Syndicated Commitment Letter if the effect of such amendment, modification, consent or waiver would be to modify the requirements of the third paragraph (in the case of the Backstop Commitment Letter) and the second paragraph (in the case of the Syndicated Commitment Letter), in each case under Section 3 (“Syndication”) of either of the Backstop Commitment Letter or the Syndicated Commitment Letter, each as in effect on the date hereof, (D) amend or modify the Backstop Commitment Letter if the effect of such amendment or modification would be to reduce the commitment of Apollo or Atlas in respect of each of the debt facilities contemplated thereby below 100% of the aggregate commitments thereunder in respect of each such debt facility (it being understood that Apollo or Atlas may syndicate such commitment in accordance with Section 3 of the Backstop Commitment Letter, subject to the third paragraph under Section 3 (“Syndication”) of the Backstop Commitment Letter), (E) amend or modify the Syndicated Commitment Letter in order to join any additional Debt Financing Source to the Syndicated Commitment Letter unless such Debt Financing Source constitutes an Approved Financing Source (provided that the aggregate number of additional Debt Financing Sources joined to the Syndicated Commitment Letter after the date hereof shall not exceed twenty (20) (the “Additional Lender Cap”, and it being understood that for purposes of calculating the Additional Lender Cap, each additional Debt Financing Source and its Affiliates party to the Syndicated Commitment Letter shall refer to a single Debt Financing Source so long as they collectively constitute an Approved Financing Source) or (F) adversely impact the ability of Parent, Merger Sub or the Company, as applicable, to enforce its rights against other parties to the Commitment Letters or the definitive agreements with respect to the Financing (such clauses (A), (B), (C), (D), (E) and (F), the “Prohibited Modifications”). Parent shall promptly deliver to the Company copies of (x) any amendment, modification or waiver to or under any Commitment Letter, any Fee Letter or the definitive agreements relating to the Financing and (y) any amendment, joinder or other documentation effecting the termination of the commitments under the Backstop Commitment Letter (whether automatically in accordance with its terms or otherwise) upon the effectiveness of the Fully Committed Syndicated Commitment Letter. Notwithstanding the foregoing, any amendment, modification, waiver or termination (i) to effectuate any “market flex”, “structure flex” or securities demand terms contained in any Debt Commitment Letter or the related Fee Letter if made on or prior to the Closing Date, (ii) to add any additional lenders, arrangers, bookrunners, agents or other financial institutions to any Debt Commitment Letter, and to reduce the commitments of any existing Debt Financing Source on a corresponding basis provided that no such amendment, modification, waiver or termination would constitute a Prohibited Modification), (iii) to terminate the commitments under the Backstop Commitment Letter (other than the commitments thereunder that backstop the Receivables Facility, but subject to clause (v) below) upon the effectiveness of the Fully Committed Syndicated Commitment Letter or to terminate the commitments under the Syndicated Commitment Letter if a Backstop Trigger Event has occurred, (iv) to reduce the commitments under any Debt Commitment Letter in respect of the Company Rollover Notes upon receipt of the requisite consents in any consent
solicitation with respect thereto or the satisfaction of any ratings condition in respect thereof, or (v) to reduce or terminate the commitments under any Debt Commitment Letter in respect of the Receivables Facility upon the effectiveness of an amendment, waiver, consent or refinancing under the Receivables Facility such that the consummation of the transactions contemplated by this Agreement would not result in an “Event of Termination” or “Unmatured Event of Termination” (each as defined in the Receivables Facility), in each case of clauses (iii) through (v), so long as the Financing (after taking into consideration the Available Funding Amounts) would be sufficient to pay the Financing Uses on the Closing Date, shall be permitted and shall not require written consent of the Company or any other Person.
(g)Parent shall keep the Company informed on a current basis and in reasonable detail of the status of its efforts to arrange the Debt Financing (including, so long as the Backstop Trigger Event has not occurred and prior to the effectiveness of the Fully Committed Syndicated Commitment Letter, providing the Company with updates, upon the Company’s reasonable request, regarding the status of Parent’s efforts to obtain commitments from additional Debt Financing Sources under the Syndicated Commitment Letter) and, upon request, provide to the Company copies (including drafts) of the material definitive documents for the Debt Financing. Parent shall give the Company prompt notice of, and keep the Company informed on a current basis and in reasonable detail of, (i) any actual or potential breach, default, termination or repudiation by any party to any of the Commitment Letters or definitive documents related to the Financing of which Parent or Merger Sub becomes aware; (ii) the receipt of any written notice or other written communication from any financing source with respect to any (A) actual or potential breach, default, termination or repudiation by any party to any of the Commitment Letters or any definitive document related to the Financing of any provisions of the Commitment Letters or any definitive document related to the Financing or (B) material dispute or disagreement between or among any parties to any of the Commitment Letters or any definitive document related to the Financing (but excluding, for the avoidance of doubt, any ordinary course negotiations with respect to the terms of the Debt Financing); and (iii) if Parent has knowledge thereof, the occurrence of an event or development that could reasonably be expected to adversely impact the ability of Parent or Merger Sub to obtain all or any portion of the Financing contemplated by the Commitment Letters on the terms and conditions (including the market flex provisions), in the manner or from the sources contemplated by any of the Commitment Letters, any of the Fee Letters or the definitive documents related to the Financing (or if at any time for any other reason Parent or Merger Sub believes that it will not be able to obtain all or any portion of the Financing contemplated by the Commitment Letters on the terms and conditions (including the market flex provisions), in the manner or from the sources contemplated by any of the Commitment Letters, any of the Fee Letters or the definitive documents related to the Financing). As soon as reasonably practicable, but in any event within three (3) Business Days of the date the Company delivers to Parent a written request, Parent and Merger Sub shall provide any pertinent and non-confidential information reasonably requested by the Company relating to any circumstance referred to in the immediately preceding sentence.
(h)If any portion of the Debt Financing becomes unavailable or Parent or Merger Sub has knowledge of any event or circumstance that would reasonably be expected to make any portion of the Debt Financing unavailable, in each case, on the terms and conditions (including the market flex provisions) contemplated by the applicable Debt Commitment Letter and the related Fee Letters and such portion is necessary to fund the Financing Uses, Parent and Merger
Sub shall use commercially reasonable efforts to arrange and obtain in replacement thereof, and negotiate and enter into definitive agreements with respect to, alternative financing from alternative sources (such financing, the “Alternative Financing”) (i) in an amount sufficient to satisfy the Financing Uses (after taking into consideration the amount of the Equity Financing and available cash of the Company and its Subsidiaries and other Available Funding Amounts), (ii) with terms (including market flex provisions) not materially less favorable (taken as a whole) and on conditions not materially less favorable (taken as a whole) to Parent and Merger Sub (or of their Affiliates) than the terms and conditions (including the market flex provisions) set forth in the applicable Debt Commitment Letter and the related Fee Letters and (iii) which would not reasonably be expected to delay or prevent or make less likely to occur the funding of the Debt Financing (or the satisfaction of the conditions to the Debt Financing) on the Closing Date, as promptly as practicable following the occurrence of such event (but not later than the last date that Parent and Merger Sub could be required to consummate the Closing in accordance with this Agreement); provided that the failure to obtain Alternative Financing shall not relieve Parent and Merger Sub of any obligation hereunder; provided, further, that, in no event shall Parent be required to pay fees or original issue discount in excess of those contemplated by the applicable Debt Commitment Letter and the related Fee Letter, each as in effect on the date of this Agreement, or to seek equity financing in excess of the Equity Financing or Preferred Financing. Parent shall deliver to the Company true, correct and complete copies of the Debt Commitment Letter (as defined in the next succeeding sentence) and fee letter (redacted in a manner consistent with Section 4.05) related to any Alternative Financing. The failure of all or any portion of the Debt Financing contemplated by the Syndicated Commitment Letter to be committed, syndicated or funded shall not be deemed to cause any portion of the Debt Financing to be unavailable for purposes of this Section 5.14(h) or otherwise under this Agreement, so long as the Debt Financing contemplated by the Backstop Commitment Letter remains available in an amount sufficient (after taking into consideration the Available Funding Amounts) to pay the Financing Uses on the Closing Date. For purposes of this Agreement, references to (x) the “Debt Financing” shall include any such Alternative Financing and (y) the “Debt Commitment Letter” shall include the commitment letters or similar documents with respect to any such Alternative Financing. For the avoidance of doubt, Parent may request the cooperation of the Company and its Subsidiaries under Section 5.14(b) from time to time between the date of this Agreement and the Closing; provided that the Marketing Period shall not be applicable as to each such attempt to access the financing markets (it being understood and agreed that once the Marketing Period has commenced and been completed in accordance with the definitions thereof, there shall not be a subsequent Marketing Period hereunder). Parent shall provide the Company with drafts of all offering memoranda, bank books and other marketing materials for the Debt Financing with a reasonable time to review such materials, and, subject to Parent’s compliance with such obligation, the Company shall use commercially reasonable efforts to review such materials and identify for Parent any information contained therein that it reasonably believes constitutes material non-public information with respect to the Company and its Subsidiaries (taken as a whole) or their respective securities (“Identified MNPI”). To the extent any Identified MNPI of the type contemplated by Section 5.14(b)(iii) is customarily included in offering memoranda or marketing materials for debt financing of the type contemplated by the Syndicated Commitment Letter, is reasonably requested by Parent to be included therein and is not information as to which the Company reasonably objects (such Identified MNPI, “Acceptable MNPI”), the
Company shall file a Current Report on Form 8-K containing such Acceptable MNPI. Parent shall remove from such materials all Identified MNPI that is not Acceptable MNPI.
SECTION 5.15.Treatment of Company Notes.
(a)Prior to the Closing, the Company shall use commercially reasonable efforts, upon Parent’s written request, to assist Parent in (v) maintaining the ratings coverage (but no specific rating) of the Company Notes as of the date of this Agreement, (w) preparing one or more notices of redemption for the outstanding aggregate principal amount of one or more series of the Company Notes, which notice of redemption shall (if permitted by the Indenture) be expressly conditioned on the occurrence of the Closing, in order to effect a redemption pursuant to the terms of the applicable Indenture, (x) commencing and conducting one or more consent solicitations, tender offers, exchange offers or offers to purchase (including with exit consents) with respect to one or more series of the Company Notes, the closing or effectiveness of each of which shall be expressly conditioned on the occurrence of the Closing, and which may be commenced at any time after the date of this Agreement as determined by Parent following reasonable consultation with the Company regarding timing and any relevant tender or consent deadlines, including, (i) requesting, and using commercially reasonable efforts to cause, the Company’s independent auditors to provide customary consents for use of their reports to the extent required in connection therewith, (ii) subject to the receipt of the requisite consents, executing (and using commercially reasonable efforts to cause the applicable trustee to execute) one or more supplemental indentures, which shall become effective upon execution thereof and, except with respect to the Company Rollover Notes to the extent requested by Parent, shall not become operative until the Closing, and (iii) furnishing any customary certificates, legal opinions or negative assurance letters in connection with any consent solicitation, (y) preparing one or more offers to purchase the Company Notes or offers to repurchase the Company Notes pursuant to a Change of Control Offer (as defined in the applicable Indenture), in each case, which offer shall be expressly conditioned on the occurrence of the Closing, and commencing one or more Change of Control Offers for one or more series of the Company Notes then outstanding, pursuant to the terms of the applicable Indenture; and (z) using commercially reasonable efforts to take such other actions consistent with the foregoing clauses (w), (x) and (y) required by the Company under any Indentures to facilitate the assumption, redemption or repayment of the Company Notes and the satisfaction and discharge of the Indentures to be performed by the Company as a result of the execution and delivery of this Agreement and the consummation of the Transactions; provided that the Company shall not be required to take any of the foregoing actions pursuant to clauses (w), (x), (y) and (z) prior to the No-Shop Period Start Date; provided, further, that each such action shall be conditioned on the occurrence of the Closing. The closing or effectiveness of any transaction described in clause (x) shall be conditioned on the occurrence of the Closing; provided that the consummation of any such transaction shall not be a condition to the Closing.
(b)The dealer manager, solicitation agent, information agent, depositary or other agent retained in connection with any consent solicitation will be selected by Parent (and reasonably acceptable to the Company).
(c)Prior to the Closing, the Company (i) shall notify Parent reasonably promptly in writing in the event the applicable issuer of the Company Notes (the “Company Notes Issuer”)
delivers or receives a notice of the occurrence of any Default or Event of Default under the Indentures and shall thereafter keep Parent reasonably informed of the actions being taken by the Company Notes Issuer to cure such Default or Event of Default and (ii) shall not, and shall cause its Subsidiaries not to, without the prior written consent of Parent, voluntarily redeem, repurchase, defease, discharge or otherwise acquire any Company Notes, other than as requested by Parent pursuant to this Section 5.15.
(d)The reimbursement and indemnification obligations of Parent set forth in Section 5.14(d), including the applicability of the Financing Cooperation Expenses Cap, shall apply, mutatis mutandis, to any actions taken by the Company, its Subsidiaries or their respective Representatives at the request of Parent pursuant to Section 5.15(a) and (b).
Notwithstanding anything to the contrary herein, it is understood and agreed that the condition precedent set forth in Section 6.02(b) as applied to the Company’s obligations under this Section 5.15 shall be deemed satisfied unless the Company has knowingly and intentionally breached its obligations under this Section 5.15.
SECTION 5.16.Payoff of Company Existing Indebtedness. On or prior to the Closing Date (drafts of which shall have been delivered by the Company to Parent no later than three (3) Business Days prior to the Closing Date), the Company will have delivered to Parent: (1) one or more reasonable and customary payoff letters, in a form reasonably satisfactory to Parent, duly executed by the administrative agents or the lenders under Indebtedness set forth on Section 5.16 of the Company Disclosure Letter (such Indebtedness, the “Payoff Indebtedness”, and such letter(s), the “Payoff Letters”) providing for the payoff, discharge and termination of such Payoff Indebtedness and release of all security interests, Liens and guarantees with respect thereto and (2) reasonable and customary lien releases and guarantee terminations relating to such Payoff Indebtedness (including UCC-3 financing statements and intellectual property releases), in final form and substance reasonably satisfactory to Parent, sufficient to evidence the complete discharge and termination of all Liens, security interests and guarantees relating to such Payoff Indebtedness, subject to not being effective until receipt of payment by the holder of such Payoff Indebtedness.
SECTION 5.17.Transfer Taxes. Parent shall bear and timely pay all transfer, documentary, sales, use, sales and use, stamp, registration, value-added and recording Taxes and other similar Taxes and fees incurred in connection with this Agreement or the Transactions, and Parent shall prepare and timely file, at its expense, any Tax Returns and other documentation with respect to such Taxes and fees.
ARTICLE VI
Conditions to the Merger
SECTION 6.01.Conditions to Each Party’s Obligation To Effect the Merger. The respective obligations of each party hereto to effect the Merger shall be subject to the
satisfaction (or written waiver by each party hereto, if permissible under applicable Law) on or prior to the Closing Date of the following conditions:
(a)No Restraints. No Judgment enacted, promulgated, issued, entered, amended or enforced by any Governmental Authority of competent jurisdiction or any applicable Law (collectively, “Restraints”) in the U.S. shall be in effect enjoining, restraining or otherwise making illegal, preventing or prohibiting the consummation of the Merger;
(b)HSR. The waiting period (and any extension thereof) applicable to the consummation of the Merger under the HSR Act shall have expired or early termination thereof shall have been granted.
(c)Company Stockholder Approval. The Company Stockholder Approval shall have been obtained.
SECTION 6.02.Conditions to the Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to effect the Merger shall be subject to the satisfaction (or written waiver by Parent, if permissible under applicable Law) on or prior to the Closing Date of the following conditions:
(a)Representations and Warranties. The representations and warranties of the Company (i) set forth in Section 3.06(b) (No Material Adverse Effect) shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date with the same effect as though made as of the Closing Date, (ii) set forth in Section 3.02(a) and (b) (Capitalization) shall be true and correct, except for de minimis inaccuracies, as of the date of this Agreement and as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), (iii) Section 3.03 (other than with respect to clause (e) thereof) (Authority; Noncontravention), Section 3.18 (No Rights Agreement; Anti-Takeover Provisions), Section 3.19 (Opinion of Financial Advisors), and Section 3.20 (Brokers and Other Advisors) shall be true and correct in all material respects as of the date of this Agreement and as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date) and (iv) set forth in this Agreement, other than those Sections specifically identified in clauses (i), (ii) and (iii) of this paragraph, shall be true and correct (disregarding all qualifications or limitations as to “materiality”, “Material Adverse Effect” and words of similar import set forth therein) as of the date of this Agreement and as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), except, in the case of this clause (iv), where the failure to be true and correct does not have and would not, individually or in the aggregate, have a Material Adverse Effect;
(b)Compliance with Covenants. The Company shall have complied with or performed in all material respects its obligations required to be complied with or performed by it at or prior to the Effective Time under this Agreement;
(c)No Material Adverse Effect. Since the date of this Agreement, there shall not have occurred any Material Adverse Effect; and
(d)Company Closing Certificate. The Company shall have delivered to Parent a certificate, dated as of the Closing Date and signed on behalf of the Company by an executive officer of the Company, certifying that the conditions set forth in Sections 6.02(a), 6.02(b) and 6.02(c) have been satisfied.
SECTION 6.03.Conditions to the Obligations of the Company. The obligations of the Company to effect the Merger shall be subject to the satisfaction (or written waiver by the Company, if permissible under applicable Law) on or prior to the Closing Date of the following conditions:
(a)Representations and Warranties. The representations and warranties of Parent and Merger Sub set forth in this Agreement shall be true and correct (disregarding all qualifications or limitations as to “materiality”, “Parent Material Adverse Effect” and words of similar import set forth therein) as of the date of this Agreement and as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), except where the failure to be true and correct would not, individually or in the aggregate, have a Parent Material Adverse Effect;
(b)Compliance with Covenants. Parent and Merger Sub shall have complied with or performed in all material respects their obligations required to be complied with or performed by them at or prior to the Effective Time under this Agreement; and
(c)Parent Closing Certificate. Parent shall have delivered to the Company a certificate, dated as of the Closing Date and signed on behalf of Parent and Merger Sub by an executive officer of Parent, certifying that the conditions set forth in Sections 6.03(a) and 6.03(b) have been satisfied.
SECTION 6.04.Frustration of Closing Conditions. None of the parties hereto may rely on the failure of any condition set forth in this Article VI to be satisfied if its failure to perform in all material respects any of its obligations under this Agreement, to act in good faith or to use in accordance with the terms of this Agreement its required efforts to cause the Closing to occur, in each case shall have been a principal cause of, or shall have been principally responsible for, the failure of any such condition.
ARTICLE VII
Termination
SECTION 7.01.Termination. This Agreement may be terminated, and the Transactions abandoned, at any time prior to the Effective Time (except as otherwise expressly noted), whether before or after receipt of the Company Stockholder Approval:
(a)by the mutual written consent of the Company and Parent;
(b)by either of the Company or Parent:
(i)if the Effective Time shall not have occurred on or prior to July 29, 2027 (the “Outside Date”); provided, that the right to terminate this Agreement under this Section 7.01(b)(i) shall not be available to any party if the breach by such party of its representations and warranties set forth in this Agreement or the failure of such party to perform any of its obligations under this Agreement has been a principal cause of or shall have been principally responsible for the events specified in this Section 7.01(b)(i) (it being understood that Parent and Merger Sub shall be deemed a single party for purposes of the foregoing proviso);
(ii)if any Restraint in the U.S. having the effect set forth in Section 6.01(a) (No Restraints) shall be in effect and shall have become final and nonappealable; provided that the party seeking to terminate this Agreement pursuant to this Section 7.01(b)(ii) shall have used the required efforts to prevent the entry of and to remove such Restraint in accordance with its obligations under this Agreement; or
(iii)if the Company Stockholders’ Meeting (including any adjournments or postponements thereof) shall have concluded and the Company Stockholder Approval shall not have been obtained;
(c)by Parent:
(i)if the Company shall have breached any of its representations or warranties or failed to perform or comply with any of its covenants or agreements set forth in this Agreement, which breach or failure to perform or comply (A) would give rise to the failure of a condition set forth in Section 6.02(a) (Company Representations) or Section 6.02(b) (Company Compliance with Covenants) and (B) is incapable of being cured or, if capable of being cured by the Outside Date, the Company shall not have cured such breach or failure to perform by the earlier of (x) the Outside Date and (y) the date that is 45 calendar days following receipt by the Company of written notice of such breach or failure to perform or comply from Parent stating Parent’s intention to terminate this Agreement pursuant to this Section 7.01(c)(i) and the basis for such termination; provided, however, that Parent shall not have the right to terminate this Agreement pursuant to this Section 7.01(c)(i) if Parent or Merger Sub is then in material breach of any of its representations, warranties, covenants or agreements hereunder; or
(ii)if (A) the Board of Directors of the Company or any duly authorized committee thereof shall have made an Adverse Recommendation Change or (B) the Company shall have materially breached its obligations under Section 5.02(b);
(d)by the Company:
(i)if either of Parent or Merger Sub shall have breached any of its representations or warranties or failed to perform or comply with any of its covenants or agreements set forth in this Agreement, which breach or failure to perform or comply (A) (x) would give rise, individually or in the aggregate, to a Parent Material Adverse Effect or (y) would give rise to the failure of a condition set forth in Section 6.03(a) (Parent Representations) or Section 6.03(b) (Parent Compliance with Covenants) and (B) is incapable of being cured or, if capable of being cured by the Outside Date, either Parent or Merger Sub, as applicable shall not have cured such breach or failure to perform by the earlier of (x) the Outside
Date and (y) the date that is 45 calendar days following receipt by Parent of written notice of such breach or failure to perform or comply from the Company stating the Company’s intention to terminate this Agreement pursuant to this Section 7.01(d)(i) and the basis for such termination; provided, however, that the Company shall not have the right to terminate this Agreement pursuant to this Section 7.01(d)(i) if the Company is then in material breach of any of its representations, warranties, covenants or agreements hereunder; or
(ii)prior to receipt of the Company Stockholder Approval, in connection with entering into a Company Acquisition Agreement in accordance with the procedures set forth in Section 5.02(e)(II) (Takeover Proposals not solicited in violation of the non-solicitation provisions); provided that prior to or concurrently with, and as a condition to, such termination the Company pays or causes to be paid the applicable Company Termination Fee to the extent due and payable under Section 7.03(a) so long as Parent has timely provided the Company with wire instructions for such payment; or
(iii)if (A) all of the conditions set forth in Section 6.01 (Conditions to Each Party’s Obligations to Effect the Merger) and Section 6.02 (Conditions to the Obligations of Parent and Merger Sub) have been satisfied or waived in writing (to the extent such waiver is permitted by applicable Law) (other than those conditions that by their nature are to be satisfied at the Closing and such conditions are actually satisfied on such date), (B) the Company has irrevocably confirmed by notice in writing to Parent that (1) all of the conditions set forth in Section 6.03 (Conditions to the Obligations of the Company) have been satisfied (other than those conditions that by their nature are to be satisfied at the Closing so long as such conditions would be satisfied if the Closing were to occur at such time) or that, the Company has irrevocably waived any such unsatisfied conditions in Section 6.03, (2) the Merger was required to be consummated pursuant to Section 1.02, and (3) the Company is ready, willing and able to consummate the Merger on the date such notice is delivered and through the end of the next succeeding three Business Days, and (C) the Merger shall not have been consummated by the later of (x) three Business Days after the delivery of such notice referred to in clause (B) and (y) the date on which the Closing is required to occur pursuant to Section 1.02; provided that, notwithstanding anything in Section 7.01(b)(i) (Termination after Outside Date) to the contrary, no party shall be permitted to terminate this Agreement pursuant to Section 7.01(b)(i) during such three Business Day period following the notice referred to in clause (B) above.
SECTION 7.02.Effect of Termination. In the event of the termination of this Agreement as provided in Section 7.01, written notice thereof shall be given to the other party or parties hereto, specifying the provision hereof pursuant to which such termination is made, and this Agreement shall forthwith become null and void (other than the penultimate sentence of Section 5.05 (Access to Information; Confidentiality), Sections 5.14(d) and 5.15(d) (Certain Financing Expense Reimbursement and Indemnification), this Section 7.02, Section 7.03 (Termination Fee) and Article VIII (Miscellaneous), all of which shall survive termination of this Agreement), and there shall be no liability on the part of Parent, Merger Sub, the Company or their respective directors, officers and Affiliates, except, subject to Section 7.03(d) (including the limitations on liability set forth therein) and the following sentence, no such termination shall relieve any party from liability for damages to another party resulting from a knowing and intentional breach of this Agreement or from Fraud which liability the parties hereto acknowledge and agree shall not be limited to reimbursement of out-of-pocket fees, costs or
expenses incurred in connection with the Transactions and may include damages based on loss of the economic benefit of the Transactions to the parties hereto and the stockholders of the Company (in each case, taking into consideration all relevant matters, including other business opportunities or combination opportunities and the time value of money). Notwithstanding the foregoing and notwithstanding anything in this Agreement to the contrary (including, for clarity, anything set forth in this Section 7.02), but subject in all respects to the Company’s right to specific performance and other equitable relief pursuant to, and subject to the limitations of, Section 8.08, from and after any termination of this Agreement, in no event or circumstance shall Parent, Merger Sub or any Parent Related Party have any monetary liability or obligation under this Agreement (including in respect of knowing and intentional breach) other than the obligation of Parent to pay the Parent Termination Fee, if and when due under Section 7.03(b) plus any Enforcement Expenses payable pursuant to Section 7.03(c) (subject to the Enforcement Expenses Cap) and Financing Cooperation Expenses payable pursuant to Section 5.14(d) and Section 5.15(d) (subject to the Financing Cooperation Expenses Cap), and the Company Related Parties hereby irrevocably waive and relinquish any other right to seek or recover any other losses, fees, costs, expenses or damages from Parent or any Parent Related Party.
SECTION 7.03.Termination Fee. (a) In the event that:
(i)this Agreement is terminated by the Company or Parent pursuant to Section 7.01(b)(i) (Termination after Outside Date), Section 7.01(b)(iii) (Failure to receive Company Stockholder Approval), or Section 7.01(c) (Breach of Company Representations or Covenants); provided that (A) at the time of termination neither Parent nor Merger Sub is then in material breach of its representations, warranties, covenants or agreements under this Agreement such that the Company would be entitled to terminate this Agreement pursuant to Section 7.01(d)(i), (B) a bona fide Takeover Proposal shall have been publicly made, publicly proposed or otherwise publicly communicated by a third party, in each case, after the date of this Agreement and not publicly withdrawn at least three Business Days prior to the time this Agreement is terminated or the date of the Company Stockholders’ Meeting, in the case of termination pursuant to Section 7.01(b)(iii), and (C) within 12 months of the date this Agreement is terminated, the Company (1) enters into a definitive agreement with respect to a Takeover Proposal and any such Takeover Proposal is subsequently consummated (regardless of whether such consummation occurs within such 12 month period) or (2) consummates a Takeover Proposal; provided that, for purposes of clauses (B) and (C) of this Section 7.03(a)(i), the references to “20%” in the definition of Takeover Proposal shall be deemed to be references to “50%”;
(ii)this Agreement is terminated (A) by Parent pursuant to Section 7.01(c)(ii) (Adverse Recommendation Change; material breach of non-solicitation) or (B) by the Company pursuant to Section 7.01(d)(ii) (Entry into a Company Acquisition Agreement);
then, in any such event under clause (i) or (ii) of this Section 7.03(a), the Company shall pay or cause to be paid the applicable Company Termination Fee to Parent or its designee by wire transfer of same-day funds so long as Parent has timely provided the Company with wire instructions for such payment (x) in the case of Section 7.03(a)(ii)(A), within two Business Days after such termination, (y) in the case of Section 7.03(a)(ii)(B), simultaneously with, and as a condition to, such termination or (z) in the case of
Section 7.03(a)(i), simultaneously with the entry into a definitive agreement with respect to a Takeover Proposal or the consummation of the Takeover Proposal, as applicable, referred to therein; it being understood that in no event shall the Company be required to pay or cause to be paid the applicable Company Termination Fee on more than one occasion.
As used herein, “Company Termination Fee” shall mean a cash amount equal to $227,000,000, except that “Company Termination Fee” shall mean a cash amount equal to $114,000,000 in the event that this Agreement is terminated by the Company pursuant to Section 7.01(d)(ii) (Entry into a Company Acquisition Agreement) in connection with entering into a Company Acquisition Agreement with:
(A) any Person at any time prior to the expiration of the Go-Shop Period, or
(B) any Excluded Party, following the expiration of the Go-Shop Period but prior to the termination of the Go-Shop Extension, or
(C) any Excluded Party within one Business Day following the expiration of the Notice Period referred to in the first proviso to Section 5.02(e) if such Excluded Party submitted the Takeover Proposal (or amendment or modification to a predecessor Takeover Proposal) giving rise to Parent’s match rights under the first proviso to Section 5.02(e) less than five Business Days prior to the expiration of the Go-Shop Extension.
For the avoidance of doubt, any determination as to whether any Person or group of Persons is an Excluded Party for the purposes of clause (A) above will be made at the time of submission of the applicable Takeover Proposal (or any amendment or modification to a predecessor Takeover Proposal) and for the purposes of clause (B) will be made at the time of termination of this Agreement and entry into the applicable Company Acquisition Agreement.
(b)In the event that (i) the Company shall terminate this Agreement pursuant to Sections 7.01(d)(i) (Breach of Parent Representations or Covenants) or 7.01(d)(iii) (Failure to Close), or (ii) Parent shall terminate this Agreement pursuant to Section 7.01(b)(i) (Termination after the Outside Date) and at such time the Company could have terminated this Agreement pursuant to either Sections 7.01(d)(i) or 7.01(d)(iii), then Parent shall pay or cause to be paid to the Company or its designee a termination fee of $473,000,000 in cash (the “Parent Termination Fee”) within two Business Days of such termination by wire transfer of same-day funds so long as the Company has timely provided Parent with wire instructions, it being understood that in no event shall Parent be obligated to pay or cause to be paid the Parent Termination Fee more than once.
(c)Each of the parties hereto acknowledges that the agreements contained in this Section 7.03 are an integral part of the Transactions, and that without these agreements, the other parties hereto would not enter into this Agreement. Accordingly, if the Company or Parent, as the case may be, fails to timely pay or cause to be paid any amount due pursuant to this Section 7.03, and, in order to obtain the payment, Parent or the Company, as the case may be,
commences an Action which results in a final and non-appealable judgment against the other party, with respect to Parent or Merger Sub, or parties, with respect to the Company, for the payment set forth in this Section 7.03, such paying party shall pay or cause to be paid the other party or parties, as applicable, its or their reasonable and documented costs and expenses (including reasonable and documented attorneys’ fees) in connection with such Action, together with interest on such amount at the prime rate as published in The Wall Street Journal in effect on the date such payment was required to be made through the date such payment was actually received (the foregoing obligations, the “Enforcement Expenses”); provided, that the Enforcement Expenses payable by a party pursuant to this Section 7.03(c) shall not exceed $5,000,000 in the aggregate (the “Enforcement Expenses Cap”).
(d)Subject in all respects to Section 7.02 and this Section 7.03, the Company’s injunction, specific performance and equitable relief rights and related rights set forth in Section 8.08(b) and the reimbursement and indemnification obligations of Parent under Section 7.03(c), Section 5.14(d) and Section 5.15(d), in the event this Agreement is terminated pursuant to this Article VII, and the Parent Termination Fee is paid to the Company in circumstances for which such fee is payable pursuant to Section 7.03(b) (it being understood, for the avoidance of doubt, that such Parent Termination Fee shall be payable to the Company solely in the circumstances described in Section 7.03(b)), payment of the Parent Termination Fee (plus any Enforcement Expenses payable pursuant to Section 7.03(c) (subject to the Enforcement Expenses Cap) and Financing Cooperation Expenses payable pursuant to Section 5.14(d) and Section 5.15(d) (subject to the Financing Cooperation Expenses Cap), in each case to the extent required to be paid) shall be the sole and exclusive monetary remedy (whether at Law, in equity, whether in contract or in tort or otherwise) of the Company and its Subsidiaries against Parent, Merger Sub or any of their respective former, current or future general or limited partners, stockholders, financing sources, managers, members, directors, officers or Affiliates (including Thrive Holdings and the Guarantor, collectively, the “Parent Related Parties”) for any losses, damages, costs and expenses suffered as a result of the failure of the Transactions to be consummated or for a breach or failure to perform hereunder (in any case, whether willfully, knowingly, intentionally, unintentionally or otherwise) or otherwise relating to or arising out of this Agreement or the Transactions, and upon payment of such amount none of the Parent Related Parties shall have any further monetary liability or obligation relating to or arising out of this Agreement or the Transactions. The Parent Termination Fee, Enforcement Expenses and Financing Cooperation Expenses shall be the maximum aggregate monetary liability of Parent, Merger Sub and the Parent Related Parties in the event that Parent or Merger Sub fails to consummate the Transactions or otherwise fails to comply with or breaches any covenant or other obligation or representation and warranty in this Agreement, and the Company on behalf of itself and the Company Related Parties hereby irrevocably waives and relinquishes any right to seek or recover, any monetary damages in excess of such amount. No Company Related Party shall be entitled to bring, and the Company shall cause all other Company Related Parties not to bring, and shall in no event support, facilitate or encourage, the bringing of any suit, action or other proceeding (under any legal theory, whether sounding in law or in equity) against a Parent Related Party with respect to, arising out of or in connection with the failure of the Closing to occur or for a breach or failure to perform hereunder, including in connection with the Financing or otherwise, and the Company shall cause any such suit, action or proceeding pending as of any termination of this Agreement to be dismissed with prejudice as promptly as practicable after such termination, other than the Company’s receipt of the Parent Termination Fee, Enforcement
Expenses (subject to the Enforcement Expenses Cap) and Financing Cooperation Expenses (subject to the Financing Cooperation Expenses Cap) and a grant of specific performance pursuant to Section 8.08; provided, that, notwithstanding anything to the contrary herein, nothing in this Section 7.03(d) shall limit (1) the Company’s right to an order of specific performance against Parent and Merger Sub, as permitted by and subject to the requirements of Section 8.08, (2) the Company’s right to enforce the Equity Commitment Letter pursuant to the terms thereof, (3) the Company’s rights and remedies under the Guarantee against the Guarantor pursuant to the terms thereof and (4) the Company’s rights and remedies under the Nondisclosure Agreement in accordance with the terms thereof. Subject in all respects to Parent’s injunction, specific performance and equitable relief rights and related rights set forth in Section 8.08 and the reimbursement obligations of the Company under Section 7.03(c), in the event the Company Termination Fee is paid to Parent in circumstances for which such fee is payable pursuant to Section 7.03(a), payment of the Company Termination Fee (plus any Enforcement Expenses payable pursuant to Section 7.03(c) (subject to the Enforcement Expenses Cap) to the extent required to be paid) shall be the sole and exclusive monetary damages remedy of the Parent Related Parties against the Company and its Subsidiaries and any of their respective former, current or future officers, directors, partners, stockholders, managers, members or Affiliates (collectively, “Company Related Parties”) for any losses, damages, costs and expenses suffered as a result of the failure of the Transactions to be consummated or for a breach or failure to perform hereunder or otherwise, and upon payment of such amount none of the Company Related Parties shall have any further liability or obligation relating to or arising out of this Agreement or the Transactions, except in the case of the Company’s knowing and intentional breach of this Agreement or Fraud. While each of the Company and Parent may pursue both a grant of specific performance in accordance with and subject to the limitations, as applicable, set forth in Section 8.08 and the payment of the Parent Termination Fee or the Company Termination Fee, as applicable, under Section 7.03, under no circumstances shall the Company or Parent be permitted or entitled to receive both a grant of specific performance that results in the Closing and any money damages, including all or any portion of the Parent Termination Fee or the Company Termination Fee, as applicable.
(e)In connection with any loss suffered by any Parent Related Party as a result of the failure of the Transactions to be consummated or for a breach or failure to perform hereunder or otherwise, other than in the circumstances in which Parent is entitled to receive the Company Termination Fee in accordance with Section 7.03(a) (in which case Section 7.03(d) shall apply), Parent agrees, on behalf of itself and the Parent Related Parties, that, except in the case of the Company’s knowing and intentional breach of this Agreement or Fraud, the maximum aggregate monetary liability of the Company and the Company Related Parties, if any, shall be limited to the amount of the Company Termination Fee, and in no event shall Parent or any Parent Related Party seek or be entitled to recover from the Company or any Company Related Party, and Parent on behalf of itself and the Parent Related Parties hereby irrevocably waives and relinquishes any right, except in the case of the Company’s knowing and intentional breach of this Agreement or Fraud, to seek or recover, any monetary damages in excess of such amount. The parties acknowledge that neither the Company Termination Fee nor the Parent Termination Fee shall constitute a penalty but is each liquidated damages, in a reasonable amount that will compensate each party in the circumstances in which the Company Termination Fee or the Parent Termination Fee, as applicable, is payable for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance on this Agreement and
on the expectation of the consummation of the Merger, which amount would otherwise be impossible to calculate with precision.
ARTICLE VIII
Miscellaneous
SECTION 8.01.No Survival of Representations and Warranties. None of the representations or warranties in this Agreement or in any document or instrument delivered pursuant to or in connection with this Agreement shall survive the Effective Time. This Section 8.01 shall not limit any covenant or agreement contained in this Agreement or in any document or instrument delivered pursuant to or in connection with this Agreement that by its terms applies in whole or in part after the Effective Time.
SECTION 8.02.Amendment or Supplement. Subject to compliance with applicable Law, at any time prior to the Effective Time, this Agreement may be amended, modified or supplemented in any and all respects by written agreement of the parties hereto; provided, however, that following receipt of the Company Stockholder Approval, there shall be no amendment or change to the provisions hereof which by Law would require further approval by the stockholders of the Company without such approval having first been obtained; provided further that any modification or amendment of this proviso of Section 8.02, Section 8.04 (solely to the extent that it relates to the Debt Financing Sources Related Parties), clause (vi) of Section 8.06, Section 8.07(c) (solely to the extent that it relates to the Debt Financing Sources Related Parties), Section 8.07(d) (solely to the extent that it relates to the Debt Financing Sources Related Parties), clause (y) of the last sentence of Section 8.08(b), Section 8.09 (solely to the extent that it relates to the Debt Financing Sources Related Parties), Section 8.15 (solely to the extent that it relates to the Debt Financing Sources Related Parties) or the definitions of Debt Commitment Letters, Debt Financing, Debt Financing Sources or Debt Financing Sources Related Parties, (or any other provision of this Agreement the amendment, modification, waiver or alteration of which has the effect of modifying any such provision listed in this proviso), in any such case that is adverse to the interests of the Debt Financing Sources Related Parties, will not be effective against the Debt Financing Sources Related Parties without the prior written consent of the Debt Financing Sources.
SECTION 8.03.Extension of Time, Waiver, Etc. At any time prior to the Effective Time, either Parent or the Company may, subject to applicable Law, (a) waive any inaccuracies in the representations and warranties of the other party contained herein or in any document delivered pursuant hereto, (b) extend the time for the performance of any of the obligations or acts of the other party or (c) waive compliance by the other party with any of the agreements contained herein applicable to such party or, except as otherwise provided herein, waive any of such party’s conditions (it being understood that Parent and Merger Sub shall be deemed a single party for purposes of the foregoing clauses (a) through (c)); provided, however, that following receipt of the Company Stockholder Approval, there shall be no waiver or extension of this Agreement that would require further approval of the stockholders of the Company without such approval having first been obtained. Notwithstanding the foregoing, no failure or delay by the Company, Parent or Merger Sub in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or
further exercise thereof or the exercise of any other right hereunder. Any agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party.
SECTION 8.04.Assignment. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned, in whole or in part, by operation of Law or otherwise, by any of the parties hereto without the prior written consent of the other parties hereto; provided, that Parent or Merger Sub may transfer or assign its rights and obligations under this Agreement, in whole or from time to time in part, to one or more of its Affiliates at any time (except any such assignment which would, or would reasonably be expected to, have a Parent Material Adverse Effect). No assignment by any party shall relieve such party of any of its obligations hereunder. Subject to the immediately preceding two sentences, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by, the parties hereto and their respective successors and permitted assigns. Any purported assignment not permitted under this Section 8.04 shall be null and void. Notwithstanding anything to the contrary in this Agreement, Parent or Merger Sub may transfer, pledge or assign any or all of its rights, interests, or obligations hereunder for collateral purposes to any financing sources (or agent therefor).
SECTION 8.05.Counterparts. This Agreement may be executed in one or more counterparts (including by electronic signature, PDF or electronic mail), each of which shall be deemed to be an original but all of which taken together shall constitute one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties hereto.
SECTION 8.06.Entire Agreement; No Third-Party Beneficiaries. This Agreement, including the Company Disclosure Letter, together with the Commitment Letters, the Nondisclosure Agreement and the Guarantee, and the other documents contemplated by the foregoing or any certificate, document or instrument delivered in connection herewith or therewith, constitutes the entire agreement, and supersedes all other prior agreements and understandings, both written and oral, among the parties and their Affiliates, or any of them, with respect to the subject matter hereof and thereof. This Agreement is not intended to and does not confer upon any Person other than the parties hereto any rights or remedies hereunder, except for: (i) if the Effective Time occurs, the right of the Company’s stockholders to receive the Merger Consideration as provided in Section 2.01; (ii) if the Effective Time occurs, the right of the holders of Equity-Based Awards to receive such amounts as provided for in Article II; (iii) if the Effective Time occurs, the rights of the Indemnitees set forth in Section 5.06; (iv) the rights of the Parent Related Parties and the Company Related Parties set forth in Section 7.03(d) and the Company Related Parties set forth in Section 7.03(e); (v) following the valid termination of this Agreement pursuant to Article VII, subject to Section 7.02, Section 7.03 and the last sentence of this Section 8.06, the right of the Company, as sole and exclusive representative for and on behalf of the stockholders of the Company (which stockholders shall not be entitled to pursue such damages on their own behalf) (who are third party beneficiaries hereunder solely to the extent necessary for this clause (v) to be enforceable), to pursue any damages (including damages based on loss of the economic benefit of the Transactions to the stockholders of the Company), which are intended for the benefit of, and shall be enforceable by, the Persons referred to in clauses (i) through (v) above, and (vi) each Debt Financing Sources Related Party shall be a third-party beneficiary of, and may enforce, the proviso in Section 8.02, Section 8.04
(solely to the extent that it relates to the Debt Financing Sources Related Parties), this clause (vi) of Section 8.06, Section 8.07(c) (solely to the extent that it relates to the Debt Financing Sources Related Parties), Section 8.07(d) (solely to the extent that it relates to the Debt Financing Sources Related Parties), clause (y) of the last sentence of Section 8.08(b), Section 8.09 (solely to the extent that it relates to the Debt Financing Sources Related Parties) and Section 8.15 (solely to the extent that it relates to the Debt Financing Sources Related Parties). Notwithstanding anything herein to the contrary, subject to Section 7.03 and prior to the Closing, the rights granted pursuant to clause (v) of this Section 8.06 and the provisions of Section 7.02 with respect to the recovery of damages based on the losses suffered by the stockholders of the Company (including the loss of the economic benefit of the Transactions to the stockholders of the Company) shall only be enforceable on behalf of the stockholders of the Company by the Company in its sole and absolute discretion, as the sole and exclusive representative for the stockholders of the Company (which stockholders shall not be entitled to pursue such enforcement on their own behalf); provided that, in such capacity as sole and exclusive representative for the stockholders of the Company, the Company shall (i) be entitled to reimbursement (from the stockholders of the Company) from any such recovery of damages of its reasonable and documented out-of-pocket costs and expenses (including reasonable and documented out-of-pocket attorneys’ fees determined by reference to standard hourly rates) that have been incurred by the Company in connection with acting as sole and exclusive representative for the stockholders of the Company pursuant to clause (v) of this Section 8.06 and (ii) not be liable to the stockholders of the Company for any action taken, suffered or omitted to be taken by it in good faith except to the extent that the Company’s gross negligence or willful misconduct was the cause of any direct loss to the stockholders of the Company.
SECTION 8.07.Governing Law; Jurisdiction. (a) This Agreement and all disputes, controversies or other Actions arising out of or relating to this Agreement or the Transactions, including matters of validity, construction, effect, performance and remedies, shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed in and to be performed entirely within that State, regardless of the laws that might otherwise govern under any applicable conflict of Laws principles.
(b)All Actions arising out of or relating to this Agreement or the Transactions shall be heard and determined in the Court of Chancery of the State of Delaware (or, if the Court of Chancery of the State of Delaware declines to accept jurisdiction over any Action, any state or federal court of competent jurisdiction within the State of Delaware). The parties hereto hereby irrevocably (i) submit to the exclusive jurisdiction and venue of such courts in any such Action, (ii) waive the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such Action, (iii) agree to not attempt to deny or defeat such jurisdiction by motion or otherwise request for leave from any such court and (iv) agree to not bring any Action arising out of or relating to this Agreement or the Transactions in any court other than the Court of Chancery of the State of Delaware (or, if the Court of Chancery of the State of Delaware declines to accept jurisdiction over any Action, any state or federal court within the State of Delaware), except for Actions brought to enforce the judgment of any such court. The consents to jurisdiction and venue set forth in this Section 8.07(b) shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed to confer rights on any Person other than the parties hereto. Each party hereto agrees that service of process upon such party in any Action arising out of or
relating to this Agreement shall be effective if notice is given by overnight courier at the address set forth in Section 8.10. The parties hereto agree that a final judgment in any such Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law; provided, however, that nothing in the foregoing shall restrict any party’s rights to seek any post-judgment relief regarding, or any appeal from, a final trial court judgment.
(c)Notwithstanding anything to the contrary in this Agreement, each party to this Agreement acknowledges and irrevocably agrees (i) that any legal action, whether at law or in equity, whether in contract or in tort or otherwise, involving any Debt Financing Sources Related Party arising out of or relating to this Agreement or any Debt Commitment Letter or the performance thereunder shall be subject to the exclusive jurisdiction of the Supreme Court of the State of New York, County of New York, or, if under applicable Law exclusive jurisdiction is vested in Federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof), (ii) that, except to the extent relating to the interpretation of any provisions in this Agreement or the Equity Commitment Letter, any legal action, whether at law or in equity, whether in contract or in tort or otherwise, involving any Debt Financing Sources Related Party shall be governed by, construed and enforced in accordance with, the Laws of the State of New York (without giving effect to any conflicts of law principles that would result in the application of the laws of another state), (iii) not to bring or permit any of their Affiliates to bring any such legal action in any other court and (iv) that the provisions of this Section 8.07(c) shall apply to any such legal action.
(d)Notwithstanding anything in this Agreement to the contrary, each party hereby irrevocably and unconditionally (x) agrees that it will not bring or support any litigation against any Debt Financing Sources Related Party in any way relating to this Agreement or any of the Transactions, including any dispute arising out of or relating in any way to the Debt Financing or the performance thereof, in any forum other than a court of competent jurisdiction sitting in the Borough of Manhattan of the City of New York, whether a state or federal court, that the provisions of Section 8.09 relating to the waiver of jury trial shall apply to such action, suit or proceeding and that, except to the extent relating to the interpretation of any provisions in this Agreement or the Equity Commitment Letter, any such action, suit or proceeding shall be governed by and construed in accordance with the Laws of the State of New York, (y) agrees that service of process upon any such party in any such action or proceeding shall be effective if notice is given in accordance with Section 8.10 and (z) waives the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such action, suit or proceeding in any such court.
SECTION 8.08.Specific Enforcement.
(a)The parties hereto agree that irreparable damage for which monetary relief (including any fees payable pursuant to Section 7.03), even if available, would not be an adequate remedy, would occur in the event that any provision of this Agreement is not performed in accordance with its specific terms or is otherwise breached, including if the parties hereto fail to take any action required of them hereunder to consummate this Agreement and the Transactions, subject to the terms and conditions of this Agreement. Subject to the express terms of this Agreement, the parties hereto acknowledge and agree that (x) the parties shall be entitled
to an injunction or injunctions, specific performance or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the courts described in Section 8.07(b) without posting of bond or other security, this being in addition to any other remedy to which they are entitled under this Agreement, (y) the provisions set forth in Section 7.03 shall not be construed to diminish or otherwise impair in any respect any party’s right to specific enforcement and (z) the right of specific enforcement is an integral part of the Transactions and without that right neither the Company nor Parent would have entered into this Agreement.
(b)Notwithstanding the foregoing, it is explicitly agreed that the right of the Company to seek an injunction, specific performance or other equitable remedies in connection with enforcing Parent’s obligation to cause the Equity Financing to be funded to fund the Merger Consideration and Parent’s and Merger Sub’s obligations to effect the Closing (but not the right of Parent, Merger Sub or the Company to seek such injunctions, specific performance or other equitable remedies for any other reason) shall be available only if (i) all of the conditions set forth in Sections 6.01 and 6.02 are satisfied or have been waived in writing (to the extent such waiver is permitted by applicable Law) (other than those conditions that by their nature are to be satisfied at the Closing, each of which are, at the time the written notice referred to in clause (iii) below is delivered by the Company, capable of being satisfied if the Closing Date were the date of such written notice and subject to the actual satisfaction of such conditions at Closing) at the time when Closing would have been required to occur pursuant to Section 1.02, (ii) the Debt Financing and the Preferred Financing have been funded in accordance with the terms thereof or will be funded in accordance with the terms thereof at the Closing if the Equity Financing is funded at the Closing, (iii) the Company has irrevocably confirmed in a written notice delivered to Parent that (A) all of the conditions set forth in Sections 6.01, 6.02 and 6.03 are satisfied or waived in writing (to the extent such waiver is permitted by applicable Law) (other than those conditions that by their nature are to be satisfied at the Closing, each of which are, at the time such written notice is delivered by the Company, capable of being satisfied if the Closing Date were the date of the receipt by Parent of such written notice and subject to the actual satisfaction of such conditions at the Closing) and (B) if specific performance is granted and the Equity Financing, the Preferred Financing and the Debt Financing are funded in accordance with the Commitment Letters, then the Company stands ready, willing and able to then consummate the Transactions on such date and through the end of the date such specific performance is granted (and the Company is actually so ready, willing and able during such period) and that it will take such actions required of it by this Agreement to cause the Closing to occur, and (iv) Parent and Merger Sub have failed to consummate the Closing prior to the third Business Day following the delivery of such confirmation specified in clause (iii) above (it being understood that the conditions to the obligations of Parent and Merger Sub to consummate the transactions contemplated hereby set forth in Section 6.01 and Section 6.02 (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the actual satisfaction of such conditions at the Closing) shall remain satisfied at the close of business on such third Business Day). The parties hereto agree not to assert that a remedy of specific enforcement is invalid or contrary to Law for any reason, and not to assert that a remedy of monetary damages would provide an adequate remedy or that the parties otherwise have an adequate remedy at law. The parties hereto acknowledge and agree that (x) any party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this Section 8.08 shall not be required to provide any bond or
other security in connection with any such order or injunction and (y) in no event shall the Company or any of its Affiliates be entitled to an injunction, specific performance, or any other equitable remedy to enforce or seek to enforce the Parent’s or any of its Affiliates’ rights to enforce specifically their respective rights under any debt commitment letter entered into in connection with the Debt Financing.
SECTION 8.09.WAIVER OF JURY TRIAL. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (INCLUDING ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THE DEBT FINANCING OR THE TRANSACTIONS CONTEMPLATED THEREBY). EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C) IT MAKES SUCH WAIVER VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 8.09.
SECTION 8.10.Notices. All notices, requests and other communications to any party hereunder shall be in writing and shall be deemed given if delivered personally, emailed (without any “bounceback” or other notice of non-delivery) or sent by overnight courier (providing proof of delivery) to the parties at the following addresses:
If to Parent or Merger Sub, to it at:
| | | | | | | | |
FLB Partners T, L.P. |
The Puck Building |
295 Lafayette Street, 7th Fl. |
New York, NY 10012 |
Attention: | | Bruce Gottlieb, General Counsel |
Email: | | legal@thriveholdings.com |
with a copy (which shall not constitute notice) to:
| | | | | | | | |
Kirkland & Ellis LLP |
601 Lexington Avenue |
New York, NY 10022 |
Attention: | | David B. Feirstein, P.C. |
| | Patrick V. Salvo |
| | | | | | | | |
| | Andrew Norwich |
Email: | | david.feirstein@kirkland.com |
| | patrick.salvo@kirkland.com |
| | andrew.norwich@kirkland.com |
| | |
and | | |
Kirkland & Ellis LLP |
200 Clarendon Street |
Boston, MA 02116 |
Attention: | | Christian A. Atwood, P.C. |
Email: | | christian.atwood@kirkland.com |
If to the Company, to it at:
| | | | | | | | |
ADT Inc. |
1501 Yamato Rd. |
Boca Raton, FL 33431 |
Attention: | | David Smail, Executive Vice President & Chief Legal Officer |
Email: | | dsmail@adt.com |
with copies (which shall not constitute notice) to:
| | | | | | | | |
Cravath, Swaine & Moore LLP |
Two Manhattan West |
375 Ninth Avenue |
New York, NY 10001 |
Attention: | | Robert I. Townsend III |
| | Michael E. Mariani |
| | Jin-Kyu Baek |
Email: | | rtownsend@cravath.com |
| | mmariani@cravath.com |
| | jbaek@cravath.com |
or such other address or email address as such party may hereafter specify by like notice to the other parties hereto. All such notices, requests and other communications shall be deemed received on the date of actual receipt by the recipient thereof if received prior to 5:00 p.m. local time in the place of receipt and such day is a Business Day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding Business Day in the place of receipt.
SECTION 8.11.Severability. If any term, condition or other provision of this Agreement is finally determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms, provisions and conditions of this Agreement shall nevertheless remain in full force and effect. Upon such determination that any term, condition or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable
Law. Notwithstanding the foregoing, the parties intend that the provisions relating to the remedies and limitations of liability set forth in Section 7.02, Section 7.03, Section 8.06 and Section 8.08 hereof shall be construed as integral provisions of this Agreement and that such provisions shall not be severable in any manner that increases any party’s or Parent Related Party’s liability or obligations hereunder or in connection with the Financing.
SECTION 8.12.Definitions. (a) As used in this Agreement, the following terms have the meanings ascribed thereto below:
“Affiliate” means as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is under common control with, such Person. For this purpose, “control” (including, with its correlative meanings, “controlled by” and “under common control with”) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of securities or partnership or other ownership interests, by Contract or otherwise. Notwithstanding anything to the contrary in this Agreement, the direct and indirect portfolio companies of investment funds or entities advised or managed by Thrive Capital Management, LLC shall not be deemed to be Affiliates of Parent or Merger Sub, except (i) in the case of the definition of “Parent Related Parties,” (ii) for purposes of Section 5.04, (iii) for purposes of Section 8.15 and (iv) in the case of the definition of “Representatives.”
“Anti-Corruption Laws” means all U.S. and applicable non-U.S. Laws relating to the prevention of corruption, money laundering, and bribery, including the U.S. Foreign Corrupt Practices Act of 1977, and the UK Bribery Act of 2010, and legislation enacted by member states and signatories implementing the OECD Convention Combating Bribery of Foreign Officials.
“Apollo” means Apollo Global Funding, LLC and Apollo Capital Management, L.P., on behalf of one or more investment funds, separate accounts, and other entities owned (in whole or in part), controlled, managed and/or advised by it or its Affiliates.
“Approved Financing Source” means (x) any bank or financial institution (or any Affiliate of such bank or financial institution) that, as of the date hereof, is a party to the Company Credit Agreement or is ranked among the top twenty (20) mandated lead arrangers by volume in the applicable leveraged loans league table most recently published by either Bloomberg Finance L.P. or London Stock Exchange Group plc (or any of their respective Affiliates or successors) or (y) a Debt Financing Source that constitutes any commercial bank, investment bank, insurance company, finance company, or other financial institution that: (a) is organized under the laws of the United States, any member state of the European Union, the United Kingdom, Switzerland, Japan, Norway, or Canada; (b) is subject to prudential supervision by a recognized banking or financial regulatory authority and (c) maintains consolidated total assets of not less than $50 billion (or the equivalent thereof in another currency) as reflected in its most recent audited financial statements and maintains investment-grade long term unsecured debt rating, in the case of this clause (c), determined as of the date that such Debt Financing Source enters into the Fully Committed Syndicated Commitment Letter.
“Atlas” means Atlas SP Partners, L.P.
“Available Funding Amounts” means, without duplication, the amount of the Equity Financing, the Preferred Financing, the rollover of the Company Rollover Notes (to the extent such Company Rollover Notes are not required to be purchased or repaid in connection with the Transactions), available cash of the Company and its Subsidiaries and other sources of funding that would be available to Parent on the Closing Date to satisfy the Financing Uses and which have conditions to availability that are no more restrictive than those applicable to the Debt Financing.
“Backstop Commitment Letter” means the debt commitment letter providing, initially, for a 100% commitment by Apollo and Atlas (subject to their respective rights to syndicate as permitted therein), dated as of the date of this Agreement, pursuant to which the Debt Financing Sources party thereto have committed to provide the Debt Financing set forth therein.
“Backstop Trigger Event” means, at any time prior to the termination of the Backstop Commitment Letter and unless another time is agreed to in writing by Parent and the Company, the earliest to occur of (a) 11:59 p.m., New York City time, on December 31, 2026, if prior to such time the Fully Committed Syndicated Commitment Letter shall not have become effective, (b) the date on which the Syndicated Commitment Letter is terminated in accordance with its terms (other than in connection with the funding thereof) and (c) the date, if any, on which Parent notifies the Company in writing that it has elected for the Debt Financing to be provided pursuant to the Backstop Commitment Letter.
“Burdensome Condition” means any undertakings, terms, conditions, liabilities, obligations, commitments, sanctions or other measures (including any Remedial Action) that would have or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the business, assets, results of operations or condition (financial or otherwise) of Parent, Thrive Holdings, the Company and their respective Subsidiaries and Affiliates, taken as a whole; provided, however, that, for this purpose, Parent, Thrive Holdings, the Company and their respective Subsidiaries and Affiliates, taken as a whole, both before and after giving effect to the Merger, shall be deemed to be a consolidated group of entities of the size and scale of a hypothetical company that is 100% of the size and scale of the Company and its Subsidiaries, taken as a whole as of the date of this Agreement.
“Business Day” means a day except a Saturday, a Sunday or other day on which the banking institutions in the City of New York, New York are authorized or required by Law or executive order to be closed.
“Code” means the Internal Revenue Code of 1986.
“Collective Bargaining Agreement” means each collective bargaining, works council or other labor union Contract or labor arrangement covering any employee of the Company or any of its Subsidiaries.
“Company Charter Documents” means the Company’s certificate of incorporation and bylaws, each as amended and/or restated, as the case may be, and as in effect on the date of this Agreement.
“Company Credit Agreement” means the Twenty-First Amended and Restated First Lien Credit Agreement, dated as of July 1, 2015, by and among Prime Security Services Holdings, LLC, a Delaware limited liability company, Prime Security Services Borrower, LLC, a Delaware limited liability company, The ADT Security Corporation, a Delaware corporation, the other subsidiary loan parties party thereto and Barclays Bank PLC, as administrative agent, as amended, restated, amended and restated, supplemented or otherwise modified from time to time.
“Company Term Loan Credit Agreement” means the Term Loan Credit Agreement, dated as of October 28, 2025, by and among Prime Security Services Holdings, LLC, a Delaware limited liability company, Prime Security Services Borrower, LLC, a Delaware limited liability company, The ADT Security Corporation, a Delaware corporation, the other lenders party thereto and Fifth Third Bank, National Association, as administrative agent, as amended, restated, amended and restated, supplemented or otherwise modified from time to time.
“Company IT Assets” means the IT Assets owned by or used by or on behalf of the Company or any of its Subsidiaries in the operation of the businesses of the Company or any of its Subsidiaries.
“Company Lease” means any lease, sublease, license or other agreement (including any amendments, guaranties, assignments or other documents related thereto) pursuant to which the Company or any of its Subsidiaries leases, subleases, licenses or occupies any Leased Real Property.
“Company Notes” means the Company’s (a) 3.375% First-Priority Senior Secured Notes due 2027, (b) 4.125% First-Priority Senior Secured Notes due 2029, (c) 4.875% First-Priority Senior Secured Notes due 2032, (d) 5.875% First-Priority Senior Secured Notes due 2033 and (e) 4.875% Notes due 2042.
“Company Rollover Notes” means the Company Notes described in clauses (b) through (e) of the definition thereof.
“Company Plan” means each plan, program, policy, agreement or other arrangement covering current or former directors, employees or individual consultants of the Company or any of its Subsidiaries, that is (a) an employee welfare plan within the meaning of Section 3(1) of ERISA (whether or not subject to ERISA), (b) an employee pension benefit plan within the meaning of Section 3(2) of ERISA, (c) an equity or equity-based agreement, program or plan, (d) an individual employment, consulting, change-in-control, severance, retention or other similar agreement or (e) a bonus, incentive, deferred compensation, profit-sharing, retirement, post-retirement, vacation, severance or termination pay, benefit or fringe benefit plan, program, policy, agreement or other arrangement, in each case, that is sponsored, maintained or contributed to by the Company or any of its Subsidiaries or which the Company or any of its Subsidiaries has any obligation or liability with respect to, other than any Multiemployer Plan, any Collective Bargaining Agreement or any plan, program, policy, agreement or arrangement maintained solely by a Governmental Authority and to which contributions by the Company or any of its Subsidiaries are mandated by applicable Law.
“Company RSU” means a restricted stock unit with respect to Company Common Stock.
“Company Stock Option” means an option to purchase shares of Company Common Stock.
“Compliant” means, with respect to Syndicated Financing Materials, that (a) such Required Financing Information does not contain any untrue statement of a material fact or omit to state any material fact necessary to make such Required Financing Information not misleading in light of the circumstances under which it was made available (giving effect to all supplements and updates provided therewith); (b) such Required Financing Information is, and remains throughout the Marketing Period, compliant in all material respects with all applicable requirements of Regulation S-K and Regulation S-X under the Securities Act for a registered public offering of non-convertible debt securities on a registration statement on Form S-1 that are applicable to such Required Financing Information (other than such provisions for which compliance is not customary in a “Rule-144A-for-life” offering of non-convertible high-yield debt securities of such type or is otherwise expressly excluded pursuant to the terms of this Agreement); and (c) the financial statements and other financial information included in such Required Financing Information that is available to Parent on the first day of the Marketing Period would be sufficiently current to satisfy the requirements of Rule 3-12 of Regulation S-X under the Securities Act to permit a registration statement using such financial statements to be declared effective by the Securities and Exchange Commission on the last day of the Marketing Period and would not become “stale” or otherwise be unusable under customary practices for “Rule-144A-for-life” offerings of non-convertible high-yield debt securities on any day during the eighteen (18) consecutive Business Day period beginning on such date and are sufficient to permit the Company’s independent auditors to issue a customary “comfort” letter to the Debt Financing Sources, including as to negative assurances and change period, in order to consummate any “Rule-144A-for-life” offering of non-convertible high-yield debt securities on any day during the Marketing Period (and such auditors have confirmed they are prepared to issue such customary comfort letters subject to their completion of customary procedures).
“Contract” means any loan or credit agreement, indenture, debenture, note, bond, mortgage, deed of trust, lease, sublease, license, contract or other legally binding agreement (whether written or oral).
“Copyright” has the meaning set forth in the definition of Intellectual Property.
“Debt Financing Documents” means the agreements, documents and certificates contemplated by the Debt Financing, including, without limitation: (a) all credit agreements, loan documents, purchase agreements, underwriting agreements, indentures, debentures, notes, intercreditor agreements, mortgages and other security documents pursuant to which the Debt Financing will be governed or otherwise contemplated by the Debt Commitment Letter; (b) officer, secretary, solvency (including a solvency certificate in the form attached to the Debt Commitment Letter) and perfection certificates, legal opinions, corporate organizational documents, good standing certificates, Lien searches, and resolutions contemplated by the Debt Commitment Letter or reasonably requested by Parent or its Debt Financing Sources; (c) all documentation and other information required by bank regulatory authorities under applicable
“know-your-customer” and anti-money laundering rules and regulations, including, but not limited to, the Patriot Act; and (d) agreements, documents or certificates that facilitate the creation, perfection or enforcement of Liens securing the Debt Financing (including original copies of all certificated securities (with transfer powers executed in blank) and control agreements) as are reasonably requested by Parent or its Debt Financing Sources.
“Debt Financing Sources” means the Persons that have committed to provide or arrange, or have otherwise entered into agreements in connection with, any Debt Financing (including any Alternative Financing), or that have agreed to purchase or place securities, or arrange or provide loans, in lieu of all or any portion of the Debt Financing, in each case, in connection with the Transactions, including the parties to any Debt Commitment Letter, Fee Letter, joinder agreement, engagement letter, fee credit letter, purchase agreement, note purchase agreement, indenture or credit agreement entered into pursuant thereto or relating thereto, together with their respective successors and assigns, and in each case whether or not any commitment of such Person has been reduced, terminated or replaced.
“Debt Financing Sources Related Party” means the Debt Financing Sources and the Preferred Financing Sources together with their respective Affiliates, and the respective directors, officers, employees, partners, members, managers, agents, advisors, controlling persons, and the other representatives, successors and assigns of each of the foregoing.
“Domain Name” has the meaning set forth in the definition of Intellectual Property.
“Equity Plans” means, collectively, the Company’s 2016 Equity Incentive Plan and the 2018 Omnibus Incentive Plan, each as may be amended from time to time, and any awards granted as “inducement grants” under relevant stock exchange rules.
“Equity-Based Awards” means, collectively, Company RSUs and Company Stock Options.
“ERISA” means the Employee Retirement Income Security Act of 1974.
“Excluded Party” means any Person, group of Persons or group that includes any Person (so long as such Person, together with all other members of such group, if any, who were members of such group or another group that included such Person immediately prior to the No-Shop Period Start Date, represent at least 50% of the equity financing of such group at all times following the No-Shop Period Start Date and prior to the termination of this Agreement) from whom the Company or any of its Representatives has received, after the execution of this Agreement and prior to the expiration of the Go-Shop Period (for the avoidance of doubt, not including during any Go-Shop Extension), a Takeover Proposal that the Board of Directors of the Company or any committee thereof determines, in good faith and after consultation with its financial advisor and outside legal counsel, constitutes or would reasonably be expected to lead to a Superior Proposal; provided, however, that any Person shall immediately and irrevocably cease to be an Excluded Party if, at any time after the No-Shop Period Start Date, the Takeover Proposal submitted by such Person is withdrawn or terminated or the Board of Directors of the Company (or any duly authorized committee thereof) determines that such Takeover Proposal no
longer is, or no longer would reasonably be expected to lead to, a Superior Proposal. A Person or group of Persons shall cease to be an Excluded Party when the condition set forth in the parenthetical in the immediately preceding sentence is no longer satisfied with respect to such Person or group of Persons and the Board of Directors of the Company receives written notice thereof.
“Financing Cooperation Expenses” means the costs and expenses payable by Parent (or its Affiliates) pursuant to Section 5.14(d) and Section 5.15(d).
“Financing Cooperation Expenses Cap” means $3,000,000.
“Fraud” means Delaware common law fraud of any Person in connection with the representations and warranties set forth in Article III and Article IV or the certificate delivered pursuant to Section 6.02(c) or Section 6.03(d), as applicable.
“GAAP” means generally accepted accounting principles in the U.S., consistently applied.
“Governmental Authority” means any government, court, regulatory or administrative agency, commission or authority or other legislative, executive or judicial governmental entity (in each case including any self-regulatory organization), whether federal, state or local, domestic, foreign or multinational or arbitral body (public or private).
“Hazardous Substances” means any materials, substances, chemicals or wastes that are defined, classified or otherwise regulated as hazardous or toxic, or as a pollutant or contaminant under Environmental Laws.
“HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
“Indenture” means each of the following (collectively, the “Indentures”): (a) that certain Indenture, dated as of July 5, 2012, by and among The ADT Corporation and Wells Fargo Bank, National Association, as trustee; (b) that certain Indenture, dated as of May 2, 2016, by and among Prime Security One MS, Inc. and Wells Fargo Bank, National Association, as trustee; (c) that certain Indenture, dated as of August 20, 2020, by and among Prime Security Services Borrower, LLC, Prime Finance Inc., the guarantors party thereto and Wells Fargo Bank, National Association, as trustee; (d) that certain Indenture, dated as of July 29, 2021, by and among The ADT Security Corporation, the guarantors party thereto and Wells Fargo Bank, National Association, as trustee; and (e) that certain Indenture, dated as of October 15, 2025, by and among The ADT Security Corporation, the guarantors party thereto and Computershare Trust Company, N.A., as trustee, in each case as amended or supplemented from time to time.
“Intellectual Property” means the following, in any and all countries: (a) patents, utility models and industrial designs, and all applications and issuances therefor, together with all reissuances, divisionals, renewals, revisions, extensions, reexaminations, provisionals, continuations and continuations-in-part with respect thereto (“Patent”); (b) trademarks, trade names, service marks, trade dress or other indicia of origin, and all applications, registrations and renewals therefor, together with the goodwill associated with any of the foregoing (“Trademark”); (c) copyrights and all applications and registrations therefor (“Copyright”); (d)
all registrations of internet domain names (“Domain Name”); (e) rights in Software; (f) any trade secrets and rights in inventions, know-how or other confidential and proprietary information (“Trade Secret”); and (g) any other intellectual property arising in any jurisdiction.
“Intervening Event” means any effect, change, event, fact, circumstance, occurrence or development with respect to the Company and its Subsidiaries, taken as a whole, that, irrespective of when such effect, change, event, fact, circumstance, occurrence or development occurred, was not known or reasonably foreseeable by the Board of Directors of the Company (or if known to the Board of Directors of the Company, the consequences of which were not known or reasonably foreseeable as of the date of this Agreement) as of or prior to the date of this Agreement, which becomes known prior to the Company Stockholders’ Meeting; provided that, in no event shall any of the following constitute an Intervening Event: (a) the receipt, existence or terms of any Takeover Proposal or offer, inquiry or proposal that could reasonably lead to a Takeover Proposal, (b) any change in the market price, trading volume or ratings of any securities or Indebtedness of the Company or any of its Subsidiaries and (c) the fact that the Company meets or exceeds, or fails to meet or exceed, internal or public projections, forecasts, guidance, estimates, milestones, budgets or internal or published financial or operating predictions of revenue, earnings, cash flow or cash position (it being understood that the exceptions in clauses (b) and (c) shall not prevent or otherwise affect a determination that the underlying cause of any such change, decline or failure referred to therein that are not otherwise excluded from the definition of “Intervening Event” may be taken into account) or the consequences of any of the foregoing.
“IRS” means the Internal Revenue Service.
“IT Assets” means computer and other information technology and communication systems and networks, including hardware, Software, computer systems, databases and documentation, reference and resource materials relating thereto.
“Knowledge” means (i) with respect to the Company, the actual knowledge, as of the date of this Agreement, of the individuals listed on Section 8.12 of the Company Disclosure Letter and (ii) with respect to Parent or Merger Sub, the actual knowledge, as of the date of this Agreement, of any of the officers or directors of Parent or Merger Sub.
“Leased Real Property” means any real property that is leased, subleased or licensed by the Company or any of its Subsidiaries from any third party (in each case, whether as tenant, subtenant or licensee) that (a) provides for annual base rental payments in excess of $250,000 or (b) is otherwise material to the business of the Company and its Subsidiaries, taken as a whole.
“Lien” means any pledge, lien, charge, license, encumbrance or security interest of any kind or nature.
“Marketing Period” means the first period of eighteen (18) consecutive Business Days after the earlier of (x) December 31, 2026 and (y) solely if the Backstop Trigger Event has not occurred, the date on which the Fully Committed Syndicated Commitment Letter becomes effective, in either case, throughout which (i) Parent has received the applicable Required
Financing Information and solely in the case of Syndicated Financing Materials, such Required Financing Information remains Compliant during such eighteen (18) consecutive Business Day period and (ii) (A) all of the conditions set forth in Article VI (other than Section 6.01(c)) have been satisfied or waived (other than conditions that by their nature can only be satisfied on the Closing Date) and no event has occurred and no condition exists that would cause any of the conditions set forth in Article VI (other than Section 6.01(c)) not to be satisfied (other than conditions that by their nature can only be satisfied on the Closing Date) assuming that the Closing were to be scheduled at any time during such eighteen (18) Business Day period and (B) commencing no earlier than the eighth Business Day prior to the Company Stockholders Meeting (for the avoidance of doubt, in the case of this clause (B), (I) if the Marketing Period would end after February 11, 2027, the Marketing Period shall not start until Required Financing Information that is Compliant, including audited financial statements for the year ended December 31, 2026, has been delivered and (II) in the event that any Company Stockholder meeting is adjourned, cancelled or postponed, the Marketing Period as then in effect shall terminate and a new Marketing Period shall commence on the eighth Business Day prior to the Company Stockholders Meeting as rescheduled), or, in the case of this clause (ii), if earlier, the date on which Parent in its sole discretion notifies the Company that it intends to commence the Marketing Period; provided that (A) November 26, 2026, November 27, 2026, January 18, 2027, February 15, 2027, May 31, 2027, June 18, 2027, July 4, 2027 and July 5, 2027 shall not constitute Business Days for purposes of calculating the Marketing Period (provided, however, that such exclusion shall not restart such period) and (B) solely in the case of Syndicated Financing Materials, if the Marketing Period has not been completed on or prior to December 18, 2026, the Marketing Period shall not commence until January 4, 2027; and provided, further, that the Marketing Period shall not be deemed to have commenced if, solely in the case of Syndicated Financing Materials, prior to the completion of such eighteen (18) consecutive Business Day period, (x) the auditor of the applicable audited financial statements of the Company has withdrawn, or has notified Parent in writing that it intends to withdraw, its audit opinion with respect to any audited financial statements included in the Required Financing Information (in which case such eighteen (18) consecutive Business Day period shall not commence unless and until a new unqualified audit opinion is issued with respect to such audited financial statements of the Company for the applicable periods by such firm or another independent public accounting firm reasonably acceptable to Parent (it being understood that any “big four” accounting firm will be deemed acceptable)), (y) the Company shall have publicly announced any intention, or the board of directors of the Company shall have determined, to restate any financial statements included in the Required Financing Information (in which case such eighteen (18) consecutive Business Day period shall not commence unless and until such restatement has been completed and the applicable Required Financing Information has been amended or the Company has announced that it has concluded that no restatement shall be required in accordance with GAAP) or (z) any Required Financing Information that constitutes Syndicated Financing Materials would not be Compliant at any time during such eighteen (18) consecutive Business Day period or otherwise ceases to meet the requirements of “Required Financing Information” as defined, in which case such eighteen (18) Business Day period shall not commence or be deemed to commence unless and until, at the earliest, such Required Financing Information is Compliant and meets the definition of “Required Financing Information” (it being understood that if any Required Financing Information provided at the commencement of such eighteen (18) Business Day period ceases to be Compliant or meet the
definition of “Required Financing Information” during such eighteen (18) Business Day period, then such eighteen (18) Business Day period will be deemed not to have commenced). If the Company reasonably and in good faith believes that it has delivered the Required Financing Information to Parent and that the Marketing Period has commenced, the Company shall deliver to Parent a written notice setting forth the date on which it believes the delivery of the Required Financing Information was completed and the Marketing Period commenced, and, subject to the foregoing provisos, the Marketing Period will be deemed to have commenced as of the date of delivery of such notice, unless Parent reasonably and in good faith believes that the Marketing Period has not commenced and, within three (3) Business Days after the delivery of such notice by the Company, delivers a written notice to the Company describing with reasonable specificity the reason(s) that Parent disagrees with the notice delivered by the Company.
“Material Adverse Effect” means any effect, change, event or occurrence that has, or would be reasonably expected to have, a material adverse effect on the business, assets, results of operations or condition (financial or otherwise) of the Company and its Subsidiaries, taken as a whole; provided, however, that none of the following, and no effect, change, event or occurrence arising out of, or resulting from, the following, shall constitute or be taken into account in determining whether a Material Adverse Effect has occurred, is continuing or would reasonably be expected to occur: any effect, change, event or occurrence (A) generally affecting the industry in which the Company and its Subsidiaries operate or the economy, credit or financial or capital markets, in the U.S. or elsewhere in the world, including changes in interest or exchange rates, monetary policy, inflation, tariffs, sanctions, trade policies or trade wars, or (B) to the extent arising out of, resulting from or attributable to (1) any change in Law or in GAAP, or any change in the interpretation or enforcement of any of the foregoing, in each case after the date of this Agreement, or any change in general legal, regulatory, political or social conditions, (2) the negotiation, execution, announcement or performance of this Agreement or the consummation of the Transactions (other than for purposes of any representation or warranty contained in Sections 3.03(e) and 3.04 or the condition to closing in Section 6.02(a) as it relates to any such representation or warranty), including the impact thereof on relationships, contractual or otherwise, with customers, suppliers, landlords, distributors, partners, employees or regulators, or any litigation arising from allegations of breach of fiduciary duty or violation of Law relating to this Agreement or the Transactions, (3) acts of war (whether or not declared), military activity, sabotage, civil disobedience, social unrest, protests, terrorism (including cyberterrorism or cyberattacks not specifically directed at the Company or its Subsidiaries), or any escalation or worsening of any such acts of war (whether or not declared), military activity, sabotage, civil disobedience, social unrest, protests or terrorism, (4) earthquakes, fires, floods, hurricanes, tornados or other natural disasters, weather-related events, casualty events, or other force majeure events, (5) (x) any action taken by the Company or its Subsidiaries that is expressly required by this Agreement, (y) any action taken by the Company or its Subsidiaries with Parent’s express written consent or at Parent’s express written request, or (z) the failure to take any action by the Company or its Subsidiaries if that action is expressly prohibited by this Agreement (provided, that this clause (z) shall not apply to any action omitted to be taken pursuant to Section 5.01 unless the Company has requested to take an action prohibited by Section 5.01 and Parent has unreasonably withheld, delayed or conditioned its written consent to such action), (6) any change or prospective change in the Company’s credit ratings, (7) any decline in the market price, or change in trading volume, of the shares of the Company, (8) any failure to meet any internal or public projections, forecasts, guidance, estimates, milestones,
budgets or internal or published financial or operating predictions of revenue, earnings, cash flow or cash position (it being understood that the exceptions in clauses (6), (7) and (8) shall not prevent or otherwise affect a determination that the underlying cause of any such change, decline or failure referred to therein (if not otherwise falling within any of the exceptions provided by clause (A) and clauses (B)(1) through (8)) is a Material Adverse Effect) or (9) any epidemic, pandemic or disease outbreak; provided, further, however, that any effect, change, event or occurrence referred to in clause (A) or clauses (B)(1), (3), (4) or (9) may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect to the extent such effect, change, event or occurrence has a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, as compared to other participants in the industry in which the Company and its Subsidiaries operate (in which case only the incremental disproportionate impact or impacts may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect).
“Multiemployer Plan” means any “multiemployer plan” within the meaning of Section 3(37) or 4001(a)(3) of ERISA.
“Owned Company Intellectual Property” means all Intellectual Property owned or purported to be owned by the Company or any of its Subsidiaries.
“Owned Real Property” means all land, together with all buildings and other structures, improvements and fixtures located thereon, and all easements and other rights and interests appurtenant thereto, owned by the Company or any of its Subsidiaries.
“Parent Material Adverse Effect” means any effect, change, event or occurrence that would or would reasonably be expected to prevent or materially delay, interfere with, hinder or impair the consummation by Parent or Merger Sub of any of the Transactions in accordance with the terms hereof.
“Patent” has the meaning set forth in the definition of Intellectual Property.
“Permitted Liens” means (a) easements, rights-of-way, encroachments, restrictions, conditions, minor title defects and other similar Liens incurred or suffered in the ordinary course of business and which, individually or in the aggregate, do not and would not reasonably be expected to materially impair the use, utility or value of the applicable real property or otherwise materially impair the present or reasonably contemplated business operations at such location, (b) zoning, entitlement, building and other land use regulations imposed by Governmental Authorities having jurisdiction over such real property, (c) statutory Liens for Taxes not yet due and payable or the amount or validity of which are being contested in good faith by appropriate proceedings, (d) mechanics’, materialmen’s, carriers’, workmen’s, warehouseman’s, repairmen’s, landlords’ liens and similar Liens granted or which arise in the ordinary course of business and that are not yet due and payable or the amount or validity of which are being contested in good faith by appropriate proceedings and for which appropriate reserves have been established in accordance with GAAP, (e) Liens securing payment, or any obligation, with respect to outstanding Indebtedness so long as there is no event of default under such Indebtedness, (f) pledges or deposits under workmen’s compensation Laws, unemployment insurance Laws or similar legislation, or good-faith deposits in connection with bids, tenders,
Contracts (other than for the payment of Indebtedness) or leases to which such entity is a party, or deposits to secure public or statutory obligations of such entity or to secure surety or appeal bonds to which such entity is a party, or deposits as security for contested Taxes, in each case incurred or made in the ordinary course of business, (g) non-exclusive licenses granted to third parties in the ordinary course of business, (h) Liens discharged at or prior to the Effective Time, (i) purchase money Liens securing obligations under finance lease arrangements, (j) terms, conditions and restrictions under leases, subleases, licenses or occupancy agreements, including statutory Liens of landlords, affecting any leased real property, none of which materially impairs the present use of such leased real property, (k) Liens that have been placed by any developer, landlord or other third party on leased real property or property over which the Company or any of its Subsidiaries have easement rights and any subordination or similar agreements relating thereto, (l) any matters shown by a current, accurate survey or physical inspection of real property and (m) such other Liens that do not materially detract from the value of or materially impair the existing use of the asset or property affected by such Lien.
“Person” means an individual, corporation, limited liability company, partnership, joint venture, association, trust, unincorporated organization or any other entity, including a Governmental Authority.
“Personal Information” means any information relating to an identified or identifiable natural person and any other information that is defined as “personal data,” “personal information,” “personally identifiable information,” “biometric data,” or any related or similar term under applicable Law. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as a name, an identification number, location data, an online identifier or one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person.
“Preferred Financing Sources” means the Persons that have committed to provide or arrange, or have otherwise entered into agreements in connection with, any Preferred Financing in connection with the Transactions, including the parties to the Preferred Commitment Letter and any subscription agreement, certificate of designation, joinder agreement or similar agreement entered into pursuant thereto or relating thereto, together with their respective successors and assigns, and in each case whether or not any commitment of such Person has been reduced, terminated or replaced.
“Privacy Laws” means all applicable Laws regulating the privacy, collection, use, access, protection, security, deletion, selling, sharing, disclosure or other processing of Personal Information.
“Receivables Facility” means the receivables purchase facility evidenced by the Receivables Purchase Agreement, dated as of March 5, 2020, by and among ADT LLC, ADT Finance LLC, the various purchasers and purchaser agents from time to time party thereto and Mizuho Bank, Ltd. (as may be amended, restated or otherwise modified from time to time).
“Registered Company Intellectual Property” means all Patent registrations and applications therefor, Trademark registrations and applications therefor, Copyright registrations
and applications therefor and Domain Name registrations included in the Owned Company Intellectual Property.
“Representatives” means, with respect to any Person, its officers, directors, employees, consultants, agents, financial advisors, investment bankers, attorneys, accountants, other advisors, Affiliates and other representatives.
“Required Financing Information” means (a) if the Backstop Trigger Event shall have occurred, (x) the financial statements described in Paragraph 9 of Exhibit D of the Backstop Commitment Letter (it being understood that such obligation may be satisfied with the filing of such financial statements with the SEC) and (y) the Lender Marketing Materials in respect of the Backstop Commitment Letter (the information set forth in this clause (a) being, “Backstop Financing Materials”) or (b) in the event that the Backstop Trigger Event shall not have occurred (the information set forth in this clause (b) being, “Syndicated Financing Materials”), (i) the financial statements described in Paragraph 9 of Exhibit E of the Syndicated Debt Commitment Letter (it being understood that such obligation may be satisfied with the filing of such financial statements with the SEC) and all other financial, business and other information of the Company to the extent required in accordance with the requirements of Regulation S-X under the Securities Act for registered offerings of securities on Form S-1 (or any successor form thereto) under the Securities Act, and of the type and form, and for the periods customarily included in an offering memorandum used in a “Rule-144A-for-life” offering of non-convertible high-yield debt securities (including all audited financial statements, all unaudited financial statements (which will have been reviewed by the Company’s independent auditors as provided in AS 4105)), it being agreed that the timely filing of the Company’s Form 10-K or Form 10-Q in accordance with the Company’s obligations under the Exchange Act will be deemed to satisfy clause (a) and this clause (b); (ii) such other financial information regarding the Company (x) as may be reasonably requested by Parent to the extent such information is of the type and form customarily included in an offering memorandum for a “Rule-144A-for-life” offering of non-convertible high-yield debt securities (including, “flash” or “recent developments” financial information for such period to the extent reasonably requested by Parent for disclosure and reasonably reliable and readily available without unreasonable effort in such an offering memorandum customary for a “Rule 144A for life” offering of non-convertible high yield debt securities; or (y) as otherwise necessary to receive from the independent auditors of the Company customary “comfort” (including customary “negative assurance” and change period comfort) with respect to the financial information of the Company to be included in such offering memorandum together with drafts of customary comfort letters compliant with AS 6101, including customary “negative assurance” and change period comfort, with respect to the historical financial statements (and pro forma financial information to the extent customary and with respect to the Company’s information only) of the Company and periods following the end of the latest fiscal year or fiscal quarter, as applicable, for which historical financial statements are included in the applicable offering documents, in each case from the independent auditors of the Company, together with customary auditor consents and management representation letters, and confirmation that such auditors are prepared to deliver such comfort letters upon the “pricing” and “closing” of such offering upon completion of customary procedures during the Marketing Period and (iii) to the extent reasonably requested in writing by Parent, such financial and related information regarding the Company and its Subsidiaries as is necessary to permit Parent to prepare a customary “public side” and “private side” bank book regarding the business
of the Company and its Subsidiaries, in each case, to the extent required for the Debt Financing and required by the Debt Commitment Letters, together with customary authorization and representation letters duly executed on behalf of the Company and its Subsidiaries authorizing the distribution of information relating to the Company and its Subsidiaries to prospective lenders or investors and containing representations with respect to the presence of or absence of material non-public information relating to the Company and its Subsidiaries and the accuracy in all material respects of the information relating to the Company and its Subsidiaries contained therein (which authorization and representation letters will become effective before the Effective Time) (this clause (iii) being “Lender Marketing Materials”).
“Revolving Credit Facility” means the revolving credit facility established under the Company Credit Agreement.
“Sanctioned Country” means any country or region or government thereof that is, or has been since April 24, 2019, the subject or target of comprehensive Sanctions (at present, Cuba, Iran, North Korea, and the Crimea region and the so-called Donetsk People’s Republic and Luhansk People’s Republic in Ukraine).
“Sanctioned Person” means any Person that is (a) listed on any Sanctions-related list of designated or blocked persons, including the U.S. Department of the Treasury Office of Foreign Assets Control’s (“OFAC”) List of Specially Designated Nationals and Blocked Persons, or the Government of Venezuela, (b) located, organized, or ordinarily resident in a Sanctioned Country, (c) in the aggregate, 50 percent or greater owned, directly or indirectly, or otherwise controlled by a Person or Persons described in clauses (a)–(b) or (d) any national of a Sanctioned Country with whom U.S. persons are prohibited from dealing.
“Sanctions” means all U.S. and non-U.S. Laws relating to economic or trade sanctions, including the Laws administered or enforced by the United States (including by OFAC), the European Union and enforced by its member states, the United Nations, and His Majesty’s Treasury including limits on engaging with Sanctioned Persons or Sanctioned Countries.
“Software” means software, firmware, applications, programs, models (including artificial intelligence models and software implementations thereof), algorithms, operating systems, middleware, application programming interfaces (APIs), software development kits (SDKs) and any other computer software or code in any form (including source code and object code) or medium and including (a) data, databases, and collections of data and (b) documentation relating to any of the foregoing.
“Subsidiary”, when used with respect to any Person, means (a) any corporation, limited liability company, partnership, association, trust or other entity of which securities or other ownership interests representing more than 50% of the ordinary voting power (or, in the case of a partnership, more than 50% of the general partnership interests) are, as of such date, owned by such Person or one or more Subsidiaries of such Person or by such Person and one or more Subsidiaries of such Person or (b) of which such Person or one of its Subsidiaries is a general partner or manager.
“Syndicated Commitment Letter” means the debt commitment letter providing the Debt Financing described therein by Apollo (and, for the avoidance of doubt, which is not the Backstop Commitment Letter), dated as of the date of this Agreement, pursuant to which the Debt Financing Sources party thereto (including any Approved Financing Sources that become party thereto pursuant to any amendment and restatement or joinder thereto, to the extent permitted hereby) have committed to provide, among other things, Debt Financing of the type contemplated therein.
“Tax Returns” means all Tax returns, declarations, statements, reports, schedules, forms and information returns and statements relating to Taxes, including any schedules and attachments thereto and any amendments thereof, in each case required or permitted to be filed with any Governmental Authority.
“Taxes” means all U.S. federal, state, local, or non-U.S. taxes or similar duties, fees or charges or assessments thereof imposed by a Governmental Authority, in each case in the nature of a tax, including any income, gross receipts, capital stock, franchise, profits, withholding, social security, employment, unemployment, disability, real property, ad valorem/personal property, stamp, excise, occupation, capital, documentary, goods and services, harmonized sales, intangible, mortgage, payroll, production, recording, rent, windfall profits, gains, inventory, sales, use, transfer, value added, alternative minimum, estimated or other tax, including any interest, penalties and additions imposed with respect to such amounts, whether disputed or not.
“Thrive Holdings” means FLB Partners T, L.P., a Delaware limited partnership.
“Trade Secret” has the meaning set forth in the definition of Intellectual Property.
“Trademark” has the meaning set forth in the definition of Intellectual Property.
“Transactions” means, collectively, the transactions contemplated by this Agreement, including the Merger and the Financing.
“WARN Act” means the Worker Adjustment and Retraining Notification Act of 1988 or any similar Law.
The following terms are defined in the Section of this Agreement set forth after such term below:
| | | | | |
Terms Not Defined in this Section 8.12 | Section |
Acceptable Confidentiality Agreement | 5.02(f) |
Action | 3.07 |
Adverse Recommendation Change | 5.02(d) |
Agreement | Preamble |
Alternative Financing | 5.14(g) |
Announcement | 5.04 |
Appraisal Shares | 2.06(a) |
Balance Sheet Date | 3.05(c) |
| | | | | |
Terms Not Defined in this Section 8.12 | Section |
Bankruptcy and Equity Exception | 3.03(a) |
Book-Entry Share | 2.01(c) |
Capitalization Date | 3.02(a) |
Certificate of Merger | 1.03 |
Citi | 3.19(a) |
Claim | 5.06(c) |
Class B Common Stock | Recitals |
Closing | 1.02 |
Closing Date | 1.02 |
Commitment Letters | 4.05(a) |
Common Stock | Recitals |
Company | Preamble |
Company Acquisition Agreement | 5.02(d) |
Company Board Recommendation | Recitals |
Company Common Stock | Recitals |
Company Disclosure Letter | Article III |
Company ERISA Affiliate | 3.10(c) |
Company Multiemployer Plan | 3.10(d) |
Company Preferred Stock | 3.02(a) |
Company Related Parties | 7.03(d) |
Company SEC Documents | 3.05(a) |
Company Securities | 3.02(b) |
Company Stock Option | 2.03(b) |
Company Stockholder Approval | 3.03(c) |
Company Stockholders’ Meeting | 5.12(b) |
Company Termination Fee | 7.03(a)(ii) |
Consent | 5.03(a) |
Contingent Cash Award | 2.03(c) |
Continuing Employee | 5.07(a) |
Debt Commitment Letter | 4.05(a) |
Debt Financing | 4.05(a) |
DGCL | Recitals |
DOJ | 5.03(d) |
DPA | 4.13 |
DTC | 2.02(b)(i) |
Effective Time | 1.03 |
Environmental Laws | 3.12 |
Equity Financing | 4.05(a) |
Equity Commitment Letter | 4.05(a) |
Equity Commitment Party | 4.05(a) |
Exchange Act | 3.04 |
Exchange Fund | 2.02(a) |
Excluded Information | 5.15(b)(ix) |
Fee Letters | 4.05(b) |
| | | | | |
Terms Not Defined in this Section 8.12 | Section |
Filed SEC Documents | Article III |
Financing | 4.05(a) |
Financing Uses | 4.05(e) |
FTC | 5.03(e) |
Go-Shop Extension | 5.02(a) |
Go-Shop Period | 5.02(a) |
Goldman Sachs | 3.19(b) |
Guarantee | 4.06 |
Guarantor | Preamble |
Indebtedness | 5.01(b)(v) |
Indemnitee | 5.06(a) |
Inside Date | 1.02 |
Judgment | 3.07 |
Laws | 3.08(a) |
Lookback Date | 3.05(a) |
Material Contract | 3.16(a) |
Merger | Recitals |
Merger Consideration | 2.01(c) |
Merger Sub | Preamble |
No-Shop Period Start Date | 5.02(b) |
Nondisclosure Agreement | 5.05 |
NYSE | 3.04 |
Outside Date | 7.01(b)(i) |
Parent | Preamble |
Parent Related Parties | 7.03(d) |
Parent Termination Fee | 7.03(b) |
Paying Agent | 2.02(a) |
Payoff Indebtedness | 5.16 |
Payoff Letters | 5.16 |
Permits | 3.08(b) |
Proxy Statement | 3.04 |
Remedial Action | 5.03(e) |
Restraints | 6.01(a) |
SEC | 3.04 |
Secretary of State of Delaware | 1.03 |
Securities Act | 3.02(d) |
Senior Service Provider | 5.01(b)(xii) |
Share Certificate | 2.01(c) |
Superior Proposal | 5.02(h) |
Surviving Corporation | 1.01 |
Takeover Law | 3.21(b) |
Takeover Proposal | 5.02(g) |
Top Vendors | 3.21 |
U.S. | 2.02(a) |
SECTION 8.13.Fees and Expenses. Whether or not the Transactions are consummated, all fees and expenses incurred in connection with this Agreement and the Transactions shall be paid by the party incurring or required to incur such fees or expenses, except as otherwise expressly set forth in this Agreement.
SECTION 8.14.Performance Guaranty. As a condition and inducement to the Company’s willingness to enter into this Agreement, Parent hereby absolutely, unconditionally and irrevocably guarantees to the Company the due, prompt and faithful performance and discharge by, and compliance with, all of the obligations, covenants, terms, conditions and undertakings of Merger Sub under this Agreement, including any obligations required to be performed after the Effective Time by the Surviving Corporation.
SECTION 8.15.No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, each of Parent, Merger Sub and the Company acknowledges and agrees, on behalf of itself and the Parent Related Parties or Company Related Parties, as applicable, that (i) none of the Debt Financing Sources Related Parties shall have any liability to the Company or any of its equityholders and Affiliates relating to or arising out of this Agreement or the Debt Financing and (ii) no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement, including any Debt Commitment Letter, shall be had against, and no rights or claims shall be asserted against, any Person that is not a party to this Agreement or the applicable document, including any past, present or future director, officer, partner, agent or employee of Parent, Merger Sub, Guarantor, the Company or any of their respective Affiliates or assigns, any Debt Financing Sources Related Parties or any other guarantor not a party hereto or thereto, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable Law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any past, present or future director, officer, partner, agent or employee of (x) Parent, the Company, Guarantor or of any Affiliate or assignee thereof, as such, or (y) any Debt Financing Sources Related Party, in each case, solely for any obligation under this Agreement or any documents or instruments delivered in connection with this Agreement, including any Debt Commitment Letter, for any claim based on, in respect of or by reason of such obligations or their creation or the performance of services thereunder; provided, however, that, notwithstanding the foregoing, nothing in this Section 8.15 shall in any way limit or modify (i) the rights and obligations of any Debt Financing Sources Related Parties’ obligations to Parent, Merger Sub or Guarantor, as applicable, under any Debt Commitment Letter or (ii) the rights of Parent, Merger Sub, the Surviving Corporation and their respective Subsidiaries against the Debt Financing Sources Related Parties under any Debt Commitment Letter or any Debt Financing Documents with respect to the Debt Financing following the Closing.
SECTION 8.16.Interpretation. (a) When a reference is made in this Agreement to an Article, Section, Exhibit or Schedule, such reference shall be to an Article of, a Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the words “include”, “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the
words “without limitation”. The words “hereof”, “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The words “date hereof” when used in this Agreement shall refer to the date of this Agreement. The terms “or”, “any” and “either” are not exclusive. The word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply “if”. The word “will” shall be construed to have the same meaning and effect as the word “shall”. The words “made available to Parent” and words of similar import refer to documents (A) posted to the “Project Floreo” electronic datasite hosted by Intralinks on behalf of the Company at least one Business Day prior to the date of this Agreement or (B) included in the Filed SEC Documents. All accounting terms used and not defined herein shall have the respective meanings given to them under GAAP. All terms defined in this Agreement shall have the defined meanings when used in any document made or delivered pursuant hereto unless otherwise defined therein. The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. Any statute defined or referred to herein or in any agreement or instrument that is referred to herein means such statute as from time to time amended, modified or supplemented, including by succession of comparable successor statutes and references to all attachments thereto and instruments incorporated therein. References herein to any statute include all rules and regulations promulgated thereunder. Unless otherwise specifically indicated, all references to “dollars” or “$” shall refer to the lawful money of the U.S. References to a Person are also to its permitted assigns and successors. References to equity securities, equity interests or any derivation thereof or similar concept contained herein means any share, share capital, capital stock, partnership, membership, joint venture or similar equity or equity-like interest of any kind or nature (including any share or stock appreciation, phantom stock, profit participation or similar rights), and any option, warrant, right or security (including debt securities) convertible, exchangeable or exercisable therefor.
(b)The parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party hereto by virtue of the authorship of any provision of this Agreement.
[Signature page follows]
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered as of the date first above written.
| | | | | | | | |
ABODE PARENT, LLC |
| | |
| by | |
| | /s/ Joshua Kushner |
| | Name: Joshua Kushner |
| | Title: Chief Executive Officer |
[Signature Page to Agreement and Plan of Merger]
| | | | | | | | |
ABODE MERGER SUB, INC. |
| | |
| by | |
| | /s/ Joshua Kushner |
| | Name: Joshua Kushner |
| | Title: Chief Executive Officer |
[Signature Page to Agreement and Plan of Merger]
| | | | | | | | |
ADT INC. |
| | |
| by | |
| | /s/ James D. DeVries |
| | Name: James D. DeVries |
| | Title: President and Chief Executive Officer |
[Signature Page to Agreement and Plan of Merger]
Certificate of Incorporation of the Surviving Corporation
[attached]
October 28, 2026
The Board of Directors
ADT Inc.
1501 Yamato Road
Boca Raton, FL 33431
Members of the Board:
You have requested our opinion as to the fairness, from a financial point of view, to the holders of the Company Common Stock (as defined below) of ADT Inc. (the “Company”) of the Merger Consideration (as defined below) to be received by such holders pursuant to the terms and subject to the conditions set forth in an Agreement and Plan of Merger (the “Merger Agreement”) proposed to be entered into by and among Abode Parent, LLC (“Parent”), Abode Merger Sub, Inc., a wholly owned subsidiary of Parent (“Merger Sub”), and the Company. As more fully described in the Merger Agreement, (i) Merger Sub will be merged with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent, and (ii) each issued and outstanding share of the common stock, par value $0.01 per share, of the Company (“Common Stock”), and each issued and outstanding share of the Class B Common Stock, par value $0.01 per share, of the Company (“Class B Common Stock” and, together with the Common Stock, “Company Common Stock”), other than shares owned by the Company as treasury shares, shares held by Parent or Merger Sub and Appraisal Shares (as defined in the Merger Agreement), will be converted into the right to receive $10.00 in cash (the “Merger Consideration”), without interest. The terms and conditions of the Merger are more fully set forth in the Merger Agreement.
In arriving at our opinion, we reviewed a draft, dated October 28, 2026, of the Merger Agreement and held discussions with certain senior officers, directors and other representatives and advisors of the Company concerning the business, operations and prospects of the Company. We reviewed certain publicly available business and financial information relating to the Company as well as certain financial forecasts and other information and data relating to the Company which were prepared and provided to or discussed with us by the management of the Company. We reviewed the financial terms of the Merger as set forth in the Merger Agreement in relation to, among other things: current and historical market prices and trading volumes of Company Common Stock; certain historical and projected earnings and other operating data of the Company; and the capitalization and financial condition of the Company. In addition to the foregoing, we conducted such other analyses and examinations and considered such other information and financial, economic and market criteria as we deemed appropriate in arriving at our opinion. The issuance of our opinion has been authorized by our fairness opinion committee.
In rendering our opinion, we have assumed and relied, without independent verification, upon the accuracy and completeness of all financial and other information and data publicly available or provided to or otherwise reviewed by or discussed with us and upon the assurances of the management of the Company that they are not aware of any relevant information that has been omitted or that remains undisclosed to us. With respect to financial forecasts and other information and data relating to the Company provided to or otherwise reviewed by or discussed with us, we have been advised by the management of the Company, and we have assumed, with your consent, that such forecasts and other information and data were reasonably prepared in good faith on bases reflecting the best currently available estimates and judgments of the management of the Company as to, and are a reasonable basis upon which to evaluate, the future financial performance of the Company. We express no view or opinion as to any financial and other information or data (or any underlying assumptions on which any
The Board of Directors
ADT Inc.
October 28, 2026
Page B-2
such financial and other information or data are based) provided to or otherwise reviewed by or discussed with us.
We have assumed, with your consent, that the Merger will be consummated in accordance with the terms, conditions and agreements set forth in the Merger Agreement, and in compliance with all applicable laws, documents and other requirements, without waiver, modification or amendment of any material term, condition or agreement and that, in the course of obtaining the necessary governmental, regulatory or third party approvals, consents and releases for the Merger, no delay, limitation, restriction or condition will be imposed or occur that would have an adverse effect on the Company or the Merger (including the contemplated benefits thereof) or that otherwise would be meaningful in any respect to our analyses or opinion. Representatives of the Company have advised us, and we further have assumed, that the final terms of the Merger Agreement will not vary, in any material respect, from those set forth in the draft reviewed by us. We have not made or been provided with an independent evaluation or appraisal of the assets or liabilities (contingent, derivative, off-balance sheet, accrued or otherwise) of the Company or any other business or person, nor have we made any physical inspection of the properties or assets of the Company or any other business or person. Our opinion does not address any terms (other than the Merger Consideration to the extent expressly specified herein), aspects or implications of the Merger, including, without limitation, the form or structure of the Merger, the allocation of the Merger Consideration between the different classes of shares of Company Common Stock, or any other agreement, arrangement or understanding to be entered into in connection with, related to or contemplated by the Merger or otherwise. We are not expressing any opinion as to the prices at which the Company Common Stock will trade at any time, or any other securities will trade or otherwise be transferable at any time, including following the announcement of the Merger. We have not evaluated the solvency or fair value of the Company, or any other entity under any state, federal or other laws relating to bankruptcy, insolvency or similar matters. We were not requested to, and we did not, solicit third party indications of interest in the possible acquisition of all or a part of the Company, nor were we requested to consider, and our opinion does not address, the underlying business decision of the Company to effect or enter into the Merger, the relative merits of the Merger as compared to any alternative business strategies that might exist for the Company or the effect of any other transaction in which the Company might engage or that the Company might consider. We also express no view as to, and our opinion does not address, the fairness (financial or otherwise) of the amount or nature or any other aspect of any compensation or other consideration to any officers, directors or employees of any parties to the Merger (in their capacity as such), or any class of such persons, relative to the Merger Consideration or otherwise. We are not expressing any opinion or view with respect to accounting, tax, regulatory, legal or similar matters and we have relied, with your consent, upon the assessments of representatives of the Company as to such matters. Our opinion is necessarily based upon information available to us, and financial, stock market and other conditions and circumstances existing, as of the date hereof. Although subsequent developments may affect our opinion, we have no obligation to update, revise or reaffirm our opinion.
Citigroup Global Markets Inc. has acted as financial advisor to the Company in connection with the proposed Merger and will receive a fee for such services, which is contingent upon the consummation of the Merger. In addition, the Company has agreed to reimburse certain expenses and to indemnify us against certain liabilities arising from our engagement.
As you are aware, we and our affiliates in the past have provided, currently are providing and in the future may provide, certain investment banking, commercial banking and other similar services to the Company and/or its affiliates, unrelated to the proposed Merger, for which services we and our affiliates have received and expect to receive compensation, including, without limitation, during the two-year period prior to the date hereof, having acted as joint bookrunning manager with respect to certain secondary public offerings and as joint lead arranger, joint bookrunner and lender with respect to certain credit
The Board of Directors
ADT Inc.
October 28, 2026
Page B-3
facilities and debt offerings of the Company and having provided or providing certain markets and securities services, treasury and trade solutions services and corporate portfolio management services. As you are further aware, we and our affiliates have not, during the two-year period prior to the date hereof, provided investment banking, commercial banking or other similar financial services to FLB Partners T, L.P. or Thrive Capital Management, LLC, each, an affiliate of Parent (collectively, “Thrive”), or their affiliates for which we and our affiliates have received or expect to receive compensation, although we and our affiliates in the future may provide such services, for which we would expect to receive compensation. In the ordinary course of our business, we and our affiliates may actively trade or hold the securities or financial instruments (including loans and other obligations) of the Company, Thrive and their respective affiliates for our own account or for the account of our customers and, accordingly, may at any time hold a long or short position or otherwise effect transactions in such securities or financial instruments. In addition, we and our affiliates (including Citigroup Inc. and its affiliates) may maintain relationships with the Company, Thrive and their respective affiliates.
Our advisory services and the opinion expressed herein are provided for the information of the Board of Directors of the Company in its evaluation of the proposed Merger, and our opinion is not intended to be and does not constitute a recommendation to any stockholder as to how such stockholder should vote or act on any matters relating to the proposed Merger.
Based upon and subject to the foregoing, our experience as investment bankers, our work as described above and other factors we deemed relevant, we are of the opinion that, as of the date hereof, the Merger Consideration to be received by the holders of Company Common Stock in the Merger pursuant to the Merger Agreement is fair, from a financial point of view, to such holders.
Very truly yours,
CITIGROUP GLOBAL MARKETS INC.
200 West Street | New York, NY 10282-2198
Tel: 212-902-1000 | Fax: 212-902-3000
PERSONAL AND CONFIDENTIAL
October 29, 2026
Board of Directors
ADT Inc.
1501 Yamato Road
Boca Raton, Florida 33431
Ladies and Gentlemen:
You have requested our opinion as to the fairness from a financial point of view to the holders (other than Abode Parent, LLC (“Parent”) and its affiliates) of the outstanding shares of common stock, par value $0.01 per share (“Common Stock”), and the outstanding shares of Class B common stock, par value $0.01 per share (“Class B Common Stock” and, together with the Common Stock, the “Shares”), of ADT Inc. (the “Company”) of the $10.00 in cash per Share to be paid to such holders, taken in the aggregate, pursuant to the Agreement and Plan of Merger, dated as of October 29, 2026 (the “Agreement”), by and among Parent, Abode Merger Sub, Inc., a wholly owned subsidiary of Parent, and the Company.
Goldman Sachs & Co. LLC and its affiliates are engaged in advisory, underwriting, lending, and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs & Co. LLC and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the Company, Parent, any of their respective affiliates and third parties, including State Farm Mutual Automobile Insurance Co., a significant shareholder of the Company (“State Farm”), FLB Partners T, L.P., an affiliate of Parent (“Thrive Holdings”) and Thrive Capital Management, LLC, an affiliate of Parent (“Thrive Capital”), and any of their respective affiliates and, as applicable, portfolio companies or any currency or commodity that may be involved in the transactions contemplated by the Agreement (the “Transaction”). Goldman Sachs Investment Banking has an existing lending relationship with the Company and with Thrive Holdings, or majority-owned subsidiaries (excluding, if applicable, portfolio companies) or funds of Thrive Holdings. We have acted as financial advisor to the Company in connection with, and have participated in certain of the negotiations leading to, the Transaction. We expect to receive fees for our services in connection with the Transaction, all of which are contingent upon consummation of the Transaction, and the Company has agreed to reimburse certain of our expenses arising, and indemnify us against certain liabilities that may arise, out of our engagement. Goldman Sachs & Co. LLC and/or its affiliates may also in the future provide financial advisory and/or underwriting services to the Company, State Farm, Parent, Thrive Holdings and Thrive Capital and their respective affiliates and, as applicable, portfolio companies, for which Goldman Sachs Investment Banking may receive compensation. Funds managed by affiliates of Goldman Sachs Investment Banking also have invested in equity interests of funds managed by affiliates of Thrive Capital. Such funds managed by affiliates of Goldman Sachs Investment Banking may co-invest with, and invest in equity interests of, Thrive Holdings, Thrive Capital and/or their respective affiliates or funds managed thereby in the future.
Board of Directors
ADT Inc.
October 29, 2026
Page C-2
In connection with this opinion, we have reviewed, among other things, the Agreement; annual reports to stockholders and Annual Reports on Form 10-K of the Company for the five years ended December 31, 2025; certain interim reports to stockholders and Quarterly Reports on Form 10-Q of the Company; certain other communications from the Company to its stockholders; certain publicly available research analyst reports for the Company; and certain internal financial analyses and forecasts for the Company prepared by its management, as approved for our use by the Company (the “Forecasts”). We have also held discussions with members of the senior management of the Company regarding their assessment of the past and current business operations, financial condition and future prospects of the Company; reviewed the reported price and trading activity for the shares of Common Stock; compared certain financial and stock market information for the Company with similar information for certain other companies the securities of which are publicly traded; reviewed the financial terms of certain recent business combinations; and performed such other studies and analyses, and considered such other factors, as we deemed appropriate.
For purposes of rendering this opinion, we have, with your consent, relied upon and assumed the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by, us, without assuming any responsibility for independent verification thereof. In that regard, we have assumed with your consent that the Forecasts have been reasonably prepared on a basis reflecting the best currently available estimates and judgments of the management of the Company. In rendering our opinion, we have not taken into account any differential voting or other rights between the shares of Common Stock and the shares of Class B Common Stock. We have not made an independent evaluation or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance-sheet assets and liabilities) of the Company or any of its subsidiaries and we have not been furnished with any such evaluation or appraisal. We have assumed that all governmental, regulatory or other consents and approvals necessary for the consummation of the Transaction will be obtained without any adverse effect on the expected benefits of the Transaction in any way meaningful to our analysis. We have assumed that the Transaction will be consummated on the terms set forth in the Agreement, without the waiver or modification of any term or condition the effect of which would be in any way meaningful to our analysis.
Our opinion does not address the underlying business decision of the Company to engage in the Transaction, or the relative merits of the Transaction as compared to any strategic alternatives that may be available to the Company; nor does it address any legal, regulatory, tax or accounting matters. We were not requested to solicit, and did not solicit, interest from other parties with respect to an acquisition of, or other business combination with, the Company or any other alternative transaction. This opinion addresses only the fairness from a financial point of view to the holders (other than Parent and its affiliates) of Shares, as of the date hereof, of the $10.00 in cash per Share to be paid to such holders, taken in the aggregate, pursuant to the Agreement. We do not express any view on, and our opinion does not address, any other term or aspect of the Agreement or Transaction or any term or aspect of any other agreement or instrument contemplated by the Agreement or entered into or amended in connection with the Transaction, including, the fairness of the Transaction to, or any consideration received in connection therewith by, the holders of any other class of securities, creditors, or other constituencies of the Company; nor as to the fairness of the amount or nature of any compensation to be paid or payable to any of the officers, directors or employees of the Company, or class of such persons, in connection with the Transaction, whether relative to the $10.00 in cash per Share to be paid to the holders (other than Parent and its affiliates) of Shares, taken in the aggregate, pursuant to the Agreement or otherwise. We are expressing no opinion with respect to the allocation of the aggregate consideration payable pursuant to the Agreement, including among the holders of the various classes of Shares pursuant to the Agreement. We are not expressing any opinion as to the prices at which the shares of Common Stock will trade at any time or, as to the potential effects of volatility in the credit, financial and stock markets on the Company, Parent or the Transaction, or as to the impact of the Transaction on the solvency or viability of the Company or Parent or the ability of the Company or Parent to pay their respective obligations when they come due. Our opinion is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof and we assume no responsibility for updating, revising or reaffirming this opinion based on circumstances, developments or events occurring after the date hereof. Our advisory services and the opinion expressed herein are provided for the information and assistance of the Board of Directors of the Company in connection with its consideration of the Transaction and such opinion does not constitute a
Securities and Investment Services Provided by Goldman Sachs & Co. LLC
C-2
Board of Directors
ADT Inc.
October 29, 2026
Page C-3
recommendation as to how any holder of Shares should vote with respect to such Transaction or any other matter. This opinion has been approved by a fairness committee of Goldman Sachs & Co. LLC.
Based upon and subject to the foregoing, it is our opinion that, as of the date hereof, the $10.00 in cash per Share to be paid to the holders (other than Parent and its affiliates) of Shares, taken in the aggregate, pursuant to the Agreement is fair from a financial point of view to such holders of Shares, taken in the aggregate.
Very truly yours,
| | | | | |
(GOLDMAN SACHS & CO. LLC) | |
Securities and Investment Services Provided by Goldman Sachs & Co. LLC
C-3

Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. PRELIMINARY PROXY CARD - SUBJECT TO COMPLETION T05614-TBD For Against Abstain ADT INC. The Board of Directors recommends you vote FOR the following proposals (as listed in the proxy statement): ADT INC. [TBD] 2. A proposal to approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to our named executive officers in connection with the consummation of the merger. 1. A proposal to adopt the Agreement and Plan of Merger, dated as of October 29, 2026 (the "merger agreement"), by and among ADT Inc., a Delaware corporation (the "Company"), Abode Parent, LLC, a Delaware limited liability company ("Parent") and Abode Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company (the "merger"), with the Company surviving the merger as a wholly owned subsidiary of Parent. 3. A proposal to adjourn the special meeting to another date, time or place, if necessary to solicit additional proxies in favor of the proposal to adopt the merger agreement. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. NOTE: In their discretion, the proxies are authorized to vote upon such other matters as may properly come before the meeting and any adjournment or postponement thereof. ! !! ! !! ! !! VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/ADT2027SM You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. SCAN TO VIEW MATERIALS & VOTE

Important Notice Regarding the Availability of Proxy Materials for the Meeting: The Notice and Proxy Statement is available at www.proxyvote.com. T05615-TBD ADT Inc. Special Meeting of Stockholders [TBD], 2027 at [TBD], Eastern Time THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoints Jeffrey Likosar and David Smail, and each of them, with power to act without the other and with power of substitution, as proxies and attorneys-in-fact and hereby authorizes them to represent and vote, as provided on the other side, all the shares of ADT Inc. (the "Company") Common Stock held or owned by the undersigned as of the close of business on the record date of [TBD], 2026 and to which the undersigned is entitled to vote and, in their discretion, to vote upon such other business as may properly come before the Special Meeting of Stockholders of the Company to be held [TBD], 2027 (the "Special Meeting") or any adjournment or thereof, with all powers which the undersigned would possess if present at the Special Meeting. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted FOR the adoption of the merger agreement as set forth in Proposal 1, FOR the advisory vote on the compensation that may be paid or become payable to the Company's named executive officers in connection with the merger as set forth in Proposal 2 and FOR any adjournment of the Special Meeting for the purpose of soliciting additional proxies as set forth in Proposal 3. If any other matters properly come before the meeting, and any adjournment or postponement thereof, the persons named in the proxy will vote in their discretion on such matters. Continued, and must be signed and dated on the other side